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Thesis summary 
 
Mesothelioma is a potentially preventable fatal disease causing almost 2000 
deaths/year in the UK, increasing in incidence, and lacking effective treatments. 
„The Experience of Mesothelioma in Northern England‟ is a community-based, 
mixed methods, case study in four parts, conducted in Barrow-in-Furness, 
Leeds and Doncaster. The study investigates the experience of pleural 
mesothelioma for patients and their families, and for healthcare professionals 
and service providers. 
 
Mesothelioma is experienced as a devastating disease that carries a severe 
burden in physical, psychological, and social domains. Breathlessness, usually 
due to recurrent pleural effusions, and/or pain occur in >90% cases and may be 
refractory. Psychosocial aspects relate to causation, latency, rapid decline in 
health, helplessness regarding severe symptoms, and impending death. The 
erratic trajectory is unusual in malignancy. Disease burden is high in terms of 
multiple invasive investigations and emergency admissions and is reflected in 
service usage: 2 or 3 hospital admissions, 5 outpatient appointments and 11 GP 
consultations, 4 of these at home, occurred on average in the last year of life. 
Median survival was 294 days and 45% died in hospital, 30% in hospice, and 
14% at home. Patients tend to react with stoicism and patients (and relatives) 
adopt a „coping narrative‟ which may prevent timely access to supportive 
services. Bereaved relatives‟ emotional accounts reflect witnessing severe 
suffering, express anger and blame around the potentially avoidable asbestos 
exposure, and present the deaths due to mesothelioma as „mass murder‟. State 
benefits and civil compensation procedures, and the Coroner‟s investigation, 
create additional distress. Severe bereavement reactions have features of 
„tragic grief‟. In spite of the severe symptom burden, less than half of the 
patients were referred to palliative care and there was no systematic approach 
to care and support of either patients or their relatives. The study has 
implications for research and service provision. 
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Chapter 1: Introduction 
 
1.1 Mesothelioma 
Definition of mesothelioma 
Mesothelioma is an aggressive fatal malignant disease of the mesothelial 
membranes; it usually affects the pleura (92%) but it may also originate in the 
peritoneum (8%) or, rarely, the tunica vaginalis of the testis (Health and Safety 
Executive, (HSE), 2005a). It is caused by exposure to asbestos that occurs 
mainly in the workplace, although para-occupational and environmental 
exposures are responsible for a small proportion of cases. Most patients die 
within 18 months; median survival in UK studies is between 8 and 14 months 
(British Thoracic Society (BTS) Standards of Care Committee, 2001; Edwards 
et al, 2000).  
 
Epidemiology   
Mesothelioma has been described in the medical literature since 1870 but was 
possibly described earlier in a French paper in 1767. Gloyne (1935) published 
the first UK report suggesting a causal link between asbestos exposure and 
mesothelioma (McDonald and McDonald, 1996). However it was an influential 
paper by Wagner et al, (1960), confirming a strong link between exposure to 
crocidolite asbestos and pleural mesothelioma, that finally convinced the 
medical establishment of the connection and demolished the persistent denial 
of asbestos-related disease by the asbestos industry (Tweedale, 2000: 53). 
 
 
People in high-risk occupations for mesothelioma are metal plate workers 
(including shipyard workers), vehicle body builders (including railway carriage 
builders), plumbers, gas fitters, joiners and electricians. Industries with the 
highest incidence are construction and extraction (including insulation and 
asbestos removal), energy, and water supply. The traditional UK shipbuilding 
areas, West Dunbartonshire and Barrow-in-Furness, have the highest 
incidences of mesothelioma with standardised mortality rates (SMR) for men of 
637 and 593 respectively (HSE, 2005b). 
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Heavy exposure to asbestos in these settings has slowly become a thing of the 
past in the developed world due to health and safety legislation and, more 
recently, a complete ban on use of all types of asbestos and its importation in 
most European countries. In the UK, amosite and crocidolite were banned in 
1985, and chrysotile was banned in 1999 (Tweedale, 2000: 2). The World Trade 
Organisation, which primarily exists to protect free trade, has supported the 
European Union asbestos import ban (Kazan-Allan, 2002). 
 
A Mesothelioma Register, based on death certificate data, was introduced in the 
UK in 1967 and figures have shown a steady increase since then with 1969 
deaths recorded in 2004 (HSE, 2006a). As the maximum use of asbestos in the 
UK occurred in the 1960s and „70s, and because mesothelioma exhibits a 
latency of 15 to 60 years from exposure to disease presentation, 
epidemiologists predict a rising incidence of mesothelioma in Europe, to peak 
around 2015 (Figure 1.1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Asbestos imports and predicted mesothelioma deaths in the 
UK (Source: HSE, 2003) 
Mesothelioma observed and fitted/projected deaths among males aged 20-89, 
asbestos imports and estimated/projected exposure index
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Mesothelioma may then account for the deaths of up to 1% of British men born 
in the 1940s, at around 1950 to 2450 per annum (Hodgson et al, 2005). 
However reports from the UK and US suggest that this may be underestimated 
by up to 20% because the predictions are based on death certificate data; 
estimates arising from cancer registry data are considerably higher (Pinheiro et 
al, 2004). Now that exposure to asbestos in heavy engineering and construction 
industries has declined in Europe, mesothelioma will increasingly occur in 
people who are exposed to existing asbestos in the fabric of buildings in the 
course of their work, for example as buildings maintenance tradesmen and 
demolition workers, or possibly as „do-it-yourself‟ enthusiasts. This shifts the 
location of cases away from clusters around the shipyards, railway plant works 
and asbestos factories, to a more generalised distribution (McElvenny et al, 
2005). Disturbingly, a recent Swedish study involving construction workers 
suggests that, rather than the expected reduction in incidence of mesothelioma 
due to their banning of asbestos 25 years ago, there may actually be an 
increase (Engholm and Englund, 2005). The situation in poorly-resourced 
countries is disturbing: in India in 2001 more than 30 asbestos mines were 
operating and employing around 100,000 workers (Ramanathan and 
Subramanian, 2001). 
 
Para-occupational exposure can result from close contact with asbestos 
workers, for example, wives of asbestos workers have developed mesothelioma 
due to inhalation of asbestos dust when laundering their husbands‟ overalls 
(Howel et al, 1997). Significant environmental exposure occurs in the vicinity of 
asbestos mines and manufacturing factories (Wagner et al, 1960; Hillerdal, 
1999) and also from deteriorating asbestos materials in commercial and 
domestic premises. This latter source probably accounts for the fact that 
currently one in four UK patients with mesothelioma has worked in the building 
or maintenance industry (HSE, 2006b).  The World Trade Centre disaster on 
9.11.2001 released considerable quantities of asbestos and resulted in 
contamination of rescue workers, local residents and workers, surrounding 
homes and offices, (Chatfield, 2001). The devastation caused by Hurricane 
Katrina includes asbestos contamination amongst more immediately dangerous 
chemical pollutants (U.S. Environmental Protection Agency, 2006). Asbestos 
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contamination in storage of some sensitive UK government documents has 
been cited as the reason for not making them available to the public, (House of 
Commons Hansard, 2004), a situation in conflict with the introduction of the 
Freedom of Information Act, (2005). 
 
Mesothelioma occurs in animals, affecting dogs and cattle most commonly. 
Peritoneal disease occurs more frequently than pleural mesothelioma, 
presumably due to ingestion rather than inhalation of asbestos materials. 
Intriguingly, calves appear to develop congenital mesothelioma (Armed Forces 
Institute of Pathology, 2000). 
 
The role of asbestos 
Asbestos encompasses a group of around 6 naturally occurring fibrous silicates 
widely distributed in nature. Its name derives from the Greek meaning 
„inextinguishable‟ or „unquenchable‟, demonstrating that its physical properties 
were known in ancient times: wicks for Greek temple lamps were said to have 
been made from asbestos and Pliny the Elder believed that asbestos resisted 
all magic potions (Selikoff and Lee, 1978; Pliny the Elder, 1991:360). Asbestos 
occurs in two main forms: the serpentine type, known as chrysotile or „white‟ 
asbestos that has long wavy fibres, and the needle-like amphibole types 
including crocidolite known as „blue‟ asbestos and amosite or „brown‟ asbestos, 
(Figure 1.2). The name amosite was derived from Asbestos Mines of South 
Africa (Tweedale, 2000:2). Crocidolite occurs as „blue clay‟ in Da-yao county, 
China, where, until recently prohibited, villagers used it to make asbestos 
stoves for heating and cooking, it was also used as colourful stucco for home 
decoration. Pleural plaques are present on X-ray in 20% of Da-yao villagers 
aged over 40 years and 22% of cancer deaths in the locality are due to 
mesothelioma (Luo et al, 2003). Erionite is a zeolite, an asbestos-like mineral 
that occurs naturally in eastern Turkey and where it is widely used as a building 
material. In this region, mesothelioma accounts for over 50% of deaths (Emri et 
al, 1979).  
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Chrysotile                                                        Crocidolite 
Figure 1.2: Electron microscope slides of asbestos fibres 
 
Asbestos fibres are extremely resistant to heat and almost indestructible by 
physical force, crocidolite is also resistant to acids. Crushed asbestos rock 
forms soft fine filaments that can be spun into lightweight strong fibres. These 
had over 3000 industrial and domestic uses: as woven textiles, added to 
cement, in insulation and friction materials, wall and floor boards; asbestos was 
also used in filters for gas masks and cigarettes (Levin et al, 2000).    
  
In the 19th century, when the industrialisation of Europe and America was 
dependent on steam driven machinery, the high temperatures generated by 
these engines posed a major practical problem. The need for insulating 
materials led to the development of the asbestos industry from 1890 onwards; 
mining of asbestos escalated in Canada, South Africa and Russia. Turner, an 
industrialist, initiated large-scale production of asbestos insulation materials in 
the UK at the turn of the 19th century. Subsequently his family firm merged with 
Newalls, the largest insulation business, and three other major asbestos 
companies in Britain, to form Turner and Newalls which eventually held 20% of 
the world asbestos market and was in the top 100 UK firms (Tweedale, 2000:9).     
 
The success of asbestos fireproofing and insulation in industry and shipping 
earned its early nickname „the magic mineral‟ and the positive image of „Lady 
Asbestos‟, (Figure 1.3), (Gorman, 2000:130). Asbestos insulation in warships 
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was credited with saving many British lives, for example, in the Battle of Jutland 
in 1916. Ironically, the removal of asbestos from British Navy ships in 
compliance with the Asbestos Regulations of 1969, in order to reduce asbestos 
hazards to servicemen, was cited as the reason for heavy loss of life from fire 
on ships during the Falklands War in 1982  (Newman-Taylor, 2002).  Heavy 
industry used large quantities of asbestos in Europe during and after World War 
11; the UK imported more crocidolite and amosite per head from South Africa 
between 1945 and 1963 than any other country (May, 1965). Russia is the 
world‟s largest producer of asbestos but virtually all is used domestically. 
Canada is the second largest producer, and the world‟s largest exporter of 
asbestos as there is virtually no domestic market, (Kazan-Allen, 2002). 
      
Figure 1.3: „Lady Asbestos‟ by Bernard Partridge taken from an 
advertisement for asbestos products ~1918 (Reproduced with permission of 
Tommy Gorman (2000) (ed) Clydebank: Asbestos the unwanted legacy). 
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Industrial Disease 
Mesothelioma is a UK Prescribed Disease, one of the four asbestos-related 
diseases that are recognised for the purposes of a specific State benefit, 
Industrial Injuries Disablement Benefit (Box 1.1).  Claims may also be made 
against the responsible employers for civil compensation. These issues are 
described in more detail in section 1.6: Mesothelioma, the law and society. 
Mesothelioma is the most common cause of death due to industrial malignancy 
in the UK (HSE, 2006a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2 Clinico-pathological features 
Pathogenesis  
 
Chronic irritation and inflammation due to asbestos fibres are involved in 
producing malignant change. A small number of mesothelioma cases, possibly 
50 – 100 per year in the UK, may develop independently of asbestos but the 
aetiology is unclear (HSE, 2006c). Other factors may be involved: genetic 
susceptibility, direct effect of asbestos on DNA, stimulation of proto-oncogenes 
 
Box 1.1: Prescribed asbestos-related diseases and „particular‟ occupations 
(National Insurance Regulations, 1966) 
 
D1: Pneumoconiosis (asbestosis); 
 
D3: Diffuse mesothelioma (primary neoplasm of the mesothelium of the pleura or of 
the pericardium or of the peritoneum); 
 
D8: Primary carcinoma of the lung where there is accompanying evidence of one or 
both of the following (a) asbestosis, (b) bilateral diffuse pleural thickening;  
 
D9: Bilateral diffuse pleural thickening 
 
The occupations for which these conditions are prescribed: 
 
(a) working or handling asbestos, or any admixture of asbestos; 
 
(b) manufacture or repair of asbestos textiles or other articles containing or 
composed of asbestos; 
 
(c) cleaning of any machinery or plant used in any of the foregoing operations 
and of any chambers, fixtures, appliances for the collection of asbestos dust;  
 
(d) substantial exposure to dust arising from any of the foregoing operations. 
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and possibly simian virus 40 (SV40) but their exact roles are unclear (Carbone 
et al, 2002, and 2006; Nowak et al, 2002). Mesothelioma is regarded as a dose-
dependent disease, even brief heavy asbestos exposure can be lethal 
(Hillerdal, 1983; Peto et al, 1999).  Amphiboles demonstrate greater 
carcinogenicity than chrysotile due to differing biopersistency (Gibbs, 1990). 
Latency between exposure and disease presentation ranges from 15 to 67 
years with a mean of 41 years (Yates et al, 1997).  
 
Asbestos fibres migrate to the periphery of the lung and into the pleural space 
from where lymphatic drainage takes them to the parietal pleura where they 
become implanted in the early stage. Fibre size is critical: mesothelioma results 
from fibres of 3µm or more in length and less than 0.1µm in diameter; most 
commercially-produced fibres are larger than this (Hillerdal, 1983). The 
deposition of fibres tends to favour the right lung (60%), possibly due to the 
larger size of the right pleura. Irritation of the pleura accounts for the 
development of pleural effusions and the tumour then extends into the visceral 
pleura and around the affected lung. Mesothelial cells produce fibrin and 
collagen which form a thick „rind‟ that frequently extends into the contralateral 
pleura as well as the pericardium and, via the diaphragm, into the peritoneum 
(Hillerdal, 1983). Mesothelioma arises in the pleura in 95%, in the peritoneum in 
5% (Yates et al, 1997).  
 
Smoking and asbestos act synergistically as co-carcinogens in lung cancer. 
Asbestos exposure increases the risk of lung cancer in non-smokers and 
smokers by factors of 10 and 100 respectively (Cancer Research UK, 2006; 
Lee, 2001a); this amounts to around one case of asbestos-related lung cancer 
for each mesothelioma (HSE, 2006b). 
 
Mesothelial cells are pluri-potential because they derive from ectodermal and 
endodermal layers, this results in several histological types of mesothelioma 
including „mixed‟ (Donna and Provana, 1977), Table 1.1. Identification of the 
particular histology can be difficult: the epithelioid type resembles 
adenocarcinoma and the sarcomatous type may be hard to distinguish from 
inflammatory reaction in the mesothelium. 
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Histological type  Percentage 
Epithelial 50% 
Mixed 34% 
Sarcomatous or spindle cell 16% 
 
Table 1.1. The main histological types of mesothelioma (Hillerdal, 1983) 
 
Prognosis 
 Prognosis varies according to histological type: epithelioid tumours give the 
longest survival, Table 1.2. There is no explanation why particular types 
develop in individual patients although Hillerdal (1983) proposes that the „gross 
environment of the tumour‟ is a factor. Pleural plaques are present in around 
29% of cases of mesothelioma and indicate asbestos exposure but are not 
regarded as pre-malignant (Yates et al, 1997). Patients with asbestosis, that is, 
pulmonary fibrosis due to asbestos, have a 10 – 15% risk of dying from 
mesothelioma (Hillerdal, 1983).  
 
 
Table 1.2: Median survival in months according to histological type. 
Source No of 
cases 
All 
types 
Epithelioid Sarcomatous Mixed or 
biphasic 
Hillerdahl, 1983 153 10 11 5 10 
Van Gelder et 
al, 1994 
83 8.1 8.4 6.9 6.3 
Johnson et al, 
1995 
 9.2    
Yates et al, 
1997 
248 14 16.2 10.1 14.7 
Edwards et al, 
2000 
142 5.9    
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Screening 
Screening is not recommended for mesothelioma because there is no specific 
test that establishes diagnosis at an early stage, although high-risk individuals 
may be monitored by annual chest x-rays in some areas (BTS, 2001). However, 
there is no evidence that this is effective and it may cause harm: by giving false 
reassurance when early disease is not detected, by raising anxiety levels due to 
reinforcing the high-risk status, or by leading to unnecessary investigations 
when x-rays are inconclusive (BTS, 2001). Recent discoveries of tumour 
markers such as osteopontin and mesothelin have not changed this situation: 
although tumour sensitive they are not tumour specific and thus do not have a 
role in screening; they may be useful in assessing treatment responses, 
particularly with regard to debulking surgical procedures. However there is a 
view that in high-risk individuals, these or future markers may be useful in 
surveillance in order to make earlier diagnoses (Peake et al, 2006:41). 
 
Clinical features 
Around 90% of UK patients give a history of occupational asbestos exposure 
(Yates et al, 1997). Most cases present as males in their 60s and 70s: the ratio 
of men to women is at least 12:1, although the male preponderance is 
increasing as fewer women now work in high risk occupations (HSE, 2006c). 
Metastases, although found in 55% at post mortem, are rarely significant during 
the illness (Yates et al, 1997). 
 
Most patients present with dyspnoea and/or chest pain, (Table 1.3). Pleural 
effusion is the most common presenting feature although breathlessness may 
be multi-factorial. The thickened pleura can become rigid and restrict chest wall 
mobility, hence a „frozen chest‟. Recurrent pleural effusions are common and 
can be difficult to drain due to loculation and pleural thickening, and the fluid 
may be heavily bloodstained. Lung invasion may reduce lung capacity and 
pericardial involvement, effusion or constriction, may further complicate the 
picture (BTS, 2001). Initially, chest pain is often dull and not localised, or it may 
be pleuritic and radiate to arm, shoulder, chest wall or abdomen. As the disease 
advances, pain may be severe and complex with multiple aetiologies due to 
involvement of pleura, nerves and neighbouring structures (Hillerdal, 1983). 
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Two studies suggest that pain may be particularly severe in mesothelioma: a 
study of opioid-responsiveness of various tumours demonstrated that, uniquely 
in mesothelioma, opioid requirements continue to rise as the illness progressed 
(Mercadante et al, 2000); in the other study, a quality of life evaluation during a 
chemotherapy trial using the EORTC QLQ-C30  lung cancer symptom 
assessment tool (Aaronson et al, 1987), pain scores in mesothelioma were 
significantly higher than those in lung cancer (Nowak et al, 2004).  
 
Chest x-ray (CXR) or computerised tomography (CT) scan typically 
demonstrate pleural effusion, pleural thickening and/or lung involvement by 
tumour. MRI scanning offers no advantage in diagnosing mesothelioma but it is 
helpful in determining local tumour extension (Peake et al, 2006:43-7).  
Table 1.3: Prevalence of symptoms in mesothelioma and lung cancer 
 
Symptom                     Mesothelioma      Lung cancer 
 Higgs and Newbury, 
1999.     
Ruffie et al, 
1989.    
Krishnasamy and  
Wilkie, 1999.    
Dyspnoea 79%  >80% 
Pain 76%  89% 
Dyspnoea and/or  
chest pain 
 90%  
Pleural effusion  84%  
Fatigue/weakness 71% 3% 73% 
Cough 29% 3% 70% 
Anorexia 21% 3% 49% 
Weight loss  29%  
Nausea 18%  24% 
Constipation 18%  29% 
Sweats 15%   
Fever  3%  
Confusion 12%   
Chest lump 12%   
Limb oedema 12%   
Asymptomatic  3%  
Dysphagia <1%  24% 
Haemoptysis <1%  11% 
No in study 34 322 209 
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Confirmation of diagnosis  
Histological diagnosis is usually made from pleural biopsy samples or pleural 
fluid, or occasionally from biopsy of a metastasis. Open pleural biopsy or, more 
commonly, video-assisted thoracoscopic (VATS) biopsy, achieve the highest 
diagnostic yield, approaching 100% (Martin-Ucar and Waller, 2006:252). As 
there is no specific marker for mesothelioma, the histological diagnosis must be 
established by a battery of staining and immunological tests that include tests 
specific for other tumours (King et al, 2006a). The problem of differentiating 
between mesothelioma and adenocarcinoma has led to a call for the 
establishment of a national reference laboratory (Haselton, 2001). 
 
At post mortem the pleural membranes show extreme thickening and fibrosis, at 
times almost impossible to incise. Macroscopic nodules and deposits are 
present, the affected mesothelial membranes become adherent to each other 
and neighbouring structures; one series demonstrated distant metastases in 
55%, pleural plaques in 29% and asbestos bodies in 46% (Yates et al, 1997). 
 
Disease trajectory 
Poor prognostic features include being of male sex, old age, a weight loss of 
more than 5%, pleuritic chest pain, poor performance status, abnormal 
haematological indices and sarcomatous histology (Edwards et al, 2000). 
Median survival times range from 5-16 months, (8 – 14 months in UK studies), 
and are related to histology, Table 1.2. Patients who present with dyspnoea but 
no pain survive twice long as those with pain (Antman et al, 1980). 
 
Most patients with mesothelioma deteriorate rapidly from presentation apart 
from the small number with very localised disease who are suitable for radical 
surgery. Alongside dyspnoea and complex pain, weight loss, sweating, 
deteriorating lung function and fatigue are common, Table 1.3. Recurrent 
pleural effusions necessitate admission to hospital for aspiration and talc 
pleurodesis is recommended to prevent further recurrence (Petrou et al, 1995). 
Tumour tracking along thoracoscopy or pleural aspiration ports is common, 
often producing painful chest wall swellings; prophylactic radiotherapy can 
prevent this in the majority of cases. The pleural „rind‟ tends to encase the lung 
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and, as it thickens, immobilises and constricts the ipsilateral hemithorax (BTS, 
2001). 
 
1.3 Treatment and palliation 
The place of surgery 
Radical surgery, extrapleural pneumonectomy, is a drastic measure in which 
the pleura, pericardium and ipsilateral diaphragm are removed in an attempt to 
remove all the tumour. Surgery is only appropriate in cases that present with 
early, localised disease but unfortunately staging is not very accurate and in 20 
– 25% of patients selected for radical surgery the disease is found to be 
inoperable (Rusch et al, 2001). Multimodality treatment, that is surgery in 
combination with chemotherapy and radiotherapy, may increase survival times, 
but this has not been established by a randomised controlled trial (Sugarbaker 
et al, 1996; Treasure and Sedrakyan, 2004) but fewer than 5% are diagnosed  
sufficiently early for this approach. Debulking surgery, decortification or 
pleurectomy, may improve respiratory function and symptoms and it may 
improve survival by reducing the tumour load (BTS, 2001).  
 
Oncological interventions 
There is no standard chemotherapy in mesothelioma in the UK because results 
to date are disappointing; any treatment tends to be part of a clinical trial (see 
the next section). Not surprisingly, patients are not easily recruited to trials 
(Chapman et al, 2006). A recently-introduced anti-folate agent, pemetrexed, 
plus an older drug, cisplatin, is currently standard treatment in North America 
and much of Western Europe. The NHS initially refused funding for pemetrexed, 
but a recent appeal was successful and this treatment is now available for UK 
patients, pending a final decision later in 2007 (NICE1, 2007), (see next 
section). Radiotherapy does not affect prognosis but is recommended to reduce 
tumour tracking along thoracoscopy ports. It may relieve pain in 50% of cases, 
but at the unacceptable cost of radiation effects on lung tissue (Ariza and 
McBeth,2004). 
 
                                                 
1
 NICE is the National Institute for Health and Clinical Excellence, the organisation responsible for the 
assessment of new medications and technologies for the NHS. 
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Current trials    
 
As described above, mesothelioma is notoriously unresponsive to 
chemotherapy agents; pemetrexed is the only agent licensed for use in 
mesothelioma. Kindler (2000:313-326), reviewing chemotherapy trials in 
mesothelioma, stated that „it is unclear whether any intervention has had a 
significant impact on more than a few highly-selected patients’. Although partial 
response, up to 20%, to combination chemotherapy has been reported in up to 
a third of patients with mesothelioma, this tends to relate to carefully-selected 
patients with early disease. The response, normally in terms of improved CT 
scan appearances, does not usually relate to improved survival times (Nowak et 
al, 2002; Vogelzang et al, 2003). However, Kindler‟s „cautious optimism‟ 
regarding newer agents may be supported by a recent trial of pemetrexed in 
combination with the platinum-based drug, cisplatin, compared with cisplatin 
alone (Vogelzang et al, 2003). This trial, involving 448 recruits, showed benefits 
from the pemetrexed/cisplatin combination in median survival (12.1 v 9.3 
months), median time to disease progression (5.7 v 3.9 months), and response 
rate (41% v 17%). The trial also revealed the need for vitamin supplementation 
to reduce toxicities. However, although the results are encouraging, survival is 
still short and virtually all patients die within 18 months. The MSO1 trial, Table 
1.4, is designed to determine whether palliative chemotherapy is more effective 
than „active symptom control‟; it is due to report in 2007 (Muers et al, 2004). 
 
Early results from animal studies using oncolytic herpes simplex virus 
treatments have been encouraging and a small study using herpes simplex 
virus thymidine kinase „suicide gene‟ into the pleural space in combination with 
systemic ganciclovir resulted in long-term survival, more than 6.5 years, in two 
of 21 patients (Sterman et al, 2005). Treasure and Sedrakyan (2004), in 
reviewing treatment options, conclude that:  
‘Mesothelioma has largely defeated treatment. Radical treatments, occupying 
the 3 months after diagnosis, can take up the best 3 months that the patient 
might have had.’   
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Contrastingly, Steele and Rudd (2006:297) state that  
‘We now know that it [chemotherapy] can be beneficial when used judiciously 
in appropriate patients’. 
 
Table 1.4: Current mesothelioma trials in the UK 
 
Palliative and supportive care 
In the face of a rapidly progressive malignancy, the early introduction of 
palliative and supportive care is recommended in mesothelioma, (BTS, 2001), 
(Boxes 1.6 and 1.7). There are no reports in the medical literature documenting 
the palliative care needs of mesothelioma patients and their families. Referrals 
of lung cancer patients to palliative care teams are variable and often occur 
relatively late in the illness (Krishnasamy and Wilkie, 1999:131) but there is no 
information concerning the referrals in mesothelioma.  
 
In more common cancers, knowledge of the disease impact on patients and 
their families has made a real difference to our understanding of the condition 
and to the development of appropriate health services (National Cancer 
Alliance, 1996; Greer and Watson, 1987). Oral histories of people with 
mesothelioma describe the devastating impact of the diagnosis and the effects 
Trial Summary Status 
MSO 1 A randomised controlled study of comparing 3 
treatments: active symptom control (ASC) alone or with 1 
or 3 chemotherapy agents (Vinorelbine or, in 
combination, mitomycin, vinblastine and cisplatin). 
Ceased 
recruiting 
2006 
MesoVATS A comparison of medical talc pleurodesis with video-
assisted thoracoscopic talc pleurodesis 
Recruiting 
MARS 
(Mesothelioma 
and radical 
surgery) 
To determine whether radical surgery (extrapleural 
pneumonectomy) with chemotherapy and radiotherapy 
provides improves survival and quality of life compared 
with other standard treatments 
Recruiting 
MALCS 
(Mesothelioma 
and lung 
cancer) 
Population-based case-control study of mesothelioma 
and lung cancer in British adults under 60 years of age 
Recruiting 
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of the illness on patients, their families and local communities (Johnston and 
McIvor, 2000:177-208; Walker and LaMontagne, 2004).  
 
Many studies have demonstrated that the major unmet needs of cancer patients 
concern psychosocial issues and communication (Thomas et al, 2001; Hill et al, 
2003; Heaven and Maguire, 1997). Patients with lung cancer have been shown 
to experience more psychosocial problems than patients with cancers in other 
sites, (Houts et al, 1986; Zabora et al, 2001), but there are few data relating to 
mesothelioma. A quality of life study during chemotherapy for mesothelioma 
revealed that scores relating to role and social functioning were „surprisingly 
high‟ (that is, worse) in comparison with lung cancer (Nowak et al, 2004).   
 
Improvements in communication in order to address the information needs of 
lung cancer patients and their families have been called for (Krishnasamy and 
Wilkie, 1999: 73; Hill et al, 2003). Family members and other close informal 
carers of cancer patients may experience severe, but often overlooked, distress 
(Kristjanson and Ashcroft, 1994). Lung cancer patients‟ concerns about their 
families and the impact of the illness on them have been shown to rank only 
second to patients‟ concerns about their illness (Hill et al, 2003).  Health service 
providers are increasingly being advised to consider the needs of 
families/carers as well as patients in planning services (Grande et al, 1998; 
Speice et al, 2000; National Cancer Alliance, 1996; Soothill et al, 2001). 
 
The disease trajectory in mesothelioma has not been specifically described but 
the frequency of recurrent effusions would suggest that it is likely to be more 
erratic than the steady decline of most malignancies in the final year of life 
(Murray et al, 2005). Concerns have been expressed about lack of medical 
knowledge of mesothelioma, even in areas of high incidence (Johnston and 
McIvor, 2000:179-87). In addition, as mesothelioma is a prescribed industrial 
disease, patients are entitled to specific State benefits and the majority are also 
eligible for civil compensation but both claims processes may be complex and 
stressful (Wikeley, 2000). Finally, as deaths from mesothelioma are „unnatural‟ 
in law, a Coroner‟s investigation is necessary involving a post mortem 
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examination and inquest that add to the burden on relatives (Downs et al, 
2002).  
 
The main physical symptoms in mesothelioma are similar to those of lung 
cancer with breathlessness, pain and fatigue predominating. Haemoptysis, 
lymphadenopathy and problems due to metastases are less common in 
mesothelioma (Cooley, 2000; BTS, 2001; Edmonds et al, 2001).  
 
Breathlessness management depends upon the underlying cause. Symptomatic 
pleural effusions should be aspirated using an ultrasound or CT-guided 
technique and, if recurrent, chemical pleurodesis should be performed with the 
intention of causing an inflammatory response resulting in adherence of the 
visceral and parietal pleural membranes, Box 1.2 (Antunes et al, 2003). Talc is 
more effective than tetracycline, (90% v 75%), for pleurodesis (Petrou et al, 
1995). Pleurodesis is more effective if performed early, that is, before the lung 
becomes unable to re-expand due to tumour. If both the lung and mediastinum 
are fixed, this limits the volume of an effusion. If the lung is fixed but the 
mediastinum and diaphragm are mobile, fluid can accumulate and may 
compromise the contralateral lung; in this situation VATS or open pleurectomy 
may be required. Complications of repeated pleural aspirations include lung 
collapse, lung infection and empyema (pleural abscess). In addition, insertion of 
a chest drain is painful and frightening (Shaw and Agarwal, 2004; Drain and 
Wells, 2006).  
 
Another option for recurrent effusions, when pleurodesis is unsuccessful or 
impractical, is the insertion of a long-term chest drain that can be managed by 
patients at home. This often causes pleurodesis. The indwelling drain abolishes 
the need for repeated aspirations and gives the patient more control over the 
situation (Burgers et al, 2006). Pleuro-peritoneal shunts have become 
unpopular due to the tendency for peritoneal disease to develop (Martin-Ucar 
and Waller, 2006:259-60). 
 
Pericardial involvement may result in a potentially fatal pericardial effusion. 
Management depends on rapid diagnosis and referral to a cardio-thoracic unit 
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for consideration of drainage in the first instance followed possibly by 
pericardectomy or other longer-term drainage procedure (Laham et al, 1996). 
Non-pharmacological treatments of dyspnoea are discussed in the next section. 
 
Box 1.2: Management of malignant pleural effusions, (Antunes et al, 2003). 
 
 
 
 
                          
                   
 
                    
 
  
 
 
 
                    
 
  
 
 
 
          
 
 
 
 
 
        
                      
 
 
 
  
                      
 
 
 
 
 
                        
 
 
        
 
  Proven malignant effusion 
Recurrence/symptomatic? 
Refer to thoracic cancer MDT 
         Pleural aspiration 
CXR to determine if lung 
has completely re-
expanded 
       Chemical pleurodesis 
     Recurrence of effusion? 
                 Stop  
            Observe 
 
NO 
Consider: 
1) Thoracoscopy or 
 
2) Long-term indwelling 
drain or 
 
3) Pleuro-peritoneal shunt 
Consider: 
 
1) Repeat pleurodesis or 
 
 2) Thoracoscopy or 
 
3) Long-term indwelling 
drain or 
 
4) Pleuro-peritoneal shunt  
 
or 
 
5) Palliative repeated 
pleural aspiration 
YES 
NO 
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Although pain in mesothelioma is acknowledged to be severe and complex, 
often with neuropathic components, there is no consensus about best 
management. Mercadante et al (2000) demonstrated that opioid requirements 
in mesothelioma continue to increase throughout the illness, and escalate more 
than in other malignancies, although the opioids considered in this study were 
restricted to dextropropoxyphene and morphine. It follows that alternative 
opioids with a broader mode of action such as methadone or fentanyl should be 
considered for complex pain in mesothelioma, alongside adjuvant analgesics 
(Ahmedzai and Clayson, 2006). A variety of nerve block procedures, usually 
performed by pain specialists, may be helpful when medication is ineffective or 
limited by side effects, including percutaneous cervical cordotomy (BTS, 2001; 
Jackson et al, 1999).   
 
Non-pharmacological therapies 
Patients who experience breathlessness often become anxious, sometimes to 
the point of panic attacks, resulting in a vicious cycle. Breathing control 
techniques, taught to patients by skilled nurses or physiotherapists, have been 
shown to be effective in reducing the symptom burden and empowering patients 
to regain a sense of control thus improving quality of life (Corner et al, 1996). 
However, effective non-pharmacological interventions are not offered to the 
majority of lung cancer patients (Hopwood and Stevens, 1995; Bredin et al, 
1999; Edmonds et al, 2001); there are no data relating specifically to 
mesothelioma. 
 
1.4 Living with a diagnosis of mesothelioma 
 
Reactions to the diagnosis 
Some patients with mesothelioma may have lived with „anticipatory anxiety‟ for 
years prior to developing the disease, the so-called „Damocles syndrome‟ 
(Barak et al, 1998; de Villiers et al, 1997). In high-risk occupational groups, such 
as shipyard metal plate workers, it is common for patients to know of work 
colleagues who have succumbed to mesothelioma. Barak et al (1998) found 
that 50% of 16 electrical plant workers who had been diagnosed with asbestosis 
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suffered post-traumatic stress disorder following the diagnosis, related to their 
increased risk of subsequently developing mesothelioma. The Asbestos 
Regulations (1968) that included risk information to protect the workforce, were 
slow to be implemented and penalties for infringements were small (Tweedale, 
2000:207-8; Johnston and McIvor, 1999:129-33). Media reports may have 
informed older workers who had not received any official risk information whilst 
working. In the notorious Wittenoom asbestos mine in Western Australia, 
miners were misled about the reason for the deaths and disease that they saw 
affecting fellow workers: they were told the cause was tuberculosis, although 
many of them suspected that asbestos dust was a health hazard (Cappelletto 
and Merler, 2002). Younger patients may have had health and safety 
information at work but often thought „it won‟t happen to me‟. Denial has been 
described as a common coping mechanism for dealing with the anxiety 
provoked by risk information and may be related to the fatalistic „macho‟ culture 
of the predominantly male workforce (Johnston and McIvor, 2000:171, 212-3, 
221).  However, patients who first have pleural plaques may be particularly 
anxious about their risk of mesothelioma, because the chest x-ray provides 
visible evidence of asbestos exposure and there is a common misconception 
that mesothelioma may develop from pleural plaques (Kazan-Allen, 2006).  
 
Most people are shocked by the diagnosis; many may have forgotten or 
suppressed their history of asbestos exposure many years ago and then have 
to try to deal with the reality of having a terminal disease (Walker and 
LaMontagne, 2004). Lebovits (1985) described denial of the danger and 
minimisation of personal exposure as common reactions in patients diagnosed 
with mesothelioma alongside emotional responses. Anger has been described 
as a common reaction in mesothelioma patients as well as „stoical fatalism‟ and 
„passive resignation‟ (Lebovits et al, 1981; Johnston and McIvor, 1999:221-3). 
 
Anger may have several foci: 1) the employer/s for allowing unsafe practice, 2) 
the government for being slow to introduce legislation and then failing to monitor 
industry adequately, 3) the medical profession for the common delays in 
diagnosis, clumsy breaking of bad news, traumatic investigations and 
interventions, lack of curative treatments and inadequate support (Walker and 
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LaMontagne, 2004). Displaced anger towards the medical profession may 
represent part of the emotional turmoil that patients with this disease face. 
Anger, guilt and remorse may be self-directed and then contribute to 
despondency and depression (Lebovits, 1985; Faller et al, 1995). A study 
comparing psychiatric illness between mesothelioma patients, pipe-coverers at 
risk of, but not suffering from mesothelioma, and a control group, demonstrated 
a depressive disorder in 45% of the mesothelioma patients (Lebovits, 1985). 
 
 
Stoicism in the face of terminal illness reflects the cultural norms of the post war 
era and the „macho‟, risk-tolerating and fatalistic attitudes of men of the 
„traditional working class‟ (Johnston and McIvor, 2000:171, 220-1). It also 
serves to reduce the stigma associated with malignant disease by presenting 
the patient as in control, respectable and unemotional - all positive features of 
traditional masculinity (Moynihan, 1998). In this context „stoicism‟ relates to an 
approach to adversity based on the classical stance in which the person adopts 
an uncomplaining, heroic attitude, typified by the „stiff upper lip‟. In contrast, 
„fatalism‟ reflects a belief set in which a person perceives events as essentially 
outside their own control, unchangeable and therefore not their own 
responsibility; sometimes associated with belief in a higher power and/or a 
preordained destiny. The stoical reaction or coping style reported in patients 
with mesothelioma (Lebovits et al, 1983, Lebovits, 1985) may well be 
associated with fatalistic beliefs concerning risk and illness. 
 
 
Psychosocial distress in malignancies has been linked to the disease site and 
the associated symptom burden. Patients with lung cancer are known to suffer 
the most psychosocial distress but mesothelioma has not been investigated 
specifically (Zabora et al, 2001; Houts et al, 1986; Nowak et al, 2004). However, 
as one study demonstrated that symptom scores for pain are higher in 
mesothelioma than in lung cancer, and scores for social role and functioning 
were also worse than in lung cancer, (Nowak et al, 2004), it is reasonable to 
assume that mesothelioma is likely to cause as much, if not more, psychosocial 
distress than lung cancer, given the similar site and more severe pain.  
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Attribution 
 
Attribution of mesothelioma to asbestos exposure appears to be complex. 
Patients with mesothelioma may have difficulty in accepting that asbestos has 
caused their illness. There are several reasons for this disbelief: 1) there is a 
general lack of public awareness of mesothelioma; 2) it is still a relatively rare 
disease and historically has clustered in areas around related industries; 3) the 
long latency period of 30-50 years makes the link between cause and effect 
seem tenuous; and 4) in some cases, asbestos exposure may have been brief 
but heavy, such as working for a few months as an apprentice (Lebovits 1985, 
Lebovits et al, 1981). In some patients the exposure may have been 
environmental or paraoccupational, in which case the patient may feel the risk 
was too small to believe; this is sometimes referred to as „bystander‟ exposure. 
In these cases the asbestos may have been in the atmosphere from 
neighbouring factories or on work-clothes that were laundered at home.   
 
 
Accepting causal attribution to asbestos leads to several associated problems. 
The blame for exposure implicates the employer and in many cases the 
workforce in post-war Britain was loyal and/or indebted to their employer/s in an 
era of job insecurity and financial hardship (Johnston and McIvor, 2000:220). 
Similarly, Australian asbestos miners in the 1970s were more concerned about 
keeping their jobs than heeding emerging reports of asbestos health hazards 
(Walker and LaMontagne, 2000). South African asbestos mine workers 
demonstrated against mine closure because they had no other employment 
prospects locally (Kisting, 2006). Lebovits‟ (1985) US study of 38 patients with 
mesothelioma reported that 65% denied any feelings of anger towards the 
asbestos industry.  
 
 
In the heyday of British manufacturing it was common for two or three 
generations to follow each other into the local manufacturing or engineering 
industry and the older patient with mesothelioma may realise that he has 
encouraged younger relations to follow his footsteps into a potentially deadly 
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trade.  In one study 78% of asbestos workers had a family member in the same 
trade (Lebovits, 1985). Some patients with mesothelioma may feel guilty for 
unsafe work practices even if they had no knowledge of the hazards at the time 
(Lebovits, 1985; Lebovits and Strain, 1984). Walker and LaMontagne (2004) 
cite avoidance of the issue as a strategy to reduce emotional distress. However 
these authors also emphasise the difference between past and current workers: 
current workers are very aware of health and safety issues concerning asbestos 
and insist on their implementation. 
 
 
The alternative blame laid on tuberculosis by the Wittenoom mine managers 
may have inadvertently served the Australian miners as well as their employers 
by reducing both feelings of personal responsibility in the person with 
mesothelioma and the responsibility on the part of the employer. The narratives 
of affected Italian migrant asbestos miners report that they were very concerned 
about the extremely dusty conditions in which they worked in Wittenoom, knew 
that workmates were dying, knew of silicosis from dust and yet still accepted 
tuberculosis as the official cause of deaths and illness. However the study also 
reveals that, with hindsight, ex-miners remain puzzled as to why they did not 
realise the risks at the time (Cappelletto and Merler, 2003). Attribution theory 
describes „false attributional errors‟ as a device for reducing emotional distress 
(Kelly, 1973). However it appears that, in the case of Wittenoom, the false 
attribution to tuberculosis, promoted by the management and apparently 
reinforced by the medical establishment, may have been at least in part a 
deliberate ploy to minimise commercial risk (Cappelletto and Merler, 2003). 
  
 
Patients with lung cancer are shown to frequently question the importance of 
smoking as the causative agent or to offer alternative explanations which 
served to minimise its impact, Faller et al (1995). The authors suggest that 
these alternative explanations or „false attributional errors‟ are developed in 
order to reduce self-blame, a similar conclusion to that of Kelly (1973). Faller et 
al (1995) also explored the uncertainty about the relationship between 
attribution and adjustment: on one hand, attribution to an external agent may 
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help to reduce personal responsibility for the illness, on the other, it is clear that 
many patients with mesothelioma do exhibit feelings of guilt and remorse, albeit 
often inappropriately in the social context of their working lives (Lebovits, 1985). 
 
 
Loss of self 
The diagnosis of a terminal disease has been described as a threat to the 
integrity of self and part of this complex notion is deterioration in body image 
and function (Brennan, 2001; Lawton 2000:87-105). This may be particularly 
hard for male patients with mesothelioma because for many of them, having 
worked in physically demanding jobs, a muscular physique and physical fitness 
were their „capital‟ (Connell, 1995:54-6).  Narrative accounts from men with 
asbestos-related disease reveal that watching their wives doing stereotypically 
male tasks at home, such as digging the garden or even driving the car, and the 
impact on social activities such as dancing, caused additional distress to men 
from these traditionally configured families (Johnston and McIvor, 2000:177-
200). Walker and LaMontagne (2004) reported that loss of the ability to 
undertake DIY tasks, travel, and participate in social events reinforced the loss 
of normality. An investigation of quality of life issues in patients undergoing 
chemotherapy for mesothelioma, (m=45, f=8), highlighted particular 
impairments: role and social function were „worse than expected‟ by the 
authors, in addition to the anticipated physical problems of dyspnoea, pain and 
cough (Nowak et al, 2004). Breathlessness and weight loss, both common 
visible manifestations of mesothelioma, cannot be concealed and may also 
cause impaired sense of self and body image (Goffman, 1963:64-8). 
 
 
Locus of control 
 
A diagnosis of cancer may force patients to confront their loss of control over 
events and challenge fundamental assumptions about their world such as 
notions of deservedness, justice, fairness and health beliefs. Many studies have 
demonstrated that individuals tend to have an inflated belief in their ability to 
control their own existence and the world they live in, believing that they actually 
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hold the locus of control. Those who appear to have most control, relating to 
wealth and position in society, may find the loss of control precipitated by illness 
hardest to bear (Park and Folkman, 1997). Patients may feel that they 
surrender autonomy to the medical authorities which may result in loss of 
control on a personal level. Deteriorating bodily functions, and treatment and 
monitoring regimes, further emphasise the loss of control and the major change 
in circumstances (Costain Schou and Hewison, 1999: 138-52).  
 
 
Bolam et al, (2003) explored the psychosocial aspects of health inequalities 
such as sense of control over health and described the complexities of agency 
in people from lower socio-economic groups. They reported that, although these 
groups may exhibit a fatalistic belief with regard to their perceived limited control 
over their own health, individuals‟ accounts also illustrated areas in which they 
made efforts to retain a sense of control such as taking care of themselves. This 
contrasts with the risk-taking macho culture prevalent in the industries relevant 
to this study (Johnston and McIvor, 2000:171, 212-3). 
 
 
1.5 Supportive services for cancer patients and their 
families 
 
Policy and palliative and supportive care services 
 
Palliative care, encompassing a holistic approach to the care of patients, initially 
relating to cancer but now proposed to apply to all „end-of-life‟ conditions, has 
been evolving in the UK since the birth of the modern hospice movement in the 
1960s (Seale, 1998:113-7, Clark et al, 2005:3-4). The current definition, in Box 
1.3, (NICE, 2004:20) was based on earlier work from the World Health 
Organisation and the National Council for Hospice and Palliative Care.  
Recently it has been acknowledged that some elements of palliative care 
should be provided earlier in the disease in order to address identified needs of 
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cancer patients and their families and these have been grouped together as 
supportive care, Box 1.4 (NICE, 2004:19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 1.3: Definition of palliative care (NICE, 2004:20) 
Palliative care is: „…the holistic care of patients with advanced, progressive illness. 
Management of pain and other symptoms and provision of psychological, social and 
spiritual support is paramount. The goal of palliative care is achievement of the best  
quality of life for patients and their families. Many aspects of palliative care are also 
applicable earlier in the course of the illness in conjunction with other treatments.‟ 
„Palliative care is based on a number of principles, and aims to: 
 Provide relief from pain and other distressing symptoms 
 Integrate the psychological and spiritual aspects of patient care 
 Offer a support system to help patients to live as actively as possible until death 
and to help the family to cope during the patient‟s illness and in their own 
bereavement 
 Be applied early in the course of the illness in conjunction with other therapies 
intended to prolong life (such as chemotherapy or radiation therapy), including 
investigations to better understand and manage distressing clinical 
complications.‟ 
 
Box 1.4: Definition of supportive care (NICE 2004:19) 
 
Supportive care „…helps the patient and their family to cope with cancer and  
treatment of it – from pre-diagnosis, through the process of diagnosis and treatment,  
to cure, continuing illness or death and into bereavement. It helps the patient to  
maximise the benefits of treatment and to live as well as possible with the effects of  
the disease. It is given equal priority alongside diagnosis and treatment.‟ 
 
Supportive care encompasses: 
 Self help and support 
 User involvement 
 Information giving 
 Psychological support 
 Symptom control 
 Social support 
 Rehabilitation 
 Complementary therapies 
 Spiritual support 
 Palliative care 
 End-of-life and bereavement care 
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In the UK, specialist palliative care (Box 1.3) is provided by multi-disciplinary 
teams, ideally including healthcare professionals from palliative medicine, 
palliative care nursing, physiotherapy, occupational therapy, and psychology 
augmented by social workers, dieticians, complementary therapists and 
ministers of religion. General palliative care is seen as being the role of GPs 
and their teams, community and hospital nurses. Specialist palliative care aims 
to provide care for patients with complex symptoms and requires knowledge of 
advanced symptom control. There are some difficulties with these intentions in 
practice because patients‟ conditions can change rapidly, their needs are often 
not predictable, and provision of specialist palliative care is patchy. Moreover, 
the role of palliative medicine specialists and when to refer patients to them, 
particularly with non-cancer conditions, has been found to be poorly understood 
by colleagues, and this may partly explain the tendency for late or insufficient 
referrals (Hanratty et al, 2006).  
 
Supportive and palliative care needs of patients have tended to be approached 
from the perspective of healthcare professionals but recently there has been 
more attention around accessing patients‟ definitions of their needs; the 
participation of patients in shaping health services is now UK policy 
(Department of Health, (DH), 2004, 2006a), although this rhetoric is not yet 
reflected in standard practice. In addition it is now accepted that provision of 
clinical investigation and treatment should be complemented by a range of 
supportive services that address the psychosocio-emotional impact of cancer. 
There is evidence that by providing these additional services, outcomes in 
terms of patient satisfaction, health-related quality of life, psychological 
morbidity and survival are improved (NICE, 2004).  
 
Service provision and usage 
A comprehensive strategy aimed at improving services for cancer patients was 
produced in the 10 year NHS Cancer Plan (Department of Health, 2000b) and 
developed in subsequent policy documents. Thirty four cancer networks were 
established, each serving a population of around 1-2 million people, and 
including both primary and secondary care organisations. Networks were 
intended to oversee the improvement of cancer services in each locality. At the 
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local level, cancer units, usually in District General Hospitals, provide basic 
investigations, some routine chemotherapy, and surgery if the unit is accredited 
for it.  Regional cancer centres provide radiotherapy, chemotherapy including 
clinical trials, and more specialised surgery. Special centres were developed to 
cater for some rare or particularly complex cancers, although none are currently 
specific for mesothelioma. 
 
One of the foremost initiatives was the development of the multidisciplinary 
approach to cancer, and cancer site-specific multidisciplinary teams (MDTs) 
were set up in each cancer centre and relating to the most common cancers. 
This approach aimed to ensure that investigations were conducted more 
efficiently, that treatment decisions were more consistent and that better 
outcomes were achieved (House of Commons Committee of Public Accounts, 
2005). As mesothelioma is a relatively rare cancer, it is included in lung cancer 
MDTs in spite of it being a pleural  tumour, and having many different features: 
these include aetiology, epidemiology, histological, pathological and clinical 
features, diagnostic difficulties, therapeutic interventions, psychosocial and 
medico-legal issues and not being amenable to similar treatments.  
 
However, an evaluation of the progress of the Cancer Plan uncovered many 
problems to date:  
‘30% of Networks visited by the National Audit Office did not have 
comprehensive plans for providing cancer services in their locality.’  
Repeated reorganisations of health services, lack of resources, lack of 
monitoring and reporting arrangements, poor inter-agency relationships and a 
need for more prevention and health education are addressed in the report, 
which suggested that the Cancer Plan needs updating and tighter performance 
monitoring (House of Commons Committee of Public Accounts, 2005). 
 
Needs of patients, families, and carers 
 
Former Australian power workers, exposed to asbestos at work, and their 
families, identified a range of unmet needs for people with asbestos-related 
diseases. These included hospice and palliative care services, and professional 
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counselling; the study also revealed a desire for local access to specialist 
respiratory medicine, radiotherapy, and equipment such as oxygen 
concentrators. This community study also indicated a need for public and GP 
education around asbestos and disease, (Walker and LaMontagne, 2004). 
Hawley et al’s (2004) results were similar but also emphasised the need for 
better communication between professionals and patients, and between 
professionals. They proposed strategies to support dying at home, suggested 
that a specialist mesothelioma nurse should be involved with each patient, and 
stressed the need to support carers whilst caring and in bereavement. 
 
There is a substantial body of literature confirming the major impact of caring for 
someone with terminal illness on family caregivers or informal carers, and 
national policies concerning carers have been introduced in the past decade 
(Nolan et al, 1997; Carers Act, 1995). Reports indicate that the unmet needs of 
family/informal carers of cancer patients may exceed those of the patients 
(Soothill et al, 2001; Higginson et al, 1990). Carers‟ unmet needs embrace 
information about the disease and its management, as well as practical, social, 
and emotional support. In mesothelioma there are additional stresses on carers 
relating to advocacy and information activities that relatives undertake relating 
to compensation procedures when patients are too ill to do these themselves 
(Johnston and McIvor, 1999:134-8; Walker and LaMontagne, 2004). In the UK, 
the coronial investigation of mesothelioma as an „unnatural death‟ creates 
further distress for relatives (Downs et al, 2002). 
 
Caring for a patient in the palliative stage of their illness reveals many unmet 
needs of carers; additional factors related to these unmet needs include carers 
in poor health, who are socially isolated, or not the spouse or partner of the 
patient (Soothill et al, 2001). In a study of lung cancer patients, although 67% of 
the patients described themselves as dependent on family and friends, only 
29% of patients felt that their informal carers had particular needs relating to 
their illness (Krishnasamy and Wilkie, 1999:70). Paradoxically, in spite of 
evidence of substantial unmet needs of carers, the majority of the carers 
reported being satisfied with the support that they received; the authors suggest 
this reflects that carers accept the patients‟ needs as priority and that health 
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services reinforce this. Krishnasamy and Wilkie, (1999:87-9), also stress that 
much more attention must be directed towards supporting lay carers in order to 
fulfil the government‟s agenda to enable more people to die at home ‘if caring is 
not to become an intolerable burden’. Walker and LaMontagne, (2004), 
described the role of women carers in mesothelioma, given that most patients 
with mesothelioma are men, as support and advocacy, including medical care, 
and providing emotional support. Most reported an adverse effect on quality of 
life and exhaustion and social isolation due to caring for a dying husband at 
home. The authors described the carers‟ narratives as revealing „extreme 
determination and strength‟.  
 
As care of dying patients at home becomes more prevalent due to initiatives 
encouraging patient choices around terminal care, the reliance on family 
members and close friends will increase. Patients with cancer tend to die in 
hospital (47%) or hospice/nursing home (17%) whereas more than 50% have 
expressed the wish to die at home (Higginson et al, 1998). Care of the dying at 
home depends heavily on family carers, yet „carer collapse‟ or exhaustion is a 
frequent cause of inappropriate hospital admission of cancer patients in the 
terminal phase (Hinton, 1994; Higginson et al, 2006; Storey et al, 2003).  
 
The recent guidance on palliative and supportive care (NICE, 2004) includes 
support services for informal carers and goes some way to addressing the 
ambiguous position of carers.  Patients are also worried about the burden of 
care on their families: Hill et al, (2003), established that, after worries about their 
illness, patients with lung cancer were most concerned about the impact of their 
illness on their close family. 
 
Self-help groups and the voluntary sector 
The UK tradition of charitable and voluntary action is extensively represented in 
healthcare: of the 166129 charities registered with the Charity Commission 
around 840 are cancer charities, (Charity  Commission, 2006), and prominent 
amongst them are Macmillan Cancer Relief2 and Cancer Bacup, both providing 
free information about cancer for patients and carers This information 
                                                 
2
 The UK charity Macmillan Cancer Relief was renamed Macmillan Cancer Support in 2006 
 40 
encompasses the various types of cancer, treatments, clinical trials, help 
available, financial advice and signposts patients and carers to other agencies. 
Macmillan Cancer Relief was the first UK charity to provide a support service 
specifically related to mesothelioma; it funded the Mesothelioma Information 
Service3 that ran a telephone helpline from a Leeds hospital base and produced 
an information book (Robinson, 2003). In 2004 Macmillan Cancer Relief 
replaced the Information Service with a new organisation, Mesothelioma UK, 
based in Leicester. This charity is run by a Macmillan nurse consultant in 
mesothelioma and provides a newsletter, a telephone helpline, web-based 
information, (www.mesothelioma.uk.org), and promotes education relating to 
mesothelioma.  
 
Support groups for people with asbestos-related diseases have developed in 
areas of high incidence and recently instituted a national forum under the 
auspices of Mesothelioma UK. Support groups have tended to focus on gaining 
financial benefits and compensation for their members; they are usually run by 
union representatives with support from legal firms. In line with the 
recommendation in a survey of lung cancer patients‟ support needs, that „one 
stop‟ services are needed, (Krishnasamy and Wilkie, 1999:90), and after 
consultation with local patients, their families and professionals, a service 
commenced in 2005 in Barrow-in Furness: BARDS (Barrow Asbestos-Related 
Disease Support), Box 1.5.  
 
There is a growing awareness of the value of support groups in providing a 
focus for a community response to asbestos-related diseases and this links to 
calls for public participation, particularly in affected communities, in the „new 
public health‟ (LaMontagne and Walker, 2005; Petersen and Lupton, 1996:7).  
 
 
 
 
 
 
                                                 
3
 An interview account of the Mesothelioma Information Service can be found in Box 6.6 
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1.6 Mesothelioma, the law and society  
In this section, financial assistance and medico-legal matters affecting patients 
suffering from mesothelioma are discussed with respect to: firstly, State benefits 
and secondly, civil compensation, and this is followed by an account of the 
procedures that follow the death of a patient due to mesothelioma.  
 
State benefits  
In the UK, people with cancer are entitled to a considerable range of State 
benefits as part of the Social Security system designed to protect them, to some 
extent, from disadvantage due to ill health. These allowances commonly include 
Incapacity Benefit, Mobility Allowance, Attendance Allowance, Carers 
Allowance and also, in mesothelioma, Industrial Injuries Benefit (IIDB). This 
benefit applies if patients can: a) provide proof of the diagnosis, and b) provide 
proof of occupational exposure to asbestos when employed after 4th July 1948 
Box 1.5: Barrow Asbestos-Related Disease Support (BARDS) 
 
A support group for people with asbestos-related disease and their families 
provided by St Mary‟s Hospice, Ulverston, Cumbria, and supported by local 
Trades Unions, the Benefits Agency, Citizens Advice Bureau and local and 
national legal firms. BARDS was set up after 2 open public meetings in which a 
Participatory Appraisal exercise was used to determine what local people 
wished to see developed to support people with mesothelioma and their 
families. As a result the following free services are available: 
 
A monthly „drop-in‟ session in Barrow-in-Furness: 
 Open access to medical, nursing, benefits and legal advice – all 
practitioners have expertise in the care of people with mesothelioma. 
Healthcare staff work alongside colleagues in hospital and general 
practice 
 Information service 
 Breathlessness management sessions  
 Complementary therapies  
 Carer support programme 
 Talks on mesothelioma and related topics 
 Social activities 
 24-hour hospice helpline 
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in a particular 4 occupation. The latter requires details of past employment; the 
benefit does not apply to the self-employed or employers and does not apply if 
occupational exposure cannot be confirmed (Social Security Regulations, 
1985). The Department of Social Security (DSS) may check these details with 
the listed firms, particularly if mesothelioma is suspected but not yet confirmed.  
However, many of the firms have gone out of business and so details cannot be 
confirmed. In these cases the claimant has to try to provide witnesses to 
corroborate the account of asbestos exposure. Many patients will have had 
multiple jobs and may have moved around the UK – it can be practically 
impossible to prove industrial asbestos exposure for some people and an added 
source of stress. The claimant needs to show that „on a balance of probabilities‟ 
their occupation exposed them to substantial asbestos dust.  
 
In some cases a posthumous claim has to be made, perhaps because the 
diagnosis of mesothelioma was only recognised at post mortem or the person 
was too ill to make a claim. A person acting on behalf of the deceased has to 
apply to be the „appointed person‟ within 6 months of the date of the death 
certificate and then has a further 6 months in which to submit the claim. This 
may pose problems for the appointed person because they may well not know 
full employment details of the deceased and have to deal with this when newly-
bereaved (Robinson, 2003; Social Security Act, 1975). When IIDB is awarded it 
is now automatically paid at the maximum rate based on a disability 
assessment of 100% in all mesothelioma cases (Gorman et al, 2004) 
 
Of the people certified as dying of mesothelioma each year, it has been 
established that around a third do not receive IIDB but the total includes people 
who have no history of industrial asbestos exposure (approx 20%) and those 
who do not satisfy the criteria for the benefit (HSE, 2006c). A recent study 
demonstrated that less than 50% of cancer patients access all the benefits that 
they are entitled to and suggests that reasons include: lack of information, 
complex form-filling, self-reliance, suspicion of State bureaucracy and the 
distracting burden of serious illness (Macmillan Cancer Relief, 2004). 
Robinson‟s (2003) mesothelioma information booklet provides details of the 
                                                 
4
 Specifically, an occupation that is accepted by the Department of Social Security as likely to expose 
workers to asbestos. 
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benefits available and how to access them. However, for people who are ill and 
who also are from a generation that tended to be self-reliant and therefore 
unfamiliar and uncomfortable with claiming benefit, the benefits process can be 
overwhelming (Gorman et al, 2004), as also demonstrated in a study of patients 
with lung cancer (Chapple et al, 2004).  
 
Civil compensation 
People who develop mesothelioma (or asbestosis) are entitled to take action 
against the employer for civil compensation. There is no national record of civil 
claims pursued by people with mesothelioma but it is known that claim rates are 
considerably higher for mesothelioma but lower for other asbestos-related 
diseases in the UK compared with the US (Durkin, 1994). Access to justice may 
be difficult: the claimants are ill and often fearful of legal proceedings and 
causation may be difficult to prove because evidence from past workmates may 
be impossible to obtain and many relevant insurance companies have ceased 
trading (Tombs, 2005). The legal process is therefore often slow and in the past 
many claimants have died before compensation has been agreed. Since 2002 
arrangements have been in place in England and Scotland to „fast track‟ 
mesothelioma claims, through the Queen‟s Bench Division, but this depends on 
patients‟ solicitors being familiar with the system (Kazan-Allen, 2004). 
 
Civil compensation awards are based on lost years of life and suffering; they 
range between £45,000 and £75,000 for general damages plus care costs and 
financial losses, but in an exceptional case the award was £4.37 million 
(Budgen and Lipsitz, 2006:445). Under the Fairchild ruling, (Budgen and Lipsitz, 
2006:444), claimants could sue a single negligent employer for the total 
compensation sum even when several employers may have been liable. This 
pragmatic ruling took into consideration the rapidly deteriorating health of the 
claimants, and the difficulty in chasing multiple employers and their insurers 
when many had gone out of business, were untraceable, or had not been 
insured. However it left several issues unresolved, such as whether or not joint 
and several liability was established. More recently a decision to overturn the 
Fairchild ruling caused great distress and anger amongst mesothelioma 
patients and campaigners as this meant that when multiple employers were 
 44 
involved it was the patient‟s responsibility to attempt to sue them all and recover 
a proportion of the compensation from each employer. The result would have 
led to long delays in the settlements being reached and much less 
compensation being received by patients as they would not have been able to 
track many of those responsible. In response to an urgent plea for justice for 
people with mesothelioma and their families, this decision has now been 
reversed by new law that also grants retrospectivity (House of Commons 
General Committee on Delegated Regulation, 2006) 
 
In the event of an eligible person being unable to recover damages from the 
employer, for example if the employer is insolvent, a statutory lump sum 
payment may be obtained under the Pneumoconiosis etc. (Workers‟ 
Compensation) Act (1979) and this is not restricted to particular occupations 
(London Hazards Centre, 1995:111). Service and ex-service personnel are not 
entitled to common law compensation for asbestos-related diseases due to 
exposure before 1987, although they are entitled to smaller financial allowances 
under War Pension arrangements (SARAG, 2004).   
 
The massive financial toll of international asbestos-related civil compensation 
claims contributed to the near-collapse of the insurance giant, Lloyds of London 
(London Hazards Centre, 1995: 99). Asbestos related claims are escalating and 
therefore insurance companies underwriting the employers are prepared to 
robustly challenge any claims. The predicted total claim against insurers of the 
responsible employers is potentially devastating: an estimate of £8 – 20 billion 
was made in 2004, 75% of which would be claims relating to pleural plaques. 
However the UK Court of Appeal has just overturned 20 years of case law and 
disallowed claims for compensation for pleural plaques; this has been seen as a 
victory for the insurance companies. Unusually, the judgement included 
permission for an appeal; this is due to occur in 2007 (Daley J 2004, Kazan-
Allen, 2006).  
 
Criticisms of the asbestos industry allege ways in which the asbestos industry 
attempts to limit compensation payments, for example by manipulating 
bankruptcy laws and petitioning for capping of the global compensation pool 
 45 
(London Hazards Centre, 1995:97-100). A test case in 1995, Margerson and 
Hancock v J W Roberts Ltd (1995), established the principle of liability in 
negligence to members of the public who develop mesothelioma due to 
neighbourhood asbestos exposure, in this case from an asbestos factory that 
contaminated the locality including a school.  
 
 
Mesothelioma as ‘unnatural’ death 
In the UK, death due to mesothelioma is classed as an „unnatural death‟ and, by 
law, has to be investigated by the Coroner (or Procurator Fiscal in Scotland) in 
order to ascertain the official cause of death. Unfortunately, at present, the law 
concerning the investigation of „unnatural deaths‟ does not discriminate 
between (usually) expected deaths due to an industrial disease such as 
mesothelioma and a sudden unexpected death due to a criminal act. The 
procedures for investigating „unnatural death‟ due to mesothelioma can, if 
handled insensitively, cause much additional distress to bereaved relatives. 
(Downs et al, 2002; Human, 2002). In the UK, the confirmation of death due to 
industrial disease rests with individual coroners and, in the absence of national 
guidance, there is no systematic assessment of mesothelioma cases, leading to 
inconsistent results and loss of financial benefits for some families (Kazan-
Allen, 2005).  
 
The doctor who confirms the death is required by law to contact the Coroner, 
usually via the Coroner‟s officer, an officer of the law. The confirming doctor is 
not entitled to issue a death certificate that would confirm the cause of death, 
even when there is no doubt that death was due to mesothelioma, because, 
technically, in the case of an „unnatural death, the cause can only be 
determined by a Coroner after appropriate investigation. The Coroner‟s officer is 
usually a policeman who has received extra training related to coronial 
investigation. However, it may be an inexperienced young officer in uniform who 
attends or one who has never heard of mesothelioma and treats the situation as 
a „suspicious‟ or „sudden unexpected‟ death, even when the diagnosis has 
already been established and the death is expected (Downs et al, 2002). The 
relatives are required to make a formal identification of the body and give a 
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statement with particular reference to the occupational history of the person 
who has died. In most instances, the Coroner will request a post mortem 
examination that usually takes place in a local hospital mortuary; relatives are 
not able to refuse this. Samples of tissue are removed for analysis of asbestos 
fibres and subsequently the relatives may be asked how these samples should 
be disposed of – a consequence of recent organ retention scandals in the UK 
(Burton and Wells, 2002). The Royal College of Pathologists (2000) has 
produced an information pack for relatives about the procedure and purpose of 
post mortem examination.  
 
The inquest, a formal procedure in court, is opened to herald the start of the 
investigation into the cause of death. The inquest is then adjourned until some 
weeks later when all the evidence has been gathered. On adjournment the 
Coroner releases the body to the funeral directors and the funeral can proceed, 
after a delay of usually a few days. The inquest hearing may occur many 
months after the death and the relatives are expected to attend. For many, the 
court procedure is threatening and unfamiliar. Worry about the inquest hangs 
over grieving relatives, and the award of civil compensation is often delayed as 
this may depend on the outcome of the inquest. Understandably, it is hard for 
recently bereaved people to cope with the investigation and frequent delays in 
the proceedings while tissue is analysed and employment records checked. In 
Scotland a group of palliative care physicians have influenced the Procurator 
Fiscal5 and changed practice regarding mesothelioma deaths, thus reducing 
distress to relatives (Downs et al, 2002). 
 
Many relatives are not made aware of the required legal procedures before the 
death and this understandably causes distress. There is no agreed national 
protocol or guidance on this matter, although some organisations in high 
incidence areas have developed their own systems (Downs et al, 2002). A UK 
survey confirmed that most relatives would prefer to be prepared in advance of 
the death but that this is often overlooked (Human, 2002).  
 
                                                 
5
 The Scottish Procurator Fiscal is the equivalent of the Coroner in England and Wales. 
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A review of coroners‟ services, as part of the Shipman6 enquiry, has made 
recommendations that could benefit relatives of people with mesothelioma. 
These will include giving bereaved people the right to raise concerns with 
coroners, clear legal rights, fewer delays, better communication, and 
information on support including bereavement services to be detailed in a 
coroners‟ charter (Department for Constitutional Affairs, 2006). 
 
 
1.7 The tradition of social medicine 
Social medicine developed in the mid-19th century and concerns the relationship 
between social factors and ill-health, alternatively described as „medicine in the 
matrix of society‟ (Oakley, 1997). A classic text published by Virchow, a radical 
German physician, in 1849, described the social factors involved in the 1848 
typhus epidemic in Upper Silesia, Germany and, for the first time, suggested a 
social solution rather than a medical one. He proposed and then implemented a 
revolutionary programme of social change involving improved employment and 
higher wages, provision of state education for all and the development of local 
rural cooperatives. This formed part of the Medical Reform Movement of 1848. 
Virchow stated that „If disease is an expression of individual life under 
unfavourable conditions, then epidemics must be indicative of mass 
disturbances of mass life.’ (Taylor and Rieger, 1985) 
 
Social medicine‟s promotion of the interplay between social circumstances and 
illness has had mixed fortunes, at least in part, because campaigners for social 
justice have frequently been in direct opposition to major political and economic 
forces (Waitzkin, 2001). The German social medicine movement started by 
Virchow grew to become a threat to the income and status of private medical 
practitioners and Virchow was briefly suspended when his political activities 
were seen as inappropriate for an eminent physician (Virchow, 2000). In the 
1930s, medical support for the Nazi Party resulted in the destruction of the 
forerunners of today‟s health-maintenance organisations and replaced them 
                                                 
6
 Shipman was a notorious GP who was convicted for the murder of 15 of his patients. He was 
imprisoned in 2000 and he committed suicide in prison in 2004. As a result of his criminal activities a 
comprehensive investigation, including Coroners’ services, was undertaken. 
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with profession-dominated rather than patient-centred services (Waitzkin, 1998; 
Light et al, 1986).  
 
In England in the 1940s, a group of doctors and scientists, with interests linking 
social factors and disease, formed the Committee for the Study of Social 
Medicine. The group produced several papers on social medicine topics but 
then dissolved during the Second World War when its London base was 
bombed during the Second World War (Watts, 2001). Morris and Titmuss, 
leaders in UK social medicine, became friends in the 1930s and collaborated 
initially on investigating the causation of coronary heart disease. Morris, a 
medically trained epidemiologist, worked in public health before war service in 
India as an officer in the Royal Army Medical Corps. Titmuss, who left school at 
14 with no qualifications, pursued a self-taught study of social topics that led to 
a wide range of academic publications7 concerning health inequalities and 
finally his appointment as Professor in Social Administration at the London 
School of Economics. After the war, Morris and Titmuss set up the Social 
Medicine Research Unit, funded by the Medical Research Council.  This unit 
was charged with the ambitious task of determining all the social factors 
involved in disease, known as the „Social Medicine Project‟. Not surprisingly, 
this was not completed, although papers were produced concerning the social 
factors, mainly relating to poverty, linked with rheumatic heart disease, juvenile 
rheumatism and peptic ulcer (Oakley, 1996; Watts, 2001; Berridge 2001). The 
unit closed when Morris retired in 1975. Titmuss and Morris both held high-level 
national appointments and were influential in developing social policies of the 
Labour governments of the 1960s. Morris was involved with setting up the 
National Health Service and was also responsible for creating the modern 
community physician from the previous role of the Medical Officer of Health 
(Ashton, 2000a). The Society for Social Medicine continues the tradition but 
acknowledges an increasing blurring of boundaries between social medicine, 
epidemiology and the „new public health‟, as discussed later (McPherson and 
Dunnell, 2002; Holland, 1994) 
 
                                                 
7
 Books by Titmuss include Poverty and Population (1936), Birth, Poverty and Wealth (1943), Problems 
of Social Policy (1950).Essays on the Welfare State (1958), Commitment to Welfare (1968) and the US 
best-seller: The Gift Relationship (1970). 
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In the USA, Parsons (1951) described sickness as a social phenomenon and 
emphasised the adverse effects of illness on the effective performance of social 
roles that underpin a successful society. He regarded medicine as a controlling 
instrument that served to stabilise society. The Cuban revolution in the 1960s 
was inspired by the experiences of Che Guevara, doctor and political activist, 
who saw at first hand the need to improve the social conditions of the 
population in order to improve health. He described this process as 
„revolutionary medicine‟ (Waitzkin, 2001).  
 
A social medicine approach to mesothelioma illustrates the importance of social 
and economic factors in the continuing increase in incidence, in spite of the 
enormous reduction in industrial use of asbestos. Implementation of workplace 
Health and Safety regulations relating to asbestos has certainly reduced the 
traditional occupational risks of asbestos exposure dramatically (Hilliard et al, 
2003). However, it is estimated that two thirds of all UK commercial buildings, 
approximately 850,000, contain asbestos, as do many public buildings and 
private homes, including many schools and hospitals built before 1975; some of 
the material is inevitably in a deteriorating condition (Health and Safety 
Executive, 1998; Tudor, 2001). The health risks to building construction and 
maintenance workers exist because Health and Safety regulations may be 
ignored, particularly in the many small firms that often employ sub-contractors. 
Asbestos removal firms have also been criticised for unsafe work practices. 
Enforcement of the regulations has been compromised by a reduction in the 
number of HSE inspectors in the past decade (London Hazards Centre 
1995:70-73). Added to this is a general lack of knowledge about asbestos 
hazards and the difficulty in identifying asbestos-containing materials. The often 
casual workforce is by definition transitory and predominantly male; risk-taking 
is part of the „macho‟ culture. Ironically, these mirror features of occupations in 
the traditional asbestos-using industries. One in four deaths due to 
mesothelioma now occurs in construction and maintenance trades workers 
(HSE, 2006b). In addition, home decoration and improvements are now 
undertaken much more frequently than in past generations, thus exposing large 
numbers of tradesmen such as joiners, plumbers, painter/decorators and 
electricians to asbestos.  
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Both government and individuals may be relatively unconcerned about a 
disease that takes many years to present following exposure to the causal 
agent: the individuals because the risk is remote compared with more obvious 
hazards such as road traffic accidents and smoking, and possibly because the 
disease does not impact on the active workforce and is still relatively 
uncommon. Sadly, a disease that affects many more men than women may 
receive less medical and political attention, even in these post-feminist times. 
 
Peto et al (1999) predict that mesothelioma in Europe will increase in incidence 
in the next two decades in spite of the campaign to ban asbestos. Even in the 
apparently enlightened developed world, politico-economic influences still put 
lives at risk: in 1998 a Canadian trade mission persuaded the British 
government to delay a total ban on UK asbestos imports for two years for purely 
commercial reasons. They argued that a total ban of white asbestos (chrysotile) 
should not be mandatory because it has some unique industrial applications 
and is much less carcinogenic than other forms of asbestos. There is a powerful 
pro-chrysotile lobby, funded by the asbestos industry, that seeks to protect 
asbestos mining, manufacture and usage (Kazan-Allen, 2003). Although 
theoretically it may be argued that chrysotile should not be banned because of 
its low carcinogenicity in comparison with the amosite group, usage would need 
to be very strictly controlled. In practice, however, there are major issues that 
make these conditions unlikely to be satisfied: the difficulty in guaranteeing pure 
chrysotile uncontaminated by tremolite (although challenged by the Canadian 
asbestos industry); the socio-economic and practical conditions in resource 
poor countries where manufacturing takes place; the commercial implications; 
and the poor record of hazard management by the asbestos industry.  
 
A powerful critique of the Canadian asbestos mining industry also condemns 
industry-funded university researchers (Egilman et al, 2003). Recent evidence 
has confirmed that Wagner, previously regarded as one of the fathers of 
mesothelioma research based on his seminal paper in 1960, was paid an 
honorarium of $SA 6000/month by the asbestos industry, (McCulloch, 2006), 
although there is no evidence that this influenced his work.  
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In resource poor countries, asbestos mining, manufacturing of asbestos 
materials and the use of asbestos in relatively inexpensive housing and 
industrial settings are widespread, for example in India and South Africa 
(Kazan-Allen, 2005a; Jacobs et al, 2005). Globalisation and the commercial 
interests of multi-national concerns perversely encourage investment in 
asbestos industries in poor countries, whilst at the same time creating major 
health hazards. Attempts to interfere with the asbestos industry in resource poor 
countries are compromised by the likelihood that the economic consequences 
would be disastrous without some other major employment initiative. This 
tension between health and profit-making industry is at the heart of the social 
medicine tradition. 
 
Social medicine may be regarded as extending the boundaries of both public 
health and epidemiology in its emphasis on whole societies and the prime 
importance of the relationship of social, political and economic factors to ill-
health. Initially, Public Health services followed a government line with the aim 
of ensuring a healthy (working) population and tended to divide societies into 
demographic groups according to criteria such as age, sex, ethnicity etc and 
then apply medical initiatives e.g. vaccination, screening for disease, treatment 
of disease outbreaks, to the relevant groups. Social medicine has examined 
whole populations or social institutions, with social rather than individual units of 
analysis, in an attempt to find social solutions for the societal factors that create 
or increase risks to health (Waitzkin, 2001). A review of a medical controversy 
in 1839 illustrates the polarised approaches: in considering whether or not 
starvation had caused deaths, the statistician, William Farr, considered that 
hunger was a major contributory factor in many deaths whereas the „pioneering 
sanitary reformer‟ Edwin Chadwick, wanted to determine the diseases which 
had been the final events (Hamlin, 1995). However, the distinctions between 
these terms are diminishing, particularly within the „new public health‟ 
movement (Ashton and Seymour, 1988) that encompasses a wider agenda, 
much of it reflecting areas previously included under social medicine (Holland, 
1994). An illustration of this trend towards more engagement with societal 
issues in the „new public health‟ is the formation of Public Health Observatories 
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in each health region that aim to integrate specific local public health needs into 
local service provision and medical education (Ashton, 2000b).  
 
The research methods underpinning the disciplines of social medicine, 
epidemiology and public health may also differ to some extent. Traditionally, 
epidemiology and public health methods may have favoured statistical studies 
in the investigation of large groups. However there are no clear divisions 
between these areas and perhaps an increasing convergence in line with the 
„new public health‟. Social medicine methodology favours a multi-method 
approach as this enables multiple perspectives to contribute to an overall 
picture. This approach, often combining quantitative and qualitative methods, 
allows individual contributions to be married with group or population units of 
analysis, de-emphasises the biomedical contribution, and can reveal the 
societal complexities around illness located „in the matrix of society‟ (Yin, 2003, 
Malterud, 2001).   
 
This study follows the tradition of social medicine in emphasising the social 
context of illness, and in which the case study approach is appropriate. 
Although UK studies abound that relate illness to the wider social context, most 
do not refer specifically to the tradition of social medicine. Many of these are 
described as epidemiological or public health studies and it may be that the 
term „social medicine‟ is no longer popular and has been replaced by „the new 
public health‟ or „social epidemiology‟ in the UK. Although there is one university 
department of social medicine in the UK, my experience of discussing social 
medicine with colleagues lead me to conclude that, as a specific discipline in its 
own right, social medicine is not widely understood (rather like palliative 
medicine).  
 
Studies that fit the definition of social medicine as „medicine in its social matrix‟ 
include much of the work around health inequalities and social disadvantage. 
Examples include the classic studies on risk factors for coronary heart disease 
(Morris, 1953), inequalities in health (Black Report, 1980), and the social 
causes of tuberculosis (Mosse and Tugendreich, 1913). General practice or 
community-based studies include „Epidemiology in a country practice‟ (Pickles, 
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1939),  Murray et al’s (2003a) study comparing dying from cancer in Scotland 
and Kenya, and a doctoral study on farmers‟ occupational health (Gerrard, 
1995).  Social medicine studies have contributed significantly to knowledge of 
mesothelioma in first identifying the occupational nature of the disease (Wagner 
et al, 1960); confirming asbestos as a cause of lung cancer (Doll, 1955); and 
illuminating the working conditions and health hazard perceptions of asbestos 
mine workers (Cappelletto and Merler, 2003). 
 
In our pluralist society it is perhaps not surprising that singular explanations of 
ill-health are less acceptable now than interactions of multiple factors. Genetic 
advances and better understanding of social and environmental impacts on 
health have also improved our understanding of causation of diseases. Coupled 
with media accounts of work-related health scandals, such as deaths due to 
lung cancer from passive smoking in the entertainment industry (Bramley, 2004) 
and the drowning of 23 illegal Chinese immigrants employed as cockle-pickers 
in Morecambe Bay in 2004 (BBC News, 2005), there is now increasing public 
and professional understanding of health issues in their social context.  
 
LaMontagne and Walker (2004) highlighted a previously unrecognised desire 
on the part of a community „damaged‟ by asbestos for some form of 
reconciliation and social healing. They also revealed a demand for community 
involvement in future public health interventions concerning asbestos-related 
conditions, such as the use of mesothelioma marker proteins, for example,  
mesothelin. In a similar vein, the plan for a memorial to the victims of asbestos 
diseases related to the Clydebank shipyard was recently presented to a UK 
conference (McKendrick, 2006) 
 
However, as mentioned earlier, there is undoubtedly an overlap in the 
disciplines and practices of social medicine and public health. There are many 
impressive examples of designated public health practitioners who have 
achieved health gain for their populations by adopting a social medicine 
approach. Morris, mentioned earlier, campaigned passionately for improved 
housing when he was Medical Officer for Health for Glasgow, and subsequently 
was responsible for the politically-challenging Black Report (1980) on health 
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inequalities in his position as Director of the Social Medicine Research Unit 
(Watts, 2000). The confusions around the various terms and their 
interrelationships are illustrated by his insightful paper explaining why 
epidemiology should expand beyond infectious diseases (Morris, 1975). The 
„new public health‟ attempts to reinstate the importance of social factors in ill-
health. Primary Care Trusts are charged with delivering health services that are 
appropriate for their local communities and, in order to do this, their public 
health strategy must take account of local social factors, although tensions are 
likely to arise between central and local priorities (Ashton and Seymour, 1988). 
However, Petersen and Lupton (1996: ix-xvi) argue that „traditionally modernist, 
science-based approaches‟ continue to prevail. 
 
There is considerable debate concerning the lack of an established theoretical 
base to social medicine. Waitzkin (2001) points out that apparent lack of theory 
may in fact not be atheoretical or antitheoretical but may mean that the theory is 
implicit. Thus it is common in the developed world for research in social 
medicine to be defined as following a tradition rather than as having a 
theoretical base.  Waitzkin (2001) states that researchers in Latin America 
utilise a theoretical stance that absorbs principles from a wide range of existing 
theories: Marxism relating to social class and the importance of economic 
production and exploitation of the workforce; feminism with regard to the burden 
of women as major wage earners, often providing a cheap source of unskilled 
labour and also carrying traditional child and home responsibilities; social group 
ideology; work process theory; and postmodernism. Waitzkin (2001) also points 
out that even epidemiological models that examine disease in relation to 
multiple causal factors may not be sufficiently wide-ranging to include dynamic 
social factors. 
 
The outbreak of Legionnaire‟s disease in 2002 in Barrow-in-Furness that 
caused 6 deaths and hospitalised 17 people serves to illustrate the differences 
between traditional public health medicine and social medicine (Barratt, 2002). 
The public health investigation of the outbreak identified the organism 
responsible for the illness and traced its source to an air conditioning unit in a 
community arts centre in the centre of town. The Barrow Borough Council 
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maintenance engineer, who allegedly had failed to carry out routine procedures, 
was pilloried in the press and civil compensation claims may prove very costly 
for the council. Publicity centred on the need for tighter controls on maintenance 
of air conditioning units (BBC News, 2005).  
 
A social medicine perspective would want to investigate why today‟s society 
feels it necessary to „condition‟ indoor air. This could include assessment of the 
factors that lead to reliance on, and unquestioning belief in, technology; the 
factors leading to air pollution; and the reasons for poor ventilation in modern 
buildings. Possible solutions from a social medicine perspective might include 
drastic and unpopular measures to seriously reduce motor transport, enhanced 
HSE powers to tackle industrial air pollution, and radical changes to the design 
of buildings to ensure adequate natural ventilation. Headlines such as „Air 
conditioning kills‟ would be as unacceptable now as those that questioned the 
safety of asbestos in the 1950s. 
 
Social medicine supporters have suffered for their work and principles because, 
by definition, there are major political, economic and commercial implications of 
this approach towards ill-health. In his paper on social medicine in Latin 
America, Waitzkin (2001) interviewed 24 leaders of social medicine and 
reported that 20 of these had experienced political repression that included 
„torture, imprisonment in concentration camps, exile, exclusion from government 
jobs, loss of economic security and work stability, loss of professional prestige 
and restriction of political activity‟.  Kazan-Allen (2003), a leading campaigner 
against asbestos, criticises the asbestos industry for „the use of legal and 
physical attacks on individuals and groups who are considered a threat‟.  
 
In 1984 there was a successful case against Alan Dalton, British author of 
„Asbestos Killer Dust: a worker/community guide‟ (Dalton, 1979). Dr Robert 
Murray, former medical adviser to the TUC, sued Dalton regarding comments in 
the book that criticised his „pro-industry views‟ and his failure to effectively 
monitor the asbestos manufacturing plant in Hebden Bridge when he was the 
responsible Factory Inspector. Damages of £500 were awarded against Dalton 
with costs of £30,000, almost ruining the British Society for Social Responsibility 
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that produced the book. In spite of this judgement, Dr Murray subsequently 
gave evidence as an expert witness for Turner and Newall in support of the use 
of asbestos (Tweedale 2000:248-9). 
 
Although trade unions have campaigned for better conditions for workers, there 
has been criticism that they were slow to act before the Asbestos Regulations 
(1968), due to awareness that jobs were potentially threatened and that 
employers were reluctant to accept any problems related to asbestos, the 
„magic mineral‟. Johnston and McIvor (2000:158-76) detail the development of 
the campaigning against asbestos of the Scottish Trades Unions, initiated by 
the insulation workers, and leading in the 1980s to the now prominent pressure 
group charity, Clydeside Action on Asbestos. Even now, the conflict between 
the need for employment against the risk of death due to occupational disease 
some decades in the future, continues in resource-poor countries. South African 
asbestos mine workers rioted when their jobs were threatened because of the 
real danger of starvation without employment (Kisting, 2006).  
 
The anti-asbestos campaign can be regarded as a social movement. In 1991 
the growing international awareness of the need to campaign effectively and 
globally, resulted in the formation of the International Ban Asbestos Network 
(Kazan-Allen, 2003). This federation of international anti-asbestos campaign 
groups represents a growing social movement that includes powerful lobbyists 
from medicine, law, workers support groups, academia, trades unions and 
politics (Kazan-Allen, 2000). Kazan-Allen (2003) describes the increasing 
tension between anti-asbestos campaigners and the pro-industry lobby in her 
article entitled „The Asbestos War‟. On the one hand, campaigners against 
asbestos are becoming more powerful and sophisticated and can engage the 
public with highly emotive arguments; on the other hand, the asbestos industry 
is fighting for survival in the face of a great reduction of opportunities for 
commercial gain in the developed world and is concentrating on securing its 
hold on income generation in resource poor countries. The World Social Forum 
Conference, Brazil 2003, described as an instrument for change, included a 
workshop on asbestos led by Brazilian campaigners. This conference called for 
a global ban on asbestos (Kazan-Allen, 2003).  
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In summary, the investigation of palliative care needs of patients with 
mesothelioma and their families has to include an understanding of the issues 
involved in the rise and decline of the asbestos industry and the social, 
economic and political situations prevalent through the 20th and early 21st 
centuries. This is essential in order to make sense of the illness from the 
perspectives of the patients and their families in the real world context of their 
individual experiences and to understand their unmet needs with regard to 
palliative care services. 
 
The above account of the „social matrix‟ around mesothelioma and healthcare 
services for patients and their families leads to a range of issues for 
investigation. The importance of the social context, the acknowledged severe 
disease burden, and the lack of curative or effective disease-modifying 
treatments, naturally lead to an approach to the investigation in the tradition of 
social medicine and with particular emphasis on the supportive and palliative 
care issues. These considerations give rise to the following questions that form 
the research objectives for this study of mesothelioma in Northern England: 
 
 What is the experience of mesothelioma for patients and their families? 
 What is the experience of mesothelioma for healthcare professionals and 
service providers? 
 
The next chapter explains how these questions led to the design of the study 
entitled „The experience of mesothelioma in Northern England‟ 
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Chapter 2: Methods 
 
2.1 Study design 
Following on from the research questions, this chapter describes how the 
design of the study was determined, the underlying theoretical framework and 
the practicalities of the investigation. These considerations led to a mixed 
method, community-based, case study in four parts and conducted in three 
sites in northern England where asbestos was used in major industries.  This 
section will describe how both qualitative and quantitative methods were 
selected in order to address the research questions by obtaining data from four 
sources: patients with mesothelioma; bereaved relatives of patients who had 
died with mesothelioma; healthcare professionals involved in the care of 
patients with mesothelioma and, fourthly, medical case notes of patients who 
had died due to mesothelioma. The study follows the tradition of social 
medicine, as described in the Introduction. 
Choice of subject and outline of the study  
As a GP and medical director of a hospice in South Cumbria I had noted an 
increasing number of patients presenting with mesothelioma. Most of these 
patients had been exposed to asbestos while working in the shipyard and heavy 
engineering works in Barrow-in-Furness. Problems controlling symptoms in 
some of these patients prompted me to search the literature for information and 
to discover that little had been written specifically about palliation in this 
disease. Discussions with palliative medicine colleagues revealed that many of 
them regarded mesothelioma as „difficult to palliate‟ and this was subsequently 
endorsed in the BTS Statement on Mesothelioma (2001). This key publication 
was designated as a statement rather than guidance due to lack of sufficient 
evidence.  
 
Mesothelioma seemed to be a particularly appropriate and locally relevant 
subject for investigation, given that Barrow-in-Furness has the highest 
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standardised mortality rate (SMR8) for mesothelioma in men in England, 593 
between 1981 and 2000 (HSE, 2005a). I specifically chose to study pleural 
mesothelioma, excluding peritoneal mesothelioma, as the latter has different 
clinical features and is much less common. The research proposal, to examine 
the experience of mesothelioma in Northern England from the perspectives of 
palliative and social medicine, was then developed and colleagues at the 
University of Sheffield offered to supervise a doctoral study. At that time, GPs 
were able to apply for up to twelve months sabbatical under the Extended Study 
Leave Scheme that provided funds for locum cover in the practice and an 
Educational Allowance. My application for twelve months‟ leave was successful 
and enabled me to set up the study and to accomplish the majority of the data 
collection whilst on study leave. A bid for research funding from the Scientific 
Foundation Board of the Royal College of General Practitioners was also 
successful.  
 
The broad aim of the study was to obtain a comprehensive understanding of the 
experience of the disease, its impact, burden and provision of health services, 
as experienced by patients and their relatives. The study builds on work in other 
diseases, for example, breast cancer, in which an understanding from the 
patients‟ perspective has led to service improvements. I felt comfortable with 
this approach as it fitted in with family-centred general practice and also suited 
the holistic approach underpinning hospice and palliative care. In addition, GPs 
see individual patients in their family, social, geographical, environmental and 
occupational contexts and develop knowledge of the social history of their 
practice area. Holden (2004) describes this as the „social geography‟ of general 
practice, formulated by each GP as a unique and privileged „mental map‟ that 
underpins their expertise. Given these considerations, and the history of 
mesothelioma, it was clear that social context could not be ignored in a 
community-based study of mesothelioma. Family members also needed to be 
included in acknowledgement of their vital role and the increasing recognition 
that carers of people with terminal illness have specific needs. (Payne and Ellis-
Hill, 2001; Nolan, 2001a; Rose, 1997; Harding and Higginson, 2003; 
Department of Health, 2006b).. 
                                                 
8
 The SMR is a measure of relative mortality: the ratio of observed number of deaths to expected number 
of deaths multiplied by 100. The SMR of the standard population is 100.  
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Choice of method and theoretical background 
In Chapter 1 the historical, industrial, and social context surrounding 
mesothelioma was described alongside the complexities concerning the 
disease and its investigation, treatment and compensation. Palliative care, like 
general practice, or family medicine, considers patients‟ problems as multi-
dimensional: interlinking physical, psychological, social, emotional and spiritual 
domains (Box 1.3, p35).  Consideration of the context around mesothelioma led 
to the conclusion that the study would follow the tradition of social medicine, 
defined as medicine in its social context and described earlier (section 1.7)  
 
Social scientists, including researchers in social medicine, have increasingly 
favoured research methods that rely on multiple sources of evidence and many 
studies incorporate both quantitative and qualitative methods in case studies 
(Yin, 1994:1-8). This supported my choice of the case study approach, in which 
four data sources from each of the three sites were sampled. Yin (1994: 38-52) 
describes the careful consideration that needs to be given to the definition of the 
case in order to ensure clarification of the limits of the study and to determine 
the method/s of investigation. The overarching case was defined as „The 
experience of mesothelioma in Northern England‟. Table 2.1 demonstrates the 
relationship between the subsets in this embedded case study; the units of 
analysis; and the chosen research methods; as explained in the next section. 
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Table 2.1: The design of the case study 
 
The case study approach 
Expert views of case study define it as either a research strategy or method. Yin 
(1981) defines case study as „a strategy for doing research which involves an 
empirical investigation of a particular contemporary phenomenon within its real 
life context using multiple sources of evidence‟. Similarly, Robson, (2002:179), 
summarises the case study approach as essentially a research strategy that is 
empirical, studies a specific case, and focuses on the phenomenon in context, 
using multiple methods of evidence or data collection. However Bowling, 
(1997:359), defines case study as a „research method that focuses on the 
circumstances, dynamics and complexity of a case or a small number of cases.‟  
 
There are several essential components to the case study approach: 
1. Case studies allow for investigation of a subject when context is an important 
factor. They reflect „lived world‟ complexities in which ill-health has many 
interrelated factors such as social, economic and political situations (Yin, 
1994:13). This mirrors the social medicine approach to this study in which an 
The sub-sets The units of analysis The research 
method 
A number of medical records of 
patients who died with 
mesothelioma in the 3 sites 
Hospital, GP and hospice 
records of 80 patients who 
died with mesothelioma 
Documentary 
survey 
Patients with mesothelioma in 3 
sites with a high incidence of 
mesothelioma 
15 individual patients 15 Semi-
structured 
interviews 
A group of bereaved relatives who 
had cared for a patient with 
mesothelioma across the 3 sites 
6 focus groups of bereaved 
relatives 
Focus groups, 2 
in each of the 3 
sites 
Healthcare professionals involved 
in mesothelioma care in the 3 sites 
11 individual health 
professionals 
11 Semi-
structured 
interviews 
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understanding of the social factors behind the asbestos industry; the history of 
mesothelioma; and its status as an industrial disease; is crucial to 
understanding the experiences of patients and their families.  
 
2. Case studies allow multiple methods and multiple sources of evidence to be 
incorporated thus obtaining more than one perspective. I wanted to extend 
beyond Barrow (although it would have been much simpler to undertake on one 
site) because this related to an outdated industrial situation unlikely to be 
repeated in the future. The same reservation applied to Leeds where the 
asbestos factory closed in 1955 but less so to Doncaster with its continuing 
power stations and railway works, albeit now governed by Health and Safety 
regulations. An additional practical consideration was the likelihood that few 
patients with mesothelioma would be available for interview in any one site 
within the study period. The use of three sites reflected at least four different 
industrial exposures to asbestos but also, by virtue of their relative regional 
importance, reflected differing levels of health service provision for cancer 
patients in the 3 sites, Table 2.2. Incorporating data from several sources allows 
for convergence of multiple data in the process of triangulation.  
 
3. Case studies allow for early or prior hypotheses that may influence the study 
design. Given my interest in mesothelioma, it was inevitable that I would come 
to this study with some prior, if naïve, ideas about the subject. Prime amongst 
these was the impression that patients with mesothelioma had particular 
palliative care needs that were neither researched nor documented and that a 
deeper knowledge of these could lead to better care. There was little specific to 
palliative care in mesothelioma to inform the study in the literature apart from 
recognition that pain and breathlessness may be difficult to alleviate (BTS, 
2001). Mercadante et al, (2000), reported a unique situation regarding 
mesothelioma in which opioid doses increase throughout the illness in contrast 
to other malignancies in which the trend is for analgesic doses to stabilise, 
(although only four patients with mesothelioma were included in a total sample 
of 434 patients with cancer). I also felt that the relatives of people with 
mesothelioma often seemed almost overwhelmed with the responsibilities of 
caring, and were severely affected by bereavement. 
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Cancer patients in general, and lung cancer patients in particular, as well as 
their family carers, have unmet needs concerning information and psychosocial 
support (Thomas et al, 2001:128-9; Krishnasamy and Wilkie, 2001:78-91; 
Department of Health, 2000b). Hill et al (2003) revealed that, after concerns 
relating to their illness, patients with lung cancer were worried about the impact 
of their disease on their close family.  From experience, I considered close 
relatives of patients with mesothelioma to have specific needs regarding 
information and bereavement support but this had not been reported in the 
literature. The rival theory, as described by Yin (1993:149), would be that they 
had no specific palliative care needs compared with the nearest clinical group, 
that is, patients with lung cancer. However, I had no way of knowing whether or 
not my early notions would be confirmed by the study. 
 
4. Case study design is flexible and there is no mandatory unit of analysis. In 
this study three of the four subsets, patients, families and healthcare 
professionals represent three social groups; each group contains multiple units 
of analysis that contribute to the overarching case: „The experience of 
mesothelioma in Northern England‟. Flexibility also applies to the ability to refine 
the study as data collection and analysis proceeds and to „learn on the job‟ 
(Robson, 2002:182). This is how the first three interviews with patients in 
Barrow were conducted as a small pilot study, used both to test the feasibility of 
the method and as a trial run for me as an inexperienced researcher. Yin 
(1994:74) calls this a pre-test rather than a pilot, unusually Yin regards a pilot as 
an experiment to trial different methods of data collection. Alternatively, „dress 
rehearsal‟, as in this study when the first three interviews informed the main 
study, is „perhaps closer to the usual meaning of a pilot study‟ (Robson, 2002: 
185). 
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Table 2.2: Hospital services for cancer patients in the 3 sites  
 
Why an embedded case study? 
The overarching case, „The experience of mesothelioma in Northern England‟, 
may be viewed as a „conceptual umbrella‟ that covers the multiple sub-sets or 
sub-units embedded in the study (Yin, 1994: 41). The aim of understanding the 
meaning and experience of mesothelioma from the perspectives of patients and 
their families could have been approached by joint or separate methods. I 
discounted the idea of trying to study patient/family carer dyads because I 
believed that recruitment of current carers would be extremely difficult given 
both the small numbers and the demands of caring. I had concluded that 
                                                 
9
 The NHS Cancer Plan (2000) defined 3 levels of cancer services: cancer units, cancer centres and 
regional cancer centres 
 Barrow Leeds Doncaster 
Hospital 
service9 
District general hospital, 
cancer unit  
Regional cancer 
centre across 3 
hospitals in the city 
District general 
hospital, cancer 
unit 
Cancer 
services 
Weekly clinic by visiting 
Clinical oncologist  
Full provision in  
Leeds 
Visiting 
oncologists 
Radiotherapy At Preston, ~70 miles 
from Barrow 
 Full provision in  
Leeds 
                 „‟  
In Leeds or 
Sheffield, ~28 and 
~17 miles away 
Chemotherapy  Limited chemotherapy  
on site, most in 
Manchester,  ~100 
miles away 
Full provision in  
Leeds 
 
                „‟ 
Limited 
chemotherapy on 
site, some in 
Sheffield. 
Cardio-thoracic  
surgery 
In Blackpool, ~80  
miles away 
Full provision in  
Leeds 
                 „‟ 
In Leeds or 
Sheffield, ~28 and 
~17miles away 
Palliative 
medicine 
1 consultant 5 consultants 1 vacant 
consultant post 
Hospice  1 8-bedded hospice, 8 
miles from Barrow 
2 hospices across 
the city – 32 and 18 
beds 
1 hospice on the 
city outskirts, 10 
beds 
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investigating patients and bereaved family carers separately would be more 
feasible. In addition, in the absence of literature around palliation in 
mesothelioma, I felt it necessary to undertake a survey of the medical records of 
a number of patients with mesothelioma in order to underpin the data from 
patients and relatives with knowledge of the disease trajectory and the medical 
care provided in each of the three sites. A second reason for studying the 
medical records was to familiarise myself with the healthcare services in Leeds 
and Doncaster10; I only knew one healthcare professional in each of these sites 
prior to the study. In order to obtain a rounded picture of healthcare related to 
mesothelioma in the three locations I felt that the views of healthcare 
professionals should also be included. At the outset I intended that all the data 
sources would have equal weight. The inclusion of four separate data sources 
permitted triangulation of data or „converging lines of enquiry‟ with the intention 
of improving research rigour. 
 
The decisions around determining the type of case study were complex 
because there were several possibilities as shown in Table 2.3 below. 
 
 
 
Table 2.3: Basic types of designs for case studies (Source: COSMOS 
Corporation, in Yin, 1994: 39) 
 
Difficulties arose around deciding if the study was a multiple case study 
encompassing three separate cases relating to the three sites or relating to the 
four data sources or alternatively, whether it was more appropriate to regard the 
study as an embedded case study: an exploration of the experience of 
mesothelioma in which data from medical records, patients, bereaved relatives 
and healthcare professionals were not regarded as separate cases but rather 
as four embedded subsets that contributed to the overall case. My original 
intention had been to investigate on three sites for mainly practical (recruiting) 
                                                 
10
 I was very familiar with the services in Barrow-in-Furness having been a GP in the area for 25 years 
 Single case designs Multiple case designs 
Holistic (single unit of 
analysis) 
Type 1 Type 3 
Embedded (multiple 
units of analysis 
Type 2 Type 4 
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reasons (p 67) and I had assumed that there would be more similarities than 
differences concerning the experience of mesothelioma in these locations; any 
differences were predicted to relate to geographical location and distance from 
specialist centres as well as local level of health service provision.  
 
A multiple case study that regarded the three locations as three separate cases 
would usually imply a comparative study and this was not the intention. If I had 
wanted a comparative study I would have chosen a more quantitative approach 
and paid more attention to „sampling logic‟ (Yin, 1994: 45). The other type of 
multiple case study that I contemplated for this investigation was to consider the 
four data sources, medical records, patients, bereaved relatives and healthcare 
professionals as four separate cases rather than as embedded subunits. Again 
this might imply a more comparative study and both methods and analysis 
would have been approached in a different way, but in my study understanding 
rather than comparison was the main intention. In addition, although the 
distinctions are not absolute, I felt that, according to Yin (1994:45-7), if four 
separate cases had been chosen I should have sought more diversity amongst 
the samples: although the data sources were all drawn from the three sites they 
were each a fairly similar group, for example, with regard to the interviews with 
patients, most had worked in the „traditional‟ asbestos-using industries. Thus 
the embedded design, with its emphasis on the overall case, seemed to fit more 
closely with both my original approach to this study and also with the tradition of 
social medicine, in which the overall experience of mesothelioma was to be 
explored in all its overlapping medical and social contexts and not to be seen as 
four separate investigations. To put it another way, patients and their relatives 
experience illness, not in isolation, but in their family, healthcare and wider 
social settings and this was reflected in the design of the study. 
Definition of the sub-sets in the embedded case study 
Table 2.1 (p 61) illustrates the relationship between the components of the case 
study, the units of analysis and the chosen research method for each subset. 
As shown, there are 80 medical records as individual units of analysis within a 
subset, 15 individual patients as separate units of analysis within another 
subset, 6 focus groups containing 17 bereaved relatives within a third subset, 
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and 11 healthcare professionals as individual units of analysis within a fourth 
subset; these are all embedded in the overall case study.  
Choice of three sites 
I realised at the outset that the study would need to be on more than one site in 
order to recruit sufficient patients and relatives due to the small numbers 
presenting with the disease in Barrow-in-Furness, approximately 12 per annum 
at the beginning of the study, and knowing that recruitment to studies in 
palliative care is difficult (Dean and McClement, 2002; Addington-Hall, 2002). I 
wanted to find other sites that would increase recruitment and that related to 
industries other than shipbuilding in order to increase generalisability, or, 
perhaps more accurately, transferability.  
 
Practical considerations in choosing the sites related to my home being near 
Barrow and my doctorate being conducted at the University of Sheffield: as a 
lone researcher I felt that I could manage two additional sites provided that they 
were within reasonable distance of Sheffield where I could arrange 
accommodation during the period of study leave. I already knew of the 
mesothelioma cases in Leeds from the notorious asbestos textile factory in 
Armley and then discovered that Doncaster had the highest incidence of 
mesothelioma in men in Trent, apparently related to the large railway 
construction and maintenance plant. Leeds and Doncaster then became the two 
other sites, and were fortunately close to Sheffield. Apart from relating to 
differing industries with regard to asbestos exposure, the three sites also varied 
in the level of healthcare provision for patients with cancer (Table 2.2).  
Entwistle et al (2002) illuminate some of the interactions between practical 
considerations and methodology in studies of experiences of cancer. 
 
Barrow-in-Furness is a declining industrial town in South Cumbria, population 
~72000 in 200111. It was built around the development of a shipyard that began 
in the late 19th century and many of the initial workers were impoverished 
migrant labourers from Ireland. The shipyard, and subsequently the 
neighbouring heavy engineering works, expanded during the Second World 
                                                 
11
 All population figures are from the Census 2001 
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War to produce many famous warships and armaments. These were the major 
source of employment in the war years and later, until production declined in the 
1980s, and were owned by Vickers Shipyard and Engineering Ltd. Asbestos 
was used extensively in both industries, mainly as insulation and fireproofing 
during manufacture and maintenance.  
 
Barrow has a district general hospital, the nearest cardiothoracic centre is in 
Blackpool, ~ 80 miles away, and radiotherapy services are based in Preston, ~ 
70 miles from Barrow. Some chemotherapy is provided in Barrow, but patients 
in clinical trials usually receive their treatment in regional cancer centres such 
as Manchester, 100 miles away. 
 
Leeds is a large and wealthy industrial city in Yorkshire, population ~715000 in 
2001. The main asbestos industry, until its closure in 1955, was the Roberts 
asbestos textile factory in Armley. This factory was responsible for heavy 
asbestos dust contamination of the surrounding residential area in one of the 
poorer districts of the city. The factory was next door to a school, former 
schoolchildren recall playing with the asbestos debris in the form of „snowballs‟. 
One of these, June Hancock, succeeded in a test case that established 
causation due to environmental exposure to asbestos (Budgen and Lipsitz, 
2006:436-7). Leeds was also a suitable site because of its status as a regional 
centre for cancer services; all specialist cancer services are available in Leeds, 
although spread across the city on several sites. In addition, the Mesothelioma 
Information Service, a telephone advice service funded by Macmillan Cancer 
Relief, was situated in hospital premises in a Leeds suburb12. 
 
Doncaster is a smaller city in South Yorkshire, population ~287000 in 2001. 
Doncaster was chosen for the study because it has the highest incidence of 
mesothelioma in Trent (Haselton, 2001). The main asbestos-using industry was 
a large railway maintenance and repair plant; however, on commencing data 
collection, I realised that the area has numerous power stations sited along the 
River Trent, and these subsequently proved to be linked to some of the cases of 
mesothelioma investigated in the study. Doncaster represents a midway 
                                                 
12
 See description of the Mesothelioma Information Service in Chapter 6, section 6.7. 
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position concerning cancer services compared to Barrow and Leeds: although 
like Barrow it has a district general hospital, tertiary services are nearby in 
Sheffield or Leeds. 
 
Initially, West Dunbartonshire in Scotland was considered as a study site 
because it has the highest incidence of mesothelioma in men in the UK: SMR 
637, 1981-2000 (HSE, 2005a). However there would have been practical 
difficulties such as travel and accommodation as well as my unfamiliarity with 
Scottish health services as distinct from English services. A significant other 
concern was my anticipated difficulty in understanding the strong Clydeside 
accent during interviews (as experienced at a Clydeside conference). 
 
2.1.1 Choice of methods used in the case study 
In this section I explain the rationale behind the choice of the methods, Table 
2.4. In order to produce credible results, the methods incorporated in a multiple 
methods case study must be selected to be the most appropriate for the 
research questions. 
 
Table 2.4: The relationship between research questions and methods 
 
Medical records survey 
 
A survey of archival documents is designed to gather recorded data and to 
produce, in this case, a large database suitable for quantitative analysis. I 
decided to undertake a survey of the medical records of a number of patients 
who had died due to mesothelioma in order to gain insight into the local 
healthcare organisations, the disease trajectory and burden, and health 
Research question Methods  
1.To investigate the experience  
of mesothelioma for patients and 
their relatives 
1. a) Semi-structured interviews with patients 
     b) Focus groups with bereaved relatives 
2.To investigate the experience of 
mesothelioma for healthcare 
professionals and service providers 
2. a) Review of medical records of deceased 
        mesothelioma patients 
     b) Interviews with health professionals 
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services provided. In order to obtain a comprehensive picture from the written 
records I decided to review GP, hospital, and where applicable, hospice records 
for each deceased patient studied. In Leeds and Doncaster, where I had almost 
no prior knowledge of the local healthcare professionals or organisations, this 
enquiry was also intended to familiarise me with the local healthcare contexts.  
 
 A proforma (Appendix 12) was used to standardise the data collection. This 
was amended by the addition of the following three questions after the first 
three records had been examined: other clinical investigations, place of death, 
and mode of death; this additional data from the first three records was then 
retrieved. The mode of death was often not recorded in the medical notes but 
could be found in the nursing records. As I felt that this was important 
information I decided to record the data regardless of its source. All other data 
was obtained from the medical records. This was for three reasons: firstly I am 
familiar with the format of medical records, secondly, I am unfamiliar with the 
format of nursing records and thirdly, the additional volume of data from nursing 
records would be overwhelming without guaranteeing any additional value in 
terms of data for this study. 
 
Semi-structured interviews with patients.  
I chose to interview patients diagnosed as having mesothelioma in order to best 
explore their „lived world‟ experience and meaning. In interviews, the task of the 
researcher is to make sense of what is said, and how it is said, by paying 
intense attention to the narrative and also to non-verbal communication. 
Interview accounts reflect the way in which people tell and retell significant life 
stories and can be viewed as a resource in which narratives may be a potent 
way of developing meaning. Interviews with patients may have a therapeutic 
effect in helping to „contain‟ distressing issues. In addition, the account may be 
a way of framing the illness from the patient‟s or couple‟s perspective or 
alternatively, retelling may gradually produce an agreed „public‟ account. 
Research interviews may have moral value as they may be seen as potentially 
helping future patients, indeed they may be regarded as a way of making a new 
and positive contribution by patients who are facing death.   
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I decided to conduct semi-structured or guided rather than open interviews in an 
attempt to focus on the main issues and to avoid over-lengthy sessions for 
people who may be very ill, short of breath or in pain.   As a GP and hospice 
doctor, my working life revolves around listening to patients and their relatives 
and this had an affinity with the interview method which relies on the 
development of a relationship between the researcher and the interviewee. An 
interview guide was used (Appendix 4) in order to ensure that key areas were 
covered. 
Focus groups with bereaved relatives  
Focus groups are recognised as being appropriate for the investigation of 
sensitive topics (Renzetti and Lee, 1993:166-176; Bowling, 1997:352-7). As 
mentioned earlier, I chose to involve bereaved relatives because I anticipated 
that the demands of caring for someone with a short and demanding illness, 
such as mesothelioma, would make recruitment of current carers extremely 
difficult. People may feel there is „safety in numbers‟, particularly when the 
participants may be a traumatised or stigmatised group. Focus group members 
may act as prompts for others as they may have shared experiences. The 
experience of meeting others with much in common may reduce emotional 
distress, although there is the risk that the opposite could occur. There are 
varying opinions regarding the accuracy of relatives‟ accounts as proxies for 
patients, particularly with regard to symptom severity (Lobchuk and Degner, 
2002; Addington-Hall and McPherson, 2001), although in this study it was 
primarily the experiences of the relatives that were being explored in the focus 
groups. There are ethical issues to consider in working with bereaved relatives 
such as concerns about „raking it up again‟ and exacerbating grief; there may 
also be the risk of focussing on the negative aspects of the experience. 
However, the participants in this study were all volunteers. 
 
Morgan (1988) describes 5 uses of focus groups: „to orientate the researcher in 
a new field; to generate hypotheses based on informants‟ insights; to evaluate 
different research sites or populations; to develop interview schedules and 
questionnaires; and to get participants‟ interpretations of results.‟ In this study, 
focus groups were chosen primarily as data sources in order to develop 
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understanding and theory and, to a lesser extent, to enable cross-site and 
cross-method comparisons as described later, p82-4. 
Semi-structured interviews with healthcare professionals  
Interviews were again chosen in order to illuminate the real world experiences 
of participants. Semi-structured rather than open-ended interviews were chosen 
in consideration of the time demands on professionals and an interview guide 
(Appendix 11) was used to focus the enquiry. As the professionals were from 
my peer group I believed it would be possible for me to delve deeper in 
response to prompts and examine variance between the participants. Edwards 
(1993), writing about feminist research, describes the value of „double 
subjectivity‟ in research interviews in which the researcher is seen as a variable 
in the interactive process of interviewing; she relates this to non-hierarchical 
woman-to-woman interactions. Self-disclosure about my position as a 
GP/hospice doctor/researcher and my reasons for the study to healthcare 
participants who were my professional peers, alongside written information 
about the study prior to the interviews, established reciprocity in the interviews.  
 
2.1.2 Accounts of the methods in the 3 settings 
Sampling 
 
The size of the sample for each of the four methods was determined by a 
combination of research quality and practical issues, Table 2.5. The overall 
study is based on qualitative data supported by a quantitative survey. Statistical 
representation is not the intention, generalisability is the goal. Therefore the 
number of qualitative investigations needed to be sufficient to allow 
generalisability to patients and relatives in similar settings and also, importantly, 
a manageable number for me as a single researcher; the sample would 
therefore be opportunistic, depending on recruitment, and purposive. Although 
the original research proposal submitted for Local Research Ethics Committee 
(LREC) approval proposed up to 12 interviews in each of the three sites, this 
number was not achieved due to recruitment difficulties. In the end however, I 
was satisfied that the total of 15 interviews with patients provided  rich data and 
fulfilled the need for transferability.   
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The size of the focus groups was limited by recruitment and they were again 
smaller numbers than I had originally envisaged. Several consented participants 
failed to attend on the day, leaving just one person for one „group‟ in Doncaster, 
as discussed later, p96. However, considering the rich data that the groups 
produced, I was not disappointed with the outcome.  
 
The choice of healthcare professionals to interview was determined by my wish 
to include the views of a range of professionals that could reveal the main 
issues around services for patients with mesothelioma. This was again an 
opportunistic and purposive sample that depended on availability at the time of 
the study. 
 
The number of medical records sampled was also decided pragmatically, in 
terms of what I thought I could reasonably manage, plus consideration that a 
period in Barrow, somewhat arbitrarily chosen as three years, would produce a 
reasonably-sized sample that could be replicated in the other two sites. The 
sample size was not based on statistical power calculations because the 
intention was not to produce a statistically rigorous comparison across the three 
sites but to allow the findings to be reported in terms of descriptive statistics. It 
was intended that this would enrich the understanding of the disease trajectory 
and healthcare services concerning mesothelioma in the three locations.
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Table 2.5: Details of the samples and data collection sites  
 
Conducting the study in my own locality, Barrow-in-Furness, was easier in every 
respect than in the other two sites. Familiarity with the Barrow healthcare 
professionals and organisations made communication and collaboration easy. 
In Leeds, as described later in the Ethics section, 2.1.3, the consultant in 
respiratory medicine invited me to give a presentation about the study to the 
hospital Lung Cancer Research meeting. This presentation led to support from 
the lung team for the study and two nurses who had been present subsequently 
participated in the study. In Doncaster, knowing the consultant in palliative 
medicine prior to the study was helpful in setting up a meeting with the team of 
Clinical Nurse Specialists, who then assisted with recruitment; two of them were 
interviewed for the study. 
 Barrow Leeds Doncaster 
Patient 
interviews 
7 5 3 
Venues Home 6, hospice 1 Home 5 Home 3 
Bereaved 
relatives focus 
groups 
2 groups  
7 participants in total 
 
2 groups 
5 participants in total 
 
2 groups 
5 participants in 
total 
Venues 1) Hospital conference 
room, Barrow-in-Furness 
2) Arts Centre, Barrow- 
in-Furness 
1) Solicitors office, 
Leeds 
2)   Solicitors office, 
Leeds      
1) Community 
Centre, 
Doncaster 
2) Hospice, 
Doncaster 
Healthcare 
Professionals 
4 4 3 
Designation Respiratory consultant, 
Specialist lung nurse,  
GP, oncologist 
Specialist lung nurse, 
Mesothelioma help-line 
nurse, respiratory ward 
sister, cardio-thoracic 
surgeon 
Specialist lung 
nurse, Palliative 
medicine 
consultant, 
Respiratory 
physician 
Hospital 
records 
26 27 27 
Venues Furness General 
Hospital, Barrow-in-
Furness 
Leeds General Infirmary, 
St James‟s Hospital, 
Cookridge Hospital. 
Doncaster Royal 
Infirmary 
GP records 26 27 27 
Venues Morecambe Bay Health 
Authority HQ, Kendal, 
Cumbria 
E. Yorkshire Agency, 
Leeds 
PCT HQ, 
Doncaster 
Hospice 
records 
5 13 9 
Venues Hospice of St Mary of 
Furness, Ulverston, 
Cumbria 
St Gemma‟s Hospice, 
Leeds 
Wheatfields Hospice, 
Leeds, Yorkshire 
St John‟s 
Hospice, 
Doncaster, 
Yorkshire 
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I began the data collection in Barrow for convenience and also because Local 
Research Ethics Committee (LREC) approval was granted there first. This 
allowed me to use experience in Barrow to effectively produce a template for 
the other two sites. In order to familiarise myself with each healthcare setting, I 
decided to undertake the review of medical records in each site before 
conducting interviews or focus groups. I also left the interviews with healthcare 
professionals until last in order to avoid reinforcing a „medicalised‟ perspective 
that could cause bias in the interviews with patients and focus groups. 
 
Conducting the medical records review 
Barrow-in-Furness 
Once LREC approval had been granted for the Barrow study, copies of the 
letter from the LREC were sent to the Chief Executive and Medical Records 
Managers of the hospitals and primary care trusts and to the Chief Executive of 
the hospice where I am the Medical Director requesting access to the records of 
deceased patients who had died with mesothelioma between 1.1.1998 and 
1.1.2001. Permission was readily obtained from all three sources. The details of 
36 patients who died due to mesothelioma, that is, those in whom 
mesothelioma was included in Part 1a or 1b of the death certificate, within the 
3-year period, were supplied on password-protected disk from the public health 
information department. The sampling frame, resulting in a final sample of 26 
records, is shown in Figure 2.1. Access was agreed with the provision that the 
notes were to be examined on official premises: the hospital notes were 
examined over 5 days in the medical records department, the GP records were 
examined in the PCT headquarters over 4 days and the hospice notes were 
examined over 2 days in the hospice by the researcher.  
 
Data collected onto a proforma, (Appendix 12) were subsequently transferred 
onto a computer software programme, Statistical Software for Social Sciences 
(SPSS), to assist with data handling and analysis. I decided to colour code the 
written proforma entries according to the data source, thus hospital data was 
entered in black, GP data in blue and hospice data in green. This was partly so 
that I could see where information came from but also to potentially be of use 
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for future research. The data collection and entry procedures were identical 
across the three sites.  
 
Leeds 
As there were considerably more patients identified than in Barrow, 28 were 
randomised by the West Yorkshire Central Services Agency, aiming to achieve 
the same number as obtained relating to the same time period as in Barrow, 
see Figure 2.1. Details of LREC approval were then sent to the hospital and 
primary care trust chief executives and medical records managers with the list 
of hospital and GP records required. Once those patients who had accessed 
hospices had been identified, similar letters, relating to these patients, were 
sent to the medical directors of the two Leeds hospices. The hospital notes 
were spread across 4 hospital sites and were examined over 8 days. The GP 
notes were made available for examination at the East Yorkshire Agency and 
were examined over 5 days. Hospice notes were examined on site. 
 
Doncaster 
Once LREC approval had been obtained, the letter of confirmation was sent to 
the manager of the medical records department. They provided details of the 
deceased patients and the total number over the 3-year period was similar to 
Barrow, see Figure 2.1. Hospital records were examined in the medical records 
department, GP records in the PCT headquarters and hospice records, after 
obtaining permission from the medical director as in Leeds, were examined in 
the hospice. 
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Figure 2.1: Sampling frame for hospital records  
 
 
 
Barrow : 
 
36 patients identified by Public Health Department from death certificate data 
 
Less 1 patient because notes not traced 
 
= 35 notes retrieved  
 
Less 6 patients treated in Lancaster not Barrow 
 
= 29 patients 
 
1 admitted in extremis, not diagnosed or treated, post mortem diagnosis 
 
= 28 patients 
 
On detailed examination, peritoneal not pleural mesothelioma in 2, excluded 
 
= 26 final sample 
 
 
Leeds: 
 
Names of 28 (same number as original Barrow sample) randomised deceased patients 
were supplied by the W Yorkshire Central Services Agency  
 
7 records not traced  by MDT co-ordinator, (records kept on 3 sites) locations) 
 
=21 retrieved 
  
A further 7 names randomised from remaining total and all retrieved 
 
 = 28 
 
Less 1 patient who had peritoneal not pleural mesothelioma 
 
= 27 final sample 
 
 
Doncaster: 
 
Trent Cancer Registry identified a total 30 deceased patients, I not traced 
 
= 29 notes retrieved  
 
Less 2 with other diagnoses – I adenocarcinoma lung, 1 had peritoneal not pleural 
mesothelioma  
 
= 27 final sample 
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Conducting the interviews with patients 
 
In all three locations, recruitment of patients was via clinical nurse specialists 
already known to them, either Macmillan nurses or Lung cancer clinical nurse 
specialists. The main entry criterion was that the patient knew and understood 
the diagnosis of mesothelioma. I met all the nurses personally to explain the 
study and to give them information leaflets, consent forms and stamped 
addressed return envelopes. An information leaflet (Appendix 1) was provided 
with the consent form. I always rechecked that consent was still valid at the start 
of each interview and offered to stop the tape if anyone became upset during 
the interview. The interview guide was a list of prompts that covered the various 
aspects of the patient‟s work and family background; disease onset; 
investigations and treatments; how the diagnosis was disclosed; the reaction to 
the diagnosis and then led onto current situation and, if appropriate, forward 
plans. The method, including the use of the interview guide, was reviewed after 
the first three interviews. I decided to use the first three interviews as a small 
pilot or in Yin‟s (1994:74) terms, a „pretest‟, and as a result three items were 
added to the proforma: other investigations; mode of death; and place of death. 
These three interviews were included in the data for analysis as they did not 
differ substantially from the subsequent interviews. The „working title‟ for these 
interviews was „Palliative care in mesothelioma: What are the needs of patients 
and their families‟; the final title arose once data collection commenced and it 
became apparent that the original did not reflect the scope of the study13. 
 
My hospice catchment area included Barrow; therefore I was careful to avoid 
introducing the study personally14 to any of the patients with mesothelioma for 
whom I was responsible. Recruitment was slow and erratic because, although 
Barrow has the highest SMR for mesothelioma in men in England, at the time of 
commencing the study that equated to around 12 cases per year.  
 
With the exception of one Barrow interview that was conducted in a hospice, (at 
the patient‟s request, he was an inpatient at that time), all the interviews were 
conducted in the patients‟ homes. The spouses of all but one of those who were 
                                                 
13
 As reflected in the study title in letters to patients etc found in Appendices 1-9 as this was the title used 
in applications to LRECs.. 
14
 The Macmillan nurses or lung cancer clinical nurse specialist recruited all the patients in Barrow 
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married were present (I had not mentioned this in the information leaflet). One 
cohabiting partner was in the house during the interview but in another room. 
 
I was aware that the patients and/or their relatives may find the interview 
distressing and made every effort to handle the interviews with sensitivity. At the 
beginning of each interview I checked that consent was still valid and assured 
the patient that they could terminate the interview at any time without penalty or 
displeasure. The patient was invited to give a brief background of their family 
and then their occupational history. This naturally led to consideration of how 
they had been exposed to asbestos and whether or not they had been aware of 
the health hazards at any time during their working life. Once this had been 
clarified I asked the patient to describe the onset of their illness and/or how 
diagnosis had been reached, how it had been communicated and how they had 
reacted at the time. This was followed by enquiring about their current 
symptoms, effects on their normal life and, if the patient was willing to discuss it, 
their thoughts on looking ahead to advancing illness and dying. I followed the 
patient‟s lead with regard to discussing death; most avoided the issue but some 
were clearly willing to confront and talk about death openly. On several 
occasions patients did become emotional but, in every case, given time to 
regain composure, they wished to continue the interview.  
 
The interviews lasted from 27 to 93 minutes apart from the contribution of one 
man that was just one word, ‘devastated’, as described in Vignette 4.2, p162. At 
the end of the interviews I thanked the participants and asked them if they had 
any questions. I also checked that the patient had access to support from either 
a Macmillan nurse or other clinical nurse specialist.  Not surprisingly, as this 
was how they had been recruited, they were all in touch with a specialist nurse. 
The mini disk recordings were then transcribed onto my laptop computer and 
entered onto a software programme, Atlas-ti for assistance with data-handling 
and analysis. The disks and transcripts were kept in a locked cabinet in my 
office. 
 
Conducting the focus groups 
 
Bereaved relatives for the focus groups were recruited either through clinical 
nurse specialists who had been involved in the care of the deceased patients or 
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via adverts or articles in the media (Appendix 5). An information leaflet was 
supplied and written consent obtained (Appendices 7 and 8). Only in one case 
was a focus group member related to a patient who was interviewed: Dora 
participated in a Barrow group 3 ½ months after the death of her husband (Mr I, 
Table 4.2) who was interviewed early in the study. In at least three cases 
recruitment was by word of mouth from people who had seen an advert or 
heard about the study on the radio.  
 
After introductions, and before the group began, I assured participants that they 
could leave or stop the group at any stage without penalty. I asked the 
participants to give a brief summary of their involvement with someone who had 
died with mesothelioma. Participants were asked to try to follow the story of the 
person that they had cared for, from the onset of symptoms to death and 
bereavement, taking one stage at a time where possible to allow for group 
discussion. I used small group facilitation skills acquired in general practice 
education to manage the groups, ensuring that all participants were able to 
contribute and that no one person or issue dominated the sessions. A guide 
(Appendix 9) was used (lightly) to ensure that key areas were covered. Light 
refreshments were provided and £5.00 for expenses was given to all 
participants. The focus groups were recorded onto mini disk then transcribed 
and entered onto Atlas-ti software. A list of support organisations including 
bereavement services was provided at the end of the sessions.  
 
Although I had planned for an assistant to be present during the focus groups in 
order to assist with practical details such as refreshments and recording, this 
did not happen: the proposed assistant for the first two groups was 
unexpectedly unavailable on those days. However these groups appeared to 
run well without an assistant and I then felt that an assistant might disturb the 
balance of the remaining groups, particularly as the numbers of participants 
were smaller than anticipated.  
 
Conducting the interviews with healthcare professionals 
 
Opportunistic, purposive, semi-structured interviews were conducted with a 
variety of healthcare professionals across the three sites. These were not 
designed to be representative, but to give a range of views and experiences 
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related to the management and care of people with mesothelioma and their 
relatives, as shown in Table 2.5. Recruitment was determined by availability 
and my knowledge of the doctors and nurses either personally or through the 
medical records review. A letter was sent confirming the agreed time and date 
of the interview and requesting a signature giving written consent to the 
interview. In each case I attempted to determine which professional in each field 
had considerable experience in mesothelioma. The interviews were all 
conducted in the normal workplaces of the professionals involved and took from 
15 minutes to 55 minutes. An interview guide was used to ensure coverage of 
key areas (Appendix 11). The interviews were recorded, then transcribed and 
entered onto a software programme, Atlas-ti, to assist with data handling and 
analysis.  
 
Analysis of qualitative and quantitative data  
Qualitative research interviews are premised on the conversation between the 
researcher and the participant, and „words are their main currency‟ (Vallis and 
Tierney, 1999). Analysis depends upon the interpretation of the data (words) in 
the hermeneutical tradition: hermeneutics can be regarded as how we reach an 
understanding of the meaning of a text (or text analogue). As interpretation is 
inherently subjective, it is important that researchers‟ perspectives are 
articulated as these will shape the understanding of the data, as in the 
Introduction, p 58-9. (Byrne, 2001).  
 
Interpretation of qualitative data in this case study was not limited to studying 
words in isolation. The process of interpretation was situated; for example, my 
observations of the setting, non-verbal communications between the participant 
and me and between the participant and their spouse, my field notes written 
following the interviews, and my prior (and developing) knowledge of 
mesothelioma, were all relevant to a growing understanding that ran alongside 
the process of data collection. Moreover this was an iterative inductive process 
in which developing notions were tested by feeding them into new interviews 
and focus groups or discussions with colleagues, essentially an informal 
process that accompanied the „formal‟ analysis, but crucial to developing a deep 
understanding of the experience of mesothelioma. 
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The more formal analysis began with careful listening to the recordings of the 
interviews and focus groups several times before moving on to using the 
transcribed data that had been entered onto Atlas-ti software. This programme 
enables words or passages of text to be selected and then coded as 
determined by the researcher. All quotes assigned to a particular code may be 
retrieved simultaneously and codes may be easily grouped together as 
developing themes emerge. Atlas-ti has many sophisticated functions but I 
simply used it for data handling and coding. An alternative programme, 
NUD*IST, was considered but I found Atlas-ti easier to use. I tried to avoid 
reductionist splitting of texts into isolated words and attempted to retain the 
essence of the accounts from the participants. 
 
After reading each transcript several times, I began the process of highlighting 
each significant section on the computer, deciding how to code it and then 
entering it under the appropriate code or forming a new code. As the number of 
codes increased, I grouped related codes together as themes or categories, 
following the Miles and Huberman (1994) first- and second- level coding 
system. From these major themes, I was able to begin to develop ideas or early 
theories relating to the findings of the interviews and focus groups. This process 
follows the grounded theory approach of Glaser and Strauss (1967) as a means 
of managing data and depends upon analytic induction as a method of data 
analysis. Thirteen tactics for generating meaning have been described by Miles 
and Huberman (1994: 245-6), Box 2.1: 
 
 
Box 2.1: Tactics for generating meaning (Miles and Huberman 1994:245-6) 
 
Initially I analysed the data from the four subsets, (Table 2.1, p61), separately 
but then began to reflect on the findings and how they were related across the 
1. Noting patterns, themes and trends 
2. Seeing plausibility 
3. Clustering  
4. Making metaphors 
5. Counting 
6. Making contrasts and comparisons 
7. Partitioning variables 
8. Subsuming particulars into the general 
9. Factoring 
10. Noting relations between variables 
11. Finding intervening variables 
12. Building a logical chain of evidence 
13. Making conceptual/theoretical coherence 
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subunits. Similar findings were brought together in what Miles and Huberman 
(1994:98) describe as „pattern matching‟ (Box 2.1) and variances or conflicting 
findings were examined to see how they affected developing theories.  
 
           For example: Several codes related to the involvement of family members, 
usually wives, in the experience of mesothelioma, and these codes reflected a 
very strong bond within the married couples. Rereading the texts, recalling the 
behaviours of the couples during interviews, reviewing the focus group data, 
and rereading my field notes, all combined to confirm my impression of the 
couples coping together as an important theme. I then grouped these related 
codes under the category of „in it together‟ – an example of triangulation of data 
from different sources and differing data collection methods. Later reflections, 
explored in the Discussion, Chapter 7, linked this category to the section on 
„caring in the family‟ and to the emerging theme of „the narrative of coping‟. 
 
          It was apparent during the early phase of analysis that coding, categorising, and 
triangulation were parts of an iterative mental process. This happened 
concurrently alongside the more structured physical coding and categorising 
using the Atlas-ti programme; on occasions „sparks‟ or „flashes‟ of insight 
occurred (Robson, 1994:478). 
 
Robson (1993:478) suggests that interim summaries are helpful in managing 
large quantities of qualitative data. Although I had not planned to do this, I found 
that requests for presentations of my work in progress starting in the first year of 
the study and increasing as awareness grew in „mesothelioma circles‟, 
(Appendix 13), actually served this function: preparing presentations clarified 
my thoughts and imposed a necessary discipline. 
 
Quantitative data from the review of medical records was entered onto the 
SPSS15 software programme. The study was not designed to produce 
statistically valid findings in terms of significance, and recruitment was not 
based on power calculations: the quantitative data was intended to 
complement the qualitative data and to inform the findings. Descriptive 
statistics are a feature of the SPSS programme that allows findings to be 
presented as mean or median values, and enables the range of results to be 
                                                 
15
 SPSS = Statistical Package for the Social Sciences. 
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readily obtained and to be presented graphically. Where there were marked 
differences between the three sites the results have been separated by 
location, but in most cases the results were aggregated because the study was 
not primarily meant to compare the three sites. 
Funding 
An initial research proposal was submitted to the June Hancock fund, at the 
time this was the only fund specifically for research into mesothelioma in the 
UK. The proposal was given to a trustee of the fund, herself a research 
assistant working in the field of patients‟ concerns in lung cancer. The proposal 
was rejected, mainly on the grounds of being too large for a sole inexperienced 
researcher. Fortuitously for me the detailed written critique was included with 
the rejection letter. I amended the proposal in light of the critique and the next 
application, to the Scientific Foundation Board of the Royal College of General 
Practitioners, was successful. At the same time I successfully applied for twelve 
months Extended Study Leave from full-time General Practice, and I was also 
granted an education allowance and locum expenses. (Sadly this scheme has 
subsequently been absorbed into general funds) 
 
2.1.3 Ethical issues  
There are concerns that interviewing people about sensitive subjects, for 
example about their way of coping with facing death, may cause harm to the 
patients; the ways in which I attempted to minimise harm to any participant is 
described later in the data collection section. However, invitation to contribute 
respects patient autonomy, and there is evidence that participating in a 
research project, even when there is no obvious gain for the patient, can be a 
positive experience in patients with terminal illness (Addington-Hall, 2002). 
 
Involvement in research may lead patients to expect some personal gain from 
the undertaking. With one exception, I was not responsible for the clinical care 
of the patients or relatives in the study and I made it clear to participants that I 
was not, and could not be, involved in their treatment. I discussed the situation 
with the one participant who was my patient in the hospice and who was clearly 
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keen to participate in the study16. I assured him that his treatment would not be 
altered by his participation and he appeared to understand the situation and 
wanted to „tell his story‟. 
 
In spite of trying to address all potential ethical issues I did not predict one 
potentially harmful outcome of a focus group: During a group discussion 
around prior knowledge of asbestos-related disease, a widow expressed 
concern that her son may have been exposed to asbestos on his father‟s work 
clothes. This conversation made another participant, a daughter of man who 
died with mesothelioma, suddenly realise that she may have been exposed to 
asbestos on her father‟s overalls.  Realising that this needed to be addressed, I 
offered to discuss the issue with her after the group. In that discussion it 
appeared that her father had been a maintenance engineer for a food 
manufacturer and he believed that he had inhaled fibres from decaying 
asbestos lagging on pipes in the cellars of the factory. He did not appear to 
have had heavy constant exposure to the extent of visible contamination of his 
work clothes. Moreover he had worked all over the plant and not mainly in the 
cellars.  In the circumstances it felt reasonable to give reassurance to his 
daughter that her exposure had probably been light. However, although on 
balance, reassurance was better than alarm when there was nothing this lady 
could have done to reduce her risks of developing mesothelioma at this stage, 
this reassurance left me uneasy. I could not quantify her risk, knew that there is 
no known safe exposure threshold and did not know the type of asbestos in the 
factory. This highlights tensions between my responsibility as the researcher; 
my knowledge of asbestos risk; the management of difficult and uncertain 
information; and my duty as a doctor to „first do no harm‟, complicated by her 
(unknown to me) expectations of me, knowing that I am a doctor. 
 
Advertising the study in media interviews, and advertisements for focus group 
participants, raised expectations in people who were not eligible for the study 
but, nevertheless, may have had unresolved bereavement issues. In spite of the 
eligibility criteria being clearly specified, several people bereaved due to 
mesothelioma, some many years ago, telephoned the secretary at the Trent 
Palliative Care Centre who had kindly agreed to take the calls. I phoned all 
                                                 
16
 His wife recruited him to the study: she had heard about it from a Macmillan nurse without my 
knowledge. Significant treatment decisions did not arise related to this patient. 
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these callers to thank them for their interest and to explain the reasons why they 
were not eligible for the study. I did not get the impression that any of them 
were currently distressed but had intended to suggest that they contact their GP 
if they had appeared to be. In most cases they expressed appreciation that I 
was researching in this area and that this would hopefully lead to improvements 
in care of future patients. 
 
Achieving LREC approval 
Applications for ethical approval were made to the Local Research Ethics 
Committees for the three sites. Each committee had its own application forms, 
ranging from 5 pages in Barrow to 13 in Leeds. Multiple copies of the 
application forms, maximum 17, had to be posted to each committee. 
 
Barrow: The first application, submitted in July 2000, related to a small 
interview study of three patients with mesothelioma in Barrow and was 
originally intended as an assignment for the Qualitative Research Methods 
Module of the MA in Health Research Methods at Lancaster University. 
Approval was granted in August 2000. Recruitment was slower than expected 
due to attrition and my inexperience. I had to request two amendments to the 
original protocol in order to increase recruitment: firstly to extend the 
recruitment criterion from „shipyard workers‟ to include „people indirectly 
exposed to asbestos‟, and secondly to further extend the same criterion to 
„three mesothelioma patients from the Barrow-in-Furness area.‟ As a result of 
slow recruitment the deadline for the assignment was exceeded, but in the 
meantime I learnt that my application for extended study leave had been 
successful. This then enabled the three interviews to constitute a pilot study for 
the interviews with patients. A further application for the complete case study 
was granted in July 2001 once two conditions had been satisfied: 1) that I 
amended the protocol to include either reimbursement of travel costs or a token 
payment (£5.00) towards costs to focus group participants, and 2) that the 
information leaflet for participants was amended accordingly.  
 
Leeds: I applied in August 2001 and LREC approval in principle was granted 
immediately, on two conditions: 1) that a Leeds consultant should be the local 
co-investigator and 2) that I comment on the recruitment of focus group 
participants through newspaper advertisement.  The committee were 
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concerned that, as a self-selected group, the sample would not be 
representative. A consultant in respiratory medicine with an interest in 
mesothelioma agreed to be co-investigator and I clarified that the sample was 
intended to be a purposive volunteer sample and not statistically 
representative. My co-investigator then sent the protocol and LREC letter 
confirming approval to the Leeds Health Authority Caldicott Guardian, (see next 
section), who also approved the study. Details of deceased mesothelioma 
patients were requested from the Northern and Yorkshire Cancer Registry and 
Information Service (NYCRIS) with copies of LREC and Caldicott Guardian 
approval but access to the records was not agreed until the study had been 
discussed at the NYCRIS Advisory Group in October 2001. 
 
Doncaster: The Doncaster LREC replied to my initial application in August 
2001 with an invitation to an early morning meeting to discuss three areas of 
concern: 1) „it was felt that a quantitative study must provide (sic) sample size 
calculations and an end point‟, 2) „whether enough information would be 
obtained from the 36 case studies‟ (referring to the original intention to recruit 
12 patients for interview in each site), and 3) „that as the study only looks at 
those referred for palliative care this could reflect a biased group‟. This last 
point was a misinterpretation of the protocol. I submitted a written response to 
the three points prior to the meeting. At the meeting, concern was expressed 
by one member about the „small‟ number of interviews proposed but the 
chairman reassured him that even smaller numbers were normal in this type of 
study. Another member was concerned about the use of statistics and did not 
want me to make comparisons between Doncaster and the other two sites – 
„we don’t want any ‘iffy’ statistics’. I assured him that I had taken expert advice 
regarding the analysis of the quantitative data and that the findings would be 
reported in the form of descriptive statistics. Approval was confirmed a few 
days later on condition that I removed one of the original objectives: ‟to develop 
recommendations concerning the provision of palliative and supportive care to 
mesothelioma patients and their families in Primary Care and community 
settings‟. The letter also repeated the request that I should not compare the 
Doncaster findings with the other two sites; I presumed it reflected anxiety in 
case of perceived poor performance. Full approval was granted in November 
2001 once I had agreed to these conditions. 
 
 88 
Data protection legislation 
Confidentiality of personal data is governed by the Data Protection Act (1998) 
and details of compliance with the act were included in each application for 
LREC approval. In this study I endeavoured to protect the identity of 
participants in a variety of ways. The medical records that I surveyed were 
each given a unique numerical identifier that was used on the proforma and 
transferred to the SPSS database. The details of individual deceased patients 
and their accompanying identifier were kept in a locked filing cabinet in my 
office. In reporting the findings I did not reveal any individual‟s details that could 
be used to trace back to a specific patient. However I did decide that, with 
regard to the records survey, the three sites should be identified separately in 
the report because variations, particularly in health service provision, usually 
depended on external factors, such as health policy or geography, rather than 
the actions of single healthcare professionals; therefore I did not feel that any 
of the information should cause harm or disadvantage to any one professional 
or department. There was also the likelihood that, if I had not identified the data 
from each of the three sites separately, it would not have been difficult for local 
readers of the report to deduce where data originated due to the differences 
between the sites. 
 
The details of the patients who were interviewed and the focus group 
participants were all amended in some way, such as alteration of their age and 
by assigning different initials, in order to make them difficult to identify by 
anyone other than close family members. It is inevitable however, that in some 
cases, for example when an extraordinary experience has been described, that 
there may be some compromise of confidentiality. I have tried to minimise this 
wherever possible but felt that the report did not include any instance where 
such compromise would disadvantage or harm the person concerned. 
 
The details of healthcare professionals were protected by not revealing their 
location and by referring to them by job titles rather than by initials. Inevitably, 
some compromise is involved, in that certain details would enable a local 
reader to deduce the data source. However, I judged that the comments made 
in these circumstances would not disadvantage the interviewee. The one 
exception was the nurse who provided the Mesothelioma Information Service, 
a unique nationally-available service that was widely publicised and associated 
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with the name of the nurse concerned. Recognising that confidentiality was not 
possible I obtained specific written permission from the nurse to include the 
interview knowing that it would identify her, although I omitted her name from 
the report. 
 
The post of Caldicott Guardian in each healthcare provider organisation was 
established in response to the Caldicott (1997) report relating to patient 
confidentiality. The Caldicott Guardian is responsible for the safe and legal 
handling of patient-identifiable data. Only in Leeds was my study submitted to 
the Caldicott Guardian of the hospital trust for approval.  
 
2.2 Methodological issues  
2.2.1 Recruitment issues        
       
The study was limited due to the familiar problems of recruitment in palliative 
care studies and also because I was working alone and in two unfamiliar sites. 
Recruitment to any palliative care research project is known to be difficult and I 
was aware that it could be particularly problematic in mesothelioma as patients 
may present with very advanced disease (Addington-Hall, 2002; BTS, 2001). In 
addition, from my experience of caring for patients with mesothelioma I 
recognised that, alongside coping with medical investigations and interventions, 
patients may also be involved in time-consuming and stressful legal procedures 
and benefit claims which would possibly also reduce the chances of 
recruitment. Recruitment was slow and erratic: it took 8 months to recruit the 
first three patients in Barrow. Gate-keeping by clinical nurse specialists in 
palliative care was difficult to determine but „clinician barriers‟ have been 
reported (Addington-Hall, 2002; Steinhauser et al, 2006). Another limiting factor 
was the busy investigation/treatment schedules that some patients were 
undergoing. One wife cancelled an interview that a patient had consented to in 
writing. When I telephoned to make an appointment the patient‟s wife said that 
he was reasonably well at that time and she did not want him to be interviewed 
because „it might upset the apple cart’. Although this left me wondering what the 
patient felt about the interview, I felt unable to ask to speak to the patient for 
fear of causing distress. 
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As a doctor myself, I predicted that access to healthcare professionals would 
not be restricted, and this was usually the case.  However I was apprehensive 
about access in Leeds and Doncaster because I was unknown there and, as 
illustrated by other researchers, (Bergen and While, 2000), familiarity is known 
to facilitate access. I also worried that my identity as an unknown GP, unknown 
researcher, and from another area, may cause some concern to the participants 
in Leeds and Doncaster although these worries appeared to be unfounded.  
 
2.2.2 Limitations of the case study approach 
The case study as a research strategy attracts three main criticisms: lack of 
research rigour, lack of scientific generalisability and time-consuming studies 
that result in unwieldy reports (Yin, 1994: 9-11).  These are addressed in the 
following 5 sections. 
 
The broad scope of this multiple method case study entailed a large literature 
review across many fields and this increased the possibility of missing 
important publications. Fortunately „alert‟ facilities provided by electronic 
databases remedy this to some extent with regard to major publications, 
although using „mesothelioma‟ as a search term results in an avalanche of 
references to legal proceedings and union activities alongside medical papers. 
 
The case study sampled patients and relatives from 3 areas with a high 
incidence of mesothelioma that, inevitably, related to traditional industries. 
Although Peto et al (1999) predict that the UK incidence of mesothelioma is 
likely to rise until around 2015, the demography and distribution of 
mesothelioma is already changing as manufacturing and heavy industry decline 
and this is not reflected in this study. The study did not investigate patients 
whose mesothelioma related to asbestos exposure when self-employed or 
when asbestos exposure did not relate to the traditional industries. However, 
although the exposure routes are changing, there is no evidence to suggest that 
the disease is any different however it is attributed, and therefore the palliative 
care needs should be the same. Two areas that may be different are: 1) 
compensation, which will be more difficult to prove away from the traditional 
industries, and 2) medical knowledge may be affected as the experience gained 
in high incidence areas is unlikely to apply generally. Given the resources and 
time limits of this project it would have been extremely difficult to recruit many 
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patients whose mesothelioma was unrelated to the „traditional‟ asbestos-using 
industries, although in two or possibly three of the patients interviewed, 
bystander exposure was implicated. 
 
The study was cross-sectional, not longitudinal, and therefore could not 
demonstrate changing needs along the disease trajectory. This may have been 
countered to some extent by recruiting patients at all stages of the disease and 
having different types of treatment, admittedly by chance rather than by design, 
including two people interviewed within a week of death. 
 
Flexibility is a feature of case study design and in this study the significant 
alteration to the original proposal was the removal of a 5th component: I had 
hoped to include a national questionnaire survey of patients with mesothelioma 
to investigate disease burden and quality of life by using validated instruments. 
Fortunately caution prevailed, because this would have made the study 
unmanageable. 
 
The findings do not reflect recent changes in healthcare services, such as: GPs 
are no longer responsible for out-of-hours cover; universal MDTs which were 
only developing at the start of the study; introduction of medical thoracoscopy; 
and slightly more promising results from chemotherapy trials. In addition, there 
has been a great increase in media coverage of mesothelioma as we head 
towards the peak of the mesothelioma epidemic in the next decade (Peto et al, 
1999) and public awareness is likely to have increased. Medical education 
around mesothelioma has also grown with an ever-increasing number of 
conferences in the UK and abroad17. 
 
Case studies may be criticised for a variety of reasons. They may be regarded 
as „not scientific‟ on the grounds that their multiple methods and multiple data 
sources do not lend themselves to thorough analysis. However the case study 
approach mirrors the way in which people see the world, not just from a single 
perspective but from a multitude of angles and with many layers of information, 
and therefore it can be argued that case studies provide a more realistic method 
of exploring experiences and meaning. Secondly, it may be argued that case 
study results cannot be generalized. However this is a misunderstanding as 
                                                 
17
 See Appendix 13 for a list of presentations related to this study 
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case studies are designed to test or develop theories, the cases are not 
selected to be representative, and the studies are not designed to answer 
specific limited questions (Yin, 1994: 37). Another criticism is that case studies 
often generate huge quantities of data and that this may lead to over-long 
reports. 
 
Alderson (1998) argues that quantitative methods do not fit well in case studies 
whereas Yin (1994:92) accepts the consideration of all methods in case studies 
in order to provide multiple perspectives and methodological triangulation and 
he suggests that there is considerable overlap between qualitative and 
quantitative methods. There is a debate about the validity of multiple methods 
approach: criticisms of „methodological pluralism‟ are, firstly, that there may be 
an implication that the results from the different data sources will be broadly 
similar, and secondly, that data sources may be variably weighted thus 
introducing bias However, a more common view is that complex and/or 
contradictory findings reflect the „messiness‟ of real life (Devine and Heath, 
1999: 48-50).  
 
Criticisms of mixed methods case studies are countered by rigorous attention to 
study design; transparency about prior hypotheses or notions and the 
theoretical underpinning of the study; transparency about data collection and 
analysis; and a clear account of conclusions and how they were derived. Yin 
(1994:33) demonstrates how the four basic tests of social science methods i.e. 
construct validity, internal and external validity and reliability can be satisfied by 
careful attention to „case study tactics‟. Several authors have produced 
guidelines for assessing the rigour of qualitative research that can be applied to 
case studies incorporating mixed methods (Mays and Pope, 1996: 18; British 
Sociological Association Medical Sociology Group, 1996; Spencer et al, 2003; 
Seale, 1999: 189-192). In the sections concerning the qualitative components of 
the case study I have attempted to address these issues. 
 
Vallis and Tierney (1999) conducted a multiple site, multiple methods case 
study into the care of patients with hip fractures. In their account of the 
methodological issues in the study, they conclude that although „complex case 
studies provide a powerful method for describing and explaining complex health 
services… the practical difficulties and methodological complexities should not 
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be underestimated.’  Similarly, Yin (1994:45) warns that such studies ‘can 
require extensive resources and time beyond the single student or independent 
research investigator’. Vallis and Tierney (1999) draw attention to the tensions 
in triangulating data from quantitative and qualitative methods given their 
different research traditions. However Sandelowski (1995) suggests moving 
from the two-dimensional model of triangulation to the more complex notion of a 
prism or crystal and attempting to reach an accommodation or „peaceful 
coexistence‟ of multiple findings rather than convergence to a single point. This 
multidimensional concept captures the complexities of real life, and applies to 
this study that is designed to investigate the lived world experience and 
meaning of mesothelioma. 
 
Limitations of the incorporated methods 
 
The medical records survey revealed the limitations and challenges of data 
collection from medical records that are well-known and include illegibility, 
incompleteness, disorganisation and problems with access and retrieval. These 
difficulties may often obscure the actual sequence of events and reasons for 
medical management decisions. These problems may be exacerbated if notes 
relating to deceased patients are given less status than notes of live patients 
and therefore not cared for adequately. Retrospective surveys of records rely on 
accuracy of the recorded data and it is not possible to validate or verify the 
recorded information. Survey methods are time-consuming and a particular 
issue in deciding to survey GP, hospital and hospice records involved accessing 
the records and collecting data in a variety of sites. A potential difficulty was 
access to the records in voluntary independent hospices, (three of the four 
involved), that are not governed by NHS regulations – in practice this was not a 
problem. 
 
Limitations of semi-structured interviews include the following: selection bias: 
some people may not want to be interviewed, particularly concerning sensitive 
topics and this will skew the sample, that is, only those who are prepared to be 
interviewed will participate. Secondly, patients with mesothelioma may be too ill 
or busy with medical interventions to be interviewed; some patients may be too 
emotionally upset to engage in the extra burden of interviews; the proforma may 
skew the content of the interview; non-verbal communications may be missed; 
 94 
the relationship between the researcher and the participant may impact on the 
process; and the quality of the data may be determined by the skill of the 
researcher. In addition it is likely that distressed or seriously ill patients may 
reasonably not wish to be interviewed. 
 
As described by Edwards (1993) the „sex, race, class and educational 
experiences of the researcher and the researched‟ can affect the degree of 
sensitivity of interviews into delicate areas. My medical status may have 
impacted on the interview process: on one hand people may have been 
prepared to discuss details of their illness with me in the expectation that I 
would understand and focus on the physical aspects of their situation; this could 
mean that more social or emotional aspects were suppressed. On the other 
hand, my professional background may have been a barrier to communication, 
in spite of my efforts to present as an interested researcher with 
„professionalised friendliness‟ (Seale, 1999:20). However, in interviewing 
patients in their own homes, the researcher is an invited guest, and has no 
control over the environment, others present (including pets), distractions and 
timing18 (see 2.2.3, p96). 
 
In addition to the limitations of the interview method described with regard to 
patients, the interviews with healthcare professionals had other potential 
restrictions. Firstly, for most of the participants, interviews were fitted into the 
working day and so time was limited. Assumptions may have been made by 
both me and the interviewees due to our common healthcare work. Some 
degree of „saving face‟ or reputation may be involved in circumstances when 
the enquiry may be perceived by the interviewee as potentially critical of 
services provided, leading to defensive responses or reluctance to discuss 
problem areas. 
 
The limitations of focus groups include the potential dominance of more 
articulate or confident members, the difficulty of ensuring the discussion does 
not veer completely off course and the skill required in the group leader or 
facilitator to achieve a reasonable balance between focus and important areas 
not necessarily included on the guide. Focus groups exploring sensitive issues 
may be emotional and a negative experience for some participants – my 
                                                 
18
 See Vignette 4.2, p162. 
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attention to minimising risks to the participants is described in the data 
collection section. Current carers were not included in this study, due to 
practical considerations, but it would have been more complete with their data. 
Bereaved carers are reporting „through the lens of loss‟; the participants were 
volunteers who were likely to have a „story to tell‟ and these retrospective 
accounts are likely to differ from contemporaneous accounts (Higginson et al, 
1994; Hinton, 1996; Addington-Hall and McPherson, 2001). However, they may 
be more honest accounts in some respects because the bereaved relatives do 
not need to either minimise their own (or the patient‟s) distress whilst actively 
caring for a patient, nor do they need to worry that criticism of healthcare 
services or individual professionals may, in some way, have a negative impact 
on the care provided, particularly when the researcher is a healthcare 
professional. 
 
I felt that it was neither practical nor appropriate to validate the data by returning 
interview transcripts to the patients that I had interviewed for the following 
reasons: firstly it would not have been possible in all cases: the patients were ill 
and two died within a week of being interviewed; secondly, at risk of sounding 
patronising, reading the transcripts may have caused additional distress; thirdly, 
patients may have then requested that transcripts be amended, thus 
compromising the original data; fourthly, I would have no control over the 
influence of others who might read and suggest alterations to the transcripts; 
fifthly, I would not necessarily know if patients had died and thus could cause 
additional distress to grieving relatives. In the submissions to LRECs I had 
requested permission to re-interview some participants if I felt it necessary but 
this did not happen in practice as the interviews felt complete and also because 
there was not sufficient time. In hindsight, it may have been useful to do this as I 
would have not been a stranger on the second occasion and may have 
obtained more data regarding the more emotive issues such as „living with 
dying‟.  
 
With regard to the focus groups, again I did not return transcripts to the 
participants for practical reasons but I have promised to send a summary of the 
collective findings to all participants at the conclusion of the study – this is now 
in preparation. (Several of these bereaved relatives have kept in contact with 
me by telephone or letter and I have met three who have subsequently become 
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involved in asbestos victims campaigning groups at conferences. Their 
feedback and that of professional peer groups related to my presentations19 has 
been positive every time.) 
 
It was difficult for me to keep notes of non-verbal communications and clues 
whilst conducting the interview or focus group. Additional data would have been 
collected by video- rather than audio-recording the interviews and focus groups, 
although this may been less acceptable to participants. Although brief field 
notes were kept, some information was inevitably missed. 
 
Being a researcher and also a doctor may have also influenced reflexivity or, 
due to the unequal power relationship, introduced bias. I attempted to reduce 
this effect by dressing informally, being careful with body language and speech, 
and stressing my role as a researcher rather than a doctor. 
 
2.2.3. Practical difficulties 
Accommodation: Facilities for the time-consuming process of data collection 
varied considerably, from the draughty basement store for medical records in 
one old hospital to generous hospitality in the 4 hospices.  
 
Dirty records: The state of the notes also varied from place to place; clerical 
staff in one hospital were reluctant to retrieve notes because they were stored in 
the basement of a decaying disused hospital that was allegedly infested with 
fleas and rats. Some of these notes were dirty. 
Profile: Although the intention had been to conduct the study firstly in Barrow, 
then in Leeds and finally in Doncaster, some of the later patients from Leeds 
„overlapped‟ with those from Doncaster due to the unpredictability of 
recruitment. It became apparent that I needed to maintain a high profile for the 
study in Leeds and Doncaster where I was relatively unknown, otherwise 
recruitment seemed to decline. 
 
Absentees: Two (unrelated) people who had given written consent and 
confirmed that they would be attending one of the focus groups did not attend 
on the day leaving one woman on her own (but happy to continue as a „group of 
                                                 
19
 A list of presentations and publications related to the study can be found in Appendix 13 
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one‟). One of the absent women telephoned the following day to say she had a 
clashing engagement, nothing was heard from the other person. 
 
Pets and other distractions: Practical problems due to pets occurred in two 
cases: in one of the early interviews a cockatiel flew around the room and 
screeched loudly from time to time causing deafening problems when 
transcribing; on another occasion, where the patient and wife were distressed 
by their situation (Vignette 4.2, p163), their dog, a nervous collie, sat on the 
microphone which was on the settee next to me and refused to move; the 
resulting recording was only just audible. Distractions from telephone calls from 
relatives or healthcare professionals occurred in three interviews and in one 
case a neighbour, who was in dispute with the patient being interviewed, was 
obviously unhappy that my car was parked (legitimately) outside her house. In 
another interview the patient answered the door to two Jehovah‟s Witnesses 
and then spent some time explaining that he was being interviewed. 
 
Colleagues: Problems in my practice caused a major hiccup. I had discussed 
the 12 months funded study leave with my part-time partner and we had 
appointed a full-time locum as my replacement. Unfortunately when I had been 
away for 7 months my partner decided to leave the practice and my locum 
suddenly had to move away, for different and unrelated reasons. This left the 
practice without a doctor and so I had to return to full-time General Practice in 
the middle of data collection. I then needed both a half-time partner and a full-
time locum in order to resume my study leave. At a difficult time for recruitment 
it took 8 months to find a new partner, one of my former GP trainees. As there 
were no locums available, my new partner was prepared to work full-time so 
that I could resume study leave on a half-time basis, for 10 months half-time 
rather than the remaining 5 months full-time. Data collection was mostly 
completed within this time but the disruption interfered with the momentum of 
the study and resulted in most of the analysis and writing up to be conducted 
whilst working full-time – not recommended practice.  
 
Other duties: During the study, in addition to being a GP, I was employed as a 
hospice medical officer with responsibility for an 8-bedded unit on a 1 in 3 rota. 
This was arranged in 7-day blocks: in a duty week the work consisted of a daily 
„ward round‟, admission of patients, death certification, liaison with the visiting 
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consultant twice a week, advice to GPs in and out-of-hours, dealing with 
relatives and being on call 24 hours/day for 7 days. This continued throughout 
the study, including when on Extended Study Leave, because there was no 
other medical cover available and it meant some inconvenience whilst engaged 
in fieldwork in Leeds and Doncaster. 
 
Parking: Hospital car parks almost all charge for parking but are still frequently 
full. In Leeds I usually had to park at some distance from the hospital in a multi-
storey car park, inconvenient for me, but worse for ill patients and their relatives.  
 
2.2.4. Rigour 
Unlike quantitative research, in which tests of statistical reliability and validity 
are clearly established, qualitative research has been criticised for being 
„unscientific‟, as if being scientific was the „gold standard‟. In fact even „gold 
standard‟ quantitative studies such as randomised controlled trials have been 
shown to have their limitations and their results neither universally 
representative nor unbiased (Aoun and Kristjanson, 2005). To counter these 
criticisms, systems for assessing the quality of qualitative research have been 
proposed. The framework produced by the Government Chief Social 
Researcher‟s Office, (Spencer et al, 2003), with respect to research design and 
conduct was used to check: that I had paid attention to their guiding principles 
and that research should be „contributory, defensible in design, rigorous in 
conduct and credible in claim‟. 
 
In considering the quality criteria suggested by Lincoln and Guba (1985) I 
decided key areas needed further discussion: truth value; applicability; 
consistency; and neutrality. Truth value was supported by the explanation of the 
way in which theory was grounded in the data and illustrated by multiple quotes 
taken from verbatim transcripts. There is bound to be some subjectivity in 
selecting quotes but I have tried to include contradicting quotes and explain 
variance when it occurs. The case study method, by examining the issues from 
multiple perspectives and with multiple data sources, is likely to provide a more 
rounded picture than a single investigation. The development of the category ‟in 
it together‟ serves to illustrate the deeper exploration of the interviews (p83) and 
the use of triangulation of data. Applicability has been addressed by providing a 
clear account of the context of the study and its limitations and discussing the 
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findings with regard to palliative care and social medicine. Consistency has 
been addressed by reference to the existing literature as far as possible with 
discussion of findings that contrast with previous work and explanation of new 
findings. Neutrality could be criticised in this study given that I work in palliative 
medicine and had „prior notions‟ of particular problems in mesothelioma as it 
affects patients and their families, but these issues were stated at the outset,  
(p 58-9), and prior knowledge is an advantage in case study work. However, I 
have tried to avoid imposing my notions by letting the patients and relatives 
speak for themselves, by using verbatim data in quotes and adding data from 
interviews with healthcare professionals. By setting the study in three sites I 
tried to ensure that my view, perhaps restricted to the situation concerning 
Barrow patients, was balanced by findings from other areas. 
 
2.2.5. Single researcher 
The mixed methods, multiple sites, case study design was an ambitious 
undertaking for me as an inexperienced single researcher and, although I 
enjoyed the field work, on many occasions I felt awash with data. When writing 
up the study I was frequently overwhelmed at the task of trying to reduce the 
thesis to a manageable size. In addition, using four methods on three sites 
required very careful organisation as well as the mental challenge of there being 
overlap of one method with another due to recruitment and other practical 
problems. If time had allowed it would have been easier to keep the methods 
separate as originally planned. 
 
Writing an academic paper,20 co-authored by my supervisors, was a valuable 
experience and dramatically eased the writing process, although it was still 
daunting. The paper was commissioned by a journal guest editor after hearing 
me present the findings of the interviews with patients at the 7th conference of 
the International Mesothelioma Interest Group in Brescia, Italy, in 2004. 
 
Researching in palliative medicine is likely to have an emotional impact on the 
researcher and this was certainly true. Whilst not particularly troubled by any 
aspects of the fieldwork conducted in my own area, Barrow-in-Furness, I found 
the interviews with patients and healthcare professionals and the focus groups 
                                                 
20
 Clayson H, Seymour J E, Noble B. Mesothelioma from the patient’s perspective. (2005). Hematol 
Oncol Clin  Am 19; 1175-1190. 
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with bereaved relatives in Leeds and Doncaster distressing. Much of this may 
have related to me being away from my professional and geographical „comfort 
zone‟ and therefore added layers of anxiety were present. These included: 
finding the patients‟ homes; arranging suitable venues for the focus groups; not 
realising how busy the M1 motorway was at certain times; knowing that I had no 
medical role or influence in the localities, therefore feeling professionally 
vulnerable when interviewing ill people in their homes; being away from regular 
contact with colleagues and missing the ability to discuss some of the troubling 
aspects of the study; and of course, being away from home. To this day, driving 
up the M1 from Sheffield towards Leeds and Doncaster, retracing the route 
towards interviews with patients and focus groups, brings on almost 
overwhelming sadness. The power of this emotional reaction surprises me as I 
am usually regarded as more practical than emotional.  However, I have chosen 
to work in palliative medicine….. 
 
The privilege of being able to study exactly the subject of my choice and having 
the luxury of some protected time and funding from the RCGP has been much 
appreciated. It is sad to know that the Extended Study Leave scheme is no 
longer available for General Practitioners. 
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Chapter 3: Medical Records Survey 
 
3.1 Introduction 
The intention of this survey of medical records was to obtain data on disease 
trajectory, burden and service usage in order to provide a broad understanding 
of the healthcare services provided. I surveyed the medical records of 80 
deceased patients who died between 1.1.1998 and 1.1.2001 and whose 
certified cause of death included pleural mesothelioma: the GP, hospital and, 
where applicable, hospice records were examined. The sampling is described in 
the Methods chapter, p75-6. A proforma (Appendix 12) was used to collect the 
data that I then entered onto SPSS software to assist data-handling and 
analysis. The data are presented in the form of descriptive statistics, as they 
apply to each site, and collectively. Percentages, when used, are rounded up to 
the nearest whole number.  
 
Details of first symptom/s, presenting and main symptoms, date of diagnosis, 
survival from presentation and medications for symptom control are reported in 
all cases regardless of survival time. Findings relating to medical interventions; 
attendances at outpatient clinics and GP surgeries; and hospital admissions are 
reported for the whole illness if patient survived less than a year, (n=50, 63%), 
and with respect to the last 12 months of life for those who survived more than 
12 months from presentation (n=30, 37%). The phrase „in the last year of life‟ is 
used for convenience to refer to data relating to all patients, acknowledging that 
most did not survive more than 12 months from presentation. 
 
3.2 Epidemiology  
Occupation and asbestos exposure 
The majority of Barrow-in-Furness patients had been skilled manual workers 
involved in shipbuilding and/or heavy engineering that occurred on neighbouring 
sites and for the same employer; both industries involved asbestos exposure. 
Employees often worked on short-term contracts and interchanged between 
shipyard and engineering depending on rates of pay and job availability. 
Commonly, all employment, in either the shipyard or the engineering works, 
was referred to by the workforce as „working in the shipyard‟.  
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The occupations of the Leeds patients reflect the local asbestos manufacturing 
industry and allied trades. The Roberts‟ asbestos textile factory closed in 1955 
but a variety of trades using asbestos products, such as floor and ceiling tiles 
and insulation materials, continued for at least a further 15 – 20 years as well as 
major post-war reconstruction work that used asbestos cement and insulation. 
 
The data from Doncaster reflects the influence of a large railway maintenance 
and construction works as a major employer as well as the power stations 
situated along the river Trent. Railway engine boilers were insulated by large 
asbestos blankets, the carriages were protected from fire risks by asbestos 
insulation and the brakes had asbestos linings. The power stations generated 
vast amounts of heat and asbestos materials were again used for insulation.  
 
Most of the deceased patients were male, (m:f, 72:8) with a mean age of 70 
years (range 45 – 94 years). As shown in Table 3.1, 65 of the 74 patients, 
(88%), in whom occupation was recorded, worked in industries acknowledged 
to expose the workforce to asbestos  (HSE, 2005b). The remaining 9 patients in 
whom occupation was recorded included a tailoress, who may have been 
exposed to asbestos lagging around pipes from the steam presses; a coal 
miner; service man and a pile cutter who may have been exposed at work. Five 
of the 75, (7%), in whom occupation was recorded, could not be considered as 
having any likely asbestos exposure due to occupation: they were four 
housewives, and a secretary. Six patients, one in Leeds and five in Doncaster, 
had no record of asbestos exposure. It was not possible to determine the 
specific type of asbestos that patients were exposed to. 
 
Non-occupational asbestos exposure 
Other types of asbestos exposure are also shown in Table 3.1. Family exposure 
usually related to contact with asbestos-contaminated working clothes, 
sometimes referred to as para-occupational or bystander exposure. The 
environmental exposures all related to living near the Leeds asbestos textile 
factory, presumably due to pollution of the surrounding residential area. Four 
patients were recorded as having more than one type of asbestos exposure: 
two shipyard workers also had family exposure: one had washed her husband‟s 
and son‟s shipyard overalls for many years; another had been exposed to his 
 103 
father‟s shipyard overalls throughout childhood and this patient‟s brother had 
also died of asbestos-related disease; a tailoress was married to a joiner who 
used asbestos; and a housewife, whose parents both worked in the asbestos 
factory, also lived near the factory.  
 
Table 3.1: Routes by which patients were exposed to asbestos  
*One patient had been an accountant working in the shipyard 
** Asbestos trades included manufacture of asbestos board and an asbestos 
floor tile layer  
 
Other asbestos-related conditions 
None of the 80 patients had a history of asbestosis. Twelve of the 80 patients 
had been known to have pleural plaques prior to the diagnosis of mesothelioma 
7, (27%), in Barrow and 5, (19%), in Doncaster.  Pleural plaques were not noted 
in any of the Leeds records21. 
                                                 
21
 This is unlikely to reflect low incidence of plaques in Leeds but is probably a recording artefact 
(personal communication from Dr Martin Muers, Consultant in Respiratory Medicine, Leeds, 2006) 
Asbestos-related occupation  Barrow Leeds 
 
Doncaster 
 
Combined 
Shipbuilding/engineering* 24 4  28* (35%) 
Railway carriage maintenance 
and construction 
 1 16 17 (21%) 
Buildings maintenance/construction 1 6 3 10 (12.5%) 
Power station 1 1 3 5   (6%) 
Asbestos insulation & trades**  3  3 (5%) 
Stainless steel/copper industry  2  2  (3%) 
Notes recording occupation 26 17 22 65 (81%) 
Non-occupational exposure     
Family contact/bystander  2 4 0 6 (7.5%) 
Environmental 0 5 0 5 (6%) 
Total sample (n= 80) 26 27 27 80 
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Latency 
Latency refers to the interval between asbestos exposure and disease 
presentation. The date of first exposure ranged from 1919 to 1983; the majority 
of exposures commenced between 1940 and 1960, peaking in the 1950s. 
 
Figure 3.1:  Date of first exposure to asbestos 
 
The recorded durations of exposure ranged from 1 month to 56 years and, 
across the three study sites, the median duration of exposure to asbestos also 
varied considerably, from 4 ½ years to 37 years, median 18 years. However, 
recording of this in medical notes also varied across the sites, Table 3.2. It was 
not possible to determine from the records if exposure had been continuous.  
 
 
Table 3.2: Duration of exposure to asbestos 
 
 
Duration of exposure  
to asbestos 
Barrow 
 
Leeds 
 
Doncaster 
 
Combined 
 
Median duration (years)  37 4.5 18 19 
Range of duration of 
exposure to asbestos 
1-56 years 1 month - 
47 years 
3 - 47 years 1month – 56 
years 
Numbers of notes with  
duration recorded 
19 10 19 50 
Missing data 7 17 6 30 
Total in the study (n=) 26 27 27 80 
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Latency also varied across the three sites, between 28 and 47 years, as 
illustrated below, Table 3.3. 
Exposure to disease 
presentation interval  
Barrow Leeds Doncaster Combined 
Median interval (years) 47 28 47 45.5 
Range (years) 29 - 79 20 - 49 15 - 62 15 - 79 
 
Table 3.3: Latency: Interval in years between first asbestos exposure and 
disease presentation  
 
3.3 Clinico-pathological features 
Presentation 
Breathlessness, chest pain and cough, singly or in combination, accounted for 
the majority, (88%), of symptoms at presentation to medical services; in eight 
patients, (10%), including two who had chest infections, mesothelioma was an 
incidental finding, Table 3.4: 
 
Presenting symptom Barrow Leeds Doncaster 
 
Combined 
Breathlessness 11  10 11 32 (40%) 
Chest pain 4    7 8 19 (24%) 
Cough 5    4 3 12 (15%) 
Breathlessness and chest pain 2    2 3 7   (9%) 
Chest infection 2      2   (3%) 
Incidental on CXR 2    2 2 6   (8%) 
Sample in study (n=80 ) 26 27 27 80 
 
Table 3.4: Main presenting symptoms 
Most patients presented initially to their GP. In 35 of the 80 cases, (44%), the 
interval between symptom onset and attending the GP was recorded or could 
be calculated and ranged from the same day to 212 days, mean 43 days, 
median 17 days. Acute presentations were common: almost half the patients 
(34/72, 47%) in whom the details could be ascertained, were admitted to 
hospital on the day that they presented to their GP or to hospital. It was 
impossible to determine from the records the route by which most of these 
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emergency patients became admitted, although at least 5 of the 34 patients 
presented directly to an Accident and Emergency department, Table 3.5: 
 
Symptom onset to presentation  
to hospital (days) 
Barrow 
 
Leeds 
 
Doncaster 
 
Combined 
 
Within 7 days 7 4 0 11 
Within 14 days 2 4 1 7 
Within 21 days 2 3 3 8 
Within 28 days 1 2 1 4 
Cumulative at 28 days 12 13 5 30 
(37.5%) 
Within 84 days 8 7 8 23 
Cumulative at 84 days 20 20 13 53 (66%) 
More than 6 months 2 1 2 5 
Missing data 4 6 12 22 
Median interval between symptom onset 
and presentation to hospital (days) 
30 30 80 36 
Range of intervals in days 0-260 2-221 11-242 0-260 
Number in sample (n= ) 26 27 27 80 
 
Table 3.5: Interval between onset of symptoms and presentation to 
hospital (includes all routes of access to hospital)   
 
In 16 cases, (20%), the GP had referred the patient for a chest x-ray within a 
week of first surgery presentation, and 29 (36%) patients attended hospital 
within 3 weeks of first attending their GP. The median interval between onset of 
symptoms and first attendance at hospital was 36 days, Table 3.5. The variation 
in median interval between symptom onset and presentation to hospital from 30 
days in Barrow and Leeds to 80 days in Doncaster is striking, as is the range 
across the sites from same day to 260 days, although data were missing for 
almost half the Doncaster patients. Examination of the records of patients who 
took longer than 6 months to be seen in hospital revealed that in most cases 
they had complicated medical histories and concurrent chronic conditions that 
may have obscured the development of a new illness. Four patients had no 
recorded contact with their GP related to mesothelioma symptoms prior to 
admission. Seven patients were already attending respiratory medicine 
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outpatient clinics at the time of presentation of mesothelioma symptoms, 3 of 
these with pleural plaques.  
Investigations in the last 12 months of life 
Multiple investigations were recorded but it was not always possible to ascertain 
the purpose of interventions from the records. In some cases it was obvious, for 
example, open pleural biopsy was invariably a diagnostic procedure, but a 
VATS22 procedure could be performed to drain an effusion, take a biopsy and/or 
perform pleurodesis. Most procedures were performed up to three times per 
patient but chest x-rays were performed more frequently, Table 3.6: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.6: Investigations performed in the last 12 months of life (in 
order of frequency across the 3 sites combined) 
 
                                                 
22
 VATS = Video-assisted thoracoscopy                     
Investigation performed Number of investigations /number of patients 
who had those investigations 
 Barrow 
N=26 
Leeds 
N=27 
Doncaster 
N=27 
Combined 
N=80 
CXR 114/26 82/25 116/25 312/78 
CT scan 25/21 33/24 9/9 67/54 
Needle biopsy (pleura) 16/14 30/24 20/18 66/56 
VATS biopsy      „‟ 1/1 13/12 11/10 25/23 
USS abdomen 6/5 7/7 7/7 20/19 
Bronchoscopy 5/5 6/6 7/7 19/19 
USS thorax 1 6/4 6/5 13/10 
Open biopsy        „‟ 4/4 4/3 5/5 13/12 
Other biopsy 0 4/4 6/6 10/10 
Upper GI endoscopy 2/2 3/3 3/3 8/8 
MRI scan 6/6 0 0 6/6 
Isotope bone scan 1 2/2 3/3 6/6 
Lower GI endoscopy 1 2/2 0 3/2 
Laparotomy 1 2/2 0 3/3 
Barium swallow 1 0 1 2/2 
Ventilation/perfusion scan 1 0 1 2/2 
Laryngoscopy 1 0 0 1/1 
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Confirmation of mesothelioma 
The median interval between presentation to hospital and confirmation of 
diagnosis in those diagnosed during life was 79 days (111 days, mean). 
Histological diagnosis of mesothelioma or suspected mesothelioma was 
obtained before death in 62 of the 80 cases, (78%), Table 3.7; in many cases 
this required several investigations. The specific histological type was confirmed 
in around half of these diagnoses (30/62), in 13 cases there was no histological 
diagnosis. The five incorrect diagnoses were as follows: anaplastic large cell 
carcinoma lung arising from the pleura with lung metastases; reactive 
mesothelial cells; carcinoma oesophagus, poorly differentiated lung cancer; 
infection and pleural plaque. In all cases mesothelioma was confirmed at post 
mortem examination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.7: Histology results during the patients‟ illness 
 
Ante mortem histology was obtained from either pleural biopsy or pleural fluid in 
57 of the 63 cases, (90%), Table 3.7. VATS procedures were performed on 23 
patients, twice in two cases, and most of these procedures were performed on 
patients from Leeds in the local thoracic surgery unit. Table 3.8 demonstrates 
no incorrect diagnoses in the Leeds patients. 
Histology (ante mortem) Barrow Leeds 
 
Doncaster Combined 
Mesothelioma, unspecified 6 11 3 20 
Epithelioid 2 9 7 18 
„Probable‟  mesothelioma 7 2 3 12 
Sarcomatous/desmoplastic 2 2 3 7 
Mixed 0 2 3 5 
Other malignancy 1 0 2 3 
Other diagnosis 1 0 1 2 
Missing data 7 1 5 13 
Totals  26 27 27 80 
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Table 3.8: Site from which ante mortem histology for mesothelioma was 
obtained 
Symptom burden 
Physical symptoms recorded during the patients‟ illness demonstrate the 
preponderance of shortness of breath and pain, and also that cough and weight 
loss affected nearly half the patients, Table 3.9: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.9: Physical symptoms in mesothelioma 
 
When psychological symptoms were aggregated, (anxiety, depression, 
emotional distress and psychiatric disorder), the recorded symptoms varied 
across the 3 sites. However, the data reveal that almost half of the patients 
were recorded as having some form of psycho-emotional distress, Table 3.10. 
In addition, social problems were recorded in 13 patients (16%).  
Histology site Barrow Leeds Doncaster Combined 
Pleura 9 18 18 45 
Pleural fluid 9 1 1 11 
Lung 0 1 1 2 
Metastasis 0 1 2 3 
Other 1 0 1 2 
Symptom Barrow Leeds Doncaster Combined 
Short of breath 26 25 26 77 (96%) 
Pain 24 25 24 73 (91%) 
Cough 12 9 12 33 (41%) 
Weight loss 14 8 11 33 (41%) 
Anorexia 6 8 6 20 (25%) 
Sweating 8 4 2 14 (18%) 
Nausea 5 5 1 11 (14%) 
Fatigue 3 5 2 10 (13%) 
Dysphagia 3 2 4 9    (11%) 
Constipation 0 3 3 6    (8%) 
Ascites 3 2 1 6    (8%) 
Vomiting 1 3 1 4    (5%) 
Painful metastasis 3 0 1 4    (5%) 
Totals  26 27 27 80 
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Table 3.10: Recorded psychological symptoms 
 
Pleural effusions 
Pleural effusions occurred at some stage during the illness in 62 of 80 (78%) 
patients. In 15 patients, the effusions had resolved prior to the last year of life, in 
10 cases this appeared to follow successful pleurodesis, Table 3.11. (see 
below, section 3.4, and Box 1.2) 
 
Table 3.11: Number of patients who had pleural effusions  
 
3.4 Clinical management 
Pleural aspiration (thoracentesis) 
All patients who had pleural effusions were treated with pleural aspiration. 
Occasionally chest drains were left in situ for some days but duration and 
volumes of fluid drained were often unclear in the notes. Forty seven patients 
who required pleural aspiration in the final year of life had 170 procedures.  
 Barrow Leeds Doncaster Combined 
Number of patients 
with recorded 
psycho-emotional  
symptoms  
14 17 6 37 (46%) 
Totals  26 27 27 80 
 Barrow Leeds Doncaster Combined 
Number of patients with effusions 18 23 21 62 (78%) 
Number whose effusions resolved prior to 
last 12/12 of life 
3 9 3 15 (19%) 
Totals in study 26 27 27 80 
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Table 3.12: Pleural aspirations per patient in the last year of life 
. 
As shown in Table 3.12, pleural aspiration was conducted more often in Barrow 
than in Leeds and Doncaster: three Barrow patients (B7, B27, B24), accounted 
for most of this variation. They required pleural aspirations 11, 14 and, 
exceptionally, 22 times respectively during their last 12 months of life, Table 
3.13. The last patient, (B24), survived 29 months from presentation and had 32 
pleural aspirations in that time. 
Pleurodesis 
Pleurodesis was attempted in 35 (56%) of the 62 patients who had effusions 
and achieved an overall success rate of 63% in that no further effusions were 
recorded. However, there were differences in the success rates across the 3 
sites as shown in Table 3.13. Three patients had pleurodesis twice and one 
patient three times but it was only finally successful in one of these patients.  
Number of pleural aspirations per patient 
with effusion in last year of life 
Barrow 
 
Leeds 
 
Doncaster 
 
Combined 
 
0 11 12 9 32 
1 1 3 9 13 
2 1 8 4 12 
3 3 2 2 7 
4 0 2 1 3 
5 2 0 2 4 
6 2 0 0 2 
7 3 0 0 3 
11 1 0 0 1 
14 1 0 0 1 
22 1 0 0 1 
Total number of pleural taps 102 33 37 170 
Total patients with effusions in last yr of life 15 14 18 47 
Number of patients in study 26 27 27 80 
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Table 3.13: Details of pleurodesis 
 
In many cases it could not be ascertained where the procedure had been 
performed, that is, whether it had been in theatre as an operative procedure 
conducted by a thoracic surgeon or as a ward procedure possibly performed by 
a physician: data were missing in almost a third of cases. Similarly, data were 
missing in almost a quarter of cases regarding the material used for the 
procedure (sterile iodised talc or tetracycline). The three Barrow patients who 
required the most aspirations described in the previous section had all 
undergone pleurodesis without success. Medical pleurodesis with tetracycline 
and two attempts at VATS talc pleurodesis had failed in one patient (B24), 
single procedures had been conducted for the other two patients; in each case 
pleurodesis was attempted after 4 or 5 pleural aspirations. Ten of 15 cases in 
which pleural effusions had resolved prior to the last 12 months of life had 
previously received successful pleurodesis, in one case this was performed 
twice; 8 of these 10 successful cases were in Leeds. 
 
There was little in the notes to suggest a standard approach to breathlessness 
although many patients were prescribed bronchodilators and oxygen as well as 
benzodiazepines, but it was not possible in most cases to determine whether 
the latter were prescribed for breathlessness or anxiety. There was no mention 
in the notes of breathless management techniques or programmes.  
Details of pleurodesis Barrow Leeds Doncaster Combined 
Number receiving pleurodesis 8 16 11 35 
Number of procedures 10 18 13 41 
Talc pleurodesis 3 12 7 22 
Tetracycline pleurodesis 4 2 2 8 
Unspecified pleurodesis 3 4 4 11 
Mean number of pleural 
aspirations prior to pleurodesis 
6* 3 2  
Number (%) successful 3 (30%) 15 (83%) 8 (62%) 26 (63%) 
Referred to thoracic surgery 4 12 9 25 
Data missing, no of cases 6 6 4 9 
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Oncological treatments: chemotherapy and radiotherapy 
Two patients from Barrow and four patients from Leeds received palliative 
chemotherapy, 7.5% of the total: one patient was recorded as participating in a 
clinical trial; the other four records were unclear. No patients from Doncaster 
were recorded as having had chemotherapy. Less than half the patients had 
radiotherapy and the referral rate varied across the three sites, Table 3.14:   
 
 
 
 
 
 
 
 
 
 
Table 3.14: Numbers of patients referred and the reasons for radiotherapy. 
 
Surgery 
Only two of the 80 patients, both from Leeds, had palliative cyto-reductive 
(debulking) surgery, they both survived less than a year from presentation. One 
had decortication three months after presentation and survived a further 7 
months; histology subtype was not recorded. The other man had extension of 
the tumour through the chest wall and this was resected, at the same time as 
decortication and insertion of a Gortex™ patch, 6 months after presentation. In 
this case several diagnoses had been considered, and even with the benefit of 
an extensive surgical tissue sample, it was not confirmed as sarcomatoid 
mesothelioma until a month before he died, 5 months following surgery. 
Management of pain 
Strong opiates had been prescribed for 68 (85%) of the 80 patients across all 
settings, most commonly oral morphine. Daily maximum doses of morphine and 
morphine-related analgesics are shown in Table 3.15 below; hydromorphone 
Radiotherapy Barrow Leeds 
 
Doncaster 
 
Combined 
 
Numbers of patients referred 
for radiotherapy 
4 (15%) 19 (70%) 9 (33%) 32 (40%) 
Prophylaxis to port sites 2 10 5 17 
Skin metastasis 1  2 3 
Bone metastasis  2  2 
Chest pain 1   1 
Missing data 0 7 2 9 
Total number of patients 26 27 27 80 
 114 
and diamorphine doses have been calculated as 24-hour oral morphine 
equivalents.  
                                                                                                                          
Table 3.15: Maximum morphine opiate doses as 24-hour equivalents to 
oral morphine23     
 
Two patients appeared to have had difficult pain management problems: one 
patient (B15) received epidural diamorphine, 90mg/24 hours equivalent to 
~135024 mg oral morphine/24 hours (see Vignette 3.1, p115). In this case, the 
24-hour oral morphine equivalent doses of other opiates (see Table 3.16) were 
also the highest recorded in the study. From his hospice notes, this patient had 
been prescribed multiple analgesic agents, see Table 3.18. The other patient 
had received intrathecal morphine but the dose was not found in the notes. 
                                                 
23
 Conversion factors used in the calculations from Twycross (1997:67) 
24
 Conversion factor for epidural to oral is not exact, approximate figure based on Mercadante (1999). 
Maximum daily opioid 
doses (oral morphine 
equivalents mg/24 hrs) 
Barrow 
 
Leeds Doncaster Combined 
Oral morphine (mg/24 
hours) mean 
131 
 
108 
 
 
165 
 
 
135  
 
Oral morphine median 
daily dose, in mg 
   100 
Range of doses 15-520 15-300 20-640 15-640 
Patients taking oral 
morphine 
18 18 18 54 (68% of 
patients) 
Subcutaneous (sc) 
infusion of diamorphine 
as mean dose oral 
morphine mg/24 hours 
177 
 
189 
 
246 
 
204  
 
Range of doses 30-390 30-900 15-1200 15-1200 
Patients receiving sc 
infusion of diamorphine 
11 6 12 29 (36% of 
patients) 
Median dose of sc 
diamorphine as oral 
morphine equivalent, 
mg/24 hours 
   90 
Hydromorphone 255 0 0 255 
Totals  (no of patients) 26 27 27 80 
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Table 3.16: Doses of other opiates 
*Prescribed for patient B15 before epidural diamorphine. 
 
The vignette below, describes multiple approaches to the management of 
particularly severe pain affecting one patient: 
 
 
 
 
 
 
 
 
 
Vignette 3.1: A patient with severe pain (patient B15) 
 
Other analgesics 
Across the three sites, the prescribed adjuvant analgesics were mainly non-
steroidal anti-inflammatory drugs and, to a lesser extent, anti-depressants. 
However, it was not possible to establish from the notes whether the 
antidepressants were prescribed for neuropathic pain or for depression. 
 
                                                 
25
 The calculation of the equivalent dose of oral morphine is not straightforward due to the long half-life 
of methadone and its effect on multiple receptors, hence this is an estimation (Twycross 1997:35). 
Mean doses of  
other opiates 
Barrow Leeds Doncaster Daily oral morphine 
equivalents,mg/24hrs 
Transdermal fentanyl 
mcg/hour (range) 
50 
(120-240) 
37.5 
(25-50)    
0 ~150-210 
Number of patients 
prescribed fentanyl 
6 6 0  
Oral methadone  
mgs/24 hours * 
110 0    
 
0 
  
? up to 110025 
Number of patients 
prescribed methadone 
1 0 0  
Patient B15 was a retired shipyard engineer in his 70s. He had been exposed to asbestos for 45 years 
from his time as an apprentice fitter and turner to later working in ships’ boiler rooms. He presented 
with chest and back pain, mesothelioma was diagnosed on clinical grounds (biopsy inconclusive), 
and a CT scan showed tumour infiltration of thoracic vertebrae. Interventions to control his severe 
pain included right-sided thoracic sympathectomy and paravertebral block and he was prescribed the 
whole range of medications used for complex pain at that time: morphine, methadone, fentanyl, 
NSAID, carbamazepine, amitriptyline, and ketamine.  He was too unwell to travel 70 miles for 
palliative radiotherapy. Pain was eventually controlled in the hospice with an epidural infusion of 
diamorphine and an intravenous infusion of midazolam. He survived 12 months from presentation 
and in that time saw his GP 8 times, attended 10 outpatient appointments, had 3 hospital admissions, 
and finally was admitted to a hospice where he died 7 weeks later. 
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Adjuvant analgesic Barrow Leeds Doncaster 
Non-steroidal anti-inflammatory drug 15 14 10 
Antidepressant 11 9 3 
Anticonvulsant drug 4 3 1 
Anaesthetic (ketamine) 1 2 1 
 
Table 3.17: Numbers of patients receiving adjuvant analgesic medications 
 
The overall prescribing of these medications is shown in Figure 3.2, but in many 
cases they were used in combination (Table 3.18) 
 
Use of adjuvant analgesics 
NSAID 
Anti-depressant 
Anti-convulsant 
Anaesthetic 
 
Figure 3.2: Prescribed adjuvant analgesics 
 
 
Twelve of the 80 patients, (15%), were prescribed two or more opiates26 plus a 
variety of other analgesics including adjuncts usually used for inflammation or  
neuropathic pain, Table 3.18: 
 
 
 
                                                 
26
 Morphine and diamorphine were counted as one opiate due to the common practice of converting oral 
morphine to subcutaneous diamorphine. 
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Table 3.18: Patients prescribed two or more opiates and adjuvant 
analgesics 
Informing the patient of the diagnosis 
 A consultant disclosed the diagnosis in most cases, Table 3.19. In two of these 
cases, it appeared that the patients were told that they probably had 
mesothelioma in spite of histology reports indicating other conditions. Patients 
with shorter survival times were more likely to have no record of being informed 
of the diagnosis compared with those living more than 12 months, (43% 
compared with 13% of patients). 
 
Table 3.19: Who informed the patient of the diagnosis? 
 
 
 
                                                 
27
 See Vignette 3.1, page 115, for an account of the management of this patient’s pain 
28
 In one case a surgical registrar informed the patient by letter that the suspected diagnosis of 
mesothelioma had been confirmed by a repeat biopsy. 
Medication                                             Patient‟s ID 
 B1 B1527 B18 L1 L8 L17 L21 L24 L26 L27 D6 D13 
Number of  
opiates 
3 3 2 3 2 4 2 3 2 3 2 2 
NSAID y y y y  y y y y y y y 
Anticonvulsant  y  y     y    
Antidepressant  y y y  y  y y    y 
Anaesthetic   y        y  y 
Sedative  y y  y   y     y  y  y  y  
Who informed the patient 
of the diagnosis? 
Barrow Leeds Doncaster Combined 
Consultant 11 14 13 38 
Registrar28 5 8 5 18 
GP  1  1 
Missing data 10 4 9 23 
Totals  26 27 27 80 
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3.5 Service usage 
Referral to specialists 
In the last twelve months of life, patients with mesothelioma attended outpatient 
appointments five times on average, range 0 to 13 times: 80 patients attended 
411 appointments of which only 8% were for palliative medicine. Table 3.20 
illustrates the most frequently attended clinics and demonstrates co-morbidities, 
in that 14% of patients were also being treated for a variety of conditions 
unrelated to mesothelioma (and see Table 3.26). 
 
Outpatient 
department 
Respiratory  
medicine 
Oncology/ 
radiotherapy 
Palliative  
medicine 
Thoracic  
surgery 
Pain  
clinic 
Other  
clinics 
Numbers of 
appointments 
194 96 33 31 1 56 
% of total 
appointments 
48% 23% 8% 8%  14% 
 
Table 3.20: Details of outpatient appointments attended in last year of life 
 
Just under half of the 80 patients (39, 49%), were referred to palliative medicine 
but in 2/3 this referral was made within two months of death and in four cases, 
within a week of death, Table 3.21. However it was not always clear if patients 
had accessed palliative medicine advice via Macmillan nurses, either hospital or 
community-based, or by direct referral, and it may be that referral pathways 
differed across the three sites – this was not clarified. Only one of the 80 
patients was recorded as having been referred to a specialist pain service, but 
this may reflect missing data as two patients received interventions usually 
performed by pain specialists: intrathecal and epidural catheters for analgesia. 
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Table 3.21: Timing of referral to palliative care 
GP involvement 
 
In the year before death, most patients consulted their GP frequently: mean 11, 
median 10, range 0-41, consultations per patient. Almost half of these 
consultations were home visits: mean 4, median 6, range 0 - 40 visits per 
patient.  Data recording varied: one GP exceptionally recorded 40 visits to one 
patient and so the data must be regarded with some caution. Thus, 80 patients 
with mesothelioma accounted for almost 900 consultations with their GPs, 
Table 3.22. GP notes recorded consultations in 13 cases with relatives.  
 
 
Table 3.22: GP consultations in last year of life 
 
Hospital admissions 
Most patients were admitted at least two or three times during their last year of 
life: 72 patients, (90%), had a total of 196 admissions to hospital in their last 
year of life, the majority of these were due to pleural effusions, Table 3.23. 
 
Time of referral to palliative 
medicine 
Numbers of patients 
N=39 
Within a week of death  4 
Between 1 and 4 weeks before death 11 
Between 1 and 2 months before death 11 
2 to 14 months before death 13 
 Barrow Leeds Doncaster Combined 
Total number of GP 
consultations 
289 350 254 893 
Number of consultations 
recorded as home visits 
104 
(36%) 
194 
(55%) 
116 
(46%) 
414 
(46%) 
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Table 3.23: Hospital admissions in last year of life 
 
The reasons for 178 mesothelioma-related admissions are shown in Table 3.24. 
In addition, there were five admissions for unrelated medical problems and 13 
admissions for unrelated surgical, mainly urological, problems. Eight patients, 
(10%), were not admitted to hospital during their last year of life. All 8 patients 
survived at least two years from presentation and, although they all had 
effusions early in their illness, pleurodesis had been successful in 7 cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.24: Reason for hospital admission 
 
 Barrow Leeds Doncaster Combined 
Patients requiring 1 hospital admission 5 7 2 14 (18%) 
       „‟                   2 hospital admissions 5 9 7 21 (26%) 
       „‟                   3              „‟ 5 3 9 17 (21%) 
       „‟                  4               „‟ 6 4 4 14 (18%) 
       „‟                  5               „‟ 2 2 1 5 
      „‟                   8               „‟ 0 0 1 1 
Total number of admissions 64 60 72 196 
Number of hospitals to which patients 
were admitted 
2 2 3 7 
Number of patients not admitted  3 2 3 8 
Totals  26 27 27 80 
 Barrow Leeds Doncaster Combined 
Pleural effusion 34 18 23 75 
Dyspnoea 6 3 3 12 
Chest pain/pain control 6 7 6 19 
Chest infection 2 5 0 7 
Pneumothorax 5 1 0 6 
Deterioration/terminal care 4 7 3 14 
Biopsy 0 5 11 16 
Pleurodesis 1 0 3 4 
Pleurectomy/debulking 0 1 1 2 
Mesothelioma complications* 0 6 8 14 
Radiotherapy 1 1 2 4 
Chemotherapy 0 5** 0 5 
Endoscopy 0 1 0 1 
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*Mesothelioma complications included anaemia requiring transfusion (n=4), 
ascites (due to extension through the diaphragm) requiring paracentesis (n=6); 
deep vein thrombosis; superior vena cava obstruction; chemotherapy side 
effects; and chest wall mass (all n=1)  
* *Only four of the five received chemotherapy, the fifth patient was too ill. 
Day Unit admissions 
Pleural aspirations accounted for most admissions to Day Units: exceptionally, 
one Barrow patient (B24), attended 22 times for pleural aspiration in his last 12 
months of life, Table 3.25. Seven admissions were for surgical procedures or 
investigations unrelated to mesothelioma, including cataract extraction; excision 
of lipoma; catheter change; and femoral arteriogram. 
 
 
 
 
 
 
 
 
 
 
 
Table 3.25: Reasons for attendance at Day Unit 
Hospice admissions 
Barrow patients accessed a hospice 9 miles away, Leeds patients could be 
referred to 2 hospices at opposite sides of the city, Doncaster patients had 
access to one hospice on the outskirts of the city. A third of the patients 
accessed hospice inpatient care and 30% died in a hospice: Table 3.26: 
 Barrow Leeds Doncaster Combined 
Pleural aspiration 40 2 5 47 
Chemotherapy 3 7 0 10 
Surgical procedure 2 1 4 7 
Pleural biopsy 4 0 1 5 
Bronchoscopy 3 0 0 3 
Upper GI endoscopy 2 0 0 2 
Radiotherapy 2 0 0 2 
Pleurodesis 1 0 0 1 
Other investigation 1 0 0 1 
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Table 3.26: Hospice admissions and deaths 
Co-morbidity 
Although 25% of patients had no recorded concurrent medical problems, the 
majority had one or more problems as shown in Table 3.27.  Fifty five patients 
(69%) were recorded as having smoked, although only 7 (9%) were smokers at 
the time of presentation.   
 
 
 
 
 
 
 
 
 
 
 
Table 3.27: Concurrent medical problems 
 
 
 
 
 
 Barrow Leeds Doncaster Combined 
Number of patients admitted to hospice 5 13 9 27 (34%) 
Total number of admissions to hospice 8 17 13 38 
Average length of stay in days 18 12 9 16 
Range of length of stay in days 9-44 2-33 2-17 2-44 
Number who died in the hospice 5 12 7 24  
Number of hospices 1 2 1 4 
 Barrow Leeds Doncaster Combined 
No concurrent conditions 6 7 7 20 (25%) 
Medical problem 20 19 20 59 (74%) 
Surgical problem 4 5 5 14 
Urological problem 7 2 3 12 
Orthopaedic problem 2 3 1 6 
ENT problem 1 0 0 1 
Ophthalmological problem 1 1 1 3 
Psychiatric problem 1 3 0 4 (5%) 
Recurrent pneumothorax 2 2 0 4 
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3.6 Dying and death 
Survival  
Over half the patients died within 12 months from presentation: 50/80 (63%). 
Overall median survival from the date of presentation to secondary care for all 
patients was 294 days; the median survival in all three sites was less than 
twelve months as demonstrated in Figure 3.3: 
 
Figure 3.3: Kaplan-Meier survival curves by location 
 
Place and mode of death 
Barrow and Doncaster data showed similar distributions of place of death but 
Leeds patients with mesothelioma were twice as likely to die in a hospice, Table 
3.28. Patients with apparently severe pain were also more likely to die in a 
hospice: of the 12 patients who were prescribed more than one opiate plus 
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other medications for pain (Table 3.18, page 117), 8 died in a hospice and three 
in hospital; place of death was not recorded in the remaining case.  
 
 
 
 
 
 
 
 
Table 3.28: Place of death 
 
Mode of death data was retrieved from nursing as well as medical records 
(medical records frequently failed to record this information). Arbitrarily, distress 
unrelieved for at least one hour prior to death was the criterion for major 
distress, distress for less than an hour as minor distress. Data available for 47 
patients revealed that 10 patients (21%) had died with unrelieved distress 
lasting for over an hour (Table 3.29):  
  
 
 
 
 
 
 
 
Table 3.29: Mode of death 
 
Resuscitation was attempted in four patients, three in Barrow and one in 
Doncaster: in hospital in two cases, once at home, and once in an ambulance, 
Box 3.2. Mesothelioma had been the confirmed or presumed diagnosis in each 
of these four cases. 
 
 Barrow Leeds Doncaster Combined 
Hospital 15 10 11 36 (45%) 
Home 6 1 4 11 (14%) 
Hospice 5 12 7 24 (30%) 
Nursing home  1 1 2   (2.5%) 
Ambulance   1 1   (1%) 
Missing data 0 3 3 6    (7.5%) 
Total  26 27 27 80  (100%) 
 Barrow Leeds Doncaster Combined 
Coma or peaceful 12 7 12 31 (66%) 
Minor distress 1 1 0 2    (4%) 
Major distress 5 2 3 10 (21%) 
Sudden 0 1 3 4    (9%) 
N= 18 11 18 47 
Missing data 8 16 9 33  
Total  26 27 27 80  
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Box 3.2: Details of resuscitation procedures. 
 
 
3.7 Summary 
The proportion of cases with a history of occupational asbestos exposure, 88% 
of those in whom occupation was recorded, agrees with other UK studies and 
also relates to purposive sampling in specific industrial locations (Yates et al, 
1997; Chapman et al, 2006). Some patients had a history of multiple exposures 
to asbestos, recorded as occurring in 5% of the records survey sample, 
although in 40% of the patients interviewed. This was often related to several 
generations of one family living close to, and working in, the same asbestos-
related industry or, alternatively, to experiencing frequent job changes in times 
of economic hardship. 
 
The shorter median duration of exposure to asbestos for the sample from Leeds 
reflects the different employment situation compared with the other sites: 
Barrow and Doncaster both had a continuing single major employer, 
shipyard/engineering and railway plant works respectively, but the asbestos 
factory in Leeds closed in 1955. Latency between exposure and disease 
presentation of 47 years in the Barrow and Doncaster samples, and the shortest 
latency of 15 years, agrees with previous UK studies that state 15 – 50 years, 
and a mean latency of 41 years (Yates et al, 1997; Doll, 1985). The shorter 
latency of 28 years in Leeds must be viewed with caution: exposure data was 
A 94 year-old former shipwright with recurrent pleural effusions was admitted for pleurodesis 
but was too ill. Two days after admission he collapsed; resuscitation was attempted but failed. 
Mesothelioma had been the „working diagnosis‟ for 6 months. 
 
An 82 year old retired shipyard worker, suffering from dementia and „presumed‟ mesothelioma, 
collapsed at home just before a GP visited him. The GP attempted resuscitation „briefly‟ before 
confirming that the patient was dead. It was not clear from the notes if this was the patient‟s 
own GP. 
 
A 67 year old retired shipyard painter with suspected mesothelioma was readmitted to hospital 
just a day after discharge following pleural aspiration. He was suffering from severe shortness 
of breath then collapsed. Resuscitation was attempted on the High Dependency Unit, 
unsuccessfully. 
 
A 55 year old pipe lagger with mesothelioma became acutely short of breath at home and 
collapsed. His daughter dialed 999 for an ambulance and the crew attempted to resuscitate the 
man in the ambulance, unsuccessfully 
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recorded in only 10 of 27 notes in the Leeds sample as opposed to Barrow and 
Doncaster in which data was recorded in 19 of 26 and 19 of 27 cases 
respectively.   
 
In common with other published studies, breathlessness, chest pain and cough 
accounted for the majority of presenting symptoms (BTS, 2001; Edwards et al, 
2000). Symptoms preceding the presentation to GP or hospital were difficult to 
determine from the records and may reflect the often insidious development of 
mesothelioma.  
 
The interval between symptom onset and presentation to a GP, was short 
(mean 43 days, median, 17 days), and 66% had presented to hospital by 84 
days. In contrast, seven of 8 patients with mesothelioma included in a 
questionnaire survey of lung cancer patients reported feeling unwell for between 
6 and 12 months before attending their GP, although this was a considerably 
shorter time than the 2 to 4 years reported by 31% of patients with lung cancer 
(Krishnasamy and Wilkie, 1999:50).  
 
The median interval between symptom onset and presentation to hospital of 36 
days relating to the mesothelioma patients in the current study is considerably 
shorter than the delay in presentation of lung cancer, mean 138 days 
(Thompson and Hetzel, 1997). This may well reflect the more dramatic 
presentation of mesothelioma compared with lung cancer due to the higher 
incidence of pleural effusion (requiring hospital treatment) and/or pain (Cooley, 
2000; Hawley et al, 2004). The figures for the intervals between symptom onset 
to GP and symptom onset to hospital appear contradictory but they relate to 
different samples: not all patients presented to their GP, some attended hospital 
directly. The median time from presentation at hospital to diagnosis of 79 days 
is considerably longer than the 21 days in lung cancer (Krishnasamy and Wilkie, 
1999: 55) 
 
The presenting symptoms agree with other studies with most patients 
presenting with shortness of breath and or pain (Robinson, 2005; Hillerdahl, 
1983; Yates et al, 1997; Lee, 2000). The incidence of pleural effusions, 78%, is 
similar to that found in previous studies, (Robinson et al, 2005; Hillerdal, 1983), 
and accounts for the acute presentations and multiple interventions. The lack of 
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any recording of pleural plaques in Leeds patients could be due to record-
keeping practice: usually around 20% of patients with mesothelioma have 
pleural plaques, (Robinson et al, 2005), as in the Barrow and Doncaster data. 
 
The recorded clinical procedures demonstrate the complexity and burden of 
procedures borne by patients in their last year of life in order to establish the 
diagnosis or monitor the condition and to manage complications such as 
recurrent pleural effusions. The majority of needle biopsies were not CT-guided 
in this study and yet „blind‟ needle biopsies are reported to yield at most 50% 
positive histology (Munavvar, 2006). The easier access to thoracoscopy in 
Leeds probably explains the apparent greater diagnostic accuracy in the Leeds 
patients (Table 3.7, p108), although the higher prevalence of mesothelioma in 
Leeds would also result in greater experience in the examination of histological 
specimens. Barrow patients were at a disadvantage due to the distance from 
the nearest thoracic surgery unit, 80 miles away, (for both inpatient and 
outpatient services), and this is the most likely explanation for the low rate of 
VATS procedures compared with the other two sites that had easier access.  
 
On average each patients had 7 investigative procedures plus four pleural 
aspirations. The number of pleural aspirations was much higher in Barrow than 
in the other two sites. Only one of the patients in the study had undergone 
pleurectomy and he was initially thought to have benign recurrent effusions; 
ironically, his pleurectomy specimen provided the diagnosis of mesothelioma. 
Data regarding pleurodesis were often incomplete but it is interesting to note 
that tetracycline had been used in 22 patients despite evidence that talc is 
superior (Martin-Ucar and Waller, 2006:256). 
 
Prophylactic radiotherapy prevents tracking of the disease through port sites 
(and also has been shown to reduce chest pain in up to 50% of cases, although 
it is not recommended for chest pain) (Boutin et al, 1995). The data again 
illustrate the relatively low rate of referral for Barrow patients, but the nearest 
radiotherapy unit is 70 miles away. It is interesting that only half of the patients 
who had pleurodesis were recorded as having received radiotherapy to port 
sites, although this is recommended practice in order to prevent tumour 
tracking; however, missing data make interpretation difficult (BTS, 2001). 
However, a recent study suggests that prophylactic radiotherapy may not be as 
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effective as thought previously and should perhaps be reserved for „high risk‟ 
cases (Chapman et al, 2006). The proportion receiving chemotherapy (7.5%) 
reflects the disappointing results of clinical trials at the time of the study. In a 
recent audit of patients with mesothelioma, 17% received chemotherapy: this 
was around half of those who were assessed as suitable for the treatment 
(Chapman et al, 2006). Patients from Leeds, a regional cancer centre, were 
most likely to be referred for chemotherapy, radiotherapy and surgery, although 
the latter numbers were small. Barrow patients, at considerable distances from 
tertiary treatment centres, had the lowest referral rates for oncological 
interventions, with Doncaster rates in between. 
 
Breathlessness was recorded for 96% of patients in this study which is higher 
than 78% previously reported in mesothelioma (Higgs and Newbury, 1999) and 
the 78% and 80% reported in studies of patients with lung cancer (Edmonds et 
al, 2001, Krishnasamy et al, 2001).  
 
Pain was recorded as affecting 91% of patients. Although 85% of the patients in 
this records survey had been prescribed opiates, the doses of morphine appear 
to be surprisingly low: the median equivalent 24-hour dose of oral morphine was 
100 mg.  Validated pain assessment tools were not found in any of the medical 
records and yet there is evidence to show that these can be used to tailor 
treatment more effectively (De Conno and Martini, 2001) Nevertheless, on 
further examination of the notes it became apparent that the median doses of 
oral morphine equivalents were misleading: 12 patients (15%) appear to have 
had pain that required multiple combined approaches to analgesia, suggesting 
complex pain. In view of the problems of accessing data from medical records, 
and studies suggesting inadequate pain relief in cancer patients, it is likely that 
15% is an underestimate of the percentage of patients who may need specialist 
advice regarding analgesia.  A large survey of hospice patients, who might be 
supposed to represent the more symptomatic patients, described 12.14% of 
opiate-treated cancer patients as receiving high dose morphine, defined as 
>300mg oral morphine equivalent/day  (Bercovitch et al,1999).  
 
The medical records survey revealed that psycho-emotional symptoms were 
recorded for 46% of patients. A review of 46 patients with mesothelioma cared 
for by a palliative care service found that 68% had psychosocial issues (Higgs 
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and Newbury, 1999). These percentages are considerably higher than have 
been reported in lung cancer (Sarna, 1998:342). This builds on previous work 
suggesting that patients with lung cancer suffer the greatest psychosocial 
distress (Zabora et al, 2001; Sarna, 1998). Chapman et al (2005) suggest that 
these factors must be addressed in pain management in mesothelioma. 
 
Diagnosis of mesothelioma was confirmed during life in 63 of 80 patients and 
strongly suspected in at least a further two cases. The records failed to show 
whether or not 23 of the 63 patients had been informed of their diagnosis 
although good practice guidelines state the importance of recording this 
information, including any decision not to inform a patient of their diagnosis, with 
reasons for this decision (Brennan, 2004:353-4). In mesothelioma, given the 
specific medico-legal issues, it is particularly important that this guidance is 
followed. Almost a third of patients were informed of the diagnosis by a junior 
doctor, this raises some questions, given that the diagnosis is particularly 
distressing for patients in the absence of effective treatments, and the need for 
the patient to have confidence in the medical staff (Brennan, 2004: 330). 
 
In the UK, men visit their GP three times a year on average, although this rises 
with age (National Statistics, 2006). The high consultation rate, 10 in the last 
year of life, for patients with mesothelioma, confirms the high disease burden 
and also the central role of primary care in the care of the dying. Leeds patients 
appeared to receive more consultations and proportionately more visits than the 
other two sites but the significance of this is unclear. Two or three hospital 
admissions in the last year of life or from disease onset represent considerable 
disease burden and patients were not necessarily always admitted to the same 
hospital. Day Unit admissions added further to the disease burden. The majority 
of these admissions were due to recurrent pleural effusions and may have been 
prevented by earlier referral for pleurodesis. 
 
In spite of the high symptom burden, short survival time and lack of effective 
disease-modifying or curative treatments, just under half of the 80 patients were 
referred to palliative medicine. In common with previous studies in patients with 
cancer, these referrals were made when the disease was advanced (Morita et 
al, 2005).  Hospices provided services to a third of the 80 patients, a high 
proportion for any disease group (Eve and Higginson, 2000). Most admissions 
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occurred when the patient was close to death, and most hospice patients died 
in the hospice, suggesting that referrals to hospice/palliative services were late.  
 
Most of the patients with mesothelioma (75%) had significant co-existing 
illnesses, some of which were smoking-related. The smoking data reflect social 
trends and are relevant because smoking and asbestos exposure are co-
carcinogens for adenocarcinoma of the lung.  Smoking does not increase the 
risk of mesothelioma in asbestos-exposed workers. 
  
Survival from first presentation to medical services, 294 days (9.7 months), 
agrees with previous UK studies that give a range from 7 to 14 months. If the 
median interval of 36 days between symptom onset and presentation to medical 
services is added, survival from symptom onset increases to almost 11 months.  
 
Studies suggest that around 50% of people with cancer wish to die at home and 
around 25% achieve this (Dunlop et al, 1998; Townsend et al, 1990) In this 
study, only 14% of the patients with mesothelioma died at home. A high 
percentage, 30%, died in a hospice in contrast to just 8% of cancer patients in 
general (Eve and Higginson, 2000). The availability of two relatively large, well-
established hospices in Leeds may explain the higher proportion of hospice 
deaths there, due to easy access. Although 61% died peacefully it is concerning 
that 21% experienced distress lasting more than an hour before they died.  
 
The following chapter investigates the patients‟ experience of mesothelioma 
and reports the findings from interviews with patients. 
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Chapter 4: Living with mesothelioma: 
Interviews with patients 
 
Semi-structured interviews were conducted with 15 patients, (m=13, f=2, mean 
age 69 years), who had malignant pleural mesothelioma, in order to reach an 
understanding of the lived experience and meaning of their situation. All the 
interviews took place in the patients‟ homes in northern England, except for 
one, with a man who was interviewed in a hospice; in twelve out of the fourteen 
patients who were married or co-habiting, their spouse or partner was present. 
Two patients were interviewed in the week before they died. The patients knew 
that I was a GP and hospice doctor with a particular interest in their illness and 
the effects it was having on them and their families. I attempted to put patients 
and their spouses/family carers at ease and conducted the interviews in the role 
of an informed and interested friend who was also a doctor. From my 
perspective, most interviews rapidly settled into the familiar, relatively informal 
nature of a GP consultation but with everyone aware that I was not there as a 
family doctor (p84) 
 
The findings from the interview data are presented to give a picture of the 
patients‟ experience of the disease and the meaning it had for them and their 
families. This report illustrates the chronological nature of the accounts given 
during the interviews: participants were invited to start by describing their work 
history and exposure to asbestos and then to recount the story of their illness 
from symptom onset, using an interview guide as a prompt (See Appendix 4). 
Themes reported under each subheading are illustrated by quotes in boxes at 
the end of each section. Key points are summarised at the end of the relevant 
subchapter. 
 
 
 132 
4.1 Asbestos exposure and hazards advice  
Occupational exposure 
 
All 15 patients reported that they were aware that they had been exposed to 
asbestos; 12 men recalled their exposure had occurred at work, which was 
related to the nature of the industry in which they were employed (see Box 4.1 
and Table 4.1). The patients interviewed had mainly been employed in those 
industries that were responsible for the majority of occupation-related cases to 
date: shipbuilding, railways maintenance and the power industries. The 
interviews described the dirty and dangerous working environments in which 
asbestos exposure occurred.  
Para-occupational or bystander exposure to asbestos 
The two women patients who participated in the study had non-occupational 
routes of exposure to asbestos. One woman, Mrs N, had washed the overalls of 
her husband and son who had both worked in the shipyard although she 
preferred to believe that she had been exposed to asbestos from the dilapidated 
market hall where she had worked. The other woman, Mrs T, believed she had 
been exposed to asbestos when an asbestos-roofed building next door to her 
house was demolished without any safety precautions. Environmental 
contamination with asbestos accounted for the exposure of one patient, Mr Q, 
who had lived close to the notorious asbestos textile factory in Armley, Leeds, 
during his childhood. His illness developed 60 years later. 
Multiple exposures to asbestos 
Six of the fifteen patients recalled being exposed to asbestos in more than one 
situation. These included four men who had been employed in up to three high-
risk occupations and two patients with mesothelioma whose fathers, both 
shipyard workers, had died from either asbestosis or mesothelioma. Two 
patients mentioned their concerns about other family members currently 
working in occupations that had previously been associated with asbestos 
exposure. 
 
‘…wrapping copper piping with asbestos cloth’ 
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Box 4.1: Exposure to asbestos 
 
Mr H: „I spent all through my apprenticeship working on them, and wrapping copper piping 
with asbestos cloth, about, nearly, some of it, 5/16, 3/8 and about 2in wide, and you're 
wrapping it round (pipes) and getting all the bits off it …they used to dump the rubbish at 
the plant down one part of (the yard), and people used to (play) snowballs with it.‟  
 
Mrs N: „They both worked in the shipyard and he worked on the Subs, didn‟t you? Well you 
used to wash their overalls, didn‟t you?‟ 
 
Mrs N: „ I worked there all them years and that‟s why I think I got it on the market...It was 
all over – in the roofs and that, well I worked on a stall and you had to go upstairs to the 
stockrooms. The roof let it in and it was all dusty coming down...even then I didn‟t think 
about what it was‟  
 
Mrs T: „…about 1985 or '86, it was an asbestos roof like that building, the garage, and they 
came and demolished it…and all they did was just smash all the asbestos off, they didn't do 
it controlled as they should have done.‟ 
Mr T:‟ I can remember coming home from work one day and (wife) had got a bucket of 
water and was washing the sills off this big window with this grey dust that she'd been 
covered in…and they smashed it [the building] so the whole cement and the fibre content 
had been swirling around…‟ 
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Table 4.1: Details of sample and asbestos exposure – patient interviews 
Asbestos hazards advice 
Most of the interviewees reported that they had not appreciated the dangers of 
working with asbestos during their years of employment. Nine of the twelve men 
who worked with asbestos could not recall being given any Health and Safety 
advice regarding asbestos hazards during their time at work. In the three cases 
who had recalled being informed of the hazards associated with asbestos, only 
one man acted upon the advice. One patient, Mr U, recalled warnings 
concerning blue asbestos whilst he was working for an insulation company in 
Australia but he had discounted it at the time because he was working with 
Pt   ID Age  m/f Exposure 
at work 
Occupation Industry Para-
occupational 
exposure 
Bystander  
exposure 
Mrs N 72 
 
f No Market 
stallholder 
Retail 
trade 
Son and 
husband‟s  
work-clothes 
? asbestos 
 in market 
ceiling 
Mr D 62 
 
m Yes Cabin 
lad/shunter 
Railway 
maintenance 
No No 
Mr M  m Yes Labourer Shipbuilding No No 
Mr J 66 
 
m Yes Apprentice 
millwright 
„‟     „‟ No No 
Mr U 68 m Yes 
 
Yes 
Sheet metal 
worker 
Shipbuilding 5 
yrs then 
Insulation firm 
4 yrs 
No No 
Mr I 61 m Yes 
 
 
Yes 
Engineering 
apprentice 9/12 
Engineering 
foreman 23 yrs 
Shipyard 
 
 
Paper mill 
No No 
Mr K 72 m Yes Shipyard worker Shipbuilding No No 
Mr Y 75 m Yes 
 
 
Yes 
Marine engineer 
4 years 
Maintenance 
engineer 
>10years 
Shipbuilding 
 
Railway then 
gasworks 
maintenance 
No No 
Mr S 58 m No Store manager Retail No Fireproof  
ceiling was 
replaced in 
 the store 
Mr C 66 m Yes Maintenance 
engineer 
Manufacturing No  
Mr T 79 m Yes Labourer Missing data No  
Mr Q 81   Floor layer 
(asbestos tiles) 
Construction  Lived near 
asbestos  
factory 
Mr V 68 m Yes Welder Power station 
construction 
No No 
Mr H 81 m Yes Lagger Railways 
maintenance 
No No 
Mrs T 55 f No Housewife/ 
Shop assistant 
Retail No ?Demolition  
of asbestos 
shed next  
door  
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white asbestos. Mr I, who had been an engineering foreman in a paper mill, 
recalled receiving Health and Safety paperwork regarding asbestos but had not 
appreciated its significance at the time; in the interview he hinted at both 
personal guilt and managerial neglect. In just one case, that of Mr V, hazards 
advice had been taken seriously and acted upon. Although he admitted initially 
ignoring the hazards warnings, following more information in the 1970s, Mr V 
left his job at a power station and moved to the relatively safer environment of a 
coal mine. However, by that time he had received sufficient exposure to 
asbestos to result in mesothelioma many years later. Ironically, Mr V, who had 
changed jobs to avoid asbestos, and whose wife had developed pleural 
plaques, presumably from washing his clothes, was diagnosed as a result of a 
screening x-ray when he was asymptomatic. The annual x-rays were originally 
suggested by his GP in 1994 when his wife was found to have pleural plaques 
(presumed to be due to washing her husband‟s work clothes). Mr V was also 
found to have pleural plaques on his initial x-ray in 1994; seven years later new 
signs developed which were then proved to be mesothelioma.  
 
Anticipatory anxiety: the ‘Damocles syndrome’29 
Mr U, although appearing to discount asbestos hazards advice at the time 
because they related to blue rather than white asbestos, had subsequently 
heard of workmates who had died due to mesothelioma. In later years this 
alerted him to his own risk of developing mesothelioma. When he suffered 
persisting pain following a minor injury it prompted him to ask for a chest x-ray 
because he suspected the diagnosis of mesothelioma at that time. Similarly, Mr 
V and his wife reflected that they had been worried about the risk of 
mesothelioma for many years, particularly as they also learnt of former 
workmates dying from mesothelioma. As well as the anxiety pre-diagnosis 
around the risk of mesothelioma, anticipatory anxiety post-diagnosis reflected 
concerns about severe pain and breathing difficulties based on media or other 
indirect accounts of patients‟ suffering. Anxiety about the risk of asbestos-
related disease appeared to extend to consideration of other family members 
once a diagnosis had been made. This led to a sense of constant alert, 
particularly regarding the younger generation (see Box 4.2). 
 
                                                 
29
 The ‘Damocles syndrome’ was first described as anticipatory anxiety experienced by people at high 
risk of developing spino-cerebellar ataxia, a fatal genetic condition ( de Villiers 1997). 
 136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Causation 
The lack of health and safety information whilst working with, or near, asbestos 
added to the difficulty in accepting asbestos as the cause for one patient, and 
caused emotional distress and anger. Two patients proposed alternative routes 
of exposure to those accepted by their medical and legal advisers: Mrs N 
wondered if her disease related to exposure to asbestos from the dilapidated 
indoor market that had been repaired while she worked there, rather than 
blaming the contaminated work clothes of her husband and son. Similarly, 
another patient, Mr D, questioned whether his illness had resulted from 
exposure due to working on railway carriages and wondered if asbestos in the 
air from the nearby shipyard had been to blame Attribution of the disease to 
Box 4.2: Asbestos hazard advice and anticipatory anxiety 
HC: „…when did you first start hearing at work about asbestos as a health risk?  
Mr V: „Well I never really took much notice of it, it were never a big fear, I should 
say, until oh maybe late '70's, something like that, and for that reason I got out of the 
game, to be honest with you. I got a chance to get back at the Coal Board because I'd 
worked there before and I got a job on the surface, still as a welder, but away from all 
the muck and filth in the power station.’ 
 
Mr I: „You were given lumps of bumph, you know, „Read through that‟, that sort of thing, 
„from a Health and Safety point of view‟, and left you to get on with it. So, if you didn't read it 
up, then it was your fault…it was down to you with no emphasis laid down, you know, main, 
look, these are the main priorities, it should have been a proper seminar, you know, training 
seminar on health and safety alone, which was of prime importance really.‟  
 
Mr U: „I‟d always been aware that I might have it because me friends around me were going 
one by one….‟cos the lad I worked with, he only went in January. 
HC: „Were these workmates from the insulation work?‟ 
Mr U: „No, they were from the sheet metal shop….whole family wiped out, father, two sons‟  
Later in the interview: 
Mr U: „Well it started really thinking I had a disc out. I pulled a plug out over there and it 
didn‟t come. It pulled all the muscle in my arm and I thought I‟d pulled a disc as well…So I 
went to the doctor…he said „I think you‟ve pulled a muscle‟. I said Can you send me for an x-
ray?‟… I mean because my chiropracter was getting no nearer with it. So he sent me for an x-
ray on my back and I said „While I‟m there will you get me one on my chest because I‟ve 
worked with asbestos when I was in my  „teens, when I was in my twenties.‟‟ 
 
Mrs V: „We've got 4 children and we hope that they don't, in time, develop this.‟ 
HC: „How much of a worry is that for you?‟ 
Mr V: „Very much.‟ 
Mrs V: „It's a niggle all the time there, isn't it?…And every time we got a cough or a cold we 
used to think "Is this the start of it?" because we knew his friends who'd developed it and died 
from it.‟ 
Mr V: „Well we were working in it in the '50's, I knew one or two lads who were in the same 
thing as me and I know at least 3 who've died with mesothelioma.‟  
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asbestos exposure many years earlier caused some problems for patients who 
found it difficult to accept the long latency period, although duration of exposure 
was not an issue raised by these patients (see Box 4.3)..   
 
 
 
 
 
 
 
 
4.2 Coping with symptoms 
 
 
Becoming unwell 
The symptoms patients experienced at onset and as the disease progressed  
corresponded with previous accounts of mesothelioma, although not 
surprisingly, most of the participants did not have severe symptoms at the time 
of their interviews (Edwards et al, 2000; BTS, 2001; Yates et al, 1997), (see 
Table 4.2).  Seven patients recalled that they initially went to their GP, or 
directly to the hospital, with shortness of breath, two with persisting chest pain; 
two with fatigue; two with chest infection and/or weight loss; one was 
asymptomatic and detected on annual chest X-ray. One man reported that he 
had injured his ribs in a fall and an X-ray performed to investigate persisting 
pain revealed pleural shadowing and prompted investigation. Symptoms were 
reported by the patients in terms of their impact on normal activities, particularly 
physical tasks around the home and hobbies. Patients had their own ideas 
about their initial symptoms, often attributing symptoms to getting older or 
working hard. 
 
Patients redefined the meaning of their symptoms as the disease developed: 
initial „benign‟ interpretations of symptoms altered as the patients developed a 
greater understanding of their illness. In some cases this knowledge appeared 
to empower the patients: they felt able to tell their doctors when pleural 
‘…my breathing was terrible’ 
Box 4.3: Causation 
 
Mr M:  „I‟m angry „cos I don‟t know where it‟s come from. I just haven‟t got a clue at all and 
that‟s what makes me feel more angry, where it comes from, where I‟ve picked it up from. 
„Cos nothing was ever said to you about asbestos at all.‟ 
 
Mr D: „It was only the water separated the shipyard from the railway yard….whether it was 
in the air I don‟t know.‟ 
 
Mrs N: „How many years does it take, more than 20? … it‟s a long long time ago.‟  
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effusions had recurred and expected appropriate intervention. However it also 
gave rise to anxieties as knowledge of the disease made it harder for patients to 
ignore or deny the symptoms that indicated disease progression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2: Clinical features and interventions (RT=radiotherapy, CT 
=chemotherapy) 
 
Patient 
ID 
Initial 
symptom 
Pleural 
effusion 
No of 
pleural 
taps 
Pleuro 
-desis 
RT*,CT, 
or 
surgery 
Condition 
at interview 
Mrs M Dyspnoea Yes 3 Y  Weak, thin, 
breathless 
Mr D Dyspnoea Yes 4 Y  Breathless,  
low mood 
Mr M Dyspnoea Yes 3 Y  Fatigued  
Mr J Weight loss,  
chest infection 
No    Breathless, 
emotional 
Mr U Chest pain No   Too ill 
for CT 
Weak, 
nephrotic 
syndrome 
Mr I Dyspnoea & 
fatigue 
Yes 3+ Y RT End-stage  
illness,  
dyspnoeic 
Mr K Dyspnoea Yes    Fatigued 
Mr Y Severe chest 
pain 
Yes 2 Y CT Low mood, 
breathless,  
tingling in arms 
Mr S Fatigue Yes 3 Y  Breathless on 
exertion 
Mr C Dyspnoea Yes    Close to death 
Mr T Dyspnoea Yes    Emaciated, 
breathless 
Mr Q Dyspnoea Yes 3 Y RT Frail, 
breathless 
Mr V No symptoms Yes 1  RT Breathless, 
chest pain 
Mr H Cough Yes 2  RT 
CT 
Fatigue,  
breathless, 
painful lump on 
chest 
Mrs T Short of breath Yes 2 Y  Breathless on 
exertion, tired 
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Many patients appeared reluctant to seek help, even when suffering from very 
distressing symptoms. This was acknowledged by two of the interviewees, one 
of them (Mr I) blamed his own „macho‟ attitude and he also admitted that 
symptoms, particularly pain in his case, caused considerable anxiety, Box 4.3. It 
was clear that most couples dealt with symptoms jointly and, in several cases, 
the male patients deferred to their wives with regard to calling for assistance 
with symptom management. 
 
Virtually all the patients were concerned to assure me that they were making 
the best of a dire situation. The spouses, 11 wives and two husbands, gave the 
same impression as the patients, perhaps taking their lead from the patients: 
that they were coping, together, as best as they could in the circumstances. 
Patients appeared reluctant to enlarge on their feelings, perhaps as a strategy 
to avoid additional emotional distress for themselves and/or their relatives, and 
in the interviews their spouses backed them up. Relatives present in the 
interviews appeared to use a variety of strategies to limit emotional distress (this 
may have impacted on the data obtained from the interviews but had not been 
predicted in the study design and specifically excluding relatives from the 
interviews may well have reduced recruitment).  
Fighting for breath 
Dyspnoea, the main symptom affecting most of the patients, was seen as a 
potential threat to life; patients and families expressed intense anxieties 
associated with it and their attempts to manage it. Fear was evident in the terms 
used such as „fighting for breath‟ and „gasping her last‟ and with reports of other 
people with mesothelioma, who they had known or learnt about in the media, 
who were said to have „drowned in fluid‟ or „suffocated to death‟. Patients 
reported that they frequently continued to be breathless, although usually to a 
lesser degree after treatment such as pleurodesis which, when successful, 
stopped effusions recurring. Self-help breathlessness management techniques, 
proven to increase patients‟ sense of mastery over breathlessness, did not 
appear to have been taught to any of the interviewees (Bredin and Corner, 
1999). Terrifying cough and breathlessness were reported as major problems 
for one couple, Mrs T, the patient, and her husband, Mr T. The extract from the 
interview with Mrs T also illustrates the impact on the patient‟s spouse and the 
efforts he was able to make, somewhat to his surprise, to help her. As in many 
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of the interviews, this patient‟s spouse was at pains to assure me (and himself) 
that they were coping but it was clear from the interview that Mr T felt solely 
responsible for managing this distressing episode (see Box 4.4, below). 
Dealing with pain 
Pain was only reported as a major problem for one of the patients interviewed 
and this had largely responded to treatment by the time of the interview. Others 
described pain as „discomfort‟ that was manageable with analgesics, although it 
appeared that a certain amount of pain was accepted by some as an inevitable 
consequence of having cancer. Reluctance to seek help was also accompanied 
by a reluctance to admit to the severity of the symptoms, as in Mr Y‟s refusal to 
admit to being an „emergency‟ when clearly in great pain (Box 4.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 4.4: Dealing with symptoms 
Mrs T: „Well, I get to the point where I cough and cough, get wind or want to burp, then I'm 
sick, and the last twice I've been sick I've nearly choked. It's a good job Ian was there, I seem 
to lose my airways or whatever… it seems I want to clear my throat somehow, and the only 
way I can do it is by being sick.‟ 
Mr T: „It's like a thick, clear fluid that comes up, a sort of – not quite wallpaper paste but that 
sort of stuff…firstly you're not as strong, to be able to cough it up, and secondly it seems to 
block all your airways…at midnight last night we were both laid on the bathroom floor with C 
going (gasp) and absolutely panic stricken that that was her last breath, and I am trying to 
console her, trying to rescue her, and well there's been times when I wouldn't have been able 
to cope, but somehow I'm coping better that I ever thought. ..So we are coping.’(patient Mrs T 
and her husband) 
 
Mr M: „…and it sometimes gets real bad at night….and I‟ve got to hang outside there, hang 
out of that window just so I can get some air.‟ 
 
Mr Y: „…about the first 2 or 3 days in April, good grief, violent pains and all this business in 
my chest. I had another day off, and that went away. Then a fortnight after that, I went down 
to work, did my usual bit of sweeping up and bit of cellar work, cleaning pipes and stuff like 
this, you know, and I came home at about 9 o'clock and - Oh dear, I started with violent pains. 
I was jumping about on that settee like no-one's business, and Betty said "Get the doctor".  I 
said "It'll go away, it went away last week, it'll be all right, it'll go away". She says "Get the 
doctor, we're not having that noise all day!" So we rang for the doctor. They asked if it was 
urgent, I said „No‟, - the doctor arrived after his surgery in about an hour. He arrived, 
examined me, gave me a severe chastising for not getting him here earlier. I said I didn't think 
it was urgent. "I'll be the judge of that" he said, and rang for an ambulance.‟  
 
Mr A: „… the pain‟s always there but I can control it with the medication, up to a point. It 
varies day by day, sometimes it‟ll pull in my back, other times it‟ll pull in my front, other times 
it‟ll pull where I had my biopsy - it‟s really nasty when it gets to that area.‟ 
 
Mr I: „A lot of it‟s my own problem. Too macho to be shouting out when I should be, you 
know, when I‟m in pain. I‟m silly and I‟ll say, look, look, what you give me, just stop this 
bloody pain will you? You know, because personality change is quite enormous when I‟m in 
pain. It‟s terrible, you know it‟s, it‟s because it also brings on the anxiety side of it which 
makes the pain worse.’  
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The erratic disease trajectory 
 
 
The unpredictable and often rapid onset of pleural effusions caused great 
distress, compromised patients‟ abilities to manage their illness and disrupted 
their „treatment calendars‟ (Costain Schou and Hewison, 1999:122-3). Pleural 
effusions tended to recur at short intervals in many patients, necessitating 
emergency hospital admissions for pleural aspiration. This was usually followed 
by referral to thoracic surgery units, often in different hospitals, for pleurodesis 
to be performed (see Table 4.2, p138).  
 
Alongside acute episodes of breathlessness and pain, patients reported that 
steady, sometimes rapid, decline in function was also common. Loss of appetite 
and weight, reduced mobility, general frailty and confusion were also raised as 
common symptoms. Mr Q had fallen on the day before the interview and hit his 
head; his wife was worried that this may have increased his confusion. The 
uncertainty of the progress of the disease also caused anxiety: patients and 
relatives struggled with not knowing the significance of symptoms and whether 
or not their condition was stable; even when they felt reasonably well, they 
revealed background awareness that the disease would be fatal (see Box 4.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 4.5: Disease progression 
Mr S: „If you could call it stable, it's stable. Or if it's creeping on I don't know about it. I 
suppose it will creep on eventually won't it?‟ (patient Mr S) 
 
Mr T: „But within 6 weeks you can't walk round town and now we're sort of 12 weeks into 
it…you are progressively getting worse, I just don't know the speed of what's coming over you, 
or the stages of it… do we have 12 weeks where you can still walk around the house then 12 
weeks in bed?  We just don't know.‟ 
Mrs T: „And nobody knows, no one can answer that, can they? It depends how I react to 
treatment, if I get any.‟(patient Mrs T and her husband) 
 
HC: „And so what are your main problems at the moment?‟ 
Mr Q:‟ Well I‟m not eating, for a start, but I put that down to not walking about, I can‟t get 
out because it‟s been cold weather…I‟ve no appetite… I‟m all right in myself.‟ 
HC: „Has it slowed you down?‟  
Mr Q: „Oh yes, I can‟t do anything…I‟m jiggered if I try and do anything.‟ 
HC: „What about concentration and memory and things like that?‟ 
Mr Q: „Well I‟m beginning to wonder today, after doing…‟ 
Mrs Q: „We‟ve been an hour taking £26 from £303! (laughs) He wouldn‟t believe me, in fact 
his daughter rang up and she had to tell him.‟ 
‘Do we have 12 weeks where you can still walk around? We just don’t know’ 
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4.3 Investigations and interventions 
 
 
 
 
Most patients were referred for a chest X-ray at their first or second GP 
consultation, one of these at the patient‟s request (Mr U). After the abnormal 
chest x-ray, patients were seen quickly by a hospital consultant, in most cases 
within a few days, two weeks at the most. Patients‟ experiences varied 
considerably: for most patients the investigations and/or interventions were 
unpleasant and distressing to a variable degree; others seemed to tolerate the 
procedures well.  
Managing pleural effusions 
Twelve patients reported that they each required several pleural aspirations, 8 
of these had also had pleurodesis, (Table 4.2). Patients seemed to understand 
the concept of „fluid on the lung‟, possibly because for these evidently practical 
men, (and also the two women), this was perceived as amendable to a practical 
technique that gave rapid results. However they also revealed that not all these 
procedures had been straightforward and complications such as „shock‟ and 
tumour tracking along thoracoscopy ports had occurred. Three patients 
reflected concerns that the procedures that they were undergoing appeared to 
be being taught to junior doctors, Box 4.6. One patient, Mr M, was an exception: 
he appeared to have enjoyed his hospital stay in which VATS biopsy and 
pleurodesis were performed, partly because the investigations were not 
distressing and he had also enjoyed the camaraderie on the cardio-thoracic 
surgery unit. 
 
 
 
 
 
 
 
 
‘They called it keyhole surgery but I was scarred like hell!‟ 
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Radiotherapy, chemotherapy and surgery 
Five of the 15 patients reported receiving oncological treatments: two patients 
had radical surgery with radiotherapy; one of these had adjuvant chemotherapy 
as part of a clinical trial; another patient had chemotherapy alone in a clinical 
trial; two other patients received prophylactic radiotherapy to port sites. One 
patient recalled that he was unable to have prophylactic radiotherapy because 
he had developed nephrotic syndrome that required in-patient hospice 
treatment. Radiotherapy alone did not seem to cause distress, although the 
distance of 70 miles to the nearest centre had initially deterred one patient in 
Box 4.6: Investigations and interventions 
 
Mr I: „It was a terrible ordeal. No pain, no…but it‟s the weirdest experience. He said this will 
happen to one say, one in a hundred…I was practically in shock. Only took about 
500mls…and I was going „Oh God, I feel as though I‟m dying‟ He (consultant) walked in and 
said „You‟d better stop now…can‟t you see that he‟s close to going into shock‟ Soon as the 
needle came out I was alright.‟ 
 
Mrs N: „...they drained the fluid off…after a fortnight I said to him „It‟s back again‟. So after 
that he took me in again…put a big tube in my back and they puffed stuff in to seal it up…that 
stuff they put inside you gives you flu-like symptoms…I was ill for 24 hours. All I wanted to do 
was get out of hospital and come home… And that was a mess, the biopsy, and I started 
coming out in big lumps. They said it‟s tracking from putting the tubes in.‟ 
 
Mr M: „I didn‟t even know they‟d done it to tell the truth, the anaesthetist knocked us 
out….when I came to I was in a different ward. I felt really great when I came out of there. In 
fact I enjoyed it in there, there was a lot of people in there getting 5 multiple bypasses!‟(Mr M 
talking about surgical pleurodesis) 
 
Mr S: „…they were going to do a biopsy… they said it would be sort of keyhole surgery so it 
didn't bother me too much so long as I was asleep (laughs)…the drain again was put on my 
lung in another area. This was a long stay, 11 days...They called it keyhole surgery but I was 
scarred like hell (laughing) then the drainage had to take place again …and they left me with 
a little bag. They said "We're not taking that bag off you, you're still mobile, just be careful 
how you sleep" I had to devise a contraption where I could hang it!‟  
 
Mr J: „…the bloke seemed to be teaching the lass how to do it [biopsy].‟ 
 
Mr T: „The gentleman, we don't know his name, who came to do the talc…‟ 
Mrs T: „…and he came in an all green gown into the nurse station and said he'd got to do this 
talcum powder thing, and the matron said "Yes, have you done it before?" He said  "I've never 
done this before".‟  
Mr T: So he laid (wife) on her side and poured in some liquid anaesthetic, kept the tube nice 
and wet and then tried to put a dry powder down it, and it just all clogged, it just did not seem 
to work and we were convinced it hadn't worked…we thought "Yes, I don't think you have 
done that before!"  
 
Mr S: „Yes, I get discomfort from this pleurodesis…which I've had ever since they did it, but 
it's not out and out pain, it's just occasionally you know it's there.‟           
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Barrow, Mrs N. However, when she did have radiotherapy it failed to prevent 
the subsequent development of chest wall invasion due to tumour tracking 
along port sites. In contrast to patients who reported their straightforward 
experiences of radiotherapy, the two patients also receiving chemotherapy as 
part of clinical trials recalled a considerable treatment burden both in terms of 
the practical demands of multiple hospital appointments and the side effects of 
the treatments.  
 
Radical surgery appeared to cause particular concerns for patients and their 
families. The two patients who had radical surgery, Mr V and Mr H, had both 
been made aware that it was unlikely to be curative. Mr V, who had been 
operated on just three months prior to the interview, was doing well and hoping 
for an extended survival. The other patient, Mr H, had developed a lump on his 
chest wall that was found to be a recurrence of the tumour; he was then offered 
chemotherapy in a clinical trial. Both men who had undergone surgery were 
particularly well-informed about their illness, treatment and prognosis. In both 
cases they had extremely supportive wives who had also learnt as much as 
they could about the illness but their relationships with their specialists was 
different.  
 
For one couple, Mr and Mrs V, their expectations of multi-modular treatment, 
gleaned by them from North American websites via the Internet, were not 
realised and they were not happy with the explanation given by the consultant, 
causing dissatisfaction and anxiety. The lack of choice of type of treatment in a 
randomised controlled trial was also highlighted by this patient‟s wife, a practice 
nurse. She voiced more anxieties than her husband in the interview, In the 
second case, a more easy, trusting and mutually respectful relationship with the 
consultant was reported: both patient and doctor used humour, presumably as 
one way of reducing emotional tension in consultations when bad news and 
confirmation of dreaded fears were present. This patient, Mr H, whose worst 
fears were realised when his tumour recurred after radical surgery, was then 
offered chemotherapy – he recalled being anxious when asked to choose 
whether or not to undertake this treatment as part of a clinical trial. In addition, 
uncertainties concerning access to treatments and effectiveness of treatments 
caused further anxiety (see Box 4.7).  
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4.4 Finding out about mesothelioma 
 
 
 
It was a criterion for recruitment into the study that the patient knew the 
diagnosis of mesothelioma. From the interviews, it was clear that all the patients 
had been told that there was no possibility of cure. Even in the two patients who 
Box 4.7: Radiotherapy, chemotherapy and surgery 
 
Mr J: „…she said we‟ll take you in and bombard this with radiotherapy. So I went and had 
that done, but it didn‟t seem to give me much trouble‟ 
Mr Y: „I've had 3 days at radiotherapy and 12 sessions of chemotherapy. I've seen the doctor, 
is it 3 or 4 times? I saw the consultant first and since then …‟ 
Mrs Y: …once since when he got you to decide to go on the trial.‟ 
Mr Y:‟ Yes, I saw him once in [hospital] and then they transferred me from Dr A to Dr B and 
he got me to go on to this trial thing they're running, and I've been about 12 courses of 
this…and so far so good….That's the full course and I've to go for a scan, the time tunnel 
thing… where you go down and they stick this gunge in your hand and make you burn all over 
and all this business… in about a month… then see the doctor again.‟ 
 
Mrs V: „The only thing that bothered us was, Mr C the surgeon referred him to the oncologist 
with a view to multimodular treatment. Well he didn't have the multimodular treatment, he 
just had the radiotherapy and it wasn't the correct amount because of the liver, and he didn't 
have the chemo. The oncologist wasn't in favour of that, so we've had to go along with that. I 
did question him and you don't like questioning the specialist do you? But I did say "Is there 
any more?" In the nicest possible way of course, you don't want to tread on peoples' toes. But 
he said it would compromise the radiotherapy, and also there was nothing there to measure if 
he gave the chemotherapy. But people don't have anything to measure if they have breast 
cancer or bowel cancer, but he said it was different from those cancers.‟ 
Mr V: „I could see his point really, how he explained it to me. I mean obviously I was satisfied 
with the, because to me, as far as I was concerned, they'd cut out the infected lung before it 
had really got bad, and well in my mind, you know the way I was at the time, and they'd cut 
that out, and all I was bothered about was, my impression was that they were giving me this 
treatment as like an aftercare sort of thing, not to kill anything off. It was just all the 
surrounding area, to make sure anything it had been in contact with or anything like that.‟ 
(Mr V and his wife, Mrs V, who had looked up mesothelioma on the Internet)  
 
Mr H: „So when I went back to see him he told me that the cancer had, like, come back, and 
he says "I'm sending you straight down now to Dr H" becauseI was to see H one time, and V 
for check-ups. So I went straight down to Dr H and he says „I'd like you to go on this 12-15 
week trial", so I says "Well I've no option, have I, really?" He says "Even if you didn't go on it 
you'd still get treatment" but I says "Yes, I'll go on it.‟‟ 
HC: „What sort of treatment was that?‟ 
Mr H: „Radiotherapy. 
Mrs H: „Well it was a trial, wasn't it, there was three choices but you couldn't 
choose which, two was different chemotherapy and you got chosen for 
radiotherapy.‟(patient Mr H and his wife) 
‘I just turned to wood, stone, whatever, I was numbed’ 
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presented with early disease and then had surgery, it had not been suggested 
that this offered a cure (Box 4.8).  
 
Most patients recalled that they were informed of the diagnosis by the 
respiratory consultant, one was informed by his GP. The short prognosis and 
lack of curative treatment were made explicit when the diagnosis was explained 
in every case.  The patients confirmed that the status of mesothelioma as a 
prescribed industrial disease and the associated State benefits and civil claims 
procedures had usually been mentioned at the time of diagnosis. Only one of 
the fifteen patients seemed to question the doctor about the diagnosis or ask for 
further information, although several expressed problems with acceptance, 
especially regarding causation, in the interviews.  
 
Many patients recalled being unable to take in anything else at the time of 
learning the diagnosis; not surprisingly several accompanying spouses recalled 
more details of the consultation than patients. Most patients felt strongly that 
they should be informed of the diagnosis when their spouses were present but 
in two cases their wives had been told before the patients. In both these cases, 
the patients were critical of this practice but for different reasons: one man 
wanted to have control of the information and hinted that he may have chosen 
to withhold the diagnosis from his wife, at least initially, the other man and his 
wife wished that they had been together when the diagnosis was disclosed. An 
apparent breakdown in communication caused anxiety for one patient when a 
nurse telephoned him, expecting that he already knew the diagnosis.   
 
The patients‟ recalled their immediate reactions to the diagnosis: in most cases 
these appeared to occur in either of two forms, shock or stoical acceptance. 
The shock of the diagnosis was evident in the single word ‘devastated’ that one 
man used to describe his reaction to the diagnosis. He was only six days away 
from death and just raised his head to whisper this single word (see Vignette 
4.2, Mr C, p163). This was all that Mr C was able to utter apart from asking me 
to ‘talk to the wife’ when I arrived. Some patients recalled that doctors had been 
kind and sympathetic when explaining the diagnosis but the overriding 
recollection was of a hopeless message: mesothelioma was an incurable 
disease for which no treatments were offered in most cases (Boxes 4.8, 4.9). 
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4.5 Psychological reactions 
 
Facing death 
Prior knowledge of workmates or family members with mesothelioma gave rise 
to anticipatory anxiety of developing the disease, echoing the so-called 
Box 4.8: Learning the diagnosis 
Mrs N: „They said there was no cure for it, to take them lumps off... I could have radiology? 
Well he just said he were sorry and that we‟d be able to go ahead and get a solicitor…‟ 
 
Mr M: „and he said „I‟m afraid there‟s no cure for it‟…and my doctor says, „It might be a while 
yet, it‟ll give you time to get things sorted out, you know‟‟ (patient Mr M) 
 
Mr Y: „I had my wife and daughter with me…I just turned to wood. The doctor said "you've got 
mesothelioma" and I can't remember anything after that‟. 
Mrs Y: „She said "It's mesothelioma, it's malignant, it's terminal and there's no treatment".  
They wouldn't take the lung out because it was too big an operation that would only give him 
another 6 months‟. 
Mr Y: „I just went like that, I just turned to wood, stone, whatever, I was numbed.‟  
 
Mr J: „To tell you the truth, when he first told me, my mind just went bonk. Shock….I can 
remember him being quite pleasant about it…he did it in a nice way, er, as soon as he 
mentioned what it was I knew…because of father. Definitely that was the worst day.‟ (Mr J’s 
father died due to mesothelioma) 
 
Mrs T: „Yes, and I just says to him "Can you give me a time?" sort of thing, and he just says 
"No, I don't want to give you any false hope, I can't give you much hope"... They'd found these 
abnormal parts on my lung and he says "It's a type that doesn't respond to treatment"‟. 
Mr T: „He said "It's very very serious and it's in a position where we don't think we can help 
you".‟ (after protracted investigations eventually confirmed mesothelioma) 
 
Mr U: „I looked at her face and said „You know something I don‟t, they‟ve found cancer, 
haven‟t they?‟  She just broke down. So we went back to the doctor and he said „Well I‟m sorry 
you‟ve got cancer of the lung‟…It wasn‟t a good way of doing it but, on the other score, she got 
to know, or I wouldn‟t have told her. And that‟s the thing that annoyed me, I could have told her 
but I didn‟t have the chance, she had to tell me‟ 
 
Mr I: „So he had already spoken to the wife that morning, so she knew, so she was present when 
he came to give me the good news, mm, so he just came and told me what it was. He said „I‟ve 
told your wife that you need to get your finances sorted out, get your house in order and for the 
future, you know. Have you got anything to ask me?‟ „No‟ I said, „I can‟t think of 
anything.‟(patient Mr I) 
 
Mr S: „Oh yes, I thought "Well there is a problem, a hell of a problem, she wouldn't ring out of 
the blue, would she? She rang me assuming that Dr P had given me the story…I'd got an idea, I 
was getting worried…you think the worst… "Are they going to be taking my lung out? Cut a 
tumour out?‟ Because I didn't know what the hell mesothelioma was…I'd heard about a lot of 
cases in Leeds and I'd read about people in the factories.‟  
‘Sod it, I‟ll just take each day as it comes.‟ 
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„Damocles syndrome‟ (de Villiers, 1997, p28). After the initial shock of the 
diagnosis all the patients displayed an apparently unquestioning acceptance of 
the diagnosis of mesothelioma, although, as reported earlier, they sometimes 
questioned the way in which they had been exposed to asbestos. Most 
expressed their determination to cope as well as possible with support from 
their close family. In many cases it appeared that patients and families had 
negotiated an agreed way of coping with the illness and that this „framed‟ their 
accounts. Patients often balanced their accounts of their knowledge that the 
disease was incurable with descriptions of how they would attempt to stay as 
healthy as possible (See Box 4.9). 
 
Following diagnosis, most patients did not look for further information, one 
patient, Mr R, reflected that searching for further information could cause more 
problems, particularly as he accepted that he had a fatal disease (see Box 4.9). 
Two exceptions were the wives of the two post-surgical patients: they had 
actively explored a variety of sources including the Internet (Mrs V, Box 4.7) 
 
In spite of the particularly dire prognosis, it appeared that most patients still 
managed to reframe their expectations of life, often exhibited hope and humour, 
and were at pains to emphasise to me that they were coping, albeit with some 
admission that emotions surfaced at times. This was a noticeable feature of 
many of the interviews and it appeared that the married couples had agreed 
that this was how they would face the illness, and its consequences, together. 
Two patients mentioned feeling angry in the interviews but the majority 
exhibited what might be perceived as a „stiff upper lip‟ attitude and a fatalistic 
outlook. Several of the male patients did disclose emotional distress but this 
appeared to be minimised in the interviews and they reported that their 
emphasis was on making the best use of the time left. Some patients expressed 
hope of living much longer than anticipated but at the same time appeared to 
recognise that this was unrealistic. The age of the patient sometimes affected 
the way that they reacted to facing death: whilst older patients tended to be 
accepting of a terminal illness, the younger woman, 55-year old Mrs T, 
described ruminating over her situation and described how she attempted to 
view her situation from different perspectives as a way of trying to come to 
terms with it, Box 4.9. 
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Getting organised 
Some patients took a very practical approach towards facing death (See Box 
4.10). The 55 year-old woman, Mrs T, although constantly thinking about her 
situation, had also been very practical and had spent time with her husband 
sorting through her possessions and deciding how they should be distributed. A 
self-help book had advised her that the act of making organised plans for after 
Box 4.9: Reactions to the diagnosis 
 
Mr J: „Oh yeah, I realise how bad me father got, so I'm expecting the same. How I'll handle it 
when it does arrive, I don't know... I don't want to know really, till it arrives, sod it…I don't 
know.  They've never drained it yet. How I‟ll cope with it I don‟t know…It makes you feel 
angry 'cos I don't know if it's them that's caused it but somebody should be responsible for it, 
because I don‟t know what‟s caused it‟ 
 
Mr M: „it took me by surprise like, but I couldn‟t do owt about it so you‟ve just got to accept 
it‟ 
 
Mrs T: „… it's just it is continually on your mind when you're sat thinking, you think "Why 
me?" and then you think "Well why not me?"  As you say, 1 in 3 people have got it so why not 
me? I've been perfectly healthy up to 55 so I've had 55, a lot of people don't get that long. 
That's the only thing that goes through your mind.‟  
 
Mr J: „I‟m not just going to carry on, I‟m going to crack on. Well what we‟re going to do is to 
enjoy each day.‟ 
Mrs J: „It‟s a waste of time getting upset‟  
Mr J: „Aye, a waste of time…I‟ve had my upsets, I‟ve had my tears...and after that I just said 
„Sod it, I‟ll just take each day as it comes. I even go back to work once a fortnight. We both go 
don‟t we?‟ 
 
Mr R: „…they said I'd be upset, and I was, I was a bit weepy every time… I kept it to myself 
for 3 months, I never told my family, just told my good lady who lives here, but eventually the 
doctor changed the sick note, didn't he?…from "thoracic haemorrhage" he put 
"mesothelioma" on the sick note…I slowly started telling friends, relations. But you start 
talking about it and you burst into tears, so… (laughing) but I think I've got over that. It said 
on one of the leaflets that the nurse specialist gave me…for 6 months you will be upset or 
about 6 months, and you resign yourself to the fact that you've got it and try and carry on as 
best you can…I try and occupy myself, make sure I go out every day if I can…I try, doing 
what I can, I've got to keep my heart going if nothing else…and deep breathing, away from 
the traffic (laughs).‟  
 
Mr I:  „Well I dealt with it very well actually. I weren‟t going to let it get on top of me and 
that‟s why I was kind of joking all the time and putting on a false front which I still do even 
though I do think about it at times. …I just get on with my life and looking forward to the 
future…In eight years I‟ve got my 50th wedding anniversary and I‟m going to it, that‟s my 
goal at least.‟ 
 
Mr R: „I know it's bad so I think a little knowledge can be dangerous. If there's something to 
be done again, well, let the people who know what they're doing do it……I mean you can 
drive yourself bonkers, you know, looking up this that and the other. I know it's bad, …I know 
it'll never get cured.’ 
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death may help her to gain some sense of mastery over uncontrolled events, 
and she had decided to follow this advice. The other woman patient, 72 year-old 
Mrs N, clearly and unemotionally displayed a fatalistic view and seemed 
particularly accepting of the terminal nature of her illness. She knew that her 
husband could cook for himself and keep the house tidy as he had taken over 
these roles since her illness, having been taught by her. Patients sometimes 
had concerns about their responsibilities for their families: the oldest man 
interviewed, Mr Q aged 81 years, was the main carer for his wife whose 
memory was deteriorating. He had given thought to where he would like to be 
cared for when dying if unable to be at home and he based this decision on his 
past experience and realisation that his wife would not be able to look after him. 
 
The two woman participants took an essentially practical approach to dealing 
with their own death. Several of the men spoke of the emotional turmoil that 
they were experiencing and in particular their distress at being unable to 
continue to do the practical tasks that fell into the pattern of the traditional male 
„head of the household‟. In contrast to the women who were interviewed, few of 
the men spoke openly about death or dying, veiled or oblique references were 
common and may have been a way of reducing emotional distress. However, in 
all cases, the men‟s accounts of anxiety, tears, rage and frustration were brief, 
and followed by further reassurance to me that they were coping well.  
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Living with loss 
 
The patients spoke with sadness about the loss of normal everyday functions 
due to their illness and described practical ways of dealing with these problems, 
often involving other family members taking on new roles. Many of the patients 
interviewed had enjoyed physical hobbies prior to being ill and had difficulty 
handing over practical tasks to others or having to relinquish activities such as 
gardening and dancing (see Box 4.11). 
 
Loss of sexual function was mentioned by one patient, Mr D. Although I did not 
pursue the issue, it was clear that, behind the humour, this man was making 
Box 4.10: Getting organised 
HC: „…but you mentioned about selling the car and trying to be prepared, how far have you 
gone with that? Or if you don‟t want to discuss this that‟s fine. 
Mrs S: „No, well, we were sat last night, I have a jewellery collection, not expensive, A VERY  
large collection. Collectors‟ pieces…and we were discussing it, I says “What do you think I 
should do with that?” We can‟t think of anybody in the family who‟d wear it…so I said “Shall 
we just leave it then, and when anything happens to you it‟ll just go with the estate?” because 
we‟ve no children…Or do we try and sell it‟?…And the clothes! I‟ve got a couple of 
wardrobes of cruising clothes! I‟m just saying “Shall I sort that out now and we‟ll take it to 
the Cancer Research shop, or do you want me to leave it?” Anyway, my brother and sister-in-
law have got totally opposite, they‟re saying “Don‟t sell your car yet, it‟s too early…You 
might recover, they might have got it wrong” but no, we‟re more practical than that, and it is 
positive thinking. Reading that book and everything, it does say you take control, do what you 
feel like yourself. We have always been practical, haven‟t we?‟ 
 
Mrs N:  „How‟ve I dealt with it? Well…I‟m 72 years old and I‟ve got to die sometime and I‟ve 
got to die with something. I mean I could go out side and get knocked down and die, I could 
get the flu and die, so I‟ve got this and I‟m going to die, so what can I do? Especially living to 
72…I think that it would upset me if I‟d only been 30 or 40 but not now.‟(patient Mrs N) 
 
HC: „What about looking to the future, have you got any ideas about how you want things to 
be?‟ 
Mr Q: „In the future? I‟m just keeping my fingers crossed, hoping that (wife) is all right.‟ 
HC: „You said you‟d been quite practical about making plans.‟ 
Mr Q: „We try our best. We‟re not, shall I say, spendthrifts. We‟re very careful really but I 
don‟t know how she‟ll go on on her own.‟ 
HC: „It sounds like you‟ve been caring for her quite a bit.‟ 
Mr Q: „Well, for quite a long time, yes.‟ 
HC: „What about avoiding hospital, would you mind going into hospital again?‟ 
Mr Q: „Well, I‟d prefer to be here but hospital doesn‟t bother me. If I am ill, really ill, I‟d like 
to go into a hospice…(Wife‟s) dad went in when he was…he wouldn‟t go in, he didn‟t want to, 
but actually this nurse talked him into going in. Happiest he‟d been in his life, he was.‟ 
„There‟s things I used to do I can‟t do now…‟ 
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sure it was acknowledged that, for him, deterioration in sexual function was a 
significant matter. His wife was obviously embarrassed at this point and I felt it 
was inappropriate to attempt to explore the issue any further.  
 
The patients described various ways in which they had made practical and 
psychological adjustments to the illness that could be construed as helping to 
preserve their sense of self in the face of the ultimate life crisis. Daily activities 
and outward appearance as well as future plans were major areas of 
adjustment and required a „mental shift‟ in order to accommodate these 
changes, without succumbing to overwhelming stress. 
 
Deterioration in bodily appearance caused great distress: two male patients 
showed photographs that portrayed them in previously good health, in marked 
contrast to their frail appearance at interview. One of the women, Mrs N, 
flapped her oversized blouse to demonstrate how much weight she had lost, 
obviously very distressed about her altered appearance. This patient showed 
more distress about her altered appearance than when talking about her 
impending death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 4.11: Psychosocial issues 
Mrs H:‟ Sport, he's lived for sport, haven't you?‟ 
Mr H: „I played football 'til I was 46, I played table tennis…Swimming‟ 
Mrs H: „Golf. Golf's been his life up till now, yes.‟ 
Mr H: „But I haven't been able to get out golfing.‟ 
Mrs H: „That's the worst part, he's usually been up at 6.20 in the morning…now it's 9.30 
before he feels like stirring‟. 
HC: „So it sounds as though this has had quite a drastic effect on your life.‟ 
Mr H: „Yes, what I've had to give up‟. 
Mrs H: „Yes, social life as well, because we only ever did sequence dancing, that were our 
life, and we've no social life whatever now‟ (laughing) 
 
Mr Q: „I am really, but I get frustrated. I think “I‟ll do that little job, I‟ll move that” but I 
can‟t move it.‟(patient Mr Q and his wife) 
 
Mr D: „There‟s things I used to do I can‟t do now..er, gardening the front, I can‟t turn that 
over. I don‟t cut the hedge, the wife cuts the hedge when we can get round to it, and, er, wash 
the car. I used to do a lot of jobs round the house, I can‟t now….do-it yourself – I can‟t do it 
now.‟(patient Mr D) 
 
Mr M: „I can bend down but I‟ve got to be careful. …Like decorating, like we‟d have done it- 
yeah, and that‟s another annoying thing – you can‟t do things….Gardens and allotment, we 
grew all our own fruit and veg, I couldn‟t dig, once I get down I‟d have to stay down for a 
while. I‟m short-tempered…And, like, I need more Viagra now! (patient Mr M- he and his 
wife then burst out laughing, his wife clearly embarrassed at this remark.) 
 
Mrs N: „I always had a good appetite, I loved my food and now I‟m , just not hungry and I‟m 
not eating. I don‟t like being thin, „cos underneath I‟m like skin and bone‟ (patient Mrs N) 
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4.6 In it together – the effects on the family 
 
 
All but two of the patients who were married or cohabiting were interviewed 
together (although not specified in the interview invitation) and there was a 
strong sense of previously good relationships being intensified and 
strengthened by the experience of the illness. Couples usually attended hospital 
appointments together and, as the patients' physical health deteriorated, the 
support of the spouse or partner was acknowledged. 
 
Non-verbal clues demonstrated the deep relationships between couples: 
touching, smiles of encouragement, sitting close together. Some „rescue bids‟ 
were evident when the interview touched very sensitive areas: Mrs M got up 
and found a tissue for her husband when his eyes filled with tears describing 
frustration over household tasks that he could no longer do; Mrs T‟s husband 
decided we would stop for a tea break when his wife started talking about her 
prognosis. Patients described practical and emotional support from family 
members (Vignette 4.1, Mr V, p154). As reported earlier, the wives of both men 
who had undergone surgery had acted as information-gatherers and 
spokesmen for their husbands and seemed to have been more assertive than 
their husbands in dealings with consultants; both husbands appeared to be 
content with this situation and comforted by the obvious care.  
 
Two male patients had no close family, one a recent widower, the other a 
bachelor, but they described help from friends and neighbours. Patients and 
family members also described protective mechanisms that they used to reduce 
distress to their loved ones. Relationship strains also surfaced or were possibly 
worsened by the stress of the situation; at times patients and their family 
members may have been at different stages of acceptance/awareness 
regarding the illness (Box 4.12). 
 
 
 
 
 
 
‘…everything should be shared with your wife… it’s a trouble shared.’ 
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Vignette 4.1: Mr  V – the story of his illness                   
 
Mr V served his engineering apprenticeship at the age of 17 years in Wakefield. 
After spells in the Army and a railway plant „nothing to do with asbestos‟ he moved 
to a gasworks and where he had to repair and maintain the compressors. 
„Everything was asbestos – the whole plant was asbestos.‟ He described drilling into 
asbestos sheets, bolting asbestos sheets onto steel frames to make screens and 
knocking asbestos lagging off pipes with a hammer „Ignorance is bliss –well in those 
days we knew nothing at all about asbestos.‟ He had never been aware of asbestos 
risks at work 
 
His illness presented with a nagging pain in his chest like a pulled muscle for a few 
days then suddenly became excrutiating. His wife insisted on calling the GP who 
arranged instant admission. A large pleural effusion was drained on the day that he 
was admitted to hospital. After x-rays and scans, mesothelioma was diagnosed by 
biopsy – it was the first time he had ever had any significant illness. It came 
„completely out of the blue‟ and he described being numb with shock. He could not 
recall the discussion of mesothelioma that the doctor had with him and his wife, 
although she could recall it word for word. He described going home and deciding 
the first thing he had to do was take his guns down to the police station so that they 
were not a problem for his wife to deal with (his firearms certificate was due for 
renewal the following month.) He decided who to leave some possessions to but felt 
unreal for about 6 weeks. Slowly he settled down and learnt to pace himself – he had 
been very fit and had loved walking. He then took up air weapons shooting but 
missed both walking and photography and rugby matches. During one outing to 
town he‟d had a „funny do‟ and so he was reluctant to go anywhere on his own and 
this had greatly curtailed his activities. 
 
He agreed to take part in a clinical trial and had been suffering tingling in his hands 
and feet as a side effect of the treatment. Pain was not a big problem but seemed to 
be increasing – the interview was stopped while he remembered to take some 
paracetamol. Shortness of breath and fatigue were the main symptoms. He had been 
given the telephone number for the Mesothelioma help-line and a leaflet on 
mesothelioma but gave up reading after a few pages and had decided to take things 
„day by day.‟ At the time of the interview he was having some bouts of low mood and 
relied on his wife to persuade him to get up out of bed and go to play snooker – he 
admitted how much he relied on her.  
 
Although praising the treatment he‟d had at the hospital he was disappointed that he 
had only seen the consultant once – he would have liked to have seen the consultant 
regularly. Likewise he had only seen his GP once since diagnosis. However his 
Macmillan nurse had been extremely supportive as had the District nurse, they had 
discussed his preferred place of care and recorded his choice of a particular 
hospice. The District nurse had also arranged a stair lift to help him up to his first 
floor maisonette. 
 
The overwhelming impression was of a previously very fit man who was coping 
bravely and without fuss with a terminal illness. His approach to his illness was 
straightforward and practical – mirroring his working life - and supported by his 
loving family. He was interested in the study because he was pleased that someone 
was paying attention to what patients thought and hoped it would help patients in 
future. 
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Spoilt plans 
As well as the effects on daily routines the illness spoilt plans for the future: 
ideas about retirement and planned future together with their loved ones had to 
be painfully reconsidered. The uncertain disease trajectory added to distress 
and led to searching for meaning and certainty (see Box 4.13). 
 
 
 
 
 
 
 
 
 
 
 
Box 4.12: In it together 
Mrs N: „Oh yes, yes, he‟s upset about it – „Don‟t talk about it mother‟, he says. I said „ 
You‟ve got to (son), you‟ve got to.‟ We‟ve got a daughter as well- she came up last weekend 
and changed all my curtains…My daughter‟s more like what I am….‟cos her husband died, 
died of cancer, so she knows like, what to expect.‟  
 
Mr J: „…I think me daughter‟s switched off. It‟s her way of handling it‟ 
(Describing help from son and son-in-law)Oh yeah, the son-in-law would (help) as well- but 
then there‟s waiting „til he‟s got time to do it and then sitting there watching him do it…silly 
little things – he changed the tap.‟(patient Mr J) 
 
Mr U: „I wouldn‟t have told her. I would have protected her „til the time come, „til I 
couldn‟t go on any further….but really, when you think about it, everything should be 
shared with your wife, because it‟s a trouble shared.‟(patient Mr U) 
 
Mr I: „Oh the kids(grandchildren). …drop in now and again you know… „your grandad‟s 
not going to be here for such a long time….we‟re lucky… we‟re getting a bit more time than 
we thought ..we were going to have, so every opportunity is hands getting hold of you, they 
give you a hug and a kiss and a cuddle.‟(patient Mr I –expressed hope that he would live 8 
years to celebrate his golden wedding) 
 
Mr J: „I‟ll be off to ..see my sister in the next fortnight. I thought she had more sense but she 
got a bit over the top and I don‟t want to lose my temper, I‟ve lost it enough.‟(patient Mr J) 
 
Mr I: „She keeps saying „Well what am I gonna do, what am I gonna have left to live on?‟ 
Sometimes I get a bit..er well, I say, „Sod all, you‟ll have to work for a living.‟(patient Mr I) 
 
Box 4.13: Spoilt plans 
 
Mr T: „…we've always, every Saturday morning, gone down to Doncaster about 8.30 and 
trotted round town, we'd never use escalators, we were always first to the top of the 
stairs…and then suddenly really it's come on so quickly, hasn't it? We walk down to our gates, 
we like the wildlife and the flowers, but the small slope there creases you doesn't it? It really 
does take it out of you, getting dry after a shower or a bath, or even getting ready for bed.‟ 
Mrs T: „Yes, I have to sit down! (laughs) to recover.‟ 
Mr T: „So what I've got to try and find is, if I know that in February we were on holiday, and 
we've had the best holiday we've had for years, absolutely not a care in the world, then 4 
weeks later you are breathless.…It does seem strange that say, even in February when we 
were on holiday we had no inkling of this, going round the Caribbean, you can't believe…and 
we were climbing hills and all sorts, we were up and down the hilly areas, you'd no breathing 
problems at all.‟  
Mrs C: „…well it was supposed to be our retirement, we were going to do all sorts of things 
and then he got ill, just a year ago and it‟s been so quick, and now, well we can‟t do 
anything.‟(Mrs C, wife of patient Mr C) 
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4.7 Medication issues 
 
 
Confusion regarding drug regimes and purpose and side effects of medication 
featured in several interviews, Box 4.14. Wives usually took some, if not most of 
the responsibility for monitoring, obtaining and often administering medication.  
A potentially life-threatening psychosis thought to be due to steroid medication 
was recalled by one patient, Mr I, Box 4.14. Steroids had been prescribed for 
loss of energy and appetite, the patient then went on holiday abroad, became 
confused and suffered a dramatic episode in which he broke into a foreign 
hospice. He recalled wanting to be admitted to a hospice but when he got there, 
early in the morning, it was closed; he climbed over the wall and fell into the 
courtyard. Fortunately the staff realised he was confused: he was transferred to 
a psychiatric hospital and sedated until fit to travel home. Intriguingly, this 
patient partly blamed himself for this episode. The cost to the patient, and to his 
wife who had to deal with this episode away from home, was considerable in 
terms of distress and potential harm. Another patient gave a clear description of 
having had potentially serious gastric side effects of steroids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 4.14: Medication issues 
Mr M: „I was getting a bit of pain in my chest but they changed me off these co-proxamols, 
taking 6 of them... So they put me on prednisolone, take 4 of these in a morning you know and 
give me enough for a fortnights trial… so I knocked the co-proxamol off like and that‟s when I 
was getting a little bit of pain on the ribs here like…the Macmillan nurse come to see me like 
she more or less played hell with me. Well I didn‟t know like I had to take them as well.‟ 
 
Mr J: „I‟ll eat, the appetite‟s good at the moment „cos I‟m on steroid tablets …and that‟s the 
only treatment I‟m on. The indigestion, it‟s terrible and weight, it‟s not brilliant but it‟s a lot 
better than what it was… I do take a sleeping tablet with me vodka because it works.‟ 
 
HC: „You can deal with it even if it is a nasty pain?‟ 
Mr U: „Well I can deal with it enough yes. Now, like yesterday was a bad day and it‟s a lot of 
the medication. And the lollipops [transmucosal fentanyl]…if one doesn‟t work take two and one 
didn‟t work and I took two and it went like that.‟ 
 
Mr I: „It was in the second week of our holidays, I was not right…I started to smoke a lot more, 
a hell of a lot more, started to drink a lot more….mood swings…, I was at that stage of life, 
being diagnosed the way I was, why should I worry if I upset someone through a slip of the 
tongue…. Well I thought I was Jesus, that was the crunch. I thought I could cure anything and 
do anything…I started to drive the wife up the wall…wasn‟t sleeping, an hour was enough…I 
was walking around, no money in my pocket and buying drinks at a bar and walking out.‟ 
HC „Did you have any insight, did you realise things were going wrong mentally?‟ 
Mr I: „Oh yeah, I thought it‟s got to be the tablets, a combination of tablets and drink…I 
was still behaving like God.. I said „‟I really need help, the way I feel you could take me 
to the cop shop and bang me up, just out of harms way „til I sort myself out.‟‟ 
 
‘…if one doesn‟t work take two…‟ 
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4.8 State benefit claims, civil compensation and 
coroner‟s investigation 
State benefits 
All the patients interviewed were unimpressed with the systems for State benefit 
claims including Industrial Injuries Disablement Benefit (IIDB). Delays, 
misunderstandings, insensitivity, the need to establish causation and the work 
ethic culture in which the interviewees had been raised caused stresses for the 
patients and their families, most of whom had not claimed benefits previously. 
The lack of entitlement to IIDB for those without a history of occupational 
exposure to asbestos caused additional distress. The need to undergo a 
medical examination in order to confirm the diagnosis offended one patient and 
caused a great deal of anxiety as he felt he may need to convince the doctor of 
his entitlement. Others were inconvenienced and upset when they had to travel 
to a benefits centre for the examination.30 
 
Many expressed appreciation for help in accessing benefits, in particular from 
the Macmillan or specialist lung nurses who had assisted in completing 
complicated claim forms – some patients admitted that they would not have 
pursued a claim without this help. Although it is not a part of the role of a 
Macmillan or specialist lung nurse, they appeared to fill an important gap in 
services for these patients as social workers or benefits advisors did not feature 
in any of the interviews, Box 4.15. 
 
 
 
 
 
 
 
 
 
 
 
                                                 
30
 The requirement for a medical examination has since been removed from the regulations. 
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Civil compensation 
Most patients were also involved in claims against former employers for civil 
compensation on the basis of negligence regarding exposure of the workforce 
to asbestos. One patient could not understand why her solicitor appeared 
uninterested in her belief that she had been exposed to asbestos in the market 
where she had worked but concentrated instead on her history of washing her 
son‟s and husband‟s overalls from the shipyard; she failed to realise that the 
legal case for establishing causation and thus a successful claim for 
compensation was much stronger against the shipyard than a test case against 
the market.  It appeared that the requirement to provide details of past 
employers, and in some cases having to contact former workmates to give 
statements, was extremely demanding and often the task fell mainly to the 
patient‟s spouse. One patient recalled media reports of the situation in other 
countries. Although mentioned with humour, Mr V, hinted at the anxiety about 
attending court in order to pursue his compensation claim (see Box 4.16). 
 
 
Box 4.15: Claiming State benefits 
Mr Q: „they sent me a pile of forms that big back to fill in….but every word, every sentence was 
about where I‟d worked. I filled them in, I wrote back and said “It‟s nothing to do with where I 
worked, it‟s where I lived”. So they said “Oh, we‟ll send you some more”. But again …mostly 
where I worked and a few about where I lived. So I filled them in but I can‟t see that doing much.‟  
 
Mr M:  „(the lung specialist nurse) was here, on with the Social, about telling them they‟d put the 
wrong thing on my claim. She‟d told them about what I‟d got..but the woman at the Social said 
that she‟s having difficulties in getting people „ cos British Rail has now broken up… she‟s just 
getting passed from one to another to another to another ….nobody wants to know now.‟(patient 
Mr M) 
 
Mr D: „She (the lung specialist nurse) filled the forms in, if it wasn‟t for her I wouldn‟t have been 
able to claim anything…My view on claiming is I don‟t see why the people in the Social or NHS 
should try and do you out of your  money…..I‟ve got a Disablement badge for the car, I didn‟t 
even know I could get that, she filled the forms in on Friday and I got it Saturday… that was very 
quick. 
‟ 
Mr J: „She (the lung specialist nurse) filled the forms in – cracking lass that, and we haven‟t 
received anything yet…I‟m still waiting for some crazy doctor to come to disprove what the 
hospital proved, and that‟s my worry. She said, and the other doctors have all said „‟When he 
comes tell him the worst‟‟. Well if he‟d come at the beginning, well there was nothing of me…the 
weight‟s back on again now…I‟m not doing any exercise and I‟m not working but it gets to me. 
I‟ve always wittered, but I am bothered. And how can I sit there and say…well I‟ll get cold feet 
like. I‟ll have to do summat (meaning he‟d have to demonstrate his breathlessness on exertion to 
the examining doctor) that‟ll be the only way. And it‟s taken too long as well, and I get up every 
morning and …has it arrived? (the appointment with the examining doctor). I want to get it all 
over with and let me get back to what I want to do. I won‟t be running but at least we can get out.‟  
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Coroner’s investigation 
The procedures after death, formal identification of the body and post mortem 
examination, were referred to by two patients. One knew from his father‟s death 
due to mesothelioma, the other had learnt from newspaper reports. None 
mentioned the inquest – possibly because this was just too distressing to 
discuss in front of their spouses, Box 4.17. 
 
 
 
 
 
4.9 Health service provision 
Appreciation 
The patients were mainly very appreciative of their local health services but had 
some ideas about improving efficiency and communication, particularly when 
modern technology was involved.  Good relationships with GPs, consultants, 
and the lung specialist nurses in particular, were valued. Being made to feel a 
„special‟ patient by professionals who were seen to be particularly helpful was 
much appreciated: for example, the surgeon who immediately proceeded to 
biopsy a suspicious chest wall mass and nurses who called regularly and 
reliably; in these circumstances warm and trusting relationships developed.  
Box 4.16: Civil compensation claims 
Mrs N: „They keep asking me where I‟ve worked….I‟ve been a canteen assistant…well you‟re 
not exposed to it in a canteen are you?….he keeps asking about the overalls…I thought that 
would be of benefit to him, the first case off a market when it is full of it.‟(patient Mrs N) 
 
Mr U: „There was something on Teletext about other countries claiming now, I think it‟s a 
British firm and there‟s a load of people..  I‟m trying to think where this South African 
thing…whether it was before or after the war…There‟s something in the back of my mind that 
I saw lads mining it (asbestos)… A long long time ago.. and then you start to think now, how 
did they know then? 
 
Mr V: „I don‟t know why it should be a trial – I haven‟t done anything wrong!‟ 
 
  
Box 4.17: The Coroner‟s investigation 
Mr J: „I know how bad me Dad was, the police came and we had to go there, we'd  
been there Christmas Day.  So that always sticks in me mind.‟   
 
Mrs N: „If anything happens to you would you have to have an autopsy if you 
died? I‟ve seen bits in the paper about that, where the doctor here has said 
„This man was full of it or that man did not die with that‟‟ 
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Lack of local facilities and postcode medicine 
Problems due to distant locations of tertiary centres mainly affected the patients 
from Barrow. Radiotherapy for Barrow patients is provided in Preston, 70 miles 
away and the nearest Thoracic Surgery Unit is in Blackpool, 80 miles away. 
This caused problems for some patients: one woman initially refused to be 
admitted to a distant hospital for pleurodesis and the discharge of another 
patient was delayed due to lack of transport over a Bank Holiday. However, two 
of the patients tried to make the best of the situation and proudly described how 
they had organised accommodation in Blackpool, likening it to a „mini-break‟. 
 
Physical access to treatments was also affected by simpler matters such as the 
difficulty in parking close to any of the hospitals relevant to this study, the 
physical effort that breathless people have to make to get from the car park to 
clinics, and the exhaustion caused by lengthy ambulance trips that transport 
several patients on the same journey. These issues compounded the burden of 
investigations and treatments. 
 
For some of the interviewees, particularly those with repeated effusions and 
both post-surgical patients, hospital doctors had made special arrangements for 
them to bypass the Medical Assessment Unit. Others had been given contact 
numbers for lung specialist nurses or, in one case, the consultant‟s secretary‟s 
office, but these were only manned 9am to 5pm weekdays. In the age of mobile 
phones it is easy to assume everyone can use a telephone but one elderly man 
had problems because he had never had a phone before his illness. He was 
distrusting of answer-phones and felt abandoned by the lack of personal 
contact. 
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Inefficiencies 
These patients were usually under the care of several hospital departments, the 
specialist lung nurse and possibly a Macmillan nurse as well as their GP. Two 
of them, the two with most advanced illness were also under the care of the 
palliative care team. Some patients were bewildered by the number of doctors 
involved and could not determine who was meant to be in overall charge. Poor 
appointment management and communication breakdowns caused a lot of 
anxiety. Patients‟ wives often had to chase up appointments. One patient, Mr T, 
had five appointments in one week at a variety of hospitals, his wife took advice 
from the Macmillan nurse in deciding which to cancel and she also commented 
that parking is a major problem for patients who are breathless and frail.  During 
the hour that I spent with the most seriously ill patient, who died six days after 
the interview, there were four interruptions: the district nurse and the Macmillan 
nurse visited separately, the hospital appointments clerk rang, and a friend rang 
too (Vignette 4.2, Mr C).  
Box 4.18: Care in distant hospitals 
Mr D: „…it took them 8 weeks to sort me out and I think that was very good…‟ 
Later in the interview, referring to Blackpool cardio-thoracic unit 
„…you could go in anytime you wanted… except between 1 and 2pm I think, they had to have 
a rest, a sleep.‟ 
Mrs D: „Yes it were really quite relaxed and yet they had open heart surgery on the same 
ward …I thought flipping heck…everything‟s so relaxed and easy.‟  
 
Mrs N: „I said, „Oh no, I don‟t want to go to Blackpool…The only reason I didn‟t want to go, 
„cos I like my home and he‟d have to be running up and down that motorway.‟  
 
Mr M: „I was in there 10 days, being a Bank Holiday I had to stop in 2 extra days, er, I 
could‟ve come out but they couldn‟t find any body to fetch me!‟ 
 
Mr D: „The wife stayed there with us. I got her in a bed and breakfast, there was one, it was 
only 5 minutes walk and the wife said it was great‟  
 
Mr I: „Absolutely perfect because we had too many holidays you know down at Blackpool and 
we thoroughly enjoyed it….Well we used our business sense – Why travel backwards and 
forwards to Barrow in the car using petrol up, tiring, mileage…She had all day to herself to 
go around – pre-Christmas shopping. We stayed with friends that we‟d known for years‟  
 162 
Patients’ comments 
At the end of each interview patients were asked if they had any suggestions for 
improving care of people with mesothelioma. Only this one patient responded: 
Mr I suggested that anyone with a history of asbestos exposure should 
immediately request a chest x-ray in the hope of detecting mesothelioma at a 
curable stage. Sadly there is no evidence for this being effective at this time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 4.19: Inefficiencies in care 
Mr M: „When I come out (the consultant) he said „I'll see you in a month's time‟, well it got 
to be a month then he put it back another 4 days and I don't know but that nobody's 
interested in me and I tried one, one or two times to get through to [specialist lung nurse] 
and I couldn't and I tried to get through there to [Macmillan nurse] one time and I couldn't 
get through to her…What's the point in having a direct phone if you can't get through to 
them?…Yeah, she says you can page me like... and those answering machines, I don't like 
them at all, I'm not used to phones but I think knowing what I know now I would have had a 
phone a good  while ago.‟ 
 
Mr J: „…he checks me out with his stethoscope and says „I want you to go and have it 
drained and an x-ray‟ but we heard it was a 2-hour wait…so go and get your blood sample 
first….done immediately…went back and [waited] an hour. Now…if I was running this 
business…you know what the course or plan is going to be, right? Your appointment, your 
x-ray is such and such a time, get your blood done and then one hour or half hour later 
you‟re in! If it was business it would be done that way.‟  
 
Mr H: „…they told us to go "Ring if there's a bed" and there was and we went. At 3.30 the 
nurse came and says "Sorry but the consultant isn't in the hospital this week.‟ 
 
Mrs G: „No, you didn't hear any more for ages. The nurse had told you she hadn't drained it 
all but Dr B would give you some tablets to drain the remainder. But it just went on and on 
and I said, „When you come home from golf, call at [the hospital] and see what's 
happening.‟ 
HC: „So what happened then?‟Mr H: „There was an appointment for me, wasn't there?‟ 
Mrs H: „Mr V wanted to see you immediately, and it was the best day's work we ever did, 
that, wasn't it?‟ 
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Summary 
In this section I outline the key findings from this chapter. These findings will be 
brought together with the other data sources, and with reference to the 
literature, in the Discussion, Chapter 7. 
 
As in previous reports, the majority of patients interviewed had been exposed to 
asbestos in industrial settings, two patients recalled para-occupational or 
environmental exposure. Multiple routes of exposure were common, affecting 6 
Vignette 4.2: Mr C – “Devastated” 
 
I knew from his Macmillan nurse that Mr C was deteriorating rapidly but Mrs C 
was adamant on the phone that they both wanted the interview to proceed saying 
„What we‟ve agreed to do we always do.‟ Their home was a neat terrace house near 
the site of a previous asbestos textile factory – demolished over 40 years ago. Mr C 
had been exposed to asbestos as a plumber. 
 
In the sitting room Mr C was sitting hunched over in a wheelchair – he looked 
extremely ill. He had piped oxygen via nasal cannulae but in spite of that his face 
was grey, his hands purple and his feet, protruding from pyjamas, were grossly 
swollen and bulging over the tops of his slippers. It was an effort for him to raise his 
head. I went over to introduce myself and shake his hand – it felt cold in spite of the 
room being extremely warm. He nodded his head then whispered „Talk to the wife‟. 
He looked much older than 66 years. 
 
Mrs C started to give details of her husband‟s illness that had begun just a few 
months before he was due to retire. She was very upset and unable to concentrate 
due to interruptions and her own distress. Once she got to the part where they learnt 
of the diagnosis I asked „How did you react to that?‟ and Mr C just raised his head 
and said „Devastated.‟ At this point Mrs C started crying and I tried to console her. 
Mrs C wanted to carry on with her story but was interrupted by a phone call from a 
relative. Then Mr C wanted to go to bed and she helped him in his chair to the stair 
lift and eventually up to his bed. My offer to help was refused „We‟ll manage, we‟re 
alright.‟ She came downstairs after about 10 minutes then the district nurse came in 
to check Mr C‟s syringe driver. After she left a hospital secretary was on the phone 
about appointments which Mrs C then cancelled. Mrs C was insistent that I heard 
the rest of the story, the main issue was the loss of all their plans for retirement but 
interspersed with this were stories about their recent burglary (in which their dog 
was stabbed) and their children. Mr C called for her twice more and she went up to 
attend to him. 
 
The nurse returned with medication from the chemist and after she left Mr C called 
for his wife again, he then went to sleep. Eventually Mrs C settled down and thanked 
me for coming and for listening to her – she hoped it might help to improve things 
for others. Mrs C said that her daughter was calling after work. I thanked her for 
giving her time in such distressing circumstances and assured Mrs C that her 
information had been very valuable.  
  
1 heard from the Macmillan nurse that Mr C died 6 days later, at Christmas. 
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of 15 patients. Most of those exposed to asbestos at work could not recall any 
asbestos hazards advice. Warnings of asbestos hazards that were recalled by 
two patients were ignored at the time: one man apparently did not appreciate 
the seriousness of the risk, the other recalled warning concerning blue asbestos 
but believed they did not apply to him as he was working with white asbestos. 
One man took the warnings seriously and moved to a „cleaner‟ job. Anticipatory 
anxiety usually developed as patients learnt of workmates succumbing to 
asbestos-related disease or from media reports. Pre-diagnosis, patients feared 
developing the disease; post-diagnosis, patients feared suffering from severe 
symptoms that they had heard about indirectly. Anxiety post-diagnosis extended 
to family members, some of whom worked in the traditional industries that had 
used asbestos in the past. All the patients knew that asbestos had caused their 
illness but the lack of hazards warning and the long latency caused some 
disbelief. Attribution was complex due to the consequences of accepting the 
former employers as negligent and, in some cases, elements of self-blame. 
 
Initial symptoms were attributed to common minor conditions or aging. 
Presenting symptoms agreed with previous accounts and were related by 
patients with regard to their impact on daily life. Increasing knowledge around 
symptoms could empower or, alternatively, worry patients. Married couples 
reported dealing with symptoms together and although patients were generally 
reluctant, their wives often took the lead in calling for help. Breathlessness 
caused severe anxiety for patients and their families, it brought fear of 
impending death or signalled disease progression. None of the patients was 
aware of self-help techniques for breathlessness. Some patients had 
experienced severe pain but the patients mostly denied severe pain at 
interview. However it was evident that some expected pain as a consequence 
of cancer. The unpredictable disease trajectory, uncertainty around disease 
progression and prognosis, and failing health, caused distress. 
 
Most patients experienced multiple investigations and interventions. The 
perceived burden of these procedures varied considerably but was distressing 
for the majority of patients. Complications were reported for some invasive 
procedures. Patients recognised that in some cases junior doctors performing 
the procedures were being trained in the techniques. Prophylactic radiotherapy 
to prevent tumour tracking was ineffective in one case. One of the two post-
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surgical patients had evidence of disease progression. Complexities and 
misunderstandings around treatment decisions caused distress 
 
Senior doctors had disclosed the diagnosis. The terminal nature of the disease, 
short survival and lack of curative treatments had been explained in every case. 
The entitlement to specific State benefits and civil compensation had usually 
been explained in the same consultation as the disclosure of diagnosis. In most 
cases the patient‟s spouse had been present when the diagnosis was disclosed 
but in two cases the patients‟ wives had been told first and this caused 
additional distress. 
 
Shock and/or stoical acceptance were the most common reactions to the 
diagnosis. Patients (and their relatives) clearly recalled the manner in which the 
doctor broke the bad news. After the shock of the diagnosis most patients 
displayed an unquestioning acceptance of the diagnosis. Patients relied mainly 
on their families, particularly their spouse, for support. Patients and their 
families appeared to have negotiated how to cope with the illness together. 
Some patients, knowing they had a terminal illness, focussed on measures to 
stay healthy. Patients (and their spouses) emphasised that they were coping 
with the situation even when it appeared that their situation was particularly 
difficult. Male patients in particular, appeared to minimise emotional distress 
and were less prepared to discuss emotional issues than the women. The two 
female patients took practical measures to prepare for death in contrast to the 
male interviewees. Loss of normal gendered roles and functions, including 
active hobbies and sexual function, as well as altered body image due to loss of 
weight, caused great distress. 
 
Most spouses attended the interviews with patients and contributed to them. In 
the interviews, the spouses sometimes used strategies to reduce emotional 
tension. The supportive role of the spouse was seen as including minimising 
distress, help-seeking and information gathering, as well as physical and 
domestic care. Couples‟ relationships often intensified, some became more 
strained. 
 
Several patients reported confusion regarding medication and medication side-
effects were common. Serious, potentially life-threatening, well-known, side 
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effects of steroids were reported by two patients as well as common side effects 
of analgesics. 
 
None of the interviewees was familiar with the State benefits system and most 
found the procedures complex and distressing. Most patients needed help, 
(usually from Macmillan nurses), with form-filling. The (no longer necessary) 
requirement for an independent medical examination caused offence, distress 
and inconvenience. Most patients were pursuing civil compensation claims but 
the legal procedures were unfamiliar and provoked anxiety. Two patients 
referred to the inquest but none referred to the post mortem examination 
 
Patients and their families were mainly appreciative of the services they had 
received, in particular, good relationships with healthcare professionals and 
special arrangements that made treatment or management more efficient and 
less distressing. Patients found that they had a bewildering number of doctors, 
hospital departments and often several hospitals involved. Criticisms were 
directed at inefficiencies with appointments, distance to tertiary centres, poor 
communication and information, as well as practical difficulties for breathless 
patients such as difficulty parking, long distances to walk in hospitals, and long 
ambulance journeys.         
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Chapter 5:  Focus Groups with bereaved 
relatives 
5.1 Introduction 
As discussed in the Methods chapter, six focus groups were conducted with 
bereaved relatives, two groups in each of the three locations. Only one related 
caregiver/patient couple took part in the study: Mr I, a patient, interviewed a 
week before he died, and his wife, Dora, who participated in Focus Group 1 four 
months after his31 death. The other interviewed patients and focus group 
participants were not related32. In some cases the bereaved relatives were 
discussing care that they had witnessed or experienced from healthcare 
professionals interviewed in Chapter 6. As discussed in the Methods chapter, 
care has been taken to preserve anonymity and confidentiality with respect to 
patients, relatives and healthcare professionals who participated in the study.  
 
Quotes relating to the subheadings are placed in boxes at the end of each 
section, in some cases the actual quotes are inserted in the text if this helps to 
illustrate a specific point. As described in the Methods chapter, each quote is 
numbered with the chapter and box number followed by the individual quote 
number, thus in this 5th chapter, the fourth quote in box 5.5 becomes 5.5.4. 
Names of the participants have been changed and each name is followed by 
the focus group (fg) number, for example, Amanda, fg1. Parts 1 to 3 refer to the 
relatives‟ experiences as carers, part 4 describes their experiences of the socio-
medico-legal issues. As also described in the Methods chapter, the terms 
relatives, participants and carers are used interchangeably to avoid frequent 
repetition. Similarly the recipients of care are usually referred to as patients and 
occasionally as loved ones.33 
 
The focus groups were highly emotional; this was in stark contrast to the 
controlled and stoical reports from the patients who had been interviewed34. 
Bereaved relatives described the „roller coaster‟ experience of living with 
someone suffering from mesothelioma and the physical and emotional impact 
                                                 
31
 Dora refers to her husband as Bob in the groups. 
32
 This limitation is described in the Methods chapter. 
33
 It appeared that all the care recipients referred to in the focus groups were ‘loved ones.’ 
34
 See Methods and patient interviews,  chapters 2 and 4 
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that it had on them as the main carers. Their accounts were not neutral: 
participants were self-selected volunteers, all were still grieving and many were 
angry about the illness or aspects of the care provided. Some accounts caused 
tears and on occasions participants comforted one another, at other times a 
break for refreshments, handing out tissues, or laughter, dissolved tensions. 
Anger was expressed towards the authorities that relatives felt had let them 
down: governments; employers; health and safety advisors; the healthcare 
system; lawyers or individual professionals. Their narratives may have been 
somewhat rehearsed in being told to family and friends and recalled through the 
lens of loss35. My role as researcher, and as a GP and hospice doctor working 
near Barrow-in-Furness and with a particular interest in mesothelioma, may also 
have influenced their stories36. 
 
5.2. Awareness, learning the diagnosis, and information 
 
Awareness: Living with worry 
 
 
 
The focus group participants reported anxiety concerning the risks of asbestos-
related disease prior to the diagnosis of mesothelioma, echoing the patients‟ 
interview accounts37. This anticipatory anxiety, described by de Villiers (1997) 
as the „Damocles syndrome‟, related to pre-existing pleural plaques in some 
cases, previous deaths due to mesothelioma in workmates or occasionally other 
family members, and/or media reports of asbestos-related diseases. However, 
even when they had been aware of asbestos health hazards, relatives had not 
always acknowledged that these risks applied to their own families, 5.1.1. Four 
relatives recalled that their loved ones had emphasised the likelihood of the 
diagnosis being asbestos-related, in three cases telling the relatives to insist on 
a post mortem examination if any doubt remained after their deaths, 5.1.2, 
5.1.3. Once the question of asbestos-related disease had been raised by 
doctors, relatives reported an increasing sense of dread as they realised the 
                                                 
35
 One participant, Lynn, subsequently sent me a copy of her comprehensive written diary of her 
husband’s illness, death and the medico-legal procedures before and after his death; in many areas the 
written text mirrored her spoken contribution to the focus group. This is considered in the Methods 
chapter. 
36
 All participants in the study were aware that I was a GP and hospice doctor as well as the researcher. 
37
 In Chapter 4 
„I had him dead and buried then, because I'd nursed people with mesothelioma.‟  
(Susan, fg2) 
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possible implications. As knowledge about mesothelioma increased, some 
participants reported then becoming aware of risks relating to other family 
members; for one participant the group discussion revealed her own risk for the 
first time from exposure to asbestos on her father‟s overalls38, 5.1.4. 
 
As awareness fluctuated during the illness the relatives reported how they had 
to keep within the boundaries set by the patients, varying their approach and 
often using careful negotiating techniques if they tried to address issues related 
to the future, dying or death. Participants described how tact and sensitivity 
were needed in dealing with the emotional minefield of patients‟ feelings, 
autonomy and independence. However, two groups laughed together as 
participants described how humour was used at times to lessen the emotional 
burden, similar to the interviews with patients, 5.1.5, 5.1.6. 
 
Relatives described specific anticipatory anxiety concerning the mode of death. 
It appeared that this was based on remarks made by health professionals, the 
media and, in some cases, by patients. They recalled frightening descriptions 
they had either heard or witnessed:  
 ‘it’s like a net that goes around the lung and chokes them’,  
 drowning in his fluid’, 
 ‘agonising death’, 
 ‘the worst sort of death’.  
 
Three participants in Focus Group 3 and one in Group 6 told that they had been 
able to discuss funeral plans with their relatives well in advance. Two 
participants avoided the issue until it was obvious that death was imminent, 
others found it too difficult to address.  Some recalled that raising the subject of 
funerals might be seen as evidence of „giving up‟. 
 
 
 
 
 
 
                                                 
38
 The potential harm resulting from this discussion had not been anticipated. This issue is discussed in 
the Methods chapter, p85 with an account of how it was handled. 
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Learning the diagnosis 
 
 
Relatives reported that reaching the diagnosis could be a difficult, lengthy 
process that caused intense anxiety. In many cases less serious meanings 
were ascribed to initial symptoms, mirroring the alternative attributions 
described in the interviews with patients. Ten of the 17 participants recalled that 
they had never heard of mesothelioma before. Relatives reported finding 
uncertainty particularly difficult to deal with: suspected, but not histologically 
confirmed, mesothelioma resulted in confusion around prognosis and left 
families in limbo regarding benefits and claims procedures.  
 
One wife recalled prompting her husband‟s doctors to consider asbestos-related 
disease; although he had been aware of his risk he had not mentioned it to his 
doctors, but was not surprised when mesothelioma was diagnosed. In another 
instance the patient‟s stepson, a doctor, suggested the diagnosis but was given 
false reassurance initially. Regardless of any prior knowledge or suspicion of 
mesothelioma all but one of the relatives recalled reacting to hearing the 
diagnosis with shock. Participants described this reaction as an extremely 
"You're telling me it's terminal?"‟ (Edna, crying, fg4) 
Box 5.1: Awareness 
1. „…we didn't equate the fact that he'd worked amongst it all those years ago with it being 
 dangerous  for him‟ (Janet, fg5).  
 
2. ‟…and he'd have his tea ,I'd fight with him on the floor and he's got his overalls on. Has  
it happened to me? My brother?‟ (Alan talking about his father, fg1) 
„You're making me think now, I never even thought of that…‟ 1 (Amanda, fg1) 
 
3. "Always remember if ever I take ill later on in life, I worked with asbestos, don't let it  
go.‟(Pam, fg2) 
 
4. „She had it put in her will, that she wanted a post mortem, because she knew it was 
mesothelioma and not a secondary from breast cancer‟ (Joy, fg6, whose mother had made 
asbestos mattresses in her 20s) 
 
5. „His 2 sisters came to see him… his older sister said "Hasn't our Joss got lovely skin?"  
and my husband turned round and said "Bloody hell Betty, I'm dying, and all you can say 
is that!‟ (Pam, fg2) 
 
6. ‘She told me not to wear black „cos it didn‟t suit me!‟(Joy, fg6) 
 
7. „…I couldn't do it because, well I did, sort of 3 days before he died I had to ask him and  
      he just left it up to me‟. (Grace, fg3, recalling difficulties discussing funeral plans) 
 171 
physical response as well as an emotional shock, 5.2.1, in marked contrast to 
the reported stoicism which characterised the patients‟ reactions39. The 
exception was Don, (fg 2), who told how his father had convinced the family that 
he knew he had mesothelioma before the doctors were sure and the visible 
rapid deterioration in his health also confirmed to the family that he was 
terminally ill. After the death of Don‟s father, the family found an article from the 
Readers Digest in his wallet: written in the 1970s, it described the health 
hazards of asbestos exposure.40 
 
Relatives confirmed patients‟ accounts regarding disclosure of the diagnosis: 
doctors explained the terminal nature of the disease, lack of effective treatments 
and, usually at that time, encouraged them to make claims for state benefits 
and civil compensation. In just one case the diagnosis was withheld from a 
patient: this was at the daughter‟s insistence based on her understanding of her 
elderly mother‟s personality. This daughter found it helpful to pretend that there 
was nothing seriously wrong with her mother initially, 5.2.2. She told how she 
had predicted that her mother would just „give up‟ when she learnt she had a 
terminal illness and sadly that proved to be the case. Several relatives reported 
dissatisfaction with the way in which the bad news had been imparted; these 
accounts created much distress amongst other group members41. Their 
criticisms related to lack of privacy; perceived insensitive or callous remarks; 
undue emphasis on the benefits and compensation claims; telling the patient 
without a relative present and telling the spouse before the patient, 5.2.3, 5.2.4, 
and Box 5.3. One relative, a nurse, recalled how confidentiality was cited as the 
reason for not informing her of her father‟s diagnosis in spite of him leaving 
explicit instructions for her to be informed.  
 
Two relatives in Focus Group 3 were shocked to discover that a consultant had 
used the same upsetting phrase to both of them when asked about prognosis:   
        ‘How long is a piece of string?  
This may have been a trite reply that the doctor had developed in order to deal 
with an emotionally-challenging and difficult question, but these two relatives, 
and the other group members on hearing these reports, had been outraged. 
                                                 
39 As described in the interviews with patients, Chapter 4 
40 This may illustrate an example of anticipatory anxiety prompted by a media article many years before the disease developed and kept safe  ‘just in case’.
 
41 The groups managed this distress without intervention from me: although upsetting accounts echoed the experiences of some other participants there was a 
sense of group support for the distressed relatives and an agreement that these types of communication had been unacceptable and unfeeling. This appeared to 
comfort the reporting relatives. 
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The hopelessness of the message could be hard to bear, particularly when 
participants felt abandoned or frightened by healthcare professionals. One 
participant was still angry at the message she perceived:  
       "You've got a terminal illness, go away…"’  (Grace, fg3).  
 
As with other reports, Grace may be recalling her interpretation of the 
conversation rather than the literal truth. However this quote does reflect the 
perceived effect of the communication from the doctor, which was presumably 
not the intended result. Similarly Susan (fg2) paraphrased what the 
radiotherapist ‘more or less’ said to her husband:   
      "There's nothing I can do…I can only offer you radiotherapy if the pain gets  
       too severe".  
 
Although surely unintended, the last remark may have been interpreted by the 
anxious patient and family as predicting inevitable severe pain. 
 
It is difficult to assess how much the shock of the diagnosis may have affected 
recall – several relatives described being „numb‟ when they heard the diagnosis, 
mirroring the patients‟ reactions42. Similarly these accounts must be seen in the 
context of bereavement and, as mentioned earlier, as retrospective and 
rehearsed narratives with implications for the moral reputations of the 
relatives.43  At diagnosis some relatives reported suddenly feeling isolated as a 
future without their spouse became clear. Lack of support or someone to talk to 
at the time of diagnosis was mentioned by some, others were annoyed by well-
meaning solicitous remarks from nurses. Many relatives recalled just wanting to 
get away from the hospital and take their loved ones home. Once mesothelioma 
was diagnosed relatives recalled how they (and the patients) had little 
opportunity to avoid physical, social and medico-legal reminders of the illness. 
 
 
 
 
 
 
                                                 
42
 Reported in Chapter 4. 
43
 These issues are discussed in the Methods chapter. 
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Information 
Heated discussions about healthcare professionals centred around poor or 
inadequate communication and information. The relatives agreed that they 
expected a senior doctor to take prime responsibility for informing the patient 
and family about the diagnosis and explaining treatment options. Conflicting, 
Box 5.2: Learning the diagnosis 
 
1. ‘… it just felt as if someone had gone "Arrgh" like that, punched you in the stomach.   
It actually winded me‟ (Gillian, fg4) 
„It was just the same.‟ (Edna, fg4) 
‘The nurse says to me "Are you all right?" I says "No I am not all right!" I thought "You've 
just told me my husband's going to die….Am I all right?" …I can remember the saucer and 
cup clanking, and my husband was so calm, I thought "How can he be like this and I'm like 
this?" And he drove home, how he did it I don't know. Looking back he said "How did I do 
that?"‟(Gillian, fg4) 
„You feel like hitting them don't you?‟ (Edna, fg4, all the group laughing) 
 
2. „When you hear people say the word cancer you think of death straight away. I didn't try 
 to block it out of my mind but I tried to carry on with everyday things, and to treat my mum as 
if she was just in hospital with a cold, that's how I tried to cope.‟ (Janet, fg 3)  
 
3. „Now trainees, I understand it's a teaching hospital, but it's not a teaching hospital for 
 bereavement or for anybody to see agony or anything.‟ (Dora, fg1)  
 
4. ‘Dreadful, I feel angry. Yes, completeness anger, and I'd like to go and tell them off, but 
 (laughing)…I don't know whether it's the thing to do or not.‟ (Jean describing her feelings 
about her husband being told when she was not with him, fg5) 
 
5. „..and my husband said to him "How long have I got?" and he said "Well,  how long is a 
piece of string?" We were given no…‟ (Grace, fg3) 
„Sorry, but those were the words he used to me: "How long is a piece of string?"’ (Janet, fg3) 
 
 
Box 5.3: Breaking bad news badly 
Dora went to see the consultant with a friend of the family while her husband was an inpatient: 
 ‘…and there was like 6 people sat there in the room when I walked in. The first words he 
says to me "Have you made a will?" I says "Pardon?"‟  
She recalled that the consultant repeated his advice to make a will and told her that Bob had 
only got 2 weeks to live:  
‘That's how he said it, in front of everybody. He says "Now we'll go to the ward and see 
Bob"‟  
They went to the ward where her husband was with 5 other patients who were having 
investigations:  
„…he put a curtain round and he brought 3 trainees with him‟.  
After the consultant had told Bob the same as he had told Dora she recalled he asked:  
‘"Any questions?" And Bob and I looked at each other and, well, under the circumstances I 
don't think there was anything we could say‟ (Dora, fg1) 
 
This account may not be the precise literal truth but may reflect Dora’s perception of the 
content of the encounter which undoubtedly included distressing and inaccurate 
information. (Her husband Bob ( Mr I) actually lived for 15 months.)   
(See Boxes 4.9 and 4.14)  
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unclear or inaccurate information from different doctors or different advice given 
to relatives and patients were reported as causing distress and loss of trust. 
Relatives reported being frustrated by the apparent unwillingness of some 
healthcare staff, particularly doctors, to share information with them about the 
illness. Some had approached other healthcare professionals, particularly if 
they had family members in healthcare, or their GP, for more information. 
Several relatives had found distressing and sometimes confusing information 
via the Internet; at times relatives would censor information available to the 
patient in order to protect them from additional distress44, some relatives wanted 
to know more than the patients. With hindsight bereaved relatives 
acknowledged the difficulties in advising about treatments of negligible value 
and burdensome clinical trials but this had not necessarily been understood at 
the time. Their experiences had led many relatives to conclude that not all the 
professionals were knowledgeable about mesothelioma which caused 
disillusion and loss of confidence. (See Box 5.4). 
 
Even when patients were obviously dying it appeared to some relatives that 
there was sometimes lack of honesty from doctors. One participant described 
how she suspected that the doctor was ‘telling porkies45 again’ when he said 
her husband‟s prognosis ‘…could be 1 year, could be 3, could even be 10.’ 
(Jean, fg5) One wife recalled that the reluctance of hospice staff to admit that 
discharge home was unlikely for one dying man meant that she wasted 
precious time trying to get their house organised when, with hindsight, she 
wished she had spent the time by his side.  
 
Relatives reported general appreciation for Macmillan nurses and for their role 
in explaining the illness and treatments, although their involvement was delayed 
 in some cases by the association of the Macmillan name with dying: 
‘…you think ‘Macmillan nurse’… the Grim Reaper’s46 coming in’  
 
For some relatives, and patients too, this association was uncomfortable and 
thus limited their access to information. Some relatives described feeling 
responsible for accessing and managing information, others described how the 
                                                 
44
 Conversely, some patients filtered information in order to protect their relatives at times as reported in 
Chapter 4. 
45
 ‘Porkies’ refers to Cockney rhyming slang for lies: pork pies = lies. 
46
 The Grim Reaper is a common representation of death. 
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task of finding out all they could about the illness gave them a sense of 
purpose. In one case the relative reported that the family believed that the 
Macmillan nurse did not know anything about mesothelioma and they decided 
her visiting was pointless, unfortunately they lived outside the area covered by 
the specialist lung cancer nurse. 
 
 
 
 
 
 
 
 
 
 
5.3. Experiences of the healthcare system 
          Investigations and treatment 
 
 
 
Relatives described the tension between their sense of responsibility for the 
care of their loved one and their feelings of helplessness in the medical setting. 
Relatives expressed distress concerning the multiplicity of investigations 
conducted, the traumatic invasive nature of many procedures, and the frequent 
delays in obtaining results – continuing anger was evident in all the groups, 
5.5.1.  They described the traumatic experience of witnessing medical 
emergencies as most of their loved ones suffered repeated emergency 
admissions for breathlessness due to recurrent pleural effusions47.  Relatives 
reported with horror and incredulity the large volumes of pleural fluid, up to 4 
litres, aspirated, 5.5.2. Three relatives voiced concerns that some invasive 
procedures were apparently performed by inexperienced doctors48. One of 
these relatives recalled requesting that the respiratory consultant would perform 
subsequent aspirations and his response:  
       „…other doctors usually do this’. (Diane, fg1) 
                                                 
47
 See medical records review, Chapter 3 
48
 As similarly described in the interviews with patients, Chapter 4. 
 Box 5.4: Information 
 
1. „Bob wouldn't look at it, I'd got books because I wanted to read, and he got very 
 annoyed at me, and he said "If I see one more book about cancer come into 
 this room…‟(Diane, fg1) 
 
2. „…I was never told anything about what it was going to be like…I kept asking "What  
have we to face? What symptoms have I to look for?" and I was just told "Oh, it'll come".‟ 
(Edna, fg4)  
 
3. „I was becoming sort of fired up, wanting to find out as much as I could and I think 
 that kept me going. I was on a crusade then to try and find something to keep him 
alive.‟(Grace, fg3) 
 
 
„Well the first time he went in, obviously his lung was practically [full] to capacity,  
and it is our opinion  that the man who did it was learning.‟(Jean, fg5) 
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Another wife told how her husband had been in severe pain during a pleural 
aspiration such that another patient on the ward had remarked:  
       „I don’t know how you put up with that’ (Jean, fg5) 
 
Relatives reported anxieties about side-effects of medication, particularly 
drowsiness and confusion, 5.5.3. One relative recalled her husband suffered a 
life-threatening psychotic reaction due to steroid prescribed to stimulate his 
appetite49, treatment commenced just as the couple went abroad on holiday. 
According to the wife (Diane, fg1), and corroborated by her husband„s account 
(Bob, Mr I, p156)50, he suffered a dramatic personality change that resulted in 
emergency admission abroad, causing much distress and inconvenience, 5.5.4. 
In one case a wife, Sue, fg6, described how her husband had a paradoxical 
response to sedatives on three occasions: he became extremely agitated and 
confused, unfortunately including some hours leading up to his death. 
 
Two wives reported that their husbands had become debilitated while having 
chemotherapy and they reported difficulty in knowing whether that deterioration 
was due to effects of treatment or disease progression. Relatives reported 
anxiety about chemotherapy in the light of medical uncertainty: one wife 
reported the consultant‟s words: 
         "…it might stop it advancing as quick, we don't know, but there is that 
           possibility." 
Participants described the delicate and difficult process of supporting their 
relatives when they tried to decide whether or not to accept chemotherapy, 
5.5.5. Although the participants described how the decision was usually made 
jointly, some of the wives had not voiced their own views if they had differed 
from their husbands‟: they did not want to add to distress by appearing not to 
support their husbands‟ decisions. With hindsight one wife reported her belief 
that her husband might have lived for an extra month without treatment. 
 
 
 
                                                 
49
 Steroid treatment is only recommended for short-term stimulation of appetite; safer alternatives are 
available. Acute psychosis is a recognised side-effect of steroid treatment, this patient was possibly at 
higher risk than normal as he had a past history of significant psychiatric illness. 
50
 Diane and Bob (Mr I) were the only patient/carer dyad who participated in the study as interviewed 
patient and subsequently bereaved wife respectively. 
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Delay in diagnosis, inadequate medical knowledge and access to 
care 
 
Relatives reported that delay in diagnosis was a common experience, despite 
exhaustive investigations; uncertainty and/or false reassurances were difficult to 
live with. This caused extended periods of worrying for relatives (and patients) 
and undermined their expectations regarding professional competence, 5.6.1, 
5.6.2. One wife described a 6 month period in which the diagnoses in sequence 
were atypical pneumonia; possible mesothelioma; normal scan; 
adenocarcinoma; and finally mesothelioma was confirmed. Another wife was 
convinced that the delay in diagnosing her husband‟s mesothelioma may have 
allowed the disease to progress to the stage of precluding surgical treatment51 
which she felt might have prolonged his life. Another wife reported that her 
husband received false reassurances twice prior to a biopsy confirming 
mesothelioma: a false negative biopsy report followed by a chest physician‟s 
opinion that a lump on his chest52 at the biopsy site was probably scar tissue. 
                                                 
51
 Mesothelioma is only operable when it is localised to one area in one lung, the vast majority of cases 
have progressed beyond this at the time of diagnosis and surgery is never curative. 
52
 Mesothelioma can spread down tracks formed by insertion of instruments for pleural procedures and 
results in chest wall swellings that are often painful. Prophylactic radiotherapy is recommended to reduce 
the risk of this occurring (BTS, 2000) 
Box 5.5: Investigations and treatments 
 
1. „…and it's waiting for the results that's worse than the actual results themselves.‟  
(Gillian, fg4) 
 
2. „…over a matter of a few days they drained 5 ½ pints of fluid off his lung…They said 
 if he'd been  left any longer he'd be drowned (Edna, fg4) 
 
3. ‟ …he was totally away with the fairies, in fact I don't think they knew what was wrong 
 with him. He had to have a catheter and he was vomiting dreadfully, nasty stuff coming up,  
but afterwards he said he had no recollection of any of it‟ (Jean, fg5). 
 
4. „... he was admitted… to a mental institution through the drugs he was on, sent him  
doolally(crazy), he tried to kill me…and then they wouldn't let me see him for 3 days…by 
the time I saw him he was a broken man.‟ (Dora, describing a steroid-induced psychosis  
that occurred on holiday abroad, fg1) 
 
5. ‘…but we sort of thought well the chemo itself is doing to debilitate him, do we have 
 that When there is no actual benefit, or do we just say "Well I'm not bad now, I'll just stay 
like this". Eventually he decided to have the treatment: "Well I've got to take it haven't I…If 
I can stay a bit longer I'll take that decision‟‟…So he had the 3rd treatment and that took a 
 lot of getting over, but I think also by that time the disease was starting to progress.‟ 
 (Gillian, fg4)  
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This wife reported feeling that the chest physician had failed them: she believed 
that an earlier diagnosis would have enabled her and her husband to spend a 
last holiday together. Grace, (fg3), also described inadequate medical 
knowledge: her husband‟s pericardial effusion53, a recognised complication in 
mesothelioma, was not diagnosed by the oncologist but later diagnosed by a 
cardiologist when it required emergency intervention, 5.6.3. 
.  
Three participants recalled knowing more about mesothelioma than some 
doctors:  one wife, (Jean, fg5) told how her husband had undergone several 
unsuccessful and, in her opinion, inappropriate attempts at pleural aspiration 
although he had previously undergone pleurodesis54. Others described doctors 
quizzing them about their own sources of information. However participants 
acknowledged, with hindsight, that mesothelioma is relatively rare and can be 
difficult to diagnose. One relative described correcting a consultant who tried to 
assure her that asbestos hazards were only recognised recently – she was 
angry that he appeared to be ill-informed, 5.6.4.     
 
Lack of knowledge may have led to inappropriate management in some cases 
although this may reflect concerns around current hospital admission 
procedures55. A daughter reported that when her elderly mother was admitted 
with a heart attack doctors initially appeared to take the situation seriously but 
lost interest once they realised the significance of mesothelioma, 5.6.5. Another 
problem related to admission procedures that treat all admissions as new 
cases: one wife, (Jean, fg5), described how on each of four admissions due to 
recurrent pleural effusions her husband was delayed in the Medical Admissions 
Unit whilst duty doctors excluded other more common diagnoses; she had 
known the diagnosis and felt that her husband should have had open access to 
the respiratory ward where his condition had been understood, 5.6.6.  
 
 
                                                 
53
 Pericardial effusion: an accumulation of fluid around the heart causing impairment of cardiac function 
due to tumour invading the pericardium and producing fluid. 
54
 Pleurodesis is a procedure that causes adhesion between the pleura and the inside of the rib cage thus 
obliterating the pleural space and preventing, or at least reducing, recurrent pleural effusions. Pleural 
aspiration is not usually attempted in patients who have had pleurodesis unless the pleurodesis has been 
unsuccessful. 
55
. Patients with medical emergencies are taken into a Medical Admissions Unit for assessment prior to 
transfer to an appropriate ward – the emphasis is on clarifying the nature of the acute problem and 
stabilising the patient’s condition. 
 
 179 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dealing with doctors and nurses 
Good relationships with professionals were highly valued by all the participants 
but recollections of difficulties with healthcare professionals arose in all the 
groups. Concurring with findings from the patients‟ interview and medical notes 
review56 data, relatives reported that most GPs had referred patients rapidly for 
investigations and supported the families throughout the illness. One couple 
(Dora and her husband Don, both fg2) were in a unique situation because they 
had each lost a parent with mesothelioma. They contrasted the care given by 
two different GPs: one had been „excellent’ but the other GP had seemed 
uninterested in his patient and had to be „forced‟ into visiting her. They recalled 
his behaviour as inexplicable knowing that he worked at the local hospice and 
                                                 
56
 Chapters 4 and 3 respectively 
   Box 5.6: Delay in diagnosis, inadequate medical knowledge and admission 
   procedures 
 
1. „I think as a professional he should have made an accurate diagnosis, and it's his 
 responsibility, my husband was under his care.‟(Gillian, fg4)  
 
2. „We aren‟t professional, not medical people, and yet in my experience, people 
 dealing with specific areas of the body such as the lungs, they must know the symptoms 
[of mesothelioma], my mother had every single symptom of mesothelioma and yet…‟ 
(Joy, fg6, upset at the delay in diagnosis re her mother) 
 
3. „…they found out that it was fluid round his heart, his pericardium, and the  
oncologist said "I think it's just an infection" …got him across to the consultant 
cardiologist…He said  "I can tell you that it's the mesothelioma that's spread" and then 
he had to have a needle into his heart to  remove the fluid…Even the consultant, the 
consultant physician at (the local hospital), was not that au fait with mesothelioma. 
When I went in armed… with all this information off the Internet, he was more 
interested in where I got it from and the websites!‟ (Grace, fg3) 
 
4. Sheila: „…….The first appointment we had with Dr S, he spoke to George, how did  
he feel? And all about treatment and the rest of it, and he'd hardly anything to say. I 
said „I would cut their heads off‟, he said "Pardon?" I said „I would cut their heads off, 
for what they'd done to him.‟  He said "Well they didn't know till about 1966" I said 
"Come off it, they knew it caused cancer even though they didn't know it caused 
mesothelioma". But apart from that he was excellent, but I still can't get my head round 
that.‟ (fg2) 
 
5. „And I said to the doctor that came "My mum has mesothelioma". (He said) "That's 
 not the problem we're dealing with, we're dealing with a heart attack, we don't want to 
know about  that…but I just got the feeling that because my mum had got mesothelioma 
and there was no cure for it, they weren't bothered.‟ (Janet, fg3) 
 
6. „I don't know why they can't have a fast track method of getting these patients to the 
 source of  their treatment without all that.‟(Jean, fg5) 
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they subsequently changed practices to register with a GP whose own father 
they knew had died due to mesothelioma, 5.7.1.  
 
Relatives described problems when their understanding of the situation seemed 
at variance with the actions of doctors, 5.7.2.  For example, they reported 
frustration about seemingly futile treatments when patients were, to them, 
obviously dying: one relative recalled her husband was given lipid-lowering 
medication on the day he died:  
       ‘Did it matter his cholesterol was up?’ (Jean, fg5).  
However relatives also expressed their understanding of the complexities of 
decision-making when only marginal benefits could result and the pressures on 
both patients and doctors to „clutch at straws‟, 5.7.3 
 
Nurses, particularly clinical nurse specialists, were greatly appreciated for their 
professional care and kindness, with just three exceptions reported, 5.7.4, 5.7.5. 
In one case a wife reported her anger at the way in which a hospital nurse had 
attempted to exclude her from her husband‟s care; in another case a Macmillan 
nurse had reportedly persisted in trying to persuade a patient to be admitted to 
the hospice against his wishes and had also appeared to exclude the daughter 
from the situation. As mentioned earlier, one family cancelled further visits from 
a Macmillan nurse who didn‟t appear to know anything about mesothelioma, 
furthermore she had suggested a wheelchair which was clearly impractical 
given the design of the house. 
 
Dissatisfaction with the healthcare system 
Inefficiencies around obtaining results of investigations and inadequate follow 
up arrangements were recalled as sources of stress. Several participants 
worked in the NHS and reported using this advantage to achieve faster access 
to information and treatment by directly contacting consultants, chasing up 
appointments, and accessing other healthcare professionals for support.  
 
Most relatives reported that they perceived it as their responsibility to obtain, 
monitor and often to administer medication. Difficulties were recalled with 
inflexible GP repeat prescription procedures and the apparent reluctance of 
some doctors to prescribe morphine, particularly when the patient was not 
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known to them, 5.7.6. Lack of continuity of care, particularly out-of-hours, and 
not knowing who to contact or who was in charge were reported as problems by 
several relatives. Out-of-hours arrangements for primary care caused great 
distress to one participant, a nurse, who found NHS Direct57 unhelpful when she 
rang them as her father was dying, Box 5.8.  
 
A common practical problem was difficulty finding a parking space near the 
hospital when the patient was severely breathless. Once inside, long distances 
between different departments caused distress for some patients and their 
relatives. As reported in the medical notes review, Chapter 3, some hospitals 
were up to 80 miles from patients‟ homes and three participants commented on 
lack of consideration for relatives living at a distance: one wife drove for 90 
minutes each way to see her husband every day because although 
accommodation was available, for a charge: 
        ‘There was no point in staying because you couldn't get in until 2 o'clock, 
        so… all morning you'd be wandering about. (Jean, fg5) 
 
Two relatives told of contrasting experiences with the same hospital: one had 
nothing but praise for the hospital and the care received; the other reported 
being given no information about meals or visiting times and almost as soon as 
her husband arrived she recalled she was told to leave ‘…because it was the 
patients’ rest period’ (Dora, fg1)  
 
Three participants reported that they were still considering making formal 
complaints, none had complained earlier. One wife was contemplating a 
complaint concerning the way in which her husband was told the diagnosis on 
his own, ahead of the appointment that had been made for them to receive the 
diagnosis together. She explained that she had needed time to calm down 
before she could proceed. However she may have been too busy and 
concerned about her husband at the time to pursue a formal complaint against 
one of the doctors responsible for his treatment. With hindsight, she 
acknowledged that raising the issue might help others although she 
emphasised that it was for her own sake and would help her „enormously‟. One 
other relative was considering making a formal complaint about the way in 
                                                 
57
 NHS Direct is a national telephone service that patients can access for advice, in this case the service 
dealt with out-of-hours calls to Primary Care, replacing the former arrangements that GPs provided out-
of-hours cover prior to the new GP Contract, 2004. 
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which a procedure was carried out which caused her husband unnecessary 
pain. She reported that her husband had suffered complications from 
pleurodesis during an earlier admission, prolonging his stay from three to 7 
days – perhaps this had made her less tolerant of subsequent problems58, Box 
5.8. In the third case the GP had subsequently encouraged a patient‟s daughter 
to make a formal complaint about the response they received from NHS Direct 
when her father was dying, Box 5.9. This daughter explained that the family had 
not felt able to complain at that time but might do so in the near future. 
 
Although most reports regarding hospices were very appreciative, three 
relatives recalled dissatisfaction.  One patient and his relatives had apparently 
felt pressured to accept hospice services that they did not want, and were upset 
by the staff who they perceived to be patronising. In another hospice, Jean (fg5) 
described how her husband had been unhappy with his room which was dark 
and overshadowed by trees, and he was distressed at not being allowed to 
handle his own medication. Two wives complained about communication 
issues: with ironic humour, one wife recalled a hospice doctor‟s questions to her 
husband about his feelings as inappropriate and intrusive, this doctor had also 
made the remark about „feeding the tumour’ mentioned earlier in the 
communication section: 
       „That's wonderful isn't it? Absolutely wonderful…So I took him [her 
       husband] a bottle of whisky in!’ (Jean, fg5, laughing) 
 
The other wife, Dora, (fg1), had been very upset to be told by hospice nurses 
that her dying husband only became distressed when she was visiting him. In 
the group she disclosed, for the first time, that her husband‟s distress was 
because she would not assist his suicide which they had agreed before his 
admission – she had not explained this to the hospice staff at the time and their 
remarks continued to distress her59. 
 
 
 
 
 
                                                 
58
 See Methods chapter for an account of the discussion that I had with Jean following the focus group. 
59
 Discussed later in section 3, ‘In it together’. 
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Box 5.7: Dealing with doctors and nurses and dissatisfaction 
 
1. „…really he should be caring for his own patients and not the hospice…whereas  
(other GP), she'd just call in…and I think if he'd have just called in it would have put my 
Mam's mind at rest. You know, we had to force him into coming to see her‟ (Dora, fg2) 
 
2. „Why were they giving a dying man all those pills? Why? Did it matter? That morning 
 they'd been trying to force them down his throat when he was actually…(dying) but with 
a 7lb thing in your chest like that,
1
 how could you swallow pills? What difference does it 
make?’(Jean, fg5) 
 
3. „I thought "Why are they doing this? Why don't we just let it take its course and enjoy 
 being well? …But I think sometimes you feel under pressure to do it, it's like a carrot and 
stick scenario. If the treatment's there I think a lot of people feel compelled to have it.‟ 
(Gillian, who by her husband’s third session of chemotherapy, realised its futility and 
opportunity costs, fg4) 
 
4. „I could go out and I could cry – she'd hold my hands or she'd put her arms round me,  
give me a cuddle, and I could cry out in them grounds, then go back …(the nurse) came in 
her own time, late on at 11 o'clock at night sometimes‟ (Pam, fg2, describing her ‘special’ 
district nurse) 
 
5. „The Macmillan nurse that we had was no use. She didn't come for 3 months… she 
 brought some forms for Attendance Allowance, and I said "Oh thanks for that, I'll fill 
them in" and "Oh no, I shall do that" she said, and I felt she didn't think I was capable of 
filling a form in…and she said to my Mum that I was too possessive of my Dad. And she 
didn't appear again for 3 months. She didn't offer anything, any suggestions or even any 
sympathy… I understood the Macmillan nurses were supposed to treat the whole family? 
And do you know when she next came? …3 months later…2 days before my Dad died, and 
she stayed for 1¾  hours... And then my Dad died on Christmas Day and we never heard 
again from her… Mum thought at least she could have rung .‟ (Amanda, fg1) 
 
6. „…and it looks awful…to a doctor you look like a lay person telling the doctor what to 
do, But you know about it, you can then speak up, and I had to prove who I was, 'cos I 
could be anybody going in,.’ (Pam, fg2, recalling trying to obtain a repeat morphine 
prescription from her local hospital, prescribed but not supplied by a distant  hospital.) 
 
7. „…he was whipped back into hospital again and he kept on vomiting…and the man 
 sat next to Jimmy had said (whispering) "He's been like this all day". And of course I 
went in (behind the curtains) and this nurse said "Do you mind? I'm seeing to your 
husband, he's being sick."  I said   "I'm well aware of that and yes, I do mind!" I thought 
it's my husband, he's dying, you know. …I was so upset I couldn't speak, I couldn't even 
go and tell her.‟(Pam, fg2) 
 
 
 
 
 
 
Box 5. 8: „Do I have a complaint?‟ 
 
„Well the first time he went in, obviously his lung was practically to capacity, and it is our  
opinion that the man who did it was learning. He had Dr A with him, but this man, you've never 
 seen such…it was like the tubing and the way it was put and everything, it was like oh I don't 
know, an engine. And the nurse came along and she had a look and she said "Dr F wouldn't 
 have accepted that". Now Sam was not a complainer and he said it was bad. Now for him to  
say it was bad, it was…Pain yes, bad. …he was done on the ward, the other patients said to me  
"I don't know how you put up with that" and the doctor had had to say to the person doing it 
 "Just be gentle"-obviously he'd just gone…and out had just come a lungful! And this pipe was  
stuck all round his hand. Another thing I would have liked to have killed the man for, when he 
 took it off he ripped the plaster off and he took 2 lumps of skin off his chest with this plaster,  
just ripped it off, "Oh I'm sorry!" …Do you think I…Do you think I have a complaint?…‟I've  
waited this time because I didn't want to do it unless I could do it without getting emotional.  
It wants to be factual, and up to now I couldn't have done it, because you know it's too close.‟ 
(Jean, fg5, deliberating whether or not to make a formal complaint about her husband’s care) 
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5.4. Caring in the family setting 
In it together 
 
 
All the 17 participants had been closely involved in the care of the patient and 
they recalled how they faced the illness together, either husband/wife in 14 
cases or parent/child in three cases. Bereaved spouses told how, as couples, 
they faced the illness following their usual patterns: some discussed things 
openly if this had been the style of their relationship, others built upon clues in 
conversation and behaviour as mentioned in the first section on awareness. 
Relatives recalled that the patients had „set the scene‟ in demonstrating or 
expressing how they wanted the family to deal with the situation. „Normalising‟ 
the situation was expressed as important for many couples; with hindsight some 
relatives reflected that this approach had helped them to cope until the disease 
impact was unavoidable although the „pretence‟ involved created tensions. 
Another source of stress was the conflict between „dealing with the now‟ at the 
same time as „dealing with the future‟, some relatives recalled feeling guilty and 
selfish, thinking ahead while their loved one was still alive. 
 
Box 5.9: A problem with NHS Direct 
 
One relative, Amanda, (fg1), described the problems she had in accessing the emergency out-
of-hours GP service when her father was dying just before midnight on Christmas Day. She 
rang the surgery and a recorded message gave her another number to ring – she subsequently 
discovered this was NHS Direct, 70 miles away from her home. She gave her father’s details 
and said that he couldn’t get his breath. The receptionist said that she’d send an ambulance. 
Amanda was not happy with this as her father had not wanted to go into hospital and so she 
again asked to speak to doctor. At this point the receptionist wanted more details, asking 
seemingly endless questions about the exact details of names and dates of birth: 
„…I told her he was 80, I didn't know what year, I was becoming very frustrated. I 
told her my father was dying and put the phone down‟. 
 
Amanda recalled her father being very scared, his condition worsened rapidly, his breathing 
slowed and then it stopped: 
„I got him onto the floor… I put a pillow under his head. 2 minutes later I rang back, same 
 number, and said they'd have to send a doctor now, my father had died.‟ (Amanda, distressed, 
 fg1) 
Amanda, her sister and their frail elderly mother were all nurses – they did not panic in this  
situation presumably as a result of their training but they felt that the NHS Direct service 
failed them.  
 
 
„He only wanted me to look after him.‟ (Grace, (fg3) 
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Participants described how the situation resulted in altered roles within their 
relationships which caused distress and sadness for both husbands and wives. 
They described how their loved ones, as in the patients interviewed60, had been 
physically active in all but one case, who had Parkinson‟s disease, and it 
appeared that both husbands and wives had enjoyed traditional roles and 
responsibilities in their marriages which were challenged by the illness. 
Relatives described increased intensity in some relationships due to the 
proximity of death. 
 
Wives told how they had respected the wishes of their husbands in the three 
cases in which their husbands had specifically preferred them to manage 
without outside help, although this had actually increased the burden of care 
and responsibility for them and added to social isolation.  Other relatives 
described sensing that the patients needed explicit assurance that they would 
care for them. Standing by and watching a loved one suffering was reported as 
hard to bear. Relatives told how visible loss of physique and strength upset 
them and reinforced the seriousness of the situation; this concurred with the 
distress expressed by the patients interviewed in Chapter 4. Not all the patients 
had dramatic symptoms. Some, like Sheila‟s husband, steadily lost weight and 
vitality but he, and others, tried to alleviate distress with humour. 
 
Two wives disclosed that their husbands had asked them to assist their suicide, 
this had caused huge anxiety at the time; both wives told that they continued to 
feel they had let down their husbands by not helping them to die.  In one case 
the GP had confirmed the man was dying and commenced medication to ease 
his distress; in the other case, the man (Mr I) was in a hospice and was so 
upset when his wife refused to help him die that he didn‟t speak to her during 
his final week.61 This wife reported she had felt unable to assist him to die 
because he was in a hospice – she wondered how this might have differed if he 
had been at home62. 
 
 
 
                                                 
60
 See Chapter 4 
61
 Her husband (Bob – Mr I)  was interviewed in this study just 6 days before he died and he did not make 
any mention of wishing for assisted death or wishing to die in the interview. 
62
 See Methods chapter re information given to all participants after the focus groups..  
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Spoilt plans 
Living with mesothelioma often necessitated practical changes at home, 
particularly as the disease progressed and caused increasing physical 
limitations for patients. In one case this caused major upheaval: Edna (fg 4) and 
her husband were advised to move into a bungalow by the clinical nurse 
specialist because she felt their house, the wife‟s family home for 46 years, 
would not be suitable as he deteriorated, 5.11.1. Many families brought a bed 
downstairs to make life easier as breathlessness and weakness reduced 
mobility.  
 
Several couples went away on holiday to familiar places even when symptoms 
were a problem, others did not have the opportunity as the disease progressed 
Box 5.10: In it together 
 
„…while ever he was well he kept me going, and I think I got to a point that I think I thought he 
was going to stay like that, that he was never going to be well again, you know, but he was 
going to stay at that stage and it wouldn't go any further…I knew it was going to happen but…‟ 
(Mary, fg3) 
 
‘I think I was upset but I was also very frightened, really frightened… I'd always had him there 
as a back-up and the longer it went on the more frightened I became. You know, waking up on 
an evening with, like, panic attacks and thinking "How am I going to cope without him?".‟ 
(Mary, fg3) 
 
 „He didn't like to see me doing his jobs - like put that wheelchair in the car. You could see by 
the look on his face he didn't like it, and he used to keep saying "I'm sorry I can't do more" 
(Jean, fg5) 
 
„ I didn't go to bed for 11 weeks. But he said to me "Please don't get anybody in, please" As ill 
as he was, he said "I don't want anybody going: "Well are you all right?" …"Poking her head 
around the door" (Pam, fg2) 
   
„I didn't recognize my own husband from the back 'cause he was losing weight so rapidly.‟(Pam, 
fg2) 
 
„And he just got weaker and weaker, and you could actually see the tumour under the skin, and 
he'd say "Look at me, I'm skin and bone. Fancy ending up looking like him" (That's the cat!)‟ 
(Sheila, fg2) 
 
 „He actually asked me to help him to die towards the end and I said "I can't do that"… the 
doctor fortunately came and I spoke with her and she said "It's time for a syringe driver now".‟ 
(Grace, fg3) 
 
„What they didn't know was that Bob and I had made a pact that I would give him -I had quite a 
lot of drugs – that I would finish him off  (sobbing), and once he went to the hospice he'd asked 
me to do it. … (doctor) had spoken to me, I realised there was going to be the inquest anyway, 
but that wouldn't have bothered me, I couldn't have cared less if I'd gone to jail. You live with 
somebody for 40 odd years and you couldn't care less, if they go you couldn't care less what 
happens to yourself. Bob got very annoyed with me, and a week before he died he stopped 
speaking to me, because he turned round and said to me "You wouldn't see a dog suffer like 
this". (Dora, fg1) 
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too rapidly, 5.11.2, 5.11.3. Those wives who were able to have holidays with 
their husbands told how spending time in places associated with happy 
memories gave them pleasure whilst living with the knowledge of impending 
death. An inaccurate prognosis of two weeks when the patient eventually lived 
for 13 months caused considerable problems including financial strain for one 
couple. When her husband did not die within two weeks, following a large and 
expensive farewell party, the couple (Dora, fg1, and Bob, patient interviewed) 
embarked on an extensive series of foreign holidays to the point of financial 
embarrassment. Dora reported with delight that they had no insurance cover 
reflecting the „devil may care‟ attitude this couple adopted when he lived far 
longer than predicted, 5.11.4. Unfortunately their last holiday was disrupted 
when he developed a steroid-induced psychosis as reported earlier63.  One son 
reflected sadly that the assessment of „years of life lost through the illness‟ as 
part of the compensation calculation had highlighted the family events that his 
father would miss, 5.11.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
63
 See medication section in Chapter 4, p155. 
Box 5.11: Spoilt plans 
 
1. „…and he just sat down in the chair…breathed a sigh of relief and he said "Oh well, we  
can relax now can't we?" and I thought "Can we?"(Edna, fg4, describing her reaction when  
they finally moved house) 
 
2. „…and he was struggling. I said "Do you think we should go home?" and he said "No, I'll 
 be all right" so we stuck the week out‟ (Grace, describing her husband becoming unwell on  
holiday, fg3) 
 
3. „Yes…we weren't able to have a holiday because by the time it sort of came up to us  
getting round to it my husband was too ill.‟ (Gillian, fg4) 
 
4. ‘For 2 weeks everybody had parties for us, every day, parties, going away parties, like 
 wakes…everybody wanted to give us a party, all the kids were there, they were coming from  
all over the country… then the end of the 2 weeks come, and you've not died. You feel then, a  
fraud, don't you? That's how me and my husband felt, as though we'd lied to people. You 
know, he should have been dead, that's what we'd been told…We packed a lifetime into the 
time we had left…Bob and I had so many holidays, we only used to come home to wash my 
knickers and then we were away again! Backwards and forwards all the time… No insurance, 
you know!‟ (Dora, fg1) 
 
5. „…my dad's been dead 2 years now…and he's supposed to have another 2 years left. Well 
 in that time he's missed his grandkids, 2 of them, one starting nursery and going on…he 
should be looking after my mother now. You know, my babby walking and going to school, all  
that's gone.‟(Andy, fg1) 
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Lynchpin of the family 
Some relatives reported pre-existing and competing carer responsibilities, 
usually concerning elderly parents, but Gillian, (fg 4), had children aged 12 and 
14. She told of the difficulties trying to maintain their usual routine while caring 
for her husband and that tensions sometimes developed when he was less 
tolerant than usual with their behaviour. She recalled deciding what and when to 
tell them about their father‟s illness particularly hard, trying to balance her desire 
for them to lead their normal lives with the need to prepare them for his death, 
5.12.1. One participant described caring for her daughter, husband, terminally-ill 
father and also her elderly mother with memory problems; another was the main 
carer for her demented father whilst also looking after her husband. Others 
found that they were leant on by the extended family, 5.12.2. Although relatives 
told how they sometimes could rely on family members, caring usually fell to the 
closest relative, either the wife or an adult child.  Practical help, for example, 
moving the bed downstairs, help with transport or childcare, was particularly 
appreciated but conflicting demands from other dependents caused irritation 
and sometimes resentment. Several participants agreed that the patients did 
not seem to appreciate the demands on the carers: one participant described 
how her mother, a retired nurse, appeared reluctant to „bother‟ ex-colleagues 
‘because they’re so busy’ which put extra strain on the family, 5.12.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 5.12:  Lynchpin of the family 
 
1. „…if I was to say to my children, "Your Dad's going to die" they'd be expecting it  
tomorrow, and we sort of left it until he was in the Hospice, and I said "You know 
your Dad's not going to get any better? You know what's going to happen, don't you?" 
and Emma said "Yes, he's going to die" and I thought well "Is she thinking he's going 
 to die tomorrow? Is he going to come out?" you just don't know…I was sort of  
taking the children home, my parents were looking after them, I were going back then  
coming back home…but from his mum "Oh my God he's gone into the Hospice, he's  
going to die!" I says "Look, he's only gone in because he's having trouble breathing,  
he'll get his medication sorted out, they might get some oxygen at home, he'll come  
home". I felt I were having to be caring for everybody else‟ (Gillian, fg4,  
describing supporting her children and mother-in-law). 
 
2. „I‟d got this burden sitting on my shoulders to tell my 3 brothers and my sister 
 [that their father had only got 4 weeks to live]… and at the same time to put a brave 
face on for my Mum and my sister was trying to convince me that everything was OK 
because he‟d still got his appetite.‟ (Moira, fg6) 
 
3. „And Mam sort of pushed them (the community nurses) away "I know how busy 
 you are, I don't need your help, you've got other patients to see" so they'd left it up to 
her…so we didn't like to ring.‟ (Amanda, fg2) 
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Physical care 
 
Relatives described involvement in physical care: for the majority, general 
nursing care in terms of nutrition, medication, hygiene and comfort were the 
essential tasks. These tasks were more difficult in the face of uncontrolled 
symptoms. In some cases relatives described their anxieties in trying to assess 
the severity of symptoms when the patient was stoical to the point of not 
admitting any discomfort, 5.13.1. Relatives described how lack of knowledge of 
what to do caused anxiety, particularly when patients were severely breathless, 
although most had medication available for pain, 5.13.2. One participant, 
(Gillian, fg4) recalled a frightening episode in the early hours of one morning 
when her husband was leaning out of the bedroom window gasping for air. In 
common with reports from the other relatives it was she, not her husband, who 
decided to call for their GP. 
 
Many relatives reported acquiring nursing skills such as dressings and 
managing complex medications: for example, Pam, (fg2) recalled that her 
husband had a drain in his abdomen that needed frequent dressings but which 
often blocked and leaked profusely, causing them both distress, 5.13.3. 
Relatives reported sweating was a major problem; this often involved changing 
the bed every day entailing time-consuming physical effort, 5.13.4. Most 
relatives organised and administered multiple medications, and also looked out 
for complications. Relatives described their desperation in the face of lack of 
effective treatments, two wives reported turning to complementary therapies. 
When one man developed a steroid-related psychosis abroad his wife reported 
how she had to ensure that his condition was understood in a foreign hospital 
and then had to supervise him on the flight home. The physical burden could be 
substantial: in two cases it included lifting oxygen cylinders unaided. One wife 
described her total exhaustion when her bedridden husband lived weeks rather 
than the predicted few days. In common with other wives, she reported regret at 
having agreed to his request to care for him alone: she recalled how her 
husband repeatedly rang his bell to call her back up to his room, seemingly 
oblivious of the other demands on her time, 5.13.5. With hindsight, although 
joking that this had given the community nurses an easy job, these wives 
acknowledged that they had not previously appreciated the demands of the 
carer‟s role, 5.13.6.  Several relatives reported having an enormous personal 
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responsibility for providing the best care and comfort for their husband or 
parent, at times turning to unconventional treatments, 5.13.7, 5.13.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emotional labour 
Keeping up a cheerful pretence in order to avoid adding to the patient‟s distress 
was recalled by many relatives and at times they admitted feeling guilty if they  
broke down in front of their loved ones when the strain became overwhelming. 
However, care was also reported as received by the bereaved spouses during 
Box 5.13:  Physical care 
 
1. „I don't know how much pain he was in but we had the Oramorph as well as the 
 Morphine. So that if I thought he needed it he used to get it: "Open your mouth"‟ (Jean, fg5,  
who had to use her judgement as her husband would not admit to having pain) 
 
2. „…and I think he were frightened. And I were frightened, I thought "What will I do?  
Will I Ring for an ambulance? Will I do this? Will I do that? What if he passes out?" She  
phoned for the out-of-hours GP who visited and tried to reassure her:„The GP says "Don't  
worry, if he passes out he'll just come round again in his own time" because that was what  
I was worried about, I said "What if he passes out because he can't breathe?" he says  
Well he might pass out but he will come round again once everything…it's panicking  
that's mainly (the problem)."’ (Gillian, fg4, describing her fears and decision-making) 
 
3. „…it was oozing from the suture site, it was also clotting, so what was going on in bed, 
 halfway through the night I kept on having to sort of give it a little kink to get the  
clots through…And while you were doing that it was pumping out the side… down the side  
of the sheets.(Pam, fg2, describing care of her husband’s abdominal drain) 
 
4. „I mean on a morning I could be soaked as well, laid by the side of him, I could have  
wrung the bedclothes out, and every morning the bed had to be stripped. I know it sounds  
a silly thing, but it was a very big problem‟ (Mary, describing her husband’s sweating, fg3). 
 
5. „…he'd be ringing the bell and I would be back up again, but I'd give anything to hear 
 him ring that bell again now. But he was very demanding… he was on oxygen and  
I was humping oxygen cylinders up and down stairs, he was getting through 4 cylinders.  
And just trying to sleep and be there, I mean sometimes I didn't get any breakfast till  
nearly lunchtime because I was having to get him washed and then trying to get him out  
of bed, and we had a commode wheelchair, pushing into the bathroom...‟ (Grace, fg3,  
describing her exhausting schedule) 
 
6. "What a wonderful job you're doing" you know. (laughing) They said it was the best 
 job they had.‟(Pam, fg2, describing how the District Nurses praised her care of her 
husband) 
 
7. „I found that's what I felt, when somebody is ill they're vulnerable, and it's a bit like, 
 you know like you are with your children? You know, you get into that defensive mode,  
you know: "I'm looking after this person, I want everything to be right". (Gillian, fg4,  
describing her sense of responsibility) 
 
8. „I phoned friends all over the world, put him on Echinacea …I didn't want him to 
 catch anything else, didn't want him ill, wanted to keep him alive as long as I could…You're  
only supposed to give that short-term, I gave it him it for the year because…‟ (Dora, fg1) 
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their caring role: some ill husbands had been able to express their appreciation 
of the care given and often to reflect on happy memories that they had shared. 
Relatives also reported that they appreciated expressions of concern from some 
healthcare professionals who seemed to have an understanding of the situation 
from the carer‟s perspective and did not solely concentrate on the patient‟s 
problems. 
 
Experiencing the death  
Many of the deaths the relatives had witnessed were reported as very 
distressing and were recalled in detail, Box 5.14. Severe breathlessness, 
confusion, hallucinations, terror, uncontrolled agitation and intense pain were 
described by the relatives, 5.14.1-3. At times recollections of distressing deaths 
of loved ones brought tears and other group members expressed sympathy and 
words of comfort. 
 
There was one exception: Jacky, (fg6), expressed satisfaction and pride that 
she had been able to care for her elderly mother at home. In this case the 
patient had been elderly, fully aware of the diagnosis, the symptoms had been 
well-controlled, she was not distressed and was philosophical about dying. 
Jacky described the death of her mother as „wonderful‟ and that she „would not 
have missed it for the world.’(Jacky, fg6) 64 
 
Bereaved relatives recalled that most of the patients had wished to die at home, 
but the majority had died at home or in a hospice, contrasting with the findings 
of the medical notes review, p 124. Care at home in the dying phase usually 
relied on District Nurses and, to a lesser extent, Macmillan nurses. These 
community nurses were particularly appreciated and warm personal 
relationships that went „beyond the call of duty‟ gave enormous support and 
comfort. There were some examples of good practice where services enabled 
patients to die at home if that was their wish: Pam, (fg2), praised the „Home to 
die‟ service, in Scotland, describing it as a „lifesaver‟ for her. Reasonably 
acceptable deaths according to the relatives occurred peacefully, either at home 
or in a hospice, with effective medication if necessary to control symptoms.  
                                                 
64
 This group, fg6, also heard of the most distressing death – that of Lynn’s husband as in the Vignette 
5.1, p 192.  As described in the Methods Chapter, Jacky, whose account followed Lynn’s in the group, 
was at pains to console Lynn and express her sympathy, then adding that it might help her to know that 
not all deaths are so terrible. 
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several cases confusion and hallucinations at the end added to relatives‟ 
distress, medication was frequently blamed for these problems, 5.14.3. 
 
Four participants reflected that their relatives may have been particularly scared 
because they had heard reports of distressing deaths due to mesothelioma. 
Distress also related to unexpected deaths when rapid deterioration was hard to 
believe. Mary (fg3) recalled how her husband, somewhat reluctantly, was 
admitted to the hospice for symptom control and expected to go home again but 
he deteriorated rapidly and died in the hospice two weeks later. Relatives 
expressed sadness and regret when circumstances prevented death occurring 
at home: Mary, whose husband had wished to die at home but deteriorated 
suddenly and died shortly after admission to the hospice, regretted the loss of 
physical intimacy: 
         ‘…and I really regretted that because he would have loved being at home,  
         you know….Even just to be able to lay on the side of the bed with him’ 
        (Mary, fg3).  
Many months later she remained shocked at his sudden death, her husband 
had been playing golf a few days before hospice admission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vignette 5.1: A distressing death 
 
Sue, (fg6), described her husband as a „phenomenally fit man, obsessive about DIY, he could 
do anything‟.  
 
After 6 months of repeated investigations and misdiagnoses mesothelioma was confirmed. He 
became very depressed and particularly upset that he could not do the physical activities that 
he loved. Due to her own ill-health, Sue could not continue to care for her husband at home 
when he needed constant nursing. Her husband decided to go into the hospice when he could 
no longer move without assistance. On 2 occasions sedative drugs caused paradoxical effects 
– he had become agitated and confused. Although they were repeatedly told that he might live 
3 to 4 years, he died 4 months after diagnosis. 
 
On admission to the hospice Sue was advised to go home to get some long-overdue sleep: 
„That is the biggest regret of my life, I was prompted to decide to go home to sleep…when I 
got back in the morning the same thing had happened again [agitation due to sedative 
medication]…he was so agitated and then he coughed – I was there by myself and this vile 
black substance came out of his mouth…I thought it was a haemorrhage and called for help. 
It kept coming every time he coughed. At one stage he said to me: „You wouldn‟t let a dog 
suffer like this.‟ At the end of 36 hours the staff said „We really are going to have to sedate 
him now‟ and they told me to say what I needed to say to him. Again – the opposite effect – he 
was thrashing about, trying to raise himself in the bed, eyes out on stalks, terrified, pouring 
out stuff from his earlier years all jumbled up together like he was on drugs…and all the time 
this vile black stuff was coming out of his mouth…he had no relief. The nurses asked us to 
leave the room so they could use the suction, then we heard a most terrible noise and they 
said to come back in quickly. His eyes were out on stalks, he was terrified and we could only 
hold his hands and try to comfort him as he died.’ 
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Impact on carers’ health 
The physical burden could be very heavy as described earlier. One wife 
described feeling inadequate and guilty because pre-existing arthritis prevented 
her caring for her husband as she would have liked. Many participants recalled 
how they had been able to carry on with ‘a sort of false energy’ but then 
suffered from overwhelming exhaustion when their loved ones died. 
 
Participants also described living with constant anxiety, whilst trying to keep up 
a cheerful appearance for their ill relatives. The anxiety sometimes led to panic 
attacks and often carried on into the night, insomnia was common. Sleep 
disturbances sometimes continued after the death no matter how exhausted the 
carer felt. However, Pam (fg2) recalled that although she slept on the settee for 
11 weeks with frequent interruptions to attend to her husband in the same room, 
she did not really feel the need to sleep at the time and was alert all the time in 
case he needed her:  
       „…it was as if somebody had given me an injection to keep me awake.’   
 
Box 5.14:  Distressing memories 
 
1. ‘…they have the whole thing about the choking, and that's what it is, they're just sort  
of  drowning in the fluid, and it's very distressing when you see it.‟ (Don sobbed as he 
recalled the way in which his father had died, fg2) 
 
2. „…and he felt he was being pushed under water and he just couldn‟t breathe.‟ (Grace,  
fg3, who was clearly upset at this painful memory) 
 
3. Edna was grateful that she was able to stay overnight in the hospice and that she and 
 other family members were with her husband as he died. She had hoped to take him 
home from the hospice but he deteriorated quickly at the end and plans were cancelled. 
She described his death as ‘drugged, in a morphine sleep’ at the end but earlier he had 
been very confused and hallucinating: he started searching the bedclothes for babies: 
„…and the nurse came and I said "What do you know, he's got 2 babies on his bed" so she 
just says to me "Have you ever had any miscarriages or lost any babies?" and I says „Yes, 
I lost 2 babies in miscarriage" and she says "He's got them". 
This presumably was an attempt of the nurse to comfort her with a simplistic explanation. 
it had the opposite effect because Edna interpreted this as meaning his death was 
imminent. She told how her husband then started shouting out, believing he was back in 
Japan at the end of the Second World War 
„…and the language was getting a bit rank! I thought "Oh my God, quiet, Ernie, you're 
not in Singapore now! (fg4) 
      Although Edna told this story in a humorous manner it caused concern to other members 
      in the Group and her humour may have been an attempt to minimise her own emotional  
      distress.  
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The stress of the situation resulted in three carers starting to smoke again, one 
had stopped again by the time of the focus group, another participant hinted 
that she had tended to turn to alcohol for comfort.  Apart from working full-time 
and supporting all the family, one carer recalled being very stressed by also 
trying to manage legal issues (both connected and unconnected with her 
father‟s illness) because her elderly mother was unable to understand them. 
 
The relatives often felt alone with their problems, and as shown earlier, they 
acknowledged that mesothelioma is relatively rare and that there are no public 
figures acting as „champions for the cause.‟ In the second focus group two 
participants expressed feelings linking isolation with the stigma associated with 
terminal illness and fears of contagion. 
        ‘It's as if you've got smallpox or something.‟ 
 
        ‘Exactly right, it's as if you're the one with some incurable disease, a leper,  
        and it's  catching.’ (Susan and Pam, fg2) 
 
Grieving 
The focus groups were not designed to explore the experience of bereavement 
but, as the participants were all still grieving, it featured in the discussions. 
Relatives described their reactions to the death of their loved ones and the 
ways in which being bereaved had affected them, 5.15.1. Many recalled being 
physically and emotionally exhausted at the time of the death due to the burden 
of care that fell mainly on them alone, as described earlier. The three 
exceptions related to the carers for a man who had only been in bed for a few 
days before he died, an elderly lady whose illness caused a slow decline in her 
health but without severe symptoms and who had a „good death‟ at her 
daughter‟s home and an elderly man who was in hospital throughout his brief 
illness. Relatives reported that the rapid disease progression and the demands 
of caring did not allow any time to think or plan ahead in most cases; these 
factors may have prevented anticipatory grieving which is believed to help in 
grief resolution (Sweeting and Gilhooly, 1990). 
 
Grieving relatives described a sense of isolation that was exacerbated by the 
feeling that few people knew what mesothelioma was: they contrasted this with 
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media accounts and public knowledge of the common cancers. This made it 
difficult to talk to other people and was perhaps also related to the notions of 
contagion and stigma referred to by two participants. Some relatives found it 
difficult to cope with suddenly being alone because they missed all the 
healthcare professionals visiting as well as being without their partner. Those 
relatives who had received bereavement care, usually through their involvement 
with hospices, found it very supportive. One widow felt that this type of support 
should be available and offered to every bereaved person, Box 5.15. Many 
relatives described how they were still involved in compensation claims as 
detailed in the next section.  
 
Anxiety and insomnia were reported as common in grieving relatives. In some 
cases this was a continuation of problems during the time spent caring but the 
focus had altered: one widow worried that she might become ill and have no 
one to care for her, another sobbed as she recalled how she always relied on 
her husband for support when she had any worries. Only one relative, a 
daughter, reported still feeling angry – she was a nurse and had felt let down by 
fellow professionals, (Amanda, fg2); although not said with anger, there were 
many remarks from participants about the injustice of asbestos-related 
diseases. Poor concentration was reported by two relatives, one declaring she 
felt ‘brain dead’ and now had poor memory. Some relatives described making 
an effort to avoid depression by adopting new activities, in one case an Open 
University course. Others reported relying on family and close friends for 
support, none mentioned the church. Some relatives reported feeling guilty 
because they had not said all that they had wanted to say to their loved ones, 
the other group members reassured them that this was inevitable, 5.15. 
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5.5.   Socio-medicolegal issues 
The issues covered in this section relate to the social and medicolegal contexts 
surrounding mesothelioma as they affected the focus group participants. 
Causation and attribution issues are followed by matters related to 
mesothelioma as a Prescribed (Industrial) Disease65. 
 
Mesothelioma as an ‘unnatural death 
 
 
                                                 
65
 As mentioned earlier, Prescribed Disease denotes a recognised disease caused by an occupation, in the 
case of mesothelioma it recognises causation due to industrial exposure to asbestos. Cases in which the 
exposure has been environmental or non-industrial are not categorised as Prescribed Disease and are not 
entitled to some related state benefits. 
Box 5.15: Grieving 
 
„I miss him terribly, we'd been together 55 years…It's a long time (sobbing)…It's stupid, I 
 didn't intend doing this.‟ (Mrs E, fg4) 
 
„Yes, the cut-off point – Bob died, I came, saw (the doctor), saw the Coroner, saw everybody 
 there, and yes, next day I'm on my own… and there's nobody and there's no help and there's 
nothing. Never thought I would take to my bed, took to my bed because I lived on my own, 
he's not there. You need somebody to see the bereaved widow or the next of kin, the person 
who lives with that person. You need someone there to be in touch, but without that person 
having to go to try to look for help… somebody should get in touch straight away and 
say…well "We've got a discussion group of other bereaved people, would you like to come 
along?" …if you go to a doctor, and I went to the doctor and all the doctor could suggest 
was "You're depressed, you need tablets" but no, I don't need tablets.‟ (Dora, fg1,with her 
thoughts on the support needed after a death)  
 
„I mean fortunately my local Hospice run a bereavement group for younger people and the 
 Social Worker there invited me to go there, and I found that very helpful because as you 
say, it's talking about it that helps you to come to terms with it‟ (Gillian) 
„You can talk to strangers but you can't say things to your family. I can talk to my family 
about most things but things that go through your head when you've just lost somebody, and 
you're frightened of upsetting your family…If you've got a professional to talk to who will 
know what you are going through is normal, you know, it's quite normal to feel like that. 
Perhaps you will feel that you're going mad. I was fortunate that I had that support, but I 
know not everybody does, but that's a general thing, isn't it, rather than mesothelioma? I 
think the one big point is this with the inquest, the post mortem.‟ (Edna, fg 4) 
 
„The thing for me was I couldn't speak, right at the end.‟ (Dave) 
„He couldn't say what he wanted to say, and it's always haunted him really.‟ (Diane, Dave‟s 
wife) 
„Well we all have this guilt trip, it's awful really.‟ (Pat) 
„I couldn't say what I wanted to say to my husband. You want to say it and you can't get it 
out, it's there, you want to say it to them but you can't say it. I told him I loved him, 
everything like that, but not the way I wanted…‟ (Sheila, in discussion with other fg2 
participants) 
„My husband was murdered‟ 
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In contrast to the data from interviews with patients, (Chapter 4), the relatives 
expressed no doubts regarding the cause of the illness: they all believed that 
asbestos caused mesothelioma and articulated strong feelings concerning 
blame; three relatives stated their loved ones had been ‘murdered’, 5.16.1-2.  
Relatives reported outrage and pain due to knowing that their spouse or parent 
had died as a result of avoidable exposure to asbestos. Suspicions that 
commercial considerations rather than ignorance had delayed the introduction 
of safety measures were reported as adding to their distress66. Several relatives 
voiced concerns that risks were still being taken with respect to asbestos, 
particularly by „cowboy builders‟, 5.16.3. In one case a hitherto unrecognised 
occupational exposure had been uncovered: Mary‟s, (fg3), husband had been a 
public service worker in an industry in which asbestos exposure had not 
previously been considered. Mary reported that her husband successfully 
pursued the first claim against that public service and led the way for many 
subsequent claims. Some cynicism was evident and a sense that the 
participants had lost respect for authority because the statutory bodies had 
failed to protect the patients from health hazards at work. One relative regretted 
that her father did not have a coroner‟s enquiry: with hindsight she realised that 
this would have publicised the fact that the responsibility was that of the local 
council for the sports centre where he had worked and been exposed to 
asbestos in the roof; she knew that although the council had temporarily closed 
the building to seal up the asbestos, it had since reopened. 
 
                   
 
 
 
 
 
 
 
 
 
 
                                                 
66
 The delay in implementation of relevant Health and Safety measures is described in Asbestos Killer 
Dust by Alan Dalton, 1979. 
 
Box 5.16: Mesothelioma as „murder‟‟ 
 
1. „I honestly believe that my husband was murdered.’  Emphasising that point, Mary 
 clearly held the industry responsible for her husbands death: 
„Because he was, as far as I'm concerned he was murdered, through greed and neglect. 
To me they're no different to drug dealers, because they wanted to leave the money 
through businesses and one thing and another, and they take that money and they don't 
want to pay it out and they've murdered people along the way‟. (Mary, fg3) 
 
2. From a different group, the same comment: 
„Well they were responsible, it's actually, to me it's like mass murder, isn‟t it? (Pam, 
fg2) 
Without a shadow of a doubt, yes.‟ ( Don, fg2) 
 
3. „ I do get angry when I read stuff in the paper now about it, and they're still not  
doing as much as they should be about it. You know they're still getting away with 
things.‟ (Mary, fg3) 
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Medico-legal issues 
 
 
Three specific medico-legal issues were discussed in all the groups: State 
Benefits, civil compensation claims and the coronial investigation. Industrial 
Illness Disablement Benefit applies in mesothelioma due to asbestos exposure 
at work, in addition to the usual benefits available to people with terminal illness. 
Civil compensation can be claimed against an employer or employers who have 
exposed a worker to asbestos. Death due to mesothelioma is classed as 
„unnatural‟ and as such has to be investigated by a coroner67 who usually 
requests a post mortem examination, which the relatives cannot refuse, 
followed by an inquest in order to ascertain the cause of death. 
 
Several relatives reported that the patients had been initially reluctant to claim 
benefits. The carers described how they had to negotiate this tactfully in order 
to achieve due financial assistance, this was at the risk of confronting the 
realities of the terminal illness and causing further distress for the patient. 
Relatives described their difficulties in negotiating the complexities of the State 
Benefits system, particularly when busy looking after a terminally-ill patient, and 
their additional anxieties regarding the civil compensation procedures. Relatives 
reported that they usually took the main responsibility for making these financial 
claims to avoid additional strain for terminally-ill patients. They recalled needing 
help, usually from Macmillan nurses, to complete complex benefit claim forms. 
Relatives reported being upset when patients underwent apparently 
unnecessary DSS68 medical examinations causing critical comment from other 
group participants69, Boxes 5.17 and 5.18. 
 
Some relatives revealed lack of information about State Benefits and gleaned 
knowledge from other participants. This led to some complicated discussions, 
sometimes adding to the confusion, but on other occasions prompting a 
decision to try to make a retrospective claim, 5.17.3 - 4.  
 
                                                 
67
 Under English law the coroner is responsible for investigating all unnatural or suspicious deaths. In 
Scotland, the equivalent position is the Procurator Fiscal but the investigation is similar. 
68
 Department of Social Security 
69
 This requirement, supposedly to ascertain the medical condition of the claimant, has recently been 
removed from the regulations when a diagnosis of mesothelioma has already been confirmed. 
„You must see a solicitor, you must make a claim‟ 
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Relatives reported that civil compensation claims required the patient‟s 
comprehensive employment record. In many cases the employing firms no 
longer existed and relatives described searching for the patients‟ former 
workmates in the hope that they could provide supporting information, 5.18.1. 
Most relatives reported that they had no prior experience of litigation and found 
the legal process time-consuming and worrying, 5.18.2. Relatives recalled the 
upsetting situation in that many of them, and the patients, had known that the 
patient often died before the compensation settlement was agreed. The ongoing 
responsibility of pursuing the claims was described as a further burden for 
grieving relatives: in two cases husbands had specifically insisted that their 
wives must continue the claims after their deaths. Some relatives revealed that 
the benefits and compensation actually received were less than many had been 
led to believe by accounts in the media, 5.18.3. 
 
  Box 5.17: State benefits 
 
1. ‘We could have been claiming Industrial Disease Benefit…about £114 a  
week, but we didn't know anything about that until much later…people need it 
explaining to them…you are busy 24 hours a day looking after a sick 
man…forms are not the thing that you're going to think about.‟ (Mary, fg5) 
 
2. ‟We took the government money there and then…and according to what your 
 age group is it's already there: you know exactly what you're going to get and 
within 2 weeks you've got the money. And that's what Bob and I then had a 
bloody good time, with the government money!‟(Dora, fg1) 
 
3. „So you got a lump sum from the government, did you?‟(Amanda, fg1) 
„Oh yes, it's everybody's entitlement‟ (Dora, fg1) 
„So I can get one for my mother can I?‟ (Amanda , fg1, querying a retrospective 
claim). 
 
4. ‘We had to go for medicals, which I thought was absolutely disgusting.. to  
Nottingham.‟(Grace, fg3) 
„My mum had medicals actually in the hospital.‟(Janet, fg3) 
„…to be seen by a doctor for the serious Industrial Injuries benefit, and I actually 
said to the doctor, „cos my husband was struggling to walk, "I think this is 
absolutely disgusting, you've got his notes there, you've got his X rays, you've got 
his scans. If you could change the diagnosis I'd be delighted, but you've got a 
terminally ill man" and I was angry.‟(Grace, fg3) 
  „I was angry about that.‟(Janet, fg3) 
  „My husband used to say to me "Don't get angry, it's just one of those things" and  
    I says  "it's not just one of those things, it's not bloody fair!"‟  (Grace, fg3) 
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Relatives‟ opinions differed regarding the apparently common practice of 
doctors combining disclosure of the diagnosis with advice to contact a solicitor 
in order to claim compensation. Most relatives recollected that the emphasis on 
claiming compensation and benefits at the time of diagnosis was inappropriate 
and unwanted. In contrast, the relatives in one group stated that it was 
necessary to proceed quickly: they supported compensation information at the 
time of diagnosis because the patients deteriorated so quickly. However, the 
general view was that information about benefits and compensation should not 
be raised at the time of disclosing the diagnosis but shortly afterwards. The 
relatives‟ priority was the care of their loved one; even with hindsight, and 
accepting the advantages of making early claims, the benefits and claims 
procedures were reported as distracting, stressful and time-consuming.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 5.18: Civil compensation claims 
 
1. „…the solicitor did come …Jimmy was that ill. And I'm writing down names, what  
boats he'd worked on, he knew it was the late '40's, early '50's…and my husband looked at 
me, on the Wednesday before he died… and he said "You better fight this case because 
you realise those bastards have killed me, and you make sure you don't let it go! …if you 
don't know all the details you've got to be a detective, you've got a lot of work to do.‟ 
(Pam, fg2) 
 
2. „I says to him "I actually feel like a gold digger, sat down here" you know.‟ (Mary  
Talking about her conversation with her solicitor): 
„I know my husband wanted the money for my security, because he wasn't going to be here 
and he wanted it for financial security for me and my family‟ (Grace, fg3) 
 
3. „It's a fraction… if you were in your '70's you got peanuts. If you were in your '40's 
 you got more, obviously.‟ (Susan, fg2) 
„In the paper it said you were liable to £37,000-£40,000, but when you actually got the 
thing, if your husband's older,  it's next to nothing.‟(Pam,fg2) 
„I think you had to be 36 years old to get that much money, which was very rare.’(Susan, 
fg2) 
 
4. „I really was disgusted that there should be something like that at the beginning of the 
 illness. All well and good after my mum had died,. But to do it right from the very 
beginning and then every time you went: "Have you got in touch with a solicitor?",  at the 
end of the day I did lose my temper and said "I don't want to know".‟ (Janet talking about 
being told to see a solicitor at the time of diagnosis) 
(HC) „Any other points of view?‟ 
     „ I think it's because there's a time limit on it, isn't there? Is it about 3 years or something?  
      So  I think this is why they do it, isn't it?‟(Mary) 
     „I think it's a good idea to proceed with, although it's hard to take it all in, you've got a 
      terminal diagnosis been given you, you don't know how long you've got together but I think  
      you do need to press on with that because a lot of the questions only my husband could 
      answer‟ (Grace, fg3) 
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Relatives described the coronial investigation as a source of major upset. Many 
relatives revealed they had either partial or no understanding of the procedure 
before the death of their loved one. Unprepared relatives described their shock 
at discovering at the time of the death that a death certificate could not be 
issued, that a post mortem examination had to be performed and that an 
inquest would follow. In most cases the initial procedure involved a police officer 
attending the place of death in order to conduct a formal identification of the 
body. It was apparent that, although most of the cases had been in areas of 
high incidence of mesothelioma, not all the police officers understood the 
difference between sudden unexpected or suspicious death and the situation in 
mesothelioma, in which death was expected, but unnatural, as a result of 
asbestos exposure. Amanda (fg1) recalled that when her father died, the police 
attended at the same time as the on-call GP. The police would not let the family 
be in the same room as the dead father and spent several hours questioning 
the family about his occupational history and their actions when he died; this 
caused them much distress. In other cases the situation was understood and 
approached with tact and sensitivity, particularly if a coroner‟s officer was 
involved, although they were not always available, Box 5.19.  
 
One family was given the choice by the coroner whether or not to proceed with 
an investigation. They decided against this because the company responsible 
had folded and the bereaved wife ‘could not bear the idea of further invasion of 
his body’. This caused much discussion in the group about the lack of 
consistency of coroners‟ services, 5.19.2. The post mortem caused distress to 
all but one of the participants, regardless of whether or not they had been 
prepared for it. The exception was a wife who had requested a copy of her 
husband‟s post mortem report70. Some of the other participants in her group 
found this shocking and none of them had known that they could have 
requested a report. However this wife explained it had helped her to know that 
her husband had coped with a tumour weighing 7lbs in his chest and she 
expressed her admiration for his stoicism.  
 
Two relatives recalled that the interim death certificate, issued by the coroner 
after the post mortem but before cause of death had been established by an 
inquest, was not recognised by bank and building society staff. The inquest was 
                                                 
70
 She subsequently sent me a copy of the report 
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recalled as yet another major source of distress, and often held months after the 
death. Most carers reported that they had not been aware of the procedure, 
received inadequate information about it and found it threatening and 
distressing. One participant revealed that she was still waiting for the inquest of 
her mother‟s death twelve months later. Although relatives reported that in 
general they found the inquest helpful in terms of a public acknowledgement of 
the reason for the deaths, and useful in supporting a claim for civil 
compensation, none regarded it as giving them any personal support. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
‘No closure’ – issues in bereavement 
 
 
Many of the participants reported that medico-legal processes continued for 
many months after the death of the patient. The inquest was still awaited by one 
relative, already 13 months bereaved, and others were still involved in 
compensation claims. Relatives told of delays in the legal process as, it seemed 
 „It just goes on and on and on.‟(Amanda, (fg1) 
Box 5.19: The coronial investigation 
 
1. „ I was told to go the next day for the death certificate. I rang up and asked  
when I could come for it and she said "Oh there'll have to be a post mortem". I 
said "Why? You know what he's died of, why… a post mortem?" so she says "and 
there's also to be an inquest". So I says "Oh, nobody bothered to tell me this 
yesterday, or any of my family!" I said "I don't want him to have a post mortem, 
he's gone through enough" It was a shock, a terrible shock‟ (Edna, fg4) 
 
2. „..she had to decide if she was going to arrange the funeral or going to claim  
because then she‟d have to have a PM. She‟d to sign a letter saying she‟d relinquish 
any right to a subsequent claim – wouldn‟t release the certificate until the coroner 
had the letter.‟ (Moira) 
 
3. „I mean I just got this date for the inquest and I got a court summons, I'd been 
 summonsed to court. It's not a very nice letter.‟(Grace) 
„How does that make you feel?‟(HC) 
„As though I've done something wrong.‟(Mary) 
„Well yes 'cos it's not in our Coroner's court, it's in with the Magistrate's court, so 
you're sat there with people that have been doing wrong…‟ (Grace) 
„You are summonsed on 28th May… I'm summonsed, I've never been court 
summonsed‟ (Mary, fg3) 
 
4. „Because they had to retest her lungs, her lungs had to go to Cardiff.’(Janet 
explaining the reason for the delay in holding the inquest while histology was 
clarified ) 
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to them, insurance companies tried to manoeuvre out of their financial 
responsibilities.  
 
Two relatives admitted that they had still not been to collect their husband‟s 
ashes from the funeral director, in both cases several months after the death; it 
seemed that this was yet another task and almost too much for them. In one 
case the patient had left a map and instructions for his family to travel abroad 
after his death to visit a place that had been dear to him. His relatives viewed 
this with some mixed feelings, partly because of the expense but also because 
of the sentiment, nevertheless the family members were planning to carry out 
the instructions, 5.20.3. 
 
As one widow said ‘there’s no closure’ – confirming her awareness of the 
impact on grieving caused by the ongoing legal actions, 5.20.5. Another relative 
described repeatedly getting upset on hearing of more local people diagnosed 
with asbestos-related diseases related to working in the shipyard where his 
father had worked.71. Many relatives revealed continuing anger, in two cases 
wives reported that the experience had changed them and made them more 
assertive, 5.20.1. One participant had already joined a campaign group as her 
mother‟s experience had angered her so much that she wanted to help other 
‘asbestos victims’ and another had written a full account of her husband‟s 
illness in order to support his compensation claim which was a test case against 
a public service organisation, 5.20.4. On the other hand, one participant 
described that she found the new roles and responsibilities of a life on her own 
almost overwhelming. It was obvious that for many participants the groups 
allowed them to ventilate feelings that had been suppressed to a large extent, 
5.20.6. It was also the first time that many had actually met another person who 
had experience of mesothelioma and who therefore understood the illness and 
its consequences. Perhaps as a result of the relief at being able to unload and 
finding others who shared their experience, all the groups bonded and there 
was little disagreement – confidences were exchanged as freely as tissues!72 
 
 
                                                 
71
 She sent me a copy of her report and asked me to use it in any way to campaign for better treatment for 
mesothelioma patients. She has subsequently joined a campaigning organisation. 
72
 At least 3 of the participants remain in touch and 2 have subsequently become active in support groups 
and campaigning for asbestos victims. 
 204 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary 
In this study almost half the families had some prior knowledge of asbestos-
related disease although they may not have consciously related this risk to 
their own situation. The diagnosis was imparted to virtually all patients and 
their relatives with confirmation of a fatal outcome, no hope of curative 
treatment and, according to the focus groups, little attention to supportive or 
palliative care73. Relatives had little chance of denying or ignoring the fact that 
patients were dying due to constant reminders in the form of deteriorating 
health, disease burden and medico-legal procedures.  
 
Although the diagnosis was often disclosed against a background awareness 
of asbestos-related disease, sometimes specifically mesothelioma, it almost 
always had a shocking impact on relatives. This contrasts with the stoical 
                                                 
73
 As also confirmed by the medical records survey, Chapter 3. 
Box 5.20: No closure 
 
1. ‘I feel very angry and very bitter still…I 've had to learn to be a bit more  
assertive‟(Grace) 
„I'm the same really, I'm very angry, but I've got stronger with it, with everyday life I won't 
stand back now, I'll put myself forward more than what I used to do before.‟(Janet) 
‘I'm angry… they'd known about it for so long and hadn't done anything about it.‟(Mary) 
 
2. ‘ I haven't collected the ashes, I told you.‟(Dora,fg1) 
„I haven't done that, my ashes are still at the funeral parlour.‟(Amanda,fg1) 
 
3. „I've got to go to Florence, 'cause he'd left a map for me to go…He left a map for me to 
 go to a place in Florence in Italy. Could have been Coniston, it'll cost me a fortune!‟ (Alan, 
fg1) 
 
4. „I‟ve found out that in 2001 people suspected of having mesothelioma sufferers should 
get the benefits and not have a medical but in spite of that, in my mother‟s case, they would 
not allow the benefits until the biopsy proved it…and that‟s the injustice…I‟m angry and I‟m 
going to fight it.‟ (Joy, fg6, who had become a member of an organisation fighting for 
justice for asbestos victims) 
 
5. ‟ …it's ongoing, so no it's not sorted.‟(Jean) 
„Yes, there's no closure‟ (laughing)…No closure, no, not at all, there isn't…‟  (Jean, fg5) 
 
6. However Jean, and others, apparently found the focus group experience helpful:‘ I think  
actually coming here today is helpful to me, because I'm telling you things that I have told no 
one else, regarding the hospital and the treatment and things like that.‟ (Jean, fg5) 
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reaction in patients as described in the interviews in Chapter 4. The impact 
was worsened if healthcare staff were perceived to undervalue the importance 
of the relatives and failed to involve them in matters concerning the care of the 
patients. Relatives found lack of knowledge of mesothelioma in doctors 
inexcusable and are distressed by perceived „medical nihilism‟. The relative 
rarity of mesothelioma, poor prognosis, and lack of effective treatments, 
increased relatives‟ feelings of isolation and neglect and added to the 
devastating impact of the diagnosis. Most relatives felt that combining advice 
to pursue benefits and compensation claims with disclosure of diagnosis was 
inappropriate and distressing, discussed further in section 5.4. Inadequate 
communication skills and, in particular, lack of training in breaking bad news, 
appear to be evident in these reports.   
 
As in other cancers, relatives have different information needs to patients. In 
mesothelioma, when time is short74 and the disease is incurable, the relatives 
take a particularly active role in obtaining and handling information and were 
most critical of doctors for lack of knowledge and/or the willingness to discuss 
the situation with them. In contrast to the patients, the carers, almost all 
female, were actively searching for information and assistance and felt they 
had a right to be fully informed. When frustrated by inadequate information 
from healthcare professionals, relatives looked outside the medical profession 
for information, sometimes finding inaccurate unhelpful websites.  
 
There appeared to be a lack of appreciation of the relatives‟ needs and no 
service that signposts them to appropriate resources. In addition there 
appeared to be confusion about relatives‟ right to information; sometimes this 
was complicated by concerns around confidentiality and at other times 
hindered by patients who censored the information available to their relatives.  
 
There is a considerable physical burden of care for relatives coping at home, 
in some cases exacerbated because patients reject outside help. The dramatic 
and unpredictable nature of the disease and invasive interventions add to 
anxiety. Decisions around calling for help and medication issues are usually 
shouldered by the carer rather than the patient. Traumatic experiences of 
severe distress and uncontrolled symptoms in the dying phase create yet 
                                                 
74
 Confirmed in the medical notes review, chapter 3. 
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more emotional pain for bereaved relatives and add to public (and 
professional?) expectations of mesothelioma causing a terrible death. 
 
There is also a considerable emotional burden on carers who support rapidly 
deteriorating patients, often in comparative isolation. Part of the strain relates 
to the tension engendered by trying to carry on as normal in the face of 
impending death. Family carers frequently have other carer responsibilities 
and may be in the „sandwich generation‟. There is a considerable impact on 
carers‟ own health – physical and emotional strains may lead to inappropriate 
coping strategies, anxiety and depression, sometimes adding to their health 
risks, for example resuming smoking or excessive alcohol. 
 
The burden of investigations and treatments affects relatives as well as 
patients. The traumatic investigations undergone by patients causes great 
distress to relatives and this does not appear to be taken into consideration by 
the healthcare system. System failures add to the burden on relatives: in the 
face of terminal illness, the responsibility for dealing with delays and 
inefficiencies is shouldered by relatives. 
 
The lack of defined best practice and the lack of a treatment plan in 
mesothelioma add to uncertainty and feelings of helplessness experienced by 
relatives. Lack of medical expertise in mesothelioma, even in areas with a 
relatively high incidence, adds to relatives‟ anxiety and loss of confidence in 
doctors. Relationships with doctors and nurses make a major impact on the 
quality of the experience for relatives.  
 
Dissatisfaction with the healthcare system resulted in three potential formal 
complaints: one because a patient was told the diagnosis alone when 
arrangements had been made for his wife to be present; another because a 
patient experienced severe pain during a procedure that appeared to have 
been conducted without adequate care or consideration; and the third related 
to unhelpful NHS Direct procedures when a patient was dying. These appear 
to be valid grievances but in all cases may have been avoided by a more 
patient-centred approach which took relatives into consideration. 
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None of the relatives had been used to making either state benefit or civil 
compensation claims previously. Relatives, who assume major responsibility 
for these matters need expert assistance in obtaining their entitlements but 
there is no system for this. These relatives found claiming state benefits 
somewhat distasteful and demeaning. Civil compensation is also complex, 
involves appointing a solicitor, and causes relatives a lot of work and anxiety, it 
often continues into bereavement.  
 
Relatives are outraged that their loved ones have died an unnatural and 
potentially avoidable death – many consider it to be mass murder and, as 
such, a public disaster. The responsibility for dealing with medicolegal 
processes is usually borne mainly by relatives and is disruptive, stressful and 
time-consuming. Lack of public understanding of mesothelioma and also the 
coronial investigation may stigmatise mesothelioma and exacerbate social 
exclusion of relatives. Relatives all found the coronial investigation distressing, 
many only found out about it after the patient had died. The problems related 
to the interim death certificate that upset two families highlight the lack of 
public and professional understanding of the legal situation. Coronial 
investigations and compensation claims interfere with grieving and adjustment. 
Negative emotions and unresolved grief may persist for a long time after the 
death. The above factors may result in intensified and complicated grief and 
bereavement (discussed further in Chapter 7). These accounts revealed a lack 
of support services for bereaved carers of patients with mesothelioma.      
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Chapter  6: Interviews with healthcare  
professionals 
 
6.1 Introduction 
This chapter reports the findings of semi-structured interviews with 10 
healthcare professionals who were selected as having experience in the 
management of patients with mesothelioma.  They were asked for their views 
concerning the disease burden, disease trajectory, and service provision for 
patients with mesothelioma. The purposive opportunistic sample was designed 
to give a range of perspectives from the main medical and nursing specialities 
involved in mesothelioma across the three locations. The participants were: a 
GP, Macmillan nurse, lung cancer lead nurse, lung cancer clinical nurse 
specialist, respiratory ward sister, respiratory physician, thoracic surgeon, 
clinical oncologist, palliative medicine consultant and the Mesothelioma 
Information Service nurse75, (referred to as the helpline nurse in the text).  This 
sample was not intended to provide comparative data across the 3 sites but, 
where important differences were identified, they have been reported.   
 
An interview guide76 was used to ensure coverage of the following areas: the 
local history of mesothelioma; workload due to mesothelioma; comparison with 
lung cancer; the clinical management of mesothelioma; their role in explaining 
diagnosis; financial matters and medico-legal procedures; involvement with 
patients‟ family carers; and ideas about best practice. The findings are reported 
under ten subheadings that relate to major themes that emerged from the data. 
Quotes illustrating the ten major sections are placed in boxes at the end of each 
section, for example: 6.1.3 represents Box 6.1, quote 3.  
 
                                                 
75
 See section 6 for a description of this service 
76
 See Appendix 11 
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6.2. Mesothelioma in local context 
 
 
Local situations 
There was universal knowledge of the epidemiology of mesothelioma and the 
local contexts: all the professionals who were interviewed recognised that they 
were practising in areas of high incidence; all acknowledged the specific local 
history of asbestos-related industries; all agreed that the incidence of 
mesothelioma was still rising and that asbestos was the cause of mesothelioma 
although a history of asbestos exposure was not always obtained.  One doctor 
expressed his theory regarding a neighbouring area with apparently similar 
industries that had an unexplained lower incidence of mesothelioma: he 
suggested that the later timing of exposure of the neighbouring workforce to 
blue asbestos may have accounted for the difference. There was recognition 
that patients often suffered from anxiety due to prior knowledge of the disease 
and its dire outcome, either from workmates or local media reports, and that this 
increased anxiety, particularly when awaiting diagnosis, 6.1.1- 6.1.5. 
 
Workload 
Most of the healthcare professionals were involved in respiratory specialities, 
except for the GP and the Macmillan nurse; only the helpline nurse worked 
solely in the field of mesothelioma. In the three high incidence areas included in 
the study, professionals reported differing workloads due to mesothelioma 
depending on variations in local incidence and the size and type of population 
they served. The GP recalled that his practice saw one or two patients each 
year with mesothelioma77; the respiratory physician from a district general 
hospital saw 4 to 6 new cases a year; whereas the thoracic surgeon and his 
team working in a regional cancer unit dealt with two or three cases each week 
(not all of which were new cases). The Macmillan nurse reported caring for up 
to 10 patients with mesothelioma per year; she revealed that some patients 
were referred very late in their illness and in those cases her involvement was 
brief, although often intense. The respiratory ward sister recalled that fewer 
patients with mesothelioma were now admitted to her ward since changes in 
admissions procedures due to performance measures introduced in the NHS 
                                                 
77 This concurs with data from the medical records review, Chapter 3, no GP saw more than 2 patients with mesothelioma per year in these high-incidence areas 
‘Not your typical lung cancer patients.‟  Respiratory ward sister 
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Plan78 (Department of Health, 2000) 6.1.4, 6.1.5. The helpline nurse reported 
over 1000 calls per year from patients and carers across the UK during the 43 
months that the helpline was available79. 
Comparison with lung cancer 
Healthcare professionals held differing opinions about the previous health of the 
patients with mesothelioma compared with patients with lung cancer. Most 
expressed the opinion that patients with mesothelioma were less likely to be 
smokers, generally fitter than lung cancer patients and often involved in physical 
activities and hobbies; in contrast, two respondents, the GP and the oncologist, 
reported their view that there was little difference between these groups of 
patients. The GP reported his view that mesothelioma is almost unique amongst 
malignancies in that no effective treatment was available. There was unanimous 
belief that patients with mesothelioma suffered from more severe symptoms, 
particularly complex refractory pain and recurrent pleural effusions, than 
patients with lung cancer. This view is supported by Nowak et al’s (2004) study 
mentioned earlier, p20, and also by an Australian study investigating the needs 
of patients with mesothelioma, their family carers and healthcare professionals 
in New South Wales (Hawley et al, 2004). The psychosocial impact and burden 
of mesothelioma on patients and their relatives were reported by all the 
professionals, and recalled by several interviewees as being greater than that 
related to lung cancer. This was understood to be due to issues of causation, 
blame, complicated financial and medicolegal issues and the inevitably fatal 
outcome, 6.1.6-6.1.8. These views are supported by a study in lung cancer in 
which none of the 107 consultants surveyed identified depression and only 
23.5% identified anxiety as „a main disease-related problem‟ (Krishnasamy and 
Wilkie, 1999:64) 
 
                                                 
78 Discussed in Section 6.11, Service provision issues: secondary care. 
79 The Mesothelioma Information Service telephone helpline was funded by the charity, Macmillan Cancer Relief, from 1.7.1999 until 1.12.2002 at which point 
the helpline nurse retired. Macmillan funding has subsequently been directed to the support of a National Mesothelioma Resource Centre in Leicester which offers 
a helpline and a website for patients, carers and professionals as Mesothelioma UK.: www.mesothelioma.uk.com
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Box 6.1:  Mesothelioma in context 
 
1. „…we've had some quite young patients die…I've had a builder and I asked him "How 
 do you think you got mesothelioma?" and he said "Well in the '60s and '70s we used to have 
games with each other and cut the asbestos boards and see who could create as much dust 
as possible – we never wore masks or anything…I just knew it was going to happen"‟ Lung 
cancer nurse specialist 
 
2. „some people have  "Well I worked with it, I knew I was going to get it" Others are very 
 angry and frightened seeing other people die of it‟. Lung cancer nurse specialist 
 
3. „… most of the people who worked in the shipyard have been in contact with asbestos at 
 some stage.They can number the people in their apprentice school that have died of it‟  GP 
 
4. „I would see about one [new patient] every two to three months. …they used to make the 
[railway] carriages and the locomotives, there was a large amount of blue asbestos 
then…also the power station, installing boiler work and pipe work‟  Respiratory physician  
 
5.„…a lot of them will have known workers who've had similar problems and so they have 
preconceptions of the disease, which tends to be quite distressing…we do deal with at least 
3 or 4 cases a week…and of course we're at the crest of the wave in terms of incidence so I 
would expect that thoracic surgeons are going to be busier for the next 5 years.‟ Thoracic 
surgeon 
 
      6. ‘Not your typical lung cancer patients. Don't tend to be smokers… not middle class, but  
upper working class…mesothelioma… tended to be non-smokers.‟ Respiratory ward sister 
 
4. „…I can't think of many other sorts of cancer where at least nothing is offered, where no 
 cure is offered, there's no hope offered to you.‟ GP 
 
5. „Now I'm aware that we got the most difficult, the complicated, the failures if you like, 
 in the system, but… managing these patients was more difficult because of them having a 
delay in their diagnostic phase…contractions and the distortion of the chest wall, which you 
don't tend to get with lung cancer. I think pain is more of a problem than with the average 
lung cancer because it's a pleuritic disease rather than a lung disease really.‟ Palliative 
medicine consultant 
 
6. „pain seems to be an issue at an earlier stage, and far more difficult to control.‟ GP 
 
7. „…lung cancer patients on the whole were in a fairly poor physical state of health  
      because they'd got ongoing bronchitis, emphysema…whereas the mesothelioma patients on  
      the whole were extremely fit, inordinately fit…There was a lot of anger about it, a lot of 
      feeling of injustice, I think, that affected their mental…the way they coped with it…I think 
      the age had a lot to do with it…a lot were early 60's, looking forward to retirement…the  
      biggest majority were actually non-smokers…an awful lot had never smoked, so the last  
      thing they expected was lung cancer of any kind…a lot are very diet and health-conscious, 
      so they were quite different from the lung cancer group, who were the exact opposite really! 
      …and a lot have very active  sporting hobbies.‟ Helpline nurse 
 
8. „…the biggest thing that‟s obviously different …the first symptoms tend to be  
acute…persistent effusions, which of course lung cancer patients can get…but they do seem 
to go through the mill a lot…having to go away for pleurodesis, a longer time of 
uncertainty…and the big thing is the financial side…which causes a lot of stress.‟  
Macmillan nurse 
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6.3. Investigations and interventions 
 
 
There appeared to be particular difficulties inherent in caring for patients with 
mesothelioma. Healthcare professionals reported their perceptions of problems 
occurring throughout the illness and affecting every discipline. Many recalled 
the extensive investigations and frequent delays in reaching a histologically 
confirmed diagnosis, as reported previously (Yates et al, 1997; BTS, 2001; 
Hawley et al, 2004), and that this was distressing for patients, relatives and 
clinicians. Professionals reported the investigations as painful or „harrowing‟ for 
patients due to a combination of invasive procedures, long periods of 
uncertainty and anxiety, 6.2.1, 6.2.2. However, the respiratory ward sister 
remarked that patients with mesothelioma appeared to be very accepting of 
seemingly painful procedures, 6.2.3. Echoing previous reports, (BTS, 2001, 
Hawley et al, 2004), interviewees reported that the diagnosis remained 
unconfirmed for some patients in spite of extensive investigations and/or a 
strong suspicion of mesothelioma against a history of asbestos exposure, 6.2.4.  
 
The thoracic surgeon described accurate staging as crucial to determine 
whether radical surgery was appropriate. He reported problems relating to both 
the inaccuracy of available investigations, (thoracoscopy and CT and MRI 
scanning), and the inadequacies, as he saw them, of current staging criteria. He 
explained his concern that an underassessment may result in patient receiving 
inappropriate radical surgery, with consequent high morbidity and poor 
outcome, due to their having advanced rather than early disease, 6.2.5, 6.2.6. 
His views are supported by previous studies (Rusch and Venkatraman, 1996, 
Edwards et al, 2000).  
 
Prophylactic radiotherapy, to prevent tumour tracking along chest wall ports, 
was seen as essential by several interviewees, as recommended by previous 
authors (Boutin et al, 1995; BTS, 2001). Problems were reported in complying 
with the BTS recommendation (2001) that radiotherapy should be given within 4 
weeks of the invasive procedure: two healthcare professionals reported delays 
due to waiting lists but two others reported faster access to treatment since 
„…this is a depressing disease…‟  Thoracic surgeon 
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MDTs had been introduced.80 Another radiotherapy access issue was related to 
distance; only Leeds, a regional cancer centre, provided radiotherapy locally; 
patients in Barrow and Doncaster had to travel up to 70 miles for radiotherapy. 
 
The relative rarity of mesothelioma and consequent lack of knowledge of the 
disease amongst doctors, juniors in particular, was highlighted by a Macmillan 
nurse. She reflected that patients with pleural effusions were disadvantaged 
when mesothelioma was not suspected as a diagnosis or incorrectly thought to 
be a benign condition.  
 
                                                 
80
 See later description of multidisciplinary teams in Section 5: Service provision, p242 
Box 6.2: Investigations and interventions 
 
1. … the other thing that's hard with mesothelioma patients is the diagnosis is so 
 difficult to get, so they've agonised, usually for weeks, sometimes months…So they've had 
all this agony before they eventually are told the diagnosis.‟ Respiratory ward sister 
 
2. „.. the difficulties of diagnosis can be harrowing for the patient.‟ Thoracic surgeon 
 
3. „They're very accepting, when they… have it aspirated. I think they are painful 
 procedures… it looks uncomfortable, it looks painful. But mesothelioma patients do seem 
very acceptable of it… It's a big chunk of their time... they sit there with the drain in and 
they have the pleurodesis, and that in itself can take up to a week, then if it fails and 
they're back in again… They're also starting…sending patients home with drains from 
surgery, but I think they bring complications as well.‟ Respiratory ward sister 
 
„…they get sent for pleural aspiration, cytology, and if they suspect mesothelioma they get 
a CT scan and either a needle biopsy guided by the CT or for a VATs biopsy 
next…Sometimes …all the investigations are non-contributory and one is forced just to 
wait for a passage of time to identify whether it's a malignant mesothelioma or a benign 
pleural reaction.‟ Respiratory physician 
 
„…we  know this is a depressing disease… the majority of patients we see are not suitable 
for any potentially curative surgery…It's all palliative, most of the patients we see are 
referred either for diagnosis because the chest physicians haven't been able to get a 
diagnosis [or] do a surgical procedure… so we are quite involved ...‟ Thoracic surgeon 
 
4. „I don't think this is a disease that you can stage like lung cancer, I think this is a 
 diffuse disease that effectively are all T4…you could even say they are all M1 because I 
don't think current classifications are really suitable… I think it's important to stage them 
with mediastinoscopy…But really these are all extensive stage disease…but you do get 
occasional patients… where you've just got very early studding of the parietal pleura, and 
I think they would do well with pleuropneumonectomy and pleurectomy, but you don't get 
many cases like that.‟ Thoracic surgeon referring to TNM staging classification 
 
5. „…and I think it‟s education [that is needed.]…educating the junior doctors that if 
 someone‟s admitted with a pleural effusion…make sure they‟re referred back to the chest 
team and not just discharged and left „til the next time which was happening with a lot of 
them.‟  Macmillan nurse 
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6.4. Professionals‟ views of treatments and trials 
 
Most of the interviewees emphasised the lack of effective treatments, and 
consequently that all interventions were essentially palliative.  They reported 
that this was a hard message to convey to patients and their relatives, see 
Section 6.6, Talking to patients. The lack of clear guidance on best practice, 
such as an evidence-based clinical pathway, was seen by some as 
disadvantaging patients with mesothelioma but, on the other hand, several 
participants stressed that individualised care is essential in this situation, 6.3.1, 
6.3.2, 6.3.8, 6.3.9. The helpline nurse contrasted this with lung cancer 
management where she felt that a standardised treatment plan was more 
appropriate, 6.3.2.  
   
Two doctors revealed their involvement in novel treatments: the consultant in 
palliative medicine described how he was involved in exploring the use of 
ketamine, an anaesthetic agent used „off label81‟ with encouraging results82 
(described later in Section 6.5, Palliation of symptoms), and the thoracic 
surgeon reported that he was participating in a trial of intra-pleural 
photodynamic therapy, in cooperation with other specialist centres, 6.3.3, 
(Baas, 2006). The surgeon reported that dismal results from radical surgery 
earlier in his career dissuaded him from surgery in mesothelioma but that he 
had now restarted in the light of recent published studies.  
 
Chemotherapy was recalled as another difficult area in the light of disappointing 
results of trials and the opportunity costs for patients, even enthusiasts for 
chemotherapy expressed an awareness of the treatment burden for patients 
and the limited benefits. The helpline nurse went even further: she expressed 
scepticism about the benefits of chemotherapy and doubted that a successful 
treatment would be discovered until mesothelioma was in decline, 6.3.4, 6.3.5. 
None of the participants advocated chemotherapy outside a clinical trial, 6.3.6. 
It was reported that some patients subsequently regretted having chemotherapy 
because it made them ill in the short time they had left and the Macmillan nurse 
                                                 
81
 ‘Off label’ is commonly used to describe the use of medication outside licensed indications 
82
 Ketamine is licensed for use as an anaesthetic, it is now becoming widely accepted in palliative 
medicine and specialist pain services as a useful analgesic, particularly in addition to conventional agents 
such as opioids, in severe pain. 
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implied that, in spite of any explanations that may have been given, some 
patients had not fully understood the risks and limited benefits of chemotherapy, 
6.3.7.  Ethical issues involved in entering patients into chemotherapy trials were 
raised by four interviewees: these anxieties centred around the delicate balance 
between giving accurate information about very limited improvements in survival 
times and dashing all hope for patients. These four professionals reported their 
expectation that chemotherapy may harm rather than help or, at best, offer 
minimal benefit to patients, 6.3.8, 6.3.9, 6.3.10. There was criticism of the 
media, including unregulated websites: professionals reported concerns about 
publicity surrounding new drugs for mesothelioma without full explanation of the 
results of relevant trials; this was reported as appearing to confuse and raise 
false hopes for patients and their families, 6.3.11. 
 
The professionals‟ views about chemotherapy in mesothelioma, 6.3.3-6.3.10, 
suggest an interesting divide: although almost all interviewees regarded clinical 
trials as necessary in order to search for effective treatments, there was a 
difference between, on the one hand, the secondary care doctors: the 
respiratory physician, oncologist and thoracic surgeon; and on the other hand, 
the primary and palliative care professionals: the GP, palliative medicine 
consultant, and Macmillan nurse. The secondary care doctors appeared to 
encourage patients to participate in trials. This was perhaps from a strategic or 
utilitarian perspective as the only way in which progress was to be made and in 
the belief that chemotherapy might confer some limited benefit to the individual 
patient. Contrastingly, primary care and palliative care professionals tended to 
be much more cautious about promoting chemotherapy trials and appeared to 
prioritise the potentially negative effects of the treatment in terms of impact on 
the patient‟s life with regard to treatment burden, opportunity costs and potential 
harm. This difference could be seen as reflecting the different levels of 
relationship between the patient and the professional, although these comments 
must be viewed in the context of this small sample. Whereas patients are seen 
at longer intervals and for specific advice and interventions by secondary care 
professionals, the primary care and palliative care professionals (in general) 
have more contacts with the patients and usually know their family and social 
situations and may have longstanding relationships. The greater intimacy of 
these relationships may lead to an approach that tends to be more patient-
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centred. However, in primary care, it is unlikely that the practitioner will always 
be aware of the latest results from oncological clinical trials.  
 
The respiratory ward sister and the lung cancer nurse specialist also seemed to 
fit with the patient-centred approach. This corresponds to their more in-depth 
knowledge of the patient and their family as a result of daily contact during 
hospital admissions or repeated detailed discussions of the disease and 
treatments, in comparison with the relatively brief contact with most secondary 
care doctors. It also relates to nurses‟ professional training in which „getting to 
know‟ patients and their families is central to nurses‟ identity, although this 
cannot be seen as exclusively related to nursing. GPs, palliative medicine 
physicians, psychiatrists and also many hospital doctors would regard the 
doctor/patient relationship as in itself therapeutic and dependent on an 
understanding of the patient and their family (Kleinman, 1988:222; Cassell, 
2004:144-7, Randall and Downie, 2006:176-9). Another stereotypical view of 
the different behaviours may relate to gender: all the nurses were female, all but 
one of the doctors were male. A contrasting view, considering a brief 
involvement with a patient at the end of their life, might suggest that a 
professional, supportive, albeit superficial, relationship may be the best that can 
be achieved. 
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Box 6.3: Professionals‟ views of treatment and trials 
 
1. „There's no clear cut protocol or pathway that these patients should follow, and I think 
 It would probably be nice to standardise.‟  Thoracic surgeon 
 
2. „I think they're very individual and…that is probably the key to their care. I found  with 
 lung cancer you could work along quite firm lines, you saw one patient and… providing 
they were the same type of lung cancer, the care didn't vary a lot, but with mesothelioma, 
no, it's a much more individual disease…the person needs to be treated as an individual.‟ 
Helpline nurse  
 
3. „Yes, I think there's a lot of problems with trials…I'm interested in photodynamic 
 Therapy for mesothelioma…We have pre-operative chemo, intra-pleural pneumonectomy 
with photodynamic therapy during the operation, followed by radiotherapy. Which is a lot 
for the patient to undertake…You do need a laser…the equipment's fairly expensive but we 
got it in Leeds…but that's not even been really thought about in these trials.‟ Thoracic 
surgeon  
 
4. „Yes we support the clinical trials, we're enthusiastic to recruit our patients to trials and 
 that does often mean that we are particularly keen to get a histological diagnosis… so it 
does impact to some degree upon issues like biopsies and so forth…. I don't have problems 
so long as patients are properly recruited and give proper informed consent‟ Respiratory 
physician  
 
5. „I think they‟re essential because we‟ve got to try I suppose. My feeling is…by the time 
 they get some success mesothelioma is going to be on the decline anyway…I've spoken to 
people who have had dramatic benefit from chemotherapy…others have just gone 
downhill…others that have had no treatment and they're going on nicely, 2 years on…My 
interest in mesothelioma predates chemotherapy for mesothelioma, and I had patients then 
who were living 2 or 3 years, in fact sometimes I think they lived longer.‟ Helpline nurse  
 
6. „If they have chemotherapy it must only be as part of a trial.‟ Oncologist  
 
7. „…sometimes I get patients saying "If I knew I was going to be this ill I may not have 
 chosen to have active treatment, because I wanted to feel well in the short time I had to 
live" Lung cancer clinical nurse specialist.  
 
8. „Again it's the individual's interest against the greater good, isn't it? Basically it's pure 
 academic research. I mean if the academics turn out a new type of chemotherapy which 
theoretically should make a difference, then that's different, you'd go for it. But if you've got 
a reasonable body of evidence which shows that really it's not going to tangibly improve 
your quality of life, then I don't think you should do it.‟ GP 
 
9. „These people have been through a lot already, their life expectancy isn't long, and  
you've got to be careful about what you subject them to. So I am rather negative about the 
whole area‟ Palliative medicine consultant 
 
10. „I think it's very difficult to take hope away from patients, and often my perception is 
 that they're offered that lifeline and they grab it, and it's a very brave person who says 
"Well no I don't really want to try that…‟  They usually opt to have treatment and often 
relatives can push them.‟ Lung cancer clinical nurse specialist 
 
11. „ the [local paper] putting in that there was this new wonder drug that would 
 give them an extra 12 months quality life without actually looking critically at the article…‟ 
Macmillan nurse 
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6.5. Palliation of symptoms 
The severe symptom burden for patients and the challenge of achieving good 
symptom control were referred to by all the professionals, in accord with 
previous reports (Hawley et al, 2004; Nowak et al, 2004; Mercadante et al, 
2000; Jackson et al, 1999; Ahmedzai and Clayson, 2006). In line with recent 
NICE guidance on palliative and supportive care, (NICE, 2004), two 
professionals emphasised that palliative care should be provided to patients 
with mesothelioma from the point of diagnosis, 6.4.1. In contrast, two others, 
including the consultant in palliative medicine, seemed to regard it as relevant 
when active treatments were no longer appropriate. Several participants, in both 
hospital and community settings, stressed the need for specialist palliative care 
knowledge in managing patients with mesothelioma due to the complex and 
multiple nature of their symptom, 6.4.2 – 6.4.10. Although palliation of 
symptoms in general was reported to be difficult, the major focus was on the 
relief of pain 6.4.1– 6.4.3. Most professionals recalled experiences of patients in 
whom pain had been very difficult, sometimes impossible, to control adequately. 
Four interviewees stressed the complex nature of refractory pain with multiple 
potential causes of the pain, sometimes worsened by chronicity and „wind up‟83 
(Stannard and Booth, 1998:11) 6.4.5, 6.4.6, 6.4.9, 6.4.10. The desperation of 
professionals in this distressing situation was illustrated by the consultant in 
palliative medicine who declared he was prepared to ‘try anything’ to relieve 
pain in mesothelioma when conventional treatments had failed, 6.4.5. The 
consultant in palliative medicine who reported that he was actively investigating 
an „off label‟ medication, ketamine, in response to the refractory nature of pain 
in some patients, emphasised the need to admit patients to a specialised unit 
such as a hospice in order to introduce this novel and complex treatment 
regime, 6.4.5. The need for a rapidly responsive service was emphasised by 
two professionals who referred to the erratic and often dramatic disease 
trajectory 6.4.4, (p282). 
 
Breathlessness was seen as mainly due to pleural effusions. It was regarded as 
treatable with pleural aspiration followed by pleurodesis if it became a recurrent 
problem. Surprisingly, other causes of mesothelioma-related breathing 
difficulties, such as extensive rigid pleural thickening, lung encroachment by 
                                                 
83
 ‘Wind up’ is a phenomenon in which peripheral nerve damage is accompanied by central sensitisation, 
reflecting plasticity at all levels of the nervous system  
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tumour, or pericardial involvement, were not specifically mentioned by any of 
the interviewees. Impressions of inefficiency in the management of recurrent 
pleural effusions were reported by two interviewees. The respiratory ward sister 
reported that talc pleurodesis performed as a procedure on the respiratory ward 
often failed and then patients required a further attempt in a thoracic surgery 
unit.  The same nurse also referred to inappropriate use of nebulisers, 6.4.7, 
6.4.8. The lung nurse recalled junior doctors failing to consider mesothelioma as 
a cause of pleural effusion, 6.4.7, 6.4.11. Delayed referrals and long distances 
for some patients to travel to thoracic surgery units were also seen as 
disadvantaging patients with mesothelioma, 6.4.3, 6.4.7. Non-pharmacological 
techniques to improve patients‟ control of their breathing have been shown to 
be effective (Bredin et al, 1999). However, this was not formally included in any 
of the professionals‟ roles and was acknowledged as a significant omission by 
three nurses who knew the literature, 6.4.8. 
 
Several reasons may explain the lack of attention to breathlessness due to 
causes other than effusions. Firstly, almost all patients with mesothelioma are 
short of breath and effusions are the most common factor and aspiration is an 
effective and immediate treatment; possibly less acutely breathless patients 
may be managed at home and therefore not brought to the attention of hospital 
staff. Secondly, there may be no useful medical intervention for breathlessness 
due to trapped lung or lung invasion (if the patient is not fit for surgery). Thirdly, 
although severe breathlessness is just as visible as severe pain, it is possible 
that there may lower expectation that it can be relieved. In contrast, in a national 
survey of patients, carers and healthcare professionals concerning lung cancer, 
breathlessness was seen as the most challenging aspect of disease 
management by GPs. This should be seen in the context of knowledge that pain 
is less common in lung cancer than in mesothelioma (Nowak et al, 2004; 
Krishnasamy and Wilkie, 1999:53).  
 
Healthcare professionals reflected that some colleagues had inadequate 
knowledge of mesothelioma and suggested that this was due to the relative 
rarity of mesothelioma. A Macmillan nurse recalled junior doctors who appeared 
to have no understanding of mesothelioma and in one case had thought it was 
a complication of chronic lung disease related to smoking, 6.2.7. From her 
previous experience as a lung cancer nurse specialist, this respondent also 
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reflected that specialists outside the respiratory team were uncertain how best 
to manage patients with mesothelioma and so they readily referred them to the 
respiratory physicians. This contrasts with the low level of referrals to palliative 
medicine found in the medical records survey, Chapter 3, p119, and concurs 
with the healthcare professionals‟ reports that they did not experience any 
systematic involvement of the specialist palliative care team by the respiratory 
or oncology specialists, even when a full palliative care service was available. 
This reflects similar issues concerning low referral rates of all cancer patients, 
and specifically lung cancer patients, to palliative care services, in spite of the 
acknowledged benefits to patients (Hearn and Higginson, 1998; Krishnasamy 
and Wilkie, 1999; Muers et al, 1993; Hawley et al, 2004). Negative attitudes of 
other doctors to the relatively new speciality of palliative medicine may 
contribute to low referrals as well as lack of understanding of when and why to 
refer (Hanratty et al, 2006). There may also be issues around the doctor-patient 
relationship that inhibit referral to another specialist, particularly if several 
specialist teams are already involved, for example, respiratory medicine, 
oncology, radiotherapy and thoracic surgery (Smith et al, 1999; and Table 3.20, 
p118) 
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Box 6.4: Palliative care 
 
1.  „So you're immediately into a palliative care situation, immediately you're saying 
 "Well, OK, we can't cure it but let's see what we can do about the symptoms, you 
shouldn't have to suffer" and then you've got to try and deliver that.‟ GP  
 
2. „… pain can sometimes be a real problem and we sometimes see really challenging 
 situations, infiltration into the spinal cord and paraplegia and all sorts of other things 
can arise so they do have a lot of specific palliative needs…‟ Respiratory physician  
 
3. „…in my experience, I think pain is the biggest, major symptom, and breathlessness  
is usually associated with pleural effusions… they're drained, and then patients can 
return to an adequate… we do talc pleurodesis on the ward, but to be honest they're 
often not that successful… usually they present back with them, and then they'll go for 
surgical pleurodesis…the main issue is the pain…‟ Respiratory ward sister 
 
4. „…they often present with chronic pain problems, neuropathic pain, not well…The  
patients often have got so many different symptoms, pleural effusions, neuropathic pain, 
weight loss, general fatigue, malaise…Some deteriorate within weeks while they're 
having investigations, you've got to act very quickly.‟ Lung cancer clinical nurse 
specialist 
 
5. „It was largely the mesothelioma patients that started my interest in ketamine, and I  
found that generally quite useful for the more chronic sort of wind up, complicated 
pains that were perhaps only partly opiate-sensitive… there would be a chronicity to 
it… you've got stromal constriction, you've got pleural involvement, you've possibly got 
invasion of ribs and intercostal structures… there might be four or five components to 
it. I guess that then became my main technique…using ketamine to an adjunct  to all the 
other things...I‟ll try anything…‟ Palliative medicine consultant 
 
6. „They tend to give MST and not look at the other types of pain…neuropathic 
 pain…pain management is a problem at times.‟  Macmillan nurse 
 
7. „I don‟t think they (effusions) are always managed effectively…I think people tend  
to do an aspiration and wait for the results to come back…meanwhile the fluid‟s 
building up again, sometimes they‟ve had 2 or 3 aspirations already…‟ Macmillan 
nurse 
 
8. „…patients are often put on a nebuliser, but they're not effective with 
 mesothelioma…We don't as such do breathing control… when patients are feeling 
breathless we can massage their back and just try and slow things down a bit and relax 
them.‟ Respiratory ward sister 
 
9. „…particularly when it comes to symptom control, underprescribing is a major 
 problem…they need hospice contact and advice… from pain control specialists 
really….‟ Thoracic surgeon 
 
10. „… district nurses are brilliant - they're very pressurised but… they don't do  
specialist palliative care…these patients have very unique and difficult problems, 
they're quite complex …you might solve one problem and cause another with drugs… so 
you've really got to know how to use…a combination of drugs, you just can't go in 
upping morphine all the time, that's not going to get rid of the pain.‟ Lung cancer nurse 
specialist 
 
11. …they don‟t realise it‟s a malignant disease… nurses, junior doctors… didn‟t  
understand [this lady] had cancer…they said…„Yeah, it‟s to do with her COPD‟ 
Macmillan nurse 
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6.6. Talking to patients 
 
Explaining diagnosis and treatments 
Two areas were reported as causing much concern with regard to 
communications with patients: firstly, disclosing the diagnosis, and secondly, 
explaining the limited treatment options. Doctors responsible for delivering the 
„bad news‟ of a diagnosis of mesothelioma all acknowledged that they found 
this difficult. They explained that the difficulty centred on the hopelessness of 
the message: the fatal nature of the disease and the lack of effective 
treatments, 6.5.1. At the same time as the patients were told that they had 
mesothelioma, most doctors also informed them that it was an occupational 
lung disease entitling them to related Industrial Disease benefits and civil 
compensation (described in 6.8), 6.5.2.  All the nurses who were interviewed 
saw interpretation and explanation of the information given to patients by 
doctors as a vital part of their role. Nurses recalled that, in many cases, they 
saw patients immediately after doctors had disclosed the diagnosis, and that 
they had more time to give further explanations of the disease and any 
treatment options. For example, nurses reported that they provided booklets 
about the illness, 6.5.2, 6.5.6. Doctors and nurses appeared to agree with this 
division of tasks, although two nurses recalled that they sometimes felt 
compromised because they felt they had less in-depth knowledge than the 
doctors, 6.5.2, 6.5.3.  The role of the nurse as key informant and advocate for 
individual patients was emphasised by the lung cancer nurse specialist, 
respiratory ward sister and the helpline nurse, 6.5.3, 6.5.4.   
 
Concerns about communicating the treatment options to patients and their 
families, particularly in the absence of clear treatment guidelines, were 
expressed by both doctors and nurses but some of the key issues perceived by 
each group were different. As described in the earlier section on treatments and 
trials, doctors reported dilemmas in trying to advise patients whether or not to 
accept palliative chemotherapy. Many were concerned about the opportunity 
costs for patients with a short time to live and the poor results of trials to date. In 
some cases this was against a background of support for clinical trials as the 
only way in which future patients might be helped. The oncologist and the 
‟…it's the lack of explanation that most people…suffered from.‟  Helpline nurse 
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helpline nurse both expressed the belief that patients should be encouraged to 
participate in trials. However the nurse qualified her response by stressing that 
ultimately it should be the decision of a fully-informed patient. There was some 
criticism of doctors by nurses. This related to the selective or limited detail of 
information that doctors apparently gave to patients, particularly with regard to 
treatment options, which left the nurses in the potentially difficult position of 
trying to expand on the situation without seeming to contradict the doctors, 
6.5.4, 6.5.5.  
 
Two nurses reported that some patients were in shock or very ill at the time of 
diagnosis and could not absorb any more information, 6.5.3, 6.5.4. Three nurses 
expressed disquiet about the information that was given to patients by doctors 
concerning chemotherapy trials, 6.5.4, 6.5.5. The nurses‟ comments suggest 
that incomplete information was sometimes given, in other cases the patients 
did not understand the details and needed more time with senior doctors, 6.5.3, 
6.5.4, 6.5.5. The nurses proposed differing explanations for inadequate 
information being provided: that oncologists may have a vested interest in 
recruitment to trials, or that other doctors who feel that trials have little to offer 
patients may be uncomfortable about raising the issue. In the absence of any 
offer of other treatment options, including palliative care, one nurse suggested 
that patients decide on the basis of „willing to try anything’, 6.5.4. The helpline 
nurse‟s comments suggest that she perceived some doctors as having a 
paternalistic or possibly patronising approach to patients, 6.5.5. All the nurses 
interviewed appeared to accept assisting patients with decision-making around 
clinical trials as part of their advocacy role. Although great responsibility was 
placed on specialist nurses in following on from the doctor and giving further 
explanations and advice, it appeared that some nurses had criticisms of 
doctors‟ communication with the patient but were unable or unwilling to raise 
this with the doctors concerned, 6.5.4, 6.5.5. Comments by the GP and 
palliative medicine consultant, included in Box 6.3 on the section concerning 
treatments and trials, illustrate their awareness of the influence of doctors and 
relatives on patients‟ decisions about chemotherapy and the tendency of 
vulnerable patients to „clutch at straws‟, 6.3.8, 6.3.9, 6.3.10.   
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Box 6.5: Talking to patients 
 
1. „…often my responsibility is the breaking of the diagnosis for a condition for which  
there is generally no particularly effective treatment, and with the added complication that 
this is something that is caused by their work and so there's quite a lot of psychological 
activity…I will often see the patient with a relative and that can be quite interesting…the 
relative often has a lot of needs as well…They're generally encouraged to bring somebody 
along when they're getting the news, and we will also give them the opportunity if they 
haven't done that, to come back again with a relative… some patients won't want anyone 
else and we would obviously respect that.‟ Respiratory physician 
 
„…we do involve the lung nurse, often at the first visit…the nurses are introduced early on 
in the process, and certainly at the time of diagnosis we would like to have one of the lung 
nurses present, that's very appropriate…The lung nurses have got a lot of the 
literature…some very good booklets about asbestos-related disease…it is obviously an 
important part of my job to say  "Look, this is an occupational lung disease and this is the 
diagnosis and these are the important priorities" - the notification of the DSS, the pursuit of 
civil compensation as well.‟ Respiratory physician 
 
2. I find that I like to be there when a patient is told a diagnosis, and you do find that once 
 the medic's gone they have questions, it's a shock, isn't it? And I answer what I can, but 
obviously I can't go as deep as a medic.‟ Respiratory ward sister 
 
3. „Sometimes we try and explain to patients that it's not really going to make a significant 
 difference to their lives, we may be talking a few weeks for certain treatments, and that 
sometimes makes them take stock…They often are told that immunosuppression is a risk, 
that they could die, that they're going to lose their hair, it's going to make them feel ill, etc, 
and they are often not given an alternative, and if that wasn't offered, what would happen 
and what they would experience, and if they didn't have active treatment now, what would 
be available for them in the future, could they come back and decide to have treatment in 6 
or 8 weeks time or 3 months?‟ 
HC: So you are saying those alternatives are not spelt out? 
„No, not in direct terms whatsoever. Only if a patient asks, or a family ask directly, is it spelt 
out and the same with their prognosis.‟ 
HC: „It sounds as if there needs to be someone interpreting the situation for patients. Is that 
something you would agree with?‟ 
„… the doctors try not talking jargon now, try and talk in simple terms…that concept is very 
difficult for the patients to understand, the greater picture of what's going to happen. They 
don't know what's ahead of them…or they may have seen some work friends die of 
mesothelioma, and so they take what's on offer… We should be doing follow-up phone calls, 
ringing them and saying "How are you? We're around if you need us" and try and see them 
again to explain what the doctors have said and give them their options afterwards…very 
much a big part of our role.‟ Lung cancer nurse specialist 
 
4. „ the doctors here tend to, kind of, mention it [ clinical trials] quickly, then carry on 
 About something else because they know that, more often than not, it‟s not going to help, 
but I think they should all be given that choice…some patients, no matter how poorly, want 
to go down that route but they need guidance and support and information….‟ Macmillan 
nurse 
 
5. „… it's the lack of explanation that most people that rang …suffered from… they should 
 be told exactly what's available and… the truth about clinical trials and the results of the  
trials... what is possible and what's not, and left to choose for themselves. The majority are 
very intelligent people, they're quite capable of making the decision if they are given the 
right information, but they are often not. So giving good information I think is vital, and 
giving written information that they can go home and take with them.’ Helpline nurse 
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6.7. The Mesothelioma Information Service 
The helpline nurse84 described how she had become aware, while working as a 
Macmillan nurse, of the unmet information needs of mesothelioma patients, 
6.6.1. This had prompted her to obtain charitable funding from Macmillan 
Cancer Relief in order to set up the Mesothelioma Information Service85 in 
1998. This service provided a national telephone helpline for patients, carers 
and professionals. She told how this led her to produce an information booklet86 
and also to develop the Mesothelioma Nurses Network87 that aimed to educate 
and support nurses working with patients with mesothelioma. The Information 
service was valued as an educational resource; the helpline nurse reported 
frequent calls from nurses as well as patients, family members, solicitors, social 
workers, 6.6.2.  
 
The reasons for calls to the helpline reported by the helpline nurse reflected 
deficiencies that patients and carers perceived in the information given to them 
regarding basic details of the disease and the difficulties in establishing a 
diagnosis, 6.6.1. In some cases she reported a sense that patients and their 
families had lost confidence in their doctors due to poor communication 
resulting in little understanding of the disease, treatment options and symptom 
control services, 6.6.1. The dissimilar types of information requested by differing 
groups of callers were described by the helpline nurse: patients wanted her to 
advise on their prognosis, main carers wanted to know about treatment options 
and how patients were likely to die, whereas younger relatives were often 
asking for clarification of information obtained from the Internet as well as 
prognosis, 6.6.3-6.6.6. Carers‟ and other family members‟ queries also related 
to needing to know about managing the disease and some idea of time frame 
so that they could try to plan ahead. Some carers reportedly used the helpline 
when they had experienced difficulty in obtaining information from the patients‟ 
doctors.  
 
                                                 
84
 Inevitably, confidentiality cannot be maintained  here. Explicit written consent to include this section 
and quotes was obtained from the helpline nurse concerned. 
85
 The Mesothelioma Information Service was originally run from Leeds, Yorkshire. It has now moved to 
the Macmillan-funded Mesothelioma National Resource Centre in Leicester and has been absorbed into 
the newer national charity, Mesothelioma UK, set up in 2004 
86
 10,000 copies were printed in 2003 
87
 The Mesothelioma Nurses Network, set up by the helpline nurse, held regional and national educational 
meetings to inform nurses about clinical, financial and medico-legal aspects concerning mesothelioma. 
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The helpline nurse reported that that she kept up-to-date concerning travel 
insurance in order to help patients take a final holiday with their families. The 
helpline was also a useful resource for professionals: nurses called the helpline 
to request information about mesothelioma both in the form of booklets but also 
clinical advice concerning symptom control and technical issues such as 
managing chest drains, 6.6.2. Solicitors and social workers also contacted the 
helpline, often to clarify details of the disease or treatments. The helpline also 
provided a focus for some relatives bereaved due to mesothelioma: some rang 
to speak to the nurse who they had got to know during the patient‟s illness, 
others needed to talk to someone who understood their experiences. 
 
The calls to the helpline illustrate apparently major unmet needs with regard to 
the provision of information for patients and their family carers concerning this 
terminal illness as provided by statutory services. The calls also highlighted the 
differing information needs of patients and carers as also described in Chapter 
5, Focus Groups with bereaved relatives. 
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Box 6.6: The Mesothelioma Information Service: Quotes from the helpline nurse 
 
1. „A huge number didn't even understand anything about the disease…They couldn't 
understand the delay in diagnosis, this came very clearly….why it takes so many 
investigations, so many X rays, so many biopsies, etc. So quite a few were quite 
disillusioned with the medical profession because they thought…they'd ring up to ask if 
they should get a 2nd opinion because they were dealing with somebody who was 
obviously incompetent, that couldn't make a diagnosis. And that was partly the lack of 
explanation about the disease….as to why all these things were happening, and 
describing to them the actual disease and how it worked, how it affected the outside of 
the lung…and it wasn't a big ball…that's how people imagine cancer, and that it didn't 
show on a straightforward X ray… Some were in great distress because they'd got 
somebody they loved in terrible pain and they weren't getting the services they needed… 
but that was not as common as the wanting to understand what was going to happen.‟  
 
2. „The biggest number of calls were from carers, the second biggest number… were from 
patients, and the third biggest number of calls were from relatives such as sons and 
daughters…the professional calls, most of those were from nurses wanting more 
information about mesothelioma, wanting booklets… things about pain control, 
symptom control…chest drains, which are quite a problem for some of the 
mesothelioma patients…other professionals as well – social workers, solicitor…we used 
to get quite a lot of bereavement calls‟ 
 
3.  The carers‟ questions were"How is he going to die?"… a common question. I think 
they'd tried asking the doctors and they'd been brushed off, and sometimes it was done 
very badly…they'd been: "We don't have to communicate with the carer" …some of the 
carers felt that there should be a situation where the carers could speak to the 
consultants in a private capacity, because they were the ones having to cope…and 
finding it very difficult.‟  
 
4. „The patients were often far more straightforward than the carers and would ask "When 
am I going to die?" not necessarily how, they wanted to know when? How long had they 
got? And some had asked the doctors and been fobbed off with all kinds of rubbish 
really, sometimes quite awful things like "Oh you've got years" (laughing). It was just 
awful really… because I hadn't access to their medical records, I could only guess how 
it would be for them, and I tended to ask them a few questions about how they were, was 
their appetite good, was their weight stable, etc, their energy levels…and from that 
make some guess as to whether they'd got an aggressive form or whether they were 
going along quite nicely, and kind of give them a range of time…that was usually 
quite acceptable…because they'd had an explanation that it was quite different 
from person to person and that the cell type governed how long they might have, 
and it was just somebody talking to them about that really, not actually telling 
them how long they'd got, quite different to the question they were actually 
asking, which was "How long have I got?‟‟  
 
5. „Daughters and sons…they'd usually be on the Internet (laughing) because they tended 
to be  younger…their questions were often about chemotherapy, treatments, should they 
go to America...their calls were slightly different…things like "I'd planned to get 
married in January, should I bring it forward?" 
 
6. „..things like travel insurance – a virtual impossibility to get at a reasonable cost, and a 
lot of these people, because they knew they were dying and their time was limited, 
wanted to take a holiday and they'd been quoted phenomenal fees. So I actually 
produced a sort of insurance thing, I'm still getting calls about travel insurance. £4000 
being quoted for a fortnight's holiday in Europe! It's just a way of saying "We don't 
want to insure you"  
 228 
6.8. Explaining state benefits and civil compensation 
In addition to information about the disease, interviewees recalled that patients 
and their relatives also needed accurate information regarding benefits and 
compensation. However there was disagreement about when was the best time 
to inform patients that mesothelioma, as a prescribed industrial disease, entitles 
patients with industrial asbestos exposure to state benefits and civil 
compensation. Three nurses, the Macmillan nurse, the specialist lung cancer 
nurse and the respiratory ward sister, reported the view that it was inappropriate 
to mention benefit and compensation claims at the same time as disclosing the 
diagnosis. One nurse recalled that patients who had just received shocking 
news of their fatal illness were not able to absorb additional complex information 
regarding benefits and compensation during the same consultation, 6.7.1, 6.7.2. 
However one physician reported an alternative view: he felt that on some 
occasions, knowing about the potential financial claims gave relatives the task 
of obtaining due financial benefit and that in some cases this may have helped 
to deflect relatives‟ anger. 
 
The complexity of both the state benefit system and the civil compensation 
process was emphasised by several nurses who were often put in the position 
of being the people to whom patients turned to for advice. Although the nurses 
were in general agreement that they should not function as benefits or legal 
advisors, and this was apparently confirmed by their managers, they reported 
that it was essential that they understood the details of the claims processes in 
order to assist patients to obtain their correct financial entitlements, 6.7.2. The 
helpline nurse described that she had taken on the responsibility for educating 
nurses via the Mesothelioma Nurses network about these issues because they 
mattered a great deal to patients and their families. The Macmillan nurse also 
noted the burden of financial matters on patients and their families, 6.7.3, 6.7.4, 
6.7.5. Doctors‟ lack of detailed knowledge of the criteria for civil compensation 
on the basis of occupational disease was also highlighted by the helpline nurse. 
She reported that incorrect advice to claim compensation was sometimes given 
by consultants to patients. For example, in giving incorrect advice to pursue a 
claim in cases when there had been no history of industrial exposure to 
asbestos, 6.7.2. Patients‟ motives for claiming compensation were described by 
the helpline nurse as relating to retribution rather than financial gain, 6.7.6.  
Contrastingly, the GP recalled how some solicitors were actively recruiting 
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clients from sessions they held in his area in working men‟s clubs and referred 
(in all seriousness) to this as being ‘good for [the solicitors‟] business’   6.7.7 
 
 
Box 6.7: Explaining state benefits and civil compensation 
 
1.  „…straight away almost , pretty soon after diagnosis, they're given information about 
 pursuing claims and things…And I find I really don't know what to say to them, because part of 
me feels that yes, I know they need to know about this but they've just been told, you know, some 
devastating news, and as nurses we kind of want to look after them … you feel as if they are 
being told "Ah well, you've got that but you can make a claim" you know, it just doesn't 
compensate, does it? And I do find that, as a nurse, hard, following diagnosis.‟ Respiratory 
ward sister 
 
2.  „As a nurse I was quite firmly told "You do not give legal advice" …but I need to know if 
 the patient has been given the correct legal advice, so you've got to know a certain amount 
about the law…it is very complicated. So… I suggest to people that they should see a specialist 
solicitor if I can obviously identify that they have had occupational exposure, and they should 
be aware they may have a legal case. Often they're given the wrong legal advice by the 
consultants, in actual fact. I get a lot of patients who are told "You've got mesothelioma, this is 
a compensatable disease" and then you find that the patient has absolutely no history of 
asbestos exposure at all, and they haven't got a compensatable disease…you have to use your 
common sense…the other difficult issue is about benefits, because we're not benefits advisors 
either, but if the specialist nurses don't key people into other services then they don't know... 
again it‟s complicated for the mesothelioma patients because they are entitled to industrial 
benefits if they've been exposed in their occupation, so a lot of my teaching to the nursing 
teams…was about those issues that they didn't know anything about – the legal position and the 
financial position…I mean the patients can also claim a government grant if the firms are out of 
business…if they didn't know about that it could actually cost thousands, it's absolutely vital 
that they know.’ Helpline nurse 
 
3. „The [ Mesothelioma Network] nurses came up, had a full study day with me and I 
 imparted every bit of information I possibly could to them…I devised a resource file which they 
took away with them, so if they got questions that they couldn't answer they'd find the answer in 
the file, because a lot of the queries are outside the normal nursing knowledge…about…benefits 
and compensation, the legal issues, and the nurses needed to know enough to know how to 
guide the patient to the next step.‟ Helpline nurse who started the Mesothelioma Nurses 
Network 
 
4. „…a lot of them come from… a very low socio-economic group and to just get them £50 a 
 week makes a big difference to their health.‟ Lung cancer clinical nurse specialist 
 
5. „the big thing is obviously the financial side of things which obviously causes a lot of 
 stress.‟ Macmillan nurse 
 
6. „There was a lot of anger about it, a lot of feeling of injustice, I think, that affected their 
 mental…the way they coped with it, and a lot, they didn't go for compensation claims because 
they wanted the money, it was like a way of saying "Somebody's got to pay for this" you know, 
the motives behind it were not greed or anything.‟ Helpline nurse 
 
7. „Well I think the legal advice is there, I think economically speaking for the solicitors it's 
 Good business and there are some regular little clinics they set up in working mens' clubs and 
things, where people can contact them for advice.‟ GP 
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6.9. Involvement with family carers  
 
 
6.9.1 Care of family members during the patients‟ illness 
 
Carer support appeared to be seen as primarily the responsibility of nursing 
staff, particularly Macmillan and district nurses. As mentioned in the previous 
section, nurses appeared to be responsible for expanding on information about 
the disease, state benefits and civil compensation, as well as arranging 
practical support, and liasing with other professionals and agencies as 
necessary. In most cases this was done with the involvement of family 
members. Hospital doctors all offered patients the opportunity of being 
accompanied by a relative, particularly when diagnosis was disclosed. However 
their involvement with relatives at other times seemed to depend on relatives‟ 
requests: no one reported any systematic approach to addressing relatives‟ 
needs or any acknowledgement that hospital doctors had any responsibility 
towards patients‟ relatives.   
 
However, in GP, community and hospice settings, the relatives seemed to be 
automatically included in consultations with patients from the outset. The GP 
recalled that he usually knew the patient‟s family and ward and community 
nursing staff reported that they actively engaged with patients‟ families. 
Community nursing staff reported that they usually visited patients at home with 
the exception of the nurse-led palliative care service in one location which ran 
an outpatients clinic88. Anger and anxiety were reported as common reactions in 
relatives (as well as in some patients) but no specific measures to address this 
were reported, 6.8.1. The need for family carers to have information that 
enabled them to plan ahead was described by the helpline nurse and that 
practical advice was also requested. A particular anxiety for relatives concerned 
the expected mode of death and the reports from nurses demonstrated that 
relatives turned to nurses to answer these queries. The helpline nurse recalled 
that she signposted carers to other agencies that could assist them and 
informed carers of their own entitlements although she recalled that many 
                                                 
88
 Described later in the section on service issues, p239. 
„…they wanted to be one step ahead‟   Helpline nurse 
 231 
carers were too busy looking after the patients to take their own needs into 
consideration, 6.8.2, 6.8.3.  
  
It appeared that no one had the responsibility for making sure that relatives 
know about the post mortem and inquest before the patient dies: an unresolved 
situation regarding informing relatives about the coroners procedure was 
reported by several professionals, 6.8.5 – 6.8.7. Several professionals recalled 
relatives being distressed when told about these procedures immediately after 
the patient had died. The general view reported was that relatives should know 
beforehand (Human, 2002). In one area, as described by a Macmillan nurse 
and palliative medicine consultant, a system to ensure this matter was 
addressed had been introduced. In other cases, particularly with the other 
hospital consultants, the issue appeared not to have occurred to them as being 
their responsibility, whereas the GP felt that most families in his area would 
already be aware of the coroners investigation from legal advisors and therefore 
did not specifically ensure this was understood in each case prior to the death 
of the patient, 6.8.8. Both the helpline nurse, through the Mesothelioma Nurses 
Network as reported earlier, 6.7.2, 6.7.3, and the lung cancer specialist nurse, 
6.8.7, reported that they regarded educating nursing colleagues about these 
issues as part of their professional roles. 
 
Undoubtedly support for carers was seen as the responsibility of nurses. The 
doctors‟ role was limited to seeing relatives when they accompanied the 
patients. In most instances, relatives appear to have been seen as secondary to 
the patients during the patient‟s illness. This illustrates the disease focus of 
health services and yet, if patients are going to be cared for at home as much 
as possible and to achieve their wish to die at home, carers‟ issues must be 
understood (Smith, 2001:83-99; Hinton, 1994).The complex responsibilities that 
the carers‟ role entails are well-reported (Payne and Ellis-Hill, 2001) but health 
policy has only recognised this in recent years (Carers (Recognition and 
Services) Act 1995). 
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Box 6.8: Care of family members during the patient‟s illness 
 
1. „And because diagnosis takes longer and investigations take longer, there can often 
 be a lot of anxiety and anger that comes from the relatives, not the patient.‟ Respiratory 
ward sister  
 
2. „So how people would actually die, the process of how it was going to be was quite an 
 issue with the carers, they wanted to be one step ahead…to be able to plan mentally for 
the next thing they were going to have to face…and they wanted to know how that 
progress was going to affect the life of the patient, so we had quite commonly discussions 
about how you could be one step ahead at home…how to make sure you've got a good 
handrail on the staircase…simple things that would make life manageable…for the carers 
that was a big thing.‟ Helpline nurse 
 
3. „…the relatives, you know often they will ask you how their loved one is going to die,  
because they've not seen people dying before… and they are quite frightened by that. And 
to just explain to them that someone is going to go to sleep more and be quite 
comfortable, and very few people have a horrendous death, gives them comfort as well...‟ 
Lung cancer nurse specialist 
 
4. „Exceptionally if relatives have got unfinished business that they need… they will 
 sometimes make an appointment and I have seen bereaved relatives of mesothelioma…‟ 
Respiratory physician 
 
5. HC: ‘Can I also ask you about informing the relatives and the patient about the 
 Coroner‟s investigation after death – is that part of the routine?‟  
„It's not, actually. It is a bit tricky isn't it?‟ Respiratory physician  
 
6. HC: ‘What about informing relatives in advance about the medico-legal procedures 
 after death?‟ 
„Well we tried to do that and explain to them, but actually I think by the time they came to 
us their knowledge of the situation was generally fairly good… but that would have been 
part of our management, to make sure that that happened.‟ Palliative medicine consultant 
 
7. „I try to take the families by and tell them that it will be a notifiable disease, even 
 though we haven't got histological diagnosis, that it will go to Coroner's court. That's a 
terrible time for the family, they want to have that saying goodbye, and have that ritual of 
the funeral. Also that they will take specimens... I don't tend to go into the details of what 
will happen at an autopsy unless I am really pushed, because to describe that graphically 
to someone can be very upsetting to them. But I always try and prepare them- they are not 
going to get the death certificate, they can't register the death, and try and guide them 
through that, and I try to go in, usually as soon as the death has occurred… but funeral 
directors are usually brilliant with them as well. 
HC: „Is that job left to you then, to inform the families generally?‟ 
„I've not known of a doctor go through it and I don't know how many nurses do…and if 
I'm teaching other nurses, to go through the legality issues with them and explain that 
relatives often just want to know the obvious.‟ Lung cancer nurse specialist  
 
8. „…usually sufferers from mesothelioma have had legal advice beforehand so 
 the relatives are prepared for what's going to happen.‟ GP 
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6.9.2 Care of family members in bereavement 
Bereavement following mesothelioma was perceived by several professionals 
as complex: they recalled that many relatives were angry and that the grieving 
process was often hindered by the inquest and ongoing civil compensation 
claims, 6.9.1.  Interviewees recalled that the anger evident in relatives may 
have been obvious throughout the illness or in some only became apparent 
after the patient had died.  The GP recalled bereaved relatives as being 
„haunted‟ by distressing memories of uncontrolled pain, 6.9.2. As mentioned in 
the previous section, all the palliative care or nursing professionals were in 
agreement that relatives should be prepared for the coroner‟s medico-legal 
investigation before the patient died. Several respondents recalled the distress 
caused to relatives when they had not been forewarned. The post mortem and 
inquest were perceived as having a negative impact on funeral and grieving 
rituals; in particular, some relatives had to endure many months delay awaiting 
an inquest. There appeared to be no single routine regarding the care of 
bereaved relatives. Macmillan nurses generally visited relatives after the death 
of the patient, while the GP reported that he waited for the relatives to call on 
his services rather than visit routinely. Hospital consultants did not see 
bereavement support as part of their role and reported that they rarely saw 
relatives after the patient had died unless there was some major unresolved 
issue. Hospital systems for dealing with the death certificate were reported to 
tend to prevent bereaved relatives from visiting the ward where the patient had 
been cared for and so further contact with hospital nursing staff was unlikely, 
6.9.2, 6.9.3. 
 
Macmillan nurses regarded their role as including bereavement risk 
assessment. This involved identification of relatives that would need particular 
support in bereavement and referral to specialist services appropriately. 
Although in some cases the Macmillan nurse used a bereavement risk 
assessment tool this was not routine and did not appear to be considered by the 
other professionals, 6.9.4. Two of the interviewees, the palliative medicine 
consultant and the lung cancer nurse specialist, working in the same area, 
described having access to a coordinated, partly NHS-funded bereavement 
service, 6.9.4, 6.9.5. In most cases interviewees described a range of charitable 
services that varied in scope and scale; several healthcare professionals 
commented that bereavement services were underdeveloped. Two interviewees 
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mentioned that asbestos disease support groups may help in bereavement, for 
example, by involving bereaved relatives in campaigning activities. 
 
Primary care support for carers after the death of the patient appeared to be 
equally uncoordinated: the GP saw people who presented to him, and, although 
the Macmillan nurses reported that she usually visited the bereaved relative for 
a variable time after the death, there was no consensus among those 
interviewed regarding the provision of support for bereaved relatives. Similarly, 
across the three sites, the provision of formal bereavement services was 
variable and depended on both charitable and NHS providers. This reflects the 
controversy about the place of bereavement support with respect to health care: 
on one hand bereavement is regarded as a natural process and therefore 
should not be „medicalised‟, on the other hand, people who are undoubtedly 
suffering from severe or abnormal grief reactions need access to a professional 
service. 
 
Many of the issues raised in this section have been addressed in the recent 
publication: ‘When a patient dies: Advice on developing bereavement services 
in the NHS’ (Dept of Health, 2005). This document advises that all hospital 
Trusts should develop systems aimed at supporting relatives of patient and has 
been developed following recommendations of two public enquiries89. The 
document sets out best practice guidance and includes core principles, practical 
steps and examples of best practice for Trusts to follow. Specific issues relating 
to bereavement due to mesothelioma are raised in Chapter 7, Discussion, p295. 
 
 
 
 
 
 
 
 
 
 
                                                 
89
 The Alder Hey enquiry concerned the ‘body parts scandal’ (Burton and Wells, 2002) 
The Bristol enquiry related to excessive deaths of children undergoing cardiac surgery  (Bristol Royal 
Infirmary Inquiry, 2001). 
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Box 6.9: Care of family members in bereavement 
 
1. „For a lot of them, if they are taking legal action it's not completed by the time the 
patient dies, the action is still ongoing, so there is no…they can't close, it's still ongoing, 
they're still having to be involved in the litigation…The other part is… the post-mortem, 
the Coroner's inquest, everything delays their sort of bereavement process, and I think the 
anger is there…because they've lost their husbands, wives….And they don't grieve as 
straightforwardly, I don't think, and I think that's what prompts the calls, and I get quite a 
lot. Usually these sort have anger, want to be active, want to do something, either to help 
others or to help any of you that's doing research into it, or something, they want to get 
involved because of the anger that's still around, and I just think it delays the normal 
grieving process so they do tend to be around quite a while, it's not unusual to get calls 
quite a long way on, and to get things like donations, like I got this week from somebody 
whose husband actually died 3 years ago.‟ Helpline nurse  
 
2. „…we let them spend as much time as they like with the dead relatives, but once 
 they've left the ward they needn't then return if they don't want to. Some families find it 
difficult to come back. The relatives go to the bereavement office to get a death 
certificate…they can come to the ward to collect property‟ Respiratory ward sister  
 
3. HC: „Do you routinely see relatives afterwards?‟ 
„Yes, I mean…usually the widow will come and see me a few times afterwards and we'll 
just talk through things…what I would say, from the small experience I've got of this, is 
that it's sometimes very difficult to get people over having seen their husband in severe 
pain; that tends to haunt them afterwards, and that can be difficult.‟ GP 
 
4. HC: „Would you feel [the bereavement service] should be there as part of NHS 
 provision?‟ 
„I think so, but do you have a generic bereavement service that covers everybody or do the 
community Macs [Macmillan nurses] run a service for their patients, or do the hospice 
run it?… It's a very complex sort of thing… they'd amalgamated, I think, CRUSE* and…it 
was a coming together of several agencies, I think, under one roof…and that did seem to 
work well.‟ Palliative medicine consultant 
 
5. „We have a very good bereavement service… it's run by the Chaplain service as well 
 as trained bereavement counsellors…everybody who dies in the hospital will be met by a 
bereavement counsellor on the day they pick up the death certificate…if they are known to 
the Macmillan team who have worked with them we will do up to 6 bereavement visits and 
then pass on to the bereavement service. Anybody who dies at the hospice [the relatives] 
are invited to a bereavement group…that's not always appropriate for someone who's 
bereaved, they don't feel like going to a group and sharing those thoughts and feelings. 
Some are very depressed and just don't want that sort of contact, but they are also 
referring to bereavement.‟  …I try and screen for depression as well, and try and get them 
into the right services, and I realise that my role has to stop and move on, and I need to 
channel them into the right support really.‟  Lung cancer specialist nurse  
 
* CRUSE is a national bereavement charity  
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6.10. The emotional impact of caring for patients with 
mesothelioma 
 
Mesothelioma was reported by all the interviewees as affecting them 
emotionally. Many negative feelings were expressed illustrating the 
hopelessness of the situation.  In general, difficulties were perceived to be 
associated with mesothelioma because it is a rapidly fatal, preventable, highly 
symptomatic, untreatable disease. Doctors described how they felt impotent 
and despairing at having no effective treatments to offer, and being unable, in 
many cases, to achieve good control of symptoms. Dealing with the 
psychological suffering of patients and their families was also upsetting for the 
healthcare professionals. Many interviewees appeared to share the distress of 
patients and their families: their accounts illustrated that they became fond of 
many of the patients and their families and found watching the inevitable decline 
of the patient very upsetting, 6.10.4. Nurses in particular frequently developed 
close relationships with patients and their families over the course of the illness, 
6.10.1, 6.10.2.  
 
All the professionals referred to anger that was evident in this group of patients 
and/or their relatives. They perceived that this was particularly notable in 
mesothelioma compared to other illnesses, 6.10.3.  Managing their own 
emotions as well as trying to help patients and their families cope with their 
reactions was particularly an issue for the nurses who were likely to be closest 
to them, 6.10.5, 6.10.6.  One interviewee referred to his view that the risk-
accepting culture of some of the occupations involved possibly engendered a 
stoical response in patients and he contrasted this with the desperation and fury 
of relatives. All revealed their sympathy for distraught relatives who felt the need 
for blame and retribution and although it was reported as hard to bear when 
relatives‟ anger was directed at healthcare staff (see Box 5.7), this was 
sometimes linked to relatives‟ difficulties in accepting the lack of effective 
treatments, 6.10.5, as also described by bereaved relatives in the focus groups 
(Box 5.6). The healthcare professionals expressed their compassion and 
understanding of this situation. Some healthcare staff expressed their distress 
at having to watch the inevitable decline of patients; one physician revealed that 
he also felt angry on behalf of the patients, others were upset by the lack of 
evidence for best practice and system failures that disadvantaged this group of 
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patients; concern was also expressed about the future toll of asbestos-related 
disease and the situation in resource-poor countries where asbestos industries 
continue, 6.10.6, 6.10.7. 
 
The effect on healthcare professionals of caring for patients with mesothelioma 
has not been previously described. The data reported here reveal that 
professionals are distressed by the experience of dealing with people suffering 
from this avoidable fatal illness that causes much suffering and for which 
doctors have no effective treatments. In contrast to studies of other cancers, 
particularly lung cancer, in which the psychosocial needs of patients are said to 
be ignored or unrecognised, (Krishnasamy and Wilkie 1999:100-102), it was 
apparent in this study that the emotional, financial and medicolegal needs of 
patients with mesothelioma were considered from the time of diagnosis This is 
probably related to the need to proceed with civil compensation claims while 
patients are well enough to do so. It also relates to the need to establish 
causation for specific State benefits.  The consultant is invariably required to 
provide a formal medico-legal report in order to support litigation.  
 
It may be that the inability to offer any standard effective treatments in 
mesothelioma removes the „distraction‟ of concentrating on life-prolonging 
measures: patients, their relatives and healthcare professionals may then 
become united in helplessness. Although most of the patients in this study 
appeared to react to the illness with stoicism, (Box 4.9, p149), many of the 
professionals referred to the anger evident in patients‟ relatives. As a particular 
feature of mesothelioma, this must make emotional issues hard to ignore.  
Similarly, witnessing the inevitable decline of patients and feeling impotent may 
leave professionals vulnerable themselves as this undermines their professional 
role. In this situation it is possible that the doctor-patient relationship is based on 
the need for support rather than expectations of specialist treatment.  
 
The risk of burn out in professionals who deal primarily with patients who are 
dying is well known and, to some extent, the nursing profession has addressed 
this with adopting clinical supervision, but this is not a concept familiar to 
doctors. This raises the question of care for those professional carers who, from 
these data, are placed in a very demanding and distressing situation when 
looking after patients with mesothelioma and their families.  
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Box 6.10: The emotional impact of caring for people with mesothelioma on 
healthcare professionals 
 
1. „I think the main thing with mesothelioma, the real difference is that you get this 
 diagnosis, you get a sinking feeling when you see people with chronic pleuritic  chest 
pain who've worked with asbestos, and then they go up to the hospital and they just come 
out with no prospect of a cure.‟ GP 
 
2. „And then following up patients and watching their progress and watching them 
 coming to terms with their failing health, with at the same time all the other things going 
on, the legal cases, coming to terms with their situation, which they don't come to terms 
with very quickly because of the nature of the disease, it's a slow progression.‟ 
Respiratory physician 
 
3. "Why is this happening to me?" That happens in all diseases but I think they're more 
angry because they think "This shouldn't have happened to me, this is a preventable 
disease". Thoracic surgeon 
 
4. „One of the things that I think is a bit different is, I don't know how other people feel 
about this, but something you mentioned, the patients and family being angry, I think it 
makes me angry as well: if someone has something they've developed as a constitutional 
vulnerability then fair enough, but it does make you very angry, and I share that with 
[them]…so it is particularly troubling to deal with the carers for health care 
professionals…There's something about the dynamics of the disease as well, the slow 
progression with everyone knowing what's happening, and you get to know them and you 
see them gradually failing and deteriorating, it is very distressing.‟ Respiratory physician 
 
 
5. „I don't think the patients are particularly demanding on the nurses, but I find the 
 families are probably more so. They seem to have a lot more anxiety, probably anger as 
well, and sometimes that can be inflicted on the nurses, to be honest.‟  Respiratory ward 
sister 
 
6. „…Oh, I thought it was terrible. It was heartbreaking. Patients that would phone you 
 up and ask if they could come in, and in the past you'd be able to say "Yes, we've got a 
bed, come on down" you have to say "I'm really sorry, you've got to go to A & E" and it 
was awful. It took a lot of time to get your head round it, to be honest, because you just 
felt like you were turning patients away.‟ Respiratory ward sister upset that patients no 
longer had open access to her ward 
 
 
      7. „…But I also feel there's a political agenda here, that it is an occupational disease, it is 
      going to be increasing in the future years, the next decade, and even though there were 
      laws passed, was it adhered to Health and Safety regulations? They're still mining it and 
      using it in part of the… you know it's big business and they're there really to make the 
      voices of the people quieter, and I feel that we do them a great disservice, that they need a 
      lot of support and experienced specialist palliative care, these patients.‟ Lung cancer 
      clinical nurse specialist 
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6.11 Service provision 
 
6.11.1 Community care and mesothelioma 
 
 
Responsibilities for the care of patients when at home were reported as resting 
mainly with their GP, district nurse and Macmillan nurse, usually in liaison with 
hospital colleagues. The relationship between these professionals was reported 
to be crucial and specialist nurses described being aware of the sensitivities 
around professional roles and responsibilities although relationships were 
generally reported as good, 6.11.1, 6.11.2. The particular needs of patients with 
mesothelioma were also illustrated by the GP who reported that, although not 
critical of out-of-hours services, he nevertheless gave his patients with 
mesothelioma his home telephone number so that they could call on him at any 
time. However this GP also reflected that, with the development of specialist 
palliative care and hospice services, his role in caring for patients with 
mesothelioma had been diminished. He qualified this by conceding that he had 
neither the time nor the resources to provide the same degree of care himself, 
6.11.3.    In one unusual case, the patient was supported throughout the course 
of his illness by a lung cancer nurse specialist working for a combined Trust90. 
 
Several interviewees expressed the opinion that patients with mesothelioma 
need specialist care in the community due to the complexity of their symptoms. 
The need for additional resources for community nursing and palliative medicine  
specialists was reported by three interviewees, 6.11.4. In one area where there 
was a vacant post for a consultant in palliative medicine, a clinical nurse 
specialist described an innovative nurse-led hospital-based palliative care clinic 
to which patients and families could self-refer. The nurse recalled with some 
pride that this model had been so effective in fast-tracking symptomatic patients 
to clinics that she hoped it would be extended to other areas, including the 
community, 6.11.4. She reported that this development was due to her 
employment by a combined Trust which had also improved communication 
across boundaries and allowed her to keep track of patients more efficiently. 
The need to be proactive in caring for patients with mesothelioma, because they 
                                                 
90
 A combined trust is an amalgamation of a Primary Care Trust with a Hospitals Trust. 
„…so you're immediately into a palliative care situation…‟  GP 
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may deteriorate very quickly, but tend to be undemanding of services, was also 
emphasised by the clinical nurse specialist, 6.11.4, 6.11.5. 
 
Additional issues concerning lack of equity of community service provision, 
particularly affecting rural areas or those distant from a regional cancer centre 
were recalled by two interviewees. Inconsistent services in different area were 
also highlighted: district nursing was not universally available 24 hours a day, 
and hospices services varied too, 6.11.6. The importance of siting services 
appropriately was raised by three interviewees. The need for patients to be 
cared for in a specialist setting was raised by the consultant in palliative 
medicine: he needed to admit patients to a hospice when complex drug regimes 
were to be introduced. The lung cancer nurse specialist reflected on the lack of 
local and community-based services. The practical difficulties for very 
breathless patients in trying to attend clinics was raised by the Macmillan nurse 
who was wondering if a community- or home-based breathlessness service 
might be more practical than one held in a hospital, 6.11.4- 6.11.7. 
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 Box 6.11: Community care in mesothelioma 
 
1. „So you're immediately into a palliative care situation…saying "Well, OK,  we can't  
cure it but let's see what we can do about the symptoms, you shouldn't have to suffer" and 
then you've got to try and deliver that.‟ GP 
 
2. HC: „And how strong or weak are your links with actual GPs?‟ 
„Very very strong… I know which ones to pick up the phone to, which ones I need to go 
and see personally…But that's taken a few years to build those relationships and trust up, 
and it's basically the person in the post going and seeing them, explaining the role.‟  Lung 
cancer specialist nurse 
 
3. „I think we're quite lucky in this area… really well blessed with good back up from the 
hospital, but I think palliative care, the hospice, the [consultant in palliative medicine’s] 
and the oncologists work fantastically with [the specialist palliative care] team…I was a 
Trainee in North Wales…we had a Cottage Hospital there…we did all our own palliative 
care, there was very little Hospice use… as a GP, it's quite a rewarding thing to do, 
palliative care, and to a certain extent it's taken out of our hands by the hospice. But my 
experience of the Hospice is that it does a far better job than I could ever do, I just don't 
have the time or the resources to do what they do…‟ GP 
 
3. „We run a nurse-led clinic…patients can refer themselves in…if there's a problem 
 we've got a thoracic surgeon, an oncologist, and a general chest physician to see them 
and we get them admitted, and we do letters to the GP…that has stopped patients having 
problems getting clinic appointments if they feel ill…families can come to clinic and it has 
been extremely popular. Now we're trying to move that model out so we get it at the local 
district generals, and maybe into community as well, and get the palliative care team in.‟ 
Lung cancer nurse specialist 
 
4. „…sometimes I will say to patients in clinic "I will ring you" or "I can come out and 
 see you"…I have had patients who said "I felt so wretched I couldn't pick up the phone to 
ring and ask for you to see me" So that made us think of working in a different way.‟ Lung 
cancer nurse specialist 
 
5. „…the majority of  these patients spend 90% of their time at home, so we should have 
 the services out there…we need more community focus… There's a palliative care/pain 
clinic at [another] hospital but it's difficult to ask somebody with pain to travel 50 miles 
round trip …they need to go for the local services, and those services can't be provided at 
the moment in community. Some hospices don't even do blood transfusions so you have to 
get them to your local hospital. And often mesothelioma patients are feeling so unwell, to 
make them travel anyway, can be too much for them… … it is very difficult to get services 
out to the rural communities…if we get a call to go to a patient, it may not be that 
day…we're spread very thinly.‟ Lung cancer nurse specialist. 
 
6. „A typical patient would be referred for difficult chest pain, and I would try and get 
 them in to the hospice, generally, because if you're going to start complex regimes you 
want to keep an eye on them, you want people around that are not fazed by using unusual 
agents…‟Palliative medicine consultant 
 
7. „…they were talking about a 5-week [breathlessness] programme…but if someone‟s 
 poorly they don‟t come!  Is it better to see the patient wherever they might be for 5 
weeks?‟ Macmillan nurse  
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6.11.2 Hospital care and mesothelioma 
 
 
 
In the hospital setting, there was general agreement amongst the professionals 
that the introduction of MDTs, (multi-disciplinary teams), had improved the care 
of patients with mesothelioma and led to more consistent management. In 
particular, it was reported in one area that this had significantly reduced the 
waiting time for prophylactic radiotherapy thus complying with advised practice, 
(BTS 2001). In another area it appeared to have improved recruitment into 
clinical trials, 6.12.1-6.12.3. However, some disappointments with the 
multidisciplinary approach were reported: several interviewees reported poor 
access to specialist pain services and palliative medicine consultants. In two 
areas there was reportedly lack of a clear lead doctor for each patient that 
appeared to have led to some confusion regarding role boundaries. This had 
apparently been resolved in the third area with agreement that the patients 
would be jointly managed by the respiratory physician and oncologist who 
would refer to others if necessary, 6.12.4, 6.12.6, 6.12.7. Interestingly, none of 
the other hospital specialists mentioned palliative medicine as an integral part of 
the lung cancer MDTs, although two referred to the benefit of having clinical 
nurse specialists involved. 
 
Recent changes in hospital services were reported as causing disadvantage to 
patients with mesothelioma: it was reported that national performance indicators 
and targets such as the maximum four-hour stay91 in A and E departments, 
(Department of Health, 2000a), resulted in patients with mesothelioma being 
admitted to any ward rather than directly to the respiratory ward as had 
happened previously. The ward sister recalled that it disadvantaged patients to 
be admitted to wards where they were not known and where staff had no 
particular expertise in the management of mesothelioma. She also regretted the 
loss of the previous „open access‟ arrangement where patients had referred 
themselves to the respiratory ward when, for example, they knew that a further 
pleural aspiration was needed, under the latest system she reported that 
patients requiring urgent pleural aspiration may wait for some hours in A and E 
                                                 
91
 A and E departments risk financial penalty if patients are in the department longer than 4 hours. This 
target was introduced in order to improve patient waiting times in A and E as part of the NHS Plan, 2000. 
„…it's nice to have the multi- disciplinary approach‟   Respiratory physician 
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before being admitted to any ward; her distress regarding this situation was 
obvious. A further change that was reported to disadvantage patients was 
reported due to rearrangements of chemotherapy services as recommended in 
the NHS Cancer Plan (Department of Health, 2000b) with the intention of 
concentrating specialist services in centres of excellence: the respiratory ward 
sister reported that whereas they used to administer chemotherapy on her ward 
where patients with mesothelioma were known to staff, this facility had now 
been moved to another hospital, some miles away, 6.12.5. 
 
Healthcare professionals reported that patients with mesothelioma need easy 
access to specialist help across a range of specialities, particularly respiratory 
medicine and specialist palliative care, as these dealt with the major symptoms 
of breathlessness and pain. Respondents related this need for specialist care to 
the erratic disease trajectory including emergency admissions due to pleural 
effusions, an appreciation of the challenges of symptom control and an 
acceptance that expert knowledge of mesothelioma is patchy. In one area, 
delay in referral to palliative care teams from chest teams was cited as causing 
poor symptom control for patients, although the situation was perceived to be 
improving due to the appointment of a new respiratory physician whose policy 
was to refer to palliative care at the point of diagnosis, 6.12.6. In another area 
the lung cancer nurses tended to refer patients with mesothelioma to the 
palliative care team only in the final stage of the illness, 6.10.7. Two 
respondents referred to the national shortage of consultants in palliative 
medicine and this affected the working practice of the respiratory consultant. He 
felt that he had to operate outside his area of expertise in providing symptom 
control for his patients with mesothelioma in the absence of a consultant in 
palliative medicine, 6.12.8. The lung cancer clinical nurse specialist, working in 
the same area, reported an innovative nurse-led palliative care service that she 
had developed in the absence of a consultant in palliative medicine (described 
in Box 6.11).  
 
Patients with mesothelioma were reported to attend several hospitals, some at 
considerable distance, in order to access oncology, radiotherapy and thoracic 
surgery; this was difficult when patients were frail or symptomatic. In one area, 
where patients had to travel 80 miles to the nearest thoracic surgery centre and 
around 70 miles to the nearest radiotherapy centre, it was reported that this 
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caused additional physical and emotional distress for patients with 
mesothelioma, 6.12.9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 6.12: Hospital care and mesothelioma 
 
1. HC: „ …Lung Cancer MDT? Do you think that has been a helpful development?‟ 
„Absolutely. I think we are now looking at probably 98% of all lung cancer and 
mesotheliomas in one meeting with the radiologists, oncologists, surgeons, cytologists and 
everyone else…the radiotherapists, so all these patients are discussed and treated 
appropriately.‟  Thoracic surgeon  
 
2. „… it's nice to have the multi- disciplinary approach…with the input from the oncologists 
and the surgeons speaking to each other so they get prophylactic radiotherapy in time…the 
lung nurses as well, which is particularly important.‟ Respiratory  physician  
 
3. „We always try and get the radiotherapy to the biopsy sites done within a 6 – 8 week 
window…that's really a strength of what the MDT's done.‟ Lung cancer nurse specialist 
 
4. „…the thoracic surgeon won't follow them up, apart from the exceptional patient who at 
has early disease, they will obviously follow them up…but most of the patients would be 
shared follow-up with oncology and respiratory medicine.‟ Respiratory physician 
 
5. „…when patients come in to A & E they're just found a bed, we're not able to keep beds 
free to get our mesothelioma patients up here, so wherever there's a bed in the unit, there 
are 2 other wards, they go to wherever the bed is. We do try and get them up here but… 
management and bed co-ordinators don't always let us…We used to have a self-referral 
list… mesothelioma were on this list…if they felt unwell they phoned the ward and if they 
had a bed, in you came…that was stopped because of management and they had to go 
through A & E like everyone else…they could be sat in A & E for hours….Now you just get 
a co-ordinator who says "A bed's a bed, and trolley waits are piling up‟ …but then they end 
up on a ward that isn't specialised in their problem, so the hospitals stays are doubled 
because you can't get a consultant to come and see you, the medics on that ward aren't 
specialised so they've got to refer on…It‟s all in response to government wanting star 
ratings… We used to do chemotherapy here… that got taken as well…another political…‟ 
Respiratory ward sister 
 
6. „ I think that patients fell through the net….kept by the chest team, not referred to 
palliative care „til very late in the day and they already had had months of symptoms…that 
side of things has improved….and the referral into Macmillan is now better than it was…‟ 
Macmillan nurse 
 
7. „Usually mesothelioma patients see a lung Macmillan nurse in the primary stages. Of 
course at the end they would see palliative care. And one of our lung nurses is very 
interested in mesothelioma…when they are in hospital she always picks them up very early 
on…I haven't known any mesothelioma patients in my experience be referred to specialist 
pain services.‟ 
HC: So things like nerve blocks, spinals, epidurals? 
„In my experience I don't know of any of those being done with our patients…’ Respiratory 
ward sister 
 
8.„Well I do feel that we should have more specialised palliative care, these patients are 
terminally ill and whilst I've been happy to deliver that sort of care it's not perhaps the 
totally optimal environment, so I would perhaps want to see more palliative care, but that 
also goes for our lung cancer patients actually.‟ Respiratory physician 
 
9. HC: „So how many hospitals would your local patients be accessing?‟ 
JB: „[Three] and then there's 2 hospices as well, covering those areas…They go to the 
General for biopsies and pleurodesis…[hospital]  for radiotherapy, chemotherapy.‟ Lung 
cancer nurse specialist 
 
„The biggest thing is the uncertainty and having to be away from home…’ Macmillan nurse 
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6.11.3 Improving standards of care 
 
 
 
The lack of clear guidance as to best practice was raised as a problem by two 
professionals but, when asked, interviewees found it hard to offer personal 
definitions of best practice.  Most responded with reference to their own 
speciality rather than taking an overview of the care of patients with 
mesothelioma. The exception was the palliative medicine consultant who 
included medico-legal and emotional issues as well as symptom control, 
however he limited his reply to patients who were not having active treatments. 
There was recognition that best practice would need to encompass early 
diagnosis, symptom control, emotional reactions, timely access to appropriate 
services, financial matters and medico-legal issues, 6.13.1, 6.13.2. Although 
access to specialist pain services was seen as ideal it was reported to be 
inadequate in two of the three areas. The palliative medicine consultant, who 
had access to a specialist pain service, appeared to feel that it did not meet his 
expectations, 6.13.3, 6.13.4. As discussed later (p249), several professionals 
stressed the need for individualised care and that services need to be easily 
accessible and responsive to sudden changes in the condition of patients.  
 
Specialist nurses were valued, particularly those with additional training in 
mesothelioma, although it was recognised that there was a need to clarify roles 
and responsibilities. The difficulties in attempting to create a mesothelioma 
nurse consultant post in order to achieve improvements in services were 
described by the lung cancer nurse specialist: she acknowledged that 
mesothelioma affects relatively small numbers of patients even in areas of high 
incidence and that this excluded it from being a health service priority, 6.13.5- 
6.13.7. However all the professionals affirmed that patients should have easy 
access to specialist palliative care in all settings from the point of diagnosis. 
 
 
 
 
 
 
„There's no clear cut protocol or pathway that these patients should follow… 
 it would probably be nice to standardise.‟  Thoracic surgeon 
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Summary  
There was universal understanding of the epidemiology of mesothelioma 
including the relationship with local industries in each site and 
acknowledgement that patients experienced anticipatory anxiety due to prior 
knowledge of mesothelioma. 
 
Mesothelioma was usually a small part of the work of healthcare professionals: 
most were involved in the wider fields of respiratory specialities, oncology or 
Box 6.13: Improving standards of care 
 
1.„I suppose you could cobble together a sort of best practice type approach…So I think it's a 
case of looking at those other factors, there's the symptom control, which can be, well 
certainly usually is trickier than average, but then you've got these other psycho-social factors 
as well, which I think we probably are all aware of and do take into account, but at least in 
my case not in a terribly organised way!‟ Palliative medicine consultant 
 
2.„That the patients get the help and support they want at the time they want, that they have 
easy access to that support, that they know where it's available. We really should be there as 
much or as little as they want, that if they do have a problem…’ Lung cancer nurse specialist 
 
3.„… the pain service could be better and it could be more accessible, but it's a one-man-band 
at the moment and you realise that [the consultant] is doing all that he can do, really. But 
really, yes, in an ideal world there would be a pain control service which we could tap into.‟ 
GP 
 
4.„…we tend to find with the pain specialists, everyone talks about spinals and blocks and 
things like that but usually when you get them involved they're reluctant to stick needles in 
and they do the sort of things we would do anyway, first!‟ Palliative medicine consultant 
 
5.„…it's different to lung cancer…a slightly unique set of patients in a way, in that they have 
different requirements. The question is who deals with them? I think we now have developed 
lung cancer nurses who will deal with mesothelioma patients, we also have Macmillan nurses 
as well, I also get involved with them….I mean there is some good information from, for 
instance, the solicitors…very much up to speed with what information they offer patients with 
mesothelioma etc, so I think we're getting better in that we're not sweeping it under the carpet 
as much as we used to, we can advise patients what their sort of treatment is going to be like 
and how they are going to feel.‟ Thoracic surgeon 
 
6.„Well. I think earlier diagnosis….and if we had the facilities here to do pleurodesis and 
biopsy…so patients don‟t have to travel so far to be diagnosed…I think more streamlined 
referral [to palliative care team]‟   Macmillan nurse 
 
7.„and when you go to PCTs - and I've tried myself to get a mesothelioma nurse in that area at 
consultant level so they'd be able to work across and have more influence and structure with 
them – they will look at those patients, and compared to the lung cancer cases it's still a very 
small group, but in the country, compared to the mesothelioma it's a very high incidence. And 
they will say you've got all these people dying of heart failure, respiratory problems, COPD, 
lung cancer, and we may have a couple of handfuls of mesothelioma patients and you want a 
full-time nurse at this grade. So it comes to politics and what's able to be provided within the 
strains on the Health Service, really.‟Lung cancer nurse specialist 
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General Practice. Workload due to mesothelioma, even in these high incidence 
areas, was generally small. The exception was the 200 contacts per year for the 
thoracic surgeon who performed investigative, palliative and, occasionally, 
radical procedures. 
 
Most healthcare professionals in this study believed that patients with 
mesothelioma were generally fitter than patients with lung cancer. Patients with 
mesothelioma were perceived as having more severe symptoms, particularly 
pain and recurrent pleural effusions, compared with lung cancer patients. Pain 
due to mesothelioma was perceived as complex and difficult to control. 
Psychosocial issues, acknowledged by all the professionals in the study, were 
perceived as more severe than those affecting patients with lung cancer. 
 
Healthcare professionals perceived the investigation of mesothelioma as 
difficult and burdensome for patients and frustrating for clinicians. Obtaining a 
histological diagnosis was often a lengthy process and not always possible. 
Staging in mesothelioma was seen as extremely important but technically 
difficult and hindered by lack of advanced scanning facilities. Prophylactic chest 
wall radiotherapy, although BTS advised practice after invasive procedures, 
was often not available within the recommended timeframe. Patients were seen 
as tolerating investigative procedures with stoicism but perceived to suffer 
disadvantage due to the disease being relatively rare. 
 
The lack of evidence-based best practice was seen as disadvantaging patients 
with mesothelioma although standardised treatment plans would oppose the 
view that patients with mesothelioma require individualised care. Lack of 
effective therapies tends to foster doctors‟ involvement in novel and 
experimental treatments. Healthcare professionals held mixed views about the 
value of chemotherapy: in general, hospital doctors tended to favour recruitment 
into trials, whereas those with closer relationships with patients and their 
families tended to prioritise the negative aspects such as opportunity costs to 
patients. There are many complex ethical dilemmas surrounding chemotherapy 
of limited benefit to the individual patient, including inequity of access to 
palliative care. Ethics of decision-making are involved in giving information to 
patients about treatments, particularly „low benefit‟ chemotherapy. No one 
advocated chemotherapy outside a clinical trial.  
 248 
 
Specialist palliative care was seen as essential in managing patients with 
mesothelioma. There was no agreement around the timing of referral to 
palliative care. Symptom control, particularly with respect to pain, was reported 
as difficult. Under-prescribing and inappropriate prescribing were recalled as 
common outside palliative care, particularly relating to morphine. 
Breathlessness was seen as mainly due to pleural effusions, other causes of 
breathlessness in mesothelioma did not appear to be considered. Doctors 
viewed pleural effusions as treatable but nurses reported lack of knowledge of 
mesothelioma, inefficient management, treatment failures and distances to 
treatment centres as disadvantaging some patients. Non-pharmacological 
approaches to breathlessness were not utilised. Doctors were prepared to try 
novel treatments when conventional approaches failed. 
 
Caring for patients with mesothelioma is emotionally demanding for healthcare 
staff due to the physical and psychological suffering experienced by the patients 
and inevitable fatal outcome. Doctors felt hopeless and impotent due to lack of 
effective treatments and difficulties with symptom control, nurses shared the 
distress of the patients and their families with whom they had often formed 
close relationships. Anger expressed by relatives was understood by healthcare 
professionals but sometimes added to their emotional burden. In contrast to 
reports concerning other cancers, the psychosocial burden of mesothelioma as 
affecting patients appeared to have been appreciated by healthcare 
professionals from the point of diagnosis. Clinical supervision is a recognised 
support mechanism for nurses but not familiar to doctors 
 
Effective care of patients in their homes depends on good relationships 
between primary healthcare teams, particularly GPs, district nurses and 
specialist nurses. Specialist palliative care services may lead to „deskilling‟ of 
GPs. Specialist palliative care services are under-resourced in some areas. 
Combined trust clinical nurse specialists can provide a seamless service for 
patients. Home-based care may be more appropriate for very breathless 
patients who find the effort of travelling to and from clinics burdensome. 
 
MDTs had improved access to care (particularly radiotherapy) and increased 
recruitment into trials but palliative medicine was not usually included in lung 
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MDTs. The MDT approach may cause confusion over which clinician is „in 
charge‟. Delays in radiotherapy were common. Target-driven alterations in 
admissions policies and centralisation of chemotherapy services disadvantaged 
patients with mesothelioma. There was no policy of referral of patients with 
mesothelioma to specialist palliative care at diagnosis in spite of several 
healthcare professionals believing this to be best practice. Long distances, 
particularly to tertiary centres, were seen as a burden for patients and their 
relatives. 
 
Healthcare professionals would mostly appreciate the development of best 
practice guidance in mesothelioma. Best practice should be holistic in scope 
and recognise that virtually all patients with mesothelioma have incurable 
disease at diagnosis. Manpower shortages in specialist nursing and medical 
disciplines, particularly palliative medicine and pain management, were 
common and disadvantaged patients with mesothelioma. Lack of clarity of the 
roles and responsibilities of various specialist nursing and medical staff caused 
problems. Low numbers of patients appears to result in low priority for 
mesothelioma in health services planning.       
 
Doctors found delivering the „bad news‟ of diagnosis of mesothelioma 
particularly difficult due to the lack of effective treatments, symptom burden and 
short survival time. Doctors‟ views around clinical trials varied depending upon 
whether they prioritised utilitarian or individual outcomes, whereas nurses in 
general tended to focus on the opportunity costs for individual patients but 
respected patients‟ decisions, even if they differed from the nurses‟ opinions. 
 
There seemed to be tacit agreement about division of labour between doctors 
and nurses with regard to communication of diagnosis and treatment options to 
patients: doctors disclose the diagnosis and brief details regarding trials, nurses 
interpret and expand on this information for patients and their families. This 
division of labour was not without problems: whereas it relieved senior doctors 
of some time-consuming, professionally challenging and emotionally-draining 
interactions with patients, it required nurses to undertake these same tasks and 
some felt that they do not have sufficient knowledge to do so, others were 
aware of needing to take care not to contradict what doctors had already said. 
Nurses expressed some reservations about communications from doctors to 
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patients but did not appear to voice these concerns to the doctors. Written 
information for patients to take home after receiving the diagnosis was seen as 
important. Patients‟ decision-making about clinical trials was assisted by nurses. 
Healthcare professionals were aware that patients with mesothelioma may 
accept risks of „low benefit‟ chemotherapy that clinicians would view as 
unacceptable. 
 
The Mesothelioma Information Service provided information nationally to 
patients and lay and professional carers and led to the formation of the 
Mesothelioma Nurses network. The helpline was set up in response to 
observed unmet needs of patients and families. Patients, family carers, 
bereaved relatives healthcare professionals, social workers, lawyers and State 
benefits staff used the service. Different groups of callers needed different types 
of information. An information booklet was produced as a result of the 
experience of the helpline nurse. The service provided practical information 
such as State benefits, civil compensation and travel insurance. 
 
Information about benefits and civil compensation was frequently given at the 
same time as disclosure of the diagnosis. Nurses were concerned that giving 
this financial information at the point of disclosure of diagnosis was 
inappropriate. There was no systematic approach or guidance as to the best 
time to give the medico-legal advice. Financial entitlements were of major 
importance for some families. Although nurses are advised that they are not to 
give advice on medico-legal matters, they need to know of the processes 
related to mesothelioma in order to assist the patients and their families. 
 
Support of family members was seen as primarily the responsibility of nurses, it 
was essentially informal and not systematic. The exception was at disclosure of 
diagnosis when most doctors included family members when breaking the bad 
news. Specialist nurses were responsible for further explanations of the 
diagnosis, investigations and treatments to patients, usually with their family 
carers and also providing them with written information materials. GP 
consultations frequently included family carers, particularly on home visits. In all 
cases, care of family members appeared to be considered secondary to the 
care of patients. Although generally regarded as important that families were 
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prepared in advance for the coroner‟s investigation, most services had no 
systematic approach to this and no one took overall responsibility. 
 
Bereavement after mesothelioma was seen as severe and complex, bereaved 
relatives were often angry. Medico-legal processes were seen as interfering 
with grieving and having a negative impact, especially when the inquest was 
delayed for some time after the death. Care of bereaved relatives varied 
between the three sites but there appeared to be no single systematic 
approach. Hospital healthcare staff did not feel they had any role with bereaved 
relatives. 
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Chapter 7: Discussion                  
 
7.1 Introduction 
In each of the previous four chapters I reported the findings from a separate 
data source: the survey of medical records, interviews with patients, focus 
groups with bereaved relatives, and interviews with healthcare professionals. In 
this discussion section I attempt to cut across the boundaries in order to 
synthesise/triangulate and interpret the findings from the multiple data sources, 
drawing them together under major headings. The discussion is divided into 6 
sections which, taken together, address the research questions that were posed 
at the start of the study.  
 
7.2 Asbestos exposure and risk 
Occupational exposure to asbestos 
The medical records survey demonstrates a high proportion, (88%), of patients 
with mesothelioma had been exposed to asbestos at work. This is a higher 
percentage than reported in most previous studies but reflects sampling bias: 
this was anticipated and informed my decision to recruit patients in these 
industrial areas. The high proportion of male patients, 97%, in the medical 
records surveyed, reflects the gendering of the traditional industries in two of 
the three locations: the Barrow shipyard and the railways plant at Doncaster. 
The Leeds situation is different: the workforce in the Leeds asbestos textile 
factory had a higher proportion of female workers but the factory closed in 1955. 
It follows that, given the 30 – 50 years latency between exposure and disease 
presentation, many affected female workers may have succumbed to 
mesothelioma prior to this study. The patients interviewed and the surveyed 
medical records relating to Leeds revealed a greater diversity of occupation 
than the other two sites, but a similar preponderance of men, Table 4.1, page 
134. 
 
Risk of mesothelioma 
The study revealed interesting and somewhat contradictory findings regarding 
advice about asbestos hazards at work. Although only two of the 15 patients 
who were interviewed recalled receiving hazards advice whilst working, about 
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half the bereaved relatives recollected some prior awareness about the risks of 
working with asbestos, and most of the healthcare professionals felt that 
anticipatory anxiety due to prior awareness of asbestos risks was common in 
patients with mesothelioma. The Introduction, (Chapter 1, section 1.6) detailed 
the widespread failure of industry and government to act to protect the 
workforce from asbestos hazards and that this persisted long after the 
introduction of the most recent Asbestos Regulations in 1969 (Tweedale 
2001:159-77; Johnston and McIvor 2000:112-46). Even if hazards advice had 
been given, it is possible that some patients were reluctant to admit to ignoring 
advice that may have been literally life-saving if heeded; this strategy might be 
adopted in order to reduce a sense of personal responsibility, guilt and distress. 
Hawley et al (2004:15-16) revealed a similar finding in Australia: that patients 
with mesothelioma had „little or no understanding‟ of being at risk of 
mesothelioma in spite of having worked in high-risk occupations at a time when 
health and safety information was apparently available and the authors 
commented that health education services „appear to be failing men with 
mesothelioma‟. 
 
Connell (1996) described the gender effect for men in being less influenced by 
health promotion advice than women and that this relates to „macho‟ risk-taking 
attitudes and behaviours of young men. It will be interesting to see whether this 
gender disadvantage persists in British society that is experiencing the rise of 
what has been termed „raunch culture‟ in young women: this includes „laddish‟ 
behaviour such as binge drinking (of alcohol) previously typical of young men 
(Levy, 2005). This change may indicate blurring of some traditionally-gendered 
behaviours and attitudes and could potentially alter the different relationships of 
the sexes with regard to health education. Clearly  there is no room for 
complacency: as carpenters and other construction and maintenance workers 
are at increasingly high risk of mesothelioma, (Peto et al, 2006), it is worrying to 
reflect on the possibility that asbestos hazards advice, manifestly unsuccessful 
with regard to the patients interviewed, is probably still ineffective.  
 
This challenging situation relates to what Beck (1992) describes as a „risk 
society‟: our well-resourced western society appears to be intolerant of any risks 
with an increasingly risk-averse workforce, supported by employers‟ fears of 
litigation and the burgeoning health and safety bureaucracy. Beck (1992) 
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suggests that to live without risk is both impossible and unwanted but that 
societies need to develop resilience to risk in which realistic assessments of the 
hazards are accompanied by pragmatic solutions designed to reduce risk to 
„reasonable‟ levels. In Beck‟s view, society should decide what „reasonable‟ is in 
this context and at present we do not have an obvious mechanism for this type 
of action. 
 
Asbestos, smoking, and lung cancer 
Although many of the patients interviewed had smoked (and 73% in the medical 
records sample had a history of smoking), it appeared that none of the 
interviewed patients had appreciated the additional risk of lung cancer due to 
smoking and asbestos acting as co-factors (Reid et al, 2006). However this is 
mirrored by lack of knowledge in the medical profession: in theory any patient 
who has a history of asbestos exposure and a diagnosis of lung cancer should 
be referred to a Coroner when they die because asbestos may have contributed 
to the cause of death. This could result in more compensation awards being 
made and would improve the accuracy of asbestos-related disease statistics. 
This clearly does not happen, probably because many doctors are unaware that 
asbestos and smoking are co-carcinogens for lung cancer. Asbestos exposure 
histories are not routinely taken in smoking-related lung cancer cases, and it 
may also reflect reluctance to refer cases to the Coroner unless there is a legal 
necessity or clear gain for the bereaved relatives (Hoyle, 2006). 
 
7.3 The experience of mesothelioma 
 
7.3.1 The physical experience  
 
A severe symptom burden was revealed by the patients; bereaved relatives; 
healthcare professionals and the medical notes survey; the presenting and 
ongoing symptoms mirrored findings from previous studies (Robinson et al, 
2005; Yates et al, 1997; West and Lee, 2006). The interviews with patients 
revealed how symptoms were experienced in terms of their effect on daily 
routines, in particular physical domestic tasks and active hobbies. When these 
normal pursuits became compromised, patients and their relatives were forced 
to acknowledge that this was abnormal and at this stage sought medical advice, 
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echoing Hawley et al’s (2004) findings. In common with many previous 
accounts, there was a general reluctance amongst the mostly male and older 
patients to seek medical advice until symptoms became severe and even then, 
they frequently had to be prompted by their wives (Gough, 2006).  
 
The reluctance of the patients to seek help could relate to the demographic 
features of the sample and reflect the undemanding and self-reliant nature of 
older men who may also have low expectations of physical health and expect to 
experience some symptoms as they age (Catt et al, 2005). It could also 
represent denial as a strategy for minimising anxiety when there is background 
knowledge, albeit unspoken, of being at high risk of asbestos-related disease. 
Gough, (2006), in his critique of assumptions made about men‟s health 
suggests that illness, rather than health, is the feminised area. This goes some 
way to explaining why women may be dominant in illness management but, 
before illness is established, the masculine model of not seeking health advice 
dominates. Another related element of hegemonic masculinity is that help 
seeking implies weakness and vulnerability (Gough, 2006). Interestingly, in a 
lung cancer study, younger patients were shown to be more likely to present to 
their GP early if they were widowed, separated or divorced, in contrast to the 
sample in this study; perhaps supporting an age or generational effect 
(Krishnasamy and Wilkie, 1999: 52). The interviews with patients revealed that 
their reluctance to seek medical help continued after the diagnosis of 
mesothelioma and even when severe symptoms were being experienced. 
 
Decisions to seek advice on health matters have been reported as depending 
on the meanings ascribed to symptoms by patients and their health beliefs 
around the benefits (or disadvantages) of reporting potentially significant 
symptoms promptly (Brennan, 2004:56). In patients who may have a 
background fear of asbestos-related disease, and/or known workmates who 
have died from such conditions, high anxiety may effectively inhibit action and 
delay in seeking help may be reinforced by a conviction that, in any case, 
„nothing can be done‟. This has been described as „cancer fatalism‟ and, in 
conditions where earlier diagnosis results in improved outcomes, is known to 
adversely affect those outcomes (Powe and Finnie, 2003). A study investigating 
factors that influence the attention paid to cancer symptoms and the intention to 
seek advice identified women as generally more active than men, particularly if 
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well-educated. Other relevant factors were: knowledge of cancer symptoms, 
perceived agency, perceived advantage in paying attention to cancer symptoms 
and „perceived less difficulties with paying attention to cancer symptoms‟ (de 
Nooijer et al, 2003). Many of these factors would appear to contrast with the 
characteristics of the majority of (male) patients with mesothelioma.  
 
At present, once a patient with mesothelioma is symptomatic there is no 
evidence that earlier diagnosis improves survival, although it may enable 
patients to benefit from more effective management of recurrent pleural 
effusions and other distressing symptoms. However, earlier diagnosis would 
prolong the time that a patient and their family are aware of living with terminal 
illness. The lack of effective treatment, as well as the lack of a reliable non-
invasive diagnostic test, lead to the conclusion that, at present, screening for 
mesothelioma is not recommended (BTS, 2001). This may change as new 
tumour markers are being identified and if effective treatments become 
available (Creaney et al, 2006). 
 
Breathlessness  
The main symptom of breathlessness was described by the patients, bereaved 
relatives and healthcare professionals, as severe and often refractory.  At 
presentation this was usually due to pleural effusion but later on, as the medical 
records survey and interviews with healthcare professionals indicate, chest wall 
fixation and lung encroachment were additional problems. Experiencing 
breathlessness in mesothelioma is particularly distressing and has multiple 
complex meanings for patients and their families. Severe breathlessness may 
represent a life-threatening event; it may confirm disease progression; it may 
require emergency admission to hospital and invasive procedures; it is 
physically and emotionally exhausting; it causes anxiety and it may be truly 
terrifying. It is also highly visible – unlike some other symptoms it cannot be 
disguised.  
 
Breathlessness also demonstrates one aspect of the „unbounded‟ body in which 
it is obvious to the patient and their observers that previously dependable bodily 
functions are now out of control (Lawton, 2000:128-33). This adds to the 
(visible) stigma and to the „discredit‟ that has been described as associated with 
terminal illness (Charmaz, 1983) and contributes to „loss of self‟ (Lawton, 
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2000:133). In previously fit and capable men and women, severe 
breathlessness reduces them to helpless dependency, which has a devastating 
effect on identity in terms of agency, role, function and body image (see next 
section 7.3.2.  
 
Authoritative reports (Bredin et al, 1999; Carrieri-Kohlman and Dudgeon, 2005), 
emphasise the value of a multi-dimensional approach to breathlessness and yet 
there was no evidence of this in any of the interviews with patients, nor in any of 
the focus groups with bereaved relatives. Knowledge of such an approach was 
mentioned by only two of the healthcare professionals, although neither had 
received training. Breathlessness management techniques have been shown to 
help patients with lung cancer develop a sense of mastery over breathlessness 
and reduce the symptom burden. These techniques are cheap, easily taught, 
„low-tech‟ interventions that can be delivered by nurses and physiotherapists, 
sometimes with contributions from complementary therapists (Bredin et al, 
1999; Carrieri-Kohlman, 2005).  
 
Lack of strategies for managing breathlessness resulted in relatives feeling 
helpless and increasingly anxious. This confirms findings of a previous study 
regarding non-pharmacological measures to relieve pain in which relatives 
learnt by „trial and error‟ how simple interventions could alleviate patients‟ 
suffering; they did not receive any related information from healthcare 
professionals (Ferrell et al, 1991). The study revealed that where breathless 
patients and their relatives felt uncertain and out of control, crisis situations 
occurred frequently and led to panic-driven emergency admissions to hospital.  
 
When there is so little otherwise to offer it raises the question: why are cheap 
and effective self-help methods of helping patients to deal with breathlessness 
not part of standard care?  It may be that the practice of medicine reflects 
society‟s priorities and values and, as a result, inexpensive „low tech‟ 
interventions do not have the credibility of expensive new technologies or 
medications. Another reason may be that the initial work came from nursing 
research and that the healthcare professions are still hierarchical with medicine 
in poll position, resulting in less likelihood of implementation of „nursing‟ 
initiatives. Yet another feature may be that patients (and many doctors) prefer to 
rely on a „medical‟ solution, hoping to cure the problem, rather than accepting 
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that the best that can be done is for patients to learn to manage their 
breathlessness.  This is one aspect of the „therapeutic imperative‟ that drives 
many doctors to pursue active medical treatments, and encourages patients to 
believe this is possible, when a palliative approach may be more appropriate, as 
demonstrated in other end-of-life conditions (Murray et al, 2002). As shown in 
the interviews with healthcare professionals, the doctors (and patients) tended 
to regard breathlessness as usually due to effusions and therefore readily 
treatable by aspiration. In many cases this is correct: patients with large pleural 
effusions do need rapid access to hospital for pleural aspiration and pleurodesis 
if indicated. However, in general, breathlessness management techniques may 
reduce some of the associated anxiety, and understanding their problem may 
empower patients to seek treatment at an earlier stage, thus reducing this 
particular aspect of the disease burden. 
 
The interviews with patients revealed that, even after aspiration or successful 
pleurodesis, breathlessness was still a problem, although often less severe. 
This correlates with the results of a study in lung cancer patients in which 
breathlessness was found to be the symptom least likely to be relieved (Muers 
and Round, 1993). Nevertheless, before advocating wholesale adoption of 
breathlessness management techniques, it must be remembered that the above 
studies refer to patients with lung cancer and therefore need to be evaluated in 
patients with mesothelioma; it could be that the presence of physical 
impairments to lung expansion such as loculated pleural effusions, extensive 
pleural thickening, and chest wall involvement, as well as other causes of 
breathlessness such as pericardial involvement, might make these techniques 
ineffective in mesothelioma. Other factors that may be implicated in 
breathlessness in mesothelioma are respiratory muscle deconditioning and 
cachexia. Pulmonary rehabilitation, aimed at maximising lung function, may 
seem inappropriate in mesothelioma but it might have a place in patients who 
have a longer than average prognosis – again, this would need evaluation. 
 
Another aspect that this investigation could not adequately answer was raised 
by the Muers and Round (1993) study in lung cancer that demonstrated neglect 
of concurrent medical conditions, some of which could contribute to the overall 
symptom burden. Given the high percentage (69%) of the patients (in interviews 
and the records survey) who had smoked, it is fair to assume that smoking-
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related conditions would be highly prevalent. The medical records survey 
revealed that 74% of patients had co-existing medical problems: 30% had 
ischaemic heart disease and 10% had various respiratory diseases and these 
may have contributed to breathlessness. Examination of medications prescribed 
for these patients demonstrated a lower use of medications for chronic 
respiratory conditions than I would have expected.  If all the patients whose 
notes were surveyed had been referred to palliative medicine, the apparent 
under-use of medication for concurrent conditions may have been explained by 
the established practice in palliative medicine of discontinuing non-essential 
medications in the terminal phase, but this was not the case, and therefore this 
study tends to support the findings of Muers and Round (1993). 
 
In the 1960s Cicely Saunders transformed the management of cancer pain by 
her conceptualisation of pain as a subjective phenomenon (rather than a strictly 
physical entity) that required an approach in which physical, spiritual, emotional, 
and cultural factors were addressed (Saunders, 2001). Her concept of „total 
pain‟ revolutionised the management of pain (and suffering) in cancer and 
extended it from the biomedical model (Clark, 1999). Perhaps, to paraphrase, 
the time has come to use the term „total breathlessness‟ in order to emphasise 
to clinicians the multi-factorial nature of breathlessness with the intention of 
improving its management. A palliative approach would encompass all these 
areas (Box 1.3). 
 
Pain  
Pain in mesothelioma is acknowledged to be difficult to treat due to its multi-
factorial nature and attendant psychosocial issues (BTS, 2001; Ahmedzai and 
Clayson, 2006; Chapman et al, 2005). The patients interviewed appeared not to 
have severe pain at the time of the interview, (not surprisingly, because patients 
with severe pain would be less likely to volunteer), although several participants 
had experienced severe pain on occasions. Health beliefs and attitudes may 
have impacted on admission of pain in the ways described with regard to 
breathlessness: perhaps pain was minimised in this group of patients and in this 
instance „cancer fatalism‟ would inevitably link pain with cancer. Admission of 
pain could have implied loss of control; the patients were each interviewed only 
on one occasion and therefore a trusting relationship with me had not had time 
to develop and, to some extent, they may have been presenting „public 
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accounts‟ that were based on the image that they wanted to portray to me. It 
could be postulated that patients who volunteer for research studies gain some 
„credit‟ in terms of an enhanced self-image against the „discredit‟ of terminal 
illness, as mentioned earlier (Charmaz,1983) and that to admit to suffering, for 
example, in terms of distressing symptoms, actually undermines their coping 
abilities and potentially makes them objects of pity and stigmatisation.  
 
The bereaved relatives, of whom only one was related to an interviewed patient, 
had witnessed severe pain in most cases. This may well reflect sampling issues 
around the focus groups as it is likely that these were relatives with „a story to 
tell‟ and pain would appear to be a potent feature in „horror stories‟ (Vignette 
3.1, p115). This has also to be viewed with some caution because opinions 
differ concerning the accuracy of bereaved relatives‟ proxy accounts in 
reflecting the patients‟ perceived suffering: Higginson et al (1994) and Hinton 
(1996) reveal concerns around reliable reporting of pain in particular, 
Addington-Hall and McPherson  (2001) emphasise that „memory is a dynamic 
process‟ and contextual. The healthcare professionals that I interviewed, in 
agreement with earlier reports, (BTS, 2001), all recalled experience of patients 
with mesothelioma suffering refractory pain and agreed that specialist and/or 
(sometimes unconventional) interventions may be required. Although the 
literature gives the impression that severe refractory pain is common, my 
experience, and that of colleagues currently working with patients with 
mesothelioma, is that severe uncontrolled pain is now relatively uncommon. It 
may be that, as the discipline of palliative medicine develops expertise in the 
management of complex pain, patients with pain due to mesothelioma are 
increasingly accessing a better standard of symptom control. 
 
However, other factors may be relevant: I could not find any quantitative 
information concerning the incidence of severe pain in mesothelioma and it may 
be that patients with refractory pain are particularly memorable for their doctors, 
thus producing an impression of greater numbers than in reality. In this instance 
I am referring to pain that requires specialist pain management techniques: 
invasive interventions such as nerve blocks, intrathecal or epidural analgesia, or 
percutaneous cervical cordotomy. Pain in mesothelioma is usually complex and 
includes neuropathic components (Ahmedzai and Clayson, 2006). Grond et al 
(1999) estimated that in cancer patients suffering from neuropathic pain, 10% 
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will require spinal analgesia or a neurolytic procedure. The problem of 
managing refractory complex pain in mesothelioma requires that healthcare 
professionals should consider early referral for specialist interventions (BTS, 
2001; Ahmedzai and Clayson, 2006). 
 
Technological approaches to pain were much more commonly used in the post-
war period at a time when there were considerable anxieties about the addictive 
properties of morphine and when pain was viewed as a uni-dimensional 
physical entity that should respond to obliteration or division of nerve pathways 
(Seymour et al, 2005). As Seymour et al explain, once the concerns about 
morphine had been disproved, largely by the efforts of hospice founder, Cicely 
Saunders, and the anaesthetist and pain specialist, John Bonica, use of 
morphine increased dramatically and the technological interventions waned. In 
addition, Twycross (2001:29) states that neurolytic (destructive) procedures 
decreased since the advent of spinal analgesia and infiltration of local nerve 
roots with anaesthetic and corticosteroid, although these are not practical when 
pain extensively involves the hemithorax due to the risk of causing respiratory 
complications.  
 
A retrospective review of 53 patients with mesothelioma who had undergone 
percutaneous cervical cordotomy between 1985 and 1998 revealed that the 
median daily dose of morphine was 100mg pre-cordotomy and 20mg after the 
procedure; 20 (38%) patients were able to discontinue morphine, 43 patients 
(83%) were able to halve the dose but 18 patients (34%) subsequently required 
increased doses (Jackson et al, 1999). Although the authors are enthusiastic 
about the role of cordotomy in mesothelioma, the figures demonstrate that 
prolonged benefit, (at a median post-procedure interval of 9 weeks), defined as 
opioid dose reduction or cessation, applied to 25 patients (47%) and that 11% 
experienced significant side effects in the form of „mild weakness‟ and 
„troublesome dysaesthesia‟. Previous studies have demonstrated 6% mortality 
at one week post-procedure but Jackson et al‟s (1999) study reported 6 deaths 
(11%) within 2 weeks of the procedure. However, the authors report that 
selection criteria have subsequently been adjusted to exclude patients very 
close to death. Most patients were taking morphine and non-steroidal anti-
inflammatory medication but the full range of analgesics specifically for 
neuropathic pain had not been employed in this sample; the authors refer to 
 262 
adjuvant analgesics but state that, in their experience they are „not very 
effective‟. Therefore Jackson et al’s study does not compare cordotomy with the 
efficacy of commonly used adjuvant medications for neuropathic pain such as 
corticosteroids; calcium channel blocking agents; antidepressants and NMDA-
receptor-channel blockers (Twycross 2001:51-56). The authors of this 
cordotomy study, specialists from respiratory medicine and a pain department, 
did not include a palliative medicine physician 
 
However Price et al (2003) reported that the 6% (unqualified) mortality in the 
earlier study could be attributed to the patients‟ diagnosis of advanced lung 
cancer. He investigated 37 patients who had undergone percutaneous cervical 
cordotomy, (32 had mesothelioma), and concluded that respiratory function was 
not adversely affected, apart from transient nocturnal hypoxia immediately post-
procedure. 
 
Of particular note is the finding from Jackson et al’s study (1999) that 34% of 
patients who initially benefited from cordotomy subsequently required more 
morphine. Referred pain, affecting sites distant from the original pain, was found 
in 11% of patients who had undergone cordotomy; Nagaro et al (1993) 
proposed that cordotomy removes inhibition of subsidiary neural pathways 
outside the lateral spinothalamic tracts.  
 
A review of specialist pain management in 259 patients in Italy between 1983 
and 2000 found a dramatic decrease in the use of cordotomy from 22 cases in 
1983 to none in 2000. (De Conno et al, 2003). This was attributed to growing 
appreciation that a unilateral, localised source of pain was unusual in 
malignancy, better use of adjuvant analgesia and concerns about „severe 
complications‟ including „motor, bladder and respiratory function impairment‟. 
 
Bruera (2003) in a review of treatments for cancer pain discusses neurosurgical 
ablative procedures and concludes that ‘all these interventions are complex and 
expensive and their role is not currently supported by large randomised 
controlled trials; however, they can be useful in selected intractable cases’. 
Thus it would appear that the role of cordotomy, an invasive procedure with 
potentially distressing or severe complications and no guarantee of prolonged 
symptom control, has yet to be established in mesothelioma, in contrast to the 
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conclusion of Jackson et al’s (1999) study which states that the procedure 
should be considered „as soon as pain due to chest wall invasion is suspected‟.  
 
However, recent work could lead to a reversal of the trend away from 
interventional analgesia. There are suggestions that spinal analgesia, compared 
with non-invasive routes of opioid administration, may give a survival advantage 
in cancer due to the lower doses required. This links to work suggesting that 
long-term morphine impairs the immune response and also suggestions around 
inadvertent neurotoxicity with oral morphine due to inexpert management 
(Sacerdote et al, 2000; Daeninck and Bruera, 1999). If a survival benefit of 
spinal analgesia in cancer were to be established, it would have substantial 
implications for practice. However, the holistic management of pain as a bio-
psychosocial problem, and not simply as a nerve conduction issue, is essential, 
regardless of technological advances. Chapman et al (2005) support this in 
mesothelioma, recognising the severe psychological and physical disease 
burden. 
 
The medical records data, relating to patients who died between 1998 and 
2001, suggest that at that time, pain management was sub-optimal: there was 
little use of the full range of opioids; morphine doses in general were low; and 
referrals to palliative medicine and specialist pain management services were 
very frequently late. Hawley et al (2004:23-6) found a similar problem with 
inadequate and late referral to palliative care in her study of mesothelioma in 
Australia and, in common with a UK study (Hanratty, 2006), she also concluded 
that under-referral is associated with professionals‟ knowledge of specialist 
palliative care and their belief that palliative care is synonymous with terminal 
care. The failure to access specialist advice at an early stage from experts in 
symptom control represents serious disadvantage to these patients.  
 
Society equates cancer with pain even though modern approaches to pain 
management should ensure that most cancer pain can be relieved. However 
the reality is somewhat different as accounts of cancer narratives illustrate 
(Winslow et al, 2005). As illustrated through the accounts of patients and 
relatives, there are continuing problems in hospital settings in providing 
adequate analgesia for cancer pain and issues around training and supervision 
of junior doctors in palliative care (Winslow et al, 2005). In addition, the 
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investigation of Harold Shipman, notorious GP and mass murderer, has 
paradoxically (anecdotally) led to such nervousness („opiophobia‟) amongst 
some doctors concerning the prescription of opioids that obtaining powerful 
analgesia may now be more difficult than previously (Small Practices 
Association, 2006). GPs worry about tighter regulations around the handling 
and prescription of controlled drugs to the extent that some no longer carry 
these medications and and it is now recommended practice that patients or 
family members collecting opioid analgesia from a pharmacy may now be asked 
to provide identification if they are not known to the pharmacist (Department of 
Health, 2006b). 
 
Other symptoms 
Interestingly, although acknowledged as one of the most common lung cancer 
symptoms (Cooley, 2000), fatigue was not emphasised by the patients with 
mesothelioma nor mentioned in many of the medical records. This may be 
because many of the patients‟ activities were limited by breathlessness or, 
alternatively, because fatigue was seen as inevitable, given a cancer diagnosis 
that in any case was not remediable. Perhaps a hierarchy of symptoms 
operates in healthcare, with pain at the top, and yet other symptoms may be 
most burdensome to the patient and family. This reveals the importance of 
patient-centred care in which the patient‟s concerns create the priorities for 
attention from the healthcare team. Sweating was a significant problem for 
several families and was reported in 18% of the medical records – this is likely 
to be an underestimate. Unfortunately this symptom is not included in the 
EORTC QLQ-C30 which is one of the two validated health-related quality-of-life 
instruments in mesothelioma92( Nowak et al, 2004) - perhaps it should be?  
 
The burden of medical interventions 
All four parts of the study echoed previous reports that reaching diagnosis in 
mesothelioma can be difficult and is often delayed (BTS, 2001; Hawley et al, 
2004:22-26). Repeated pleural aspiration and pleurodesis for recurrent 
effusions represent a particularly heavy investigation and treatment burden 
because the procedures are invasive, painful and, in the case of pleural 
aspiration, performed when patients are highly symptomatic and distressed. 
                                                 
92
 The other is the Lung Cancer Symptom Scale (Hollen et al, 2004) 
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Although some of the patients tolerated these invasive procedures reasonably 
well, perhaps because they were an understandable physical solution to a 
distressing symptom, spouses found them hard to witness. As shown in the 
later section on disease trajectory, the lives of patients and their families were 
disrupted by unpredictable emergency admissions usually related to effusions 
or, less commonly, to pain. This illustrates one of the disease management 
challenges: what needs to be done to pre-empt some of these crises? 
 
Aspiration of pleural effusions, also known as thoracentesis, was essential for 
symptom relief and, in some cases, the diagnosis was confirmed by analysis of 
the pleural fluid. Complications, experiences of which were described by some 
of the patients at interview, have been extensively reported and include pain (15 
– 28%), pneumothorax (up to 30%), shortness of breath, cough (9-24%) and 
vaso-vagal reaction (2-4%).  These complications can be significantly reduced if 
the procedure is performed by experienced interventional radiologists under 
ultrasound guidance but this is not common in the UK (Jones et al, 2003). The 
recent introduction of medical thoracoscopy in which a physician conducts the 
procedure using a flexible thoracoscope may improve both time to diagnosis 
and access to effective pleurodesis if early results are confirmed and if the 
service is then expanded (Munaavar, 2006). 
 
The interview data illustrates how patients balance the pros and cons of 
investigative and therapeutic procedures using a range of elements that are not 
limited to disease factors but encompass practical and social issues too. It 
would appear that healthcare professionals are mostly unaware of these wider 
considerations that affect patients‟ decision-making around interventions. 
 
The mixed views of patients with regard to pleurodesis, after the event, related 
to whether it was successful or not; whether the procedure was performed on 
the ward or in a thoracic surgery unit; the perceived expertise of the doctor; and, 
particularly with regard to Barrow patients, the distance of the surgical unit from 
their home. Distance to tertiary centres may also influence doctors‟ referral 
decisions.  A further concern is the late referral for pleurodesis that particularly 
affected patients from Barrow and the related lower success rate as predictable 
from the literature: this is because as disease advances the involvement of the 
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visceral pleura causes „trapped lung‟ which cannot expand (Martin-Ucar and 
Waller, 2006:255-6). These issues are discussed further in 7.4. 
 
7.3.2 The psychosocial experience  
 
Finding out about mesothelioma 
Prior awareness of mesothelioma, as described mainly by bereaved relatives, 
was usually associated with anxiety due to family- or community-acquired 
information that framed mesothelioma as a dreadful disease, with distressing 
stories of „drowning in fluid‟, „suffocating to death‟ and „agonising pain‟.  This 
contrasts with Thomas et al’s study (2001), which revealed that prior suspicion 
of cancer sometimes helped prepare patients and relatives for the diagnosis. 
Perhaps in the public „folklore‟ of mesothelioma the diagnosis is associated with 
such certain terrifying features that patients perceive it as an utterly hopeless 
death sentence, in contrast to other more common cancers that are increasingly 
amenable to treatment. This conflicts with the health education message that 
proposes the need for early diagnosis of cancer in order to achieve a cure. 
Some patients and relatives may have heard reports of the chemotherapy agent 
for mesothelioma, pemetrexed, which has recently been reported as an 
effective, albeit not curative, treatment in terms of an increase in median 
survival time of 2.8 months and improved symptom control (Vogelzang et al, 
2003). However, the final decision concerning NHS funding for this treatment 
will not be announced for some months (NICE, 2007). 
 
Regardless of any prior awareness the diagnosis came as a shock to most 
people (p147-9). As reported in earlier studies, alongside the content of the 
disclosure of the diagnosis, the quality of the communication, in terms of the 
doctor‟s manner and language, was recalled vividly by patients and relatives 
(Thomas C et al, 2001:87-9; Frank, 1991:27, 50-51, 56; MacDonald, 2004:65-
9). The diagnosis of terminal disease is, by definition, a once in a lifetime 
occurrence, and becomes a personal horror story that is seared into memory; 
this mirrors the detailed and persisting recollection of bad news received in 
other severely shocking circumstances such as learning that a child has been 
murdered (Riches and Dawson, 1998) or that war has been declared. 
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Patients and, to a greater extent, bereaved relatives, expressed their 
recollection of the explanation of the diagnosis as a hopeless message –no 
treatment, no cure, no planned care, sometimes no referral on to support 
services. The devastating news was frequently accompanied by details of the 
entitlement to specific Industrial Injury Disablement Benefits and 
encouragement to engage a solicitor in order to pursue a claim for civil 
compensation. As many of the patients, bereaved relatives and nursing staff 
revealed, the combination of the bad news of the diagnosis with financial claims 
advice was felt to be inappropriate and too much information at one time; for 
many families it just added to the overall distress. The best time to introduce 
information about financial claims is not clear but it is evident from this study 
that, in most cases, it should not occur at disclosure of diagnosis. Perhaps one 
reason why this practice is so widespread is that doctors may regard financial 
compensation as the single positive message amongst the otherwise bad news; 
however patients and their relatives feel otherwise. Alternatively it may be that 
financial information is a distraction, or even a „blocking technique‟, employed 
by doctors in order to reduce the focus on the fatal disease and diminish their 
own anxiety amidst the emotionally-charged conversation about incurable 
disease and the lack of effective treatments (Macdonald 2004:67; Brennan, 
2004: 311-2).  
 
Fostering hope in this situation was obviously challenging for healthcare 
professionals and, in spite of the requirement that all healthcare staff involved in 
breaking bad news should receive training in communication skills, many 
reported in interviews that they felt inadequate for the difficult task. It was 
apparent that much more than communication skills training was necessary in 
these situations and this raises fundamental issues concerning the nature of the 
doctor-patient relationship. Some doctors were clearly comfortable in 
expressing to me their own emotional distress around disclosing the diagnosis 
of mesothelioma, exhibited concern, and were able to develop a closer 
relationship with some of the patients and their families than usual. Similarly, 
some patients and relatives reported much appreciation of close relationships 
with their doctors. This echoed Buckley and Herth‟s (2004) study that 
demonstrated how good doctor-patient relationships assist in fostering hope in 
terminal illness; indeed Balint (1957) famously conceptualised „the doctor as the 
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drug‟. It could be postulated that positive relationships contributed to 
meaningfulness and helped to restore sense of self in some patients.  
 
In the situation of terminal illness, the life-world of the ill person (and their main 
carer) contracts and becomes inwardly focused; the ill person may become 
extremely sensitive to the nature of their relationship with healthcare 
professionals. Palliative care professionals in particular may regard their role as 
extending beyond the purely professional to include a deeper interpersonal 
connection. However, Sandman (2005:6) points out that this must be a 
voluntary decision of the individual. It is well recognised that there may be a 
personal cost in repeatedly extending the usual boundaries of the doctor- or 
nurse-patient relationship in terms of emotional exhaustion, burn out and impact 
on personal life (Brennan, 2004: 365-389).  
 
Reactions to the diagnosis differed between patients and relatives. The patients 
seemed to take a variable time to get over the shock of the diagnosis but 
subsequently they exhibited a very similar pattern: they all reported wanting to 
try to maintain normality and make the best of the situation for as long as 
possible, relying heavily on their spouse for support within their own homes. 
Most patients appeared to accept their situation with a mixture of stoicism and 
fatalism. Bereaved relatives, on the other hand, recalled the diagnosis as 
shocking and distressing, were more questioning, often explored a variety of 
information sources and rapidly assumed new responsibilities and roles as 
necessary to support the situation. This reflects the „seeking behaviour‟ 
described in relatives of newly diagnosed stroke patients (Brereton and Nolan, 
2002) in which they made efforts to find out about the condition and what they 
needed to know and do in order to care for the person at home.  However, the 
essential difference is that in stroke there is the hope of some, if not total, 
recovery.  The different reactions to the diagnosis as reported here concerning 
patients and bereaved relatives must be seen in the light of the different 
methodologies used: the patients were interviewed whilst suffering from 
mesothelioma and facing impending death: their accounts reflected the way in 
which they were coping with their situation. On the other hand, the bereaved 
relatives were recalling their experiences in retrospect and through the lens of 
loss, and many were still grieving; these factors will have influenced their 
accounts. 
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Care pathways are increasingly used to reduce variations in care. However, as 
is obvious from the many unanswered questions regarding mesothelioma, the 
evidence base is not sufficient to enable robust guidance to be produced at this 
stage (BTS, 2001). The UK system contrasts markedly with the US, where first-
line treatment (for the 80% of the population covered by health insurance) now 
includes chemotherapy with pemetrexed. However this has to be seen in the 
context of two very different healthcare systems with differing funding 
arrangements. Any assessment of the NHS costs of pemetrexed should 
consider the low uptake of chemotherapy in mesothelioma: a recent study has 
shown that only 36% of patients are suitable for chemotherapy and, of these, 
less than half opted for treatment i.e. 17% of the total number of patients 
(Chapman et al, 2006). The trial that compares active symptom control in 
mesothelioma either alone or with chemotherapy is not expected to report until 
autumn, 2007 (Muers et al, 2004). Although even the best results from 
chemotherapy are modest in terms of improved survival and response rates, the 
decision not to fund pemetrexed, at an estimated cost of £9.6k per patient 
(Regional Drug and Therapeutics Centre, Newcastle, 2006) adds to the 
perceived neglect and disenfranchisement of people with mesothelioma. This 
contrasts with the successful highly-publicised public campaign that overturned 
the NICE decision not to fund the breast cancer drug, Herceptin at an annual 
cost of around £21k per patient (Netdoctor, 2006). 
 
However, if truly patient-centred care were considered, empowering those 
patients who wished to understand their illness, thus potentially enhancing their 
ability to cope with its impact, would be promoted. In some conditions this is 
being undertaken in the Expert Patient Programme (Department of Health, 
2001): this scheme enables patients with chronic disease to learn as much as 
possible about their illness and self-help measures, and to use this knowledge 
to educate and support others with the same condition. Sadly, this is not likely 
to be feasible in mesothelioma for many patients, given the median survival in 
this study of 294 days, although this may change if new chemotherapy agents 
improve survival in future.  However the information needs of families with 
regard to managing symptoms do not appear to be addressed and this could 
represent an intervention to be evaluated in the future (Chapter 8). Cancer 
charities have a long history of providing patients and relatives with information 
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and mesothelioma is no exception; Mesothelioma UK provides information for 
patients on its website, www.mesothelioma.uk.org.uk and patient education was 
the theme for the 2006 national conference of the Mesothelioma Applied 
Research Foundation in Chicago (MARF, 2006). 
 
The crisis of terminal illness 
Many respected authors have described the impact of terminal illness as a 
major identity crisis involving a sudden overturning of a lifetime‟s assumptions, 
hopes, and expectations with accompanying loss of self (Macnamara, 2001:35-
7; Bury, 1982; Brennan, 2004:21-33).  This ultimate existential personal 
challenge therefore requires a reconceptualisation or renegotiation of notions of 
self (Mathieson and Stam, 1995). Brennan (2004:12) explains the process of 
adjusting to a cancer diagnosis as the move from initial turmoil to the 
establishment of a more coherent „mental map‟ that reflects the new life world. 
He also points out features of post traumatic stress disorder with denial or 
avoidance strategies to minimise the initial impact followed by intrusive thoughts 
or flashbacks and increased arousal (Brennan 2004: 16). Similar characteristics 
were demonstrated in the interviews with patients but more noticeably in the 
bereaved relatives‟ accounts.  
 
Loss of self is connected to the perceived stigma associated with manifestations 
of illness (Goffman, 1963:3). In mesothelioma many factors contribute to 
stigma: notions of contagion associated with asbestos exposure; possibly self-
blame for being careless with asbestos (even if unaware of the dangers at the 
time); the generic stigma attached to any cancer diagnosis and the particular 
stigma by association with lung cancer; (Chapple et al, 2004), the visibility and 
social embarrassment of breathlessness and associated loss of agency; the 
unpredictable disruptions caused by pleural effusions; the severe bodily 
changes; the lack of effective treatments; the connection with financial claims 
involving legal processes; and, in some cases, unsatisfactory relationships with 
some healthcare professionals.  
 
Some of these issues are gendered: the majority of the male patients had 
worked in traditional, physically demanding, occupations in male-dominated 
industries where their physique was their capital and they also fulfilled a „manly‟ 
role at home by undertaking the more physically-demanding tasks. The loss of 
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gendered identity, as affecting sexual function, has been reported with regard to 
hormone treatments in prostate cancer that cause impotence but, in 
mesothelioma, the emasculation, hinted at by two patients in interview, appears 
to be more to do with loss of general physical function and change in body 
image resulting in loss of traditional masculine role.  Inevitably this alters the 
presentation of self and social interactions (although one male patient did report 
a sexual problem) (Brennan, 2004:127-130; Moynihan, 1998). However, loss of 
a traditionally gendered role also affected the female patients as they became 
too ill to undertake their normal domestic tasks. Costain Schou and Hewison 
(1999:85-92) describe this in terms of the impact of the illness on the patients‟ 
personal calendar as well as their role. 
 
The rapid progression of mesothelioma means that the illness usually impacts 
rapidly on many of these areas and, in contrast to more slowly progressive 
conditions, does not allow any time for adjustment. Charmaz (1983) reports how 
these conditions can impose „an all-consuming retreat into illness‟ and may lead 
to „an encompassing concern with self‟. To some extent this could explain 
relatives‟ reports that some patients became very demanding in advanced 
illness, seemingly inconsiderate of other demands on the carers‟ time.  
 
Another perspective on dealing with the challenge of a terminal illness derives 
from narrative and biographical studies and emphasises the need to regain a 
sense of coherence when life is disrupted by illness; this may be achieved by 
re-establishing a legitimate life story, a narrative that encompasses the 
curtailment of hopes and expectations and indeed life itself, in other words, by 
revising the way in which life has previously been understood (Frank 1991:60; 
Kellehear, 1996:157). Narrative accounts do not necessarily report literal truth 
but they do reveal how people experienced their individual situations. In these 
accounts the narrative eventually becomes the experience, evolving meaning 
with the telling and retelling, and also impacts upon the listener and becomes 
the understanding and meaning of the illness for them too (Kleinman, 1985:49-
50). Biographical approaches, in which patients are enabled to produce a 
written „life storybook‟ have been shown to enhance family relationships and 
improve staff attitudes to older people (Clarke et al, 2003). Similarly, Frank, 
(1991:59-68), a sociologist who has experienced cancer and a heart attack, 
illuminates how suffering due to illness requires a narrative that attempts to 
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reform the disrupted „life map‟ and loss of self caused by illness. Cassell (2004: 
106, 282-3) contrasts reductionist medical case histories with the broader 
patients‟ illness stories and emphasises the value of listening to patients‟ illness 
narratives in order to understand how they experience their conditions and how 
to direct any interventions in terminal illness towards the patients‟ own goals 
rather than at the disease. Similarly, Kleinman (1985:121-36) illustrates that an 
understanding of patients‟ illness meanings can lead to more effective care. 
These authors make a strong case for the value of illness narratives in 
improving care of patients and reducing their suffering. 
 
It has been argued that patients with terminal illness need to find a new 
meaning within the unfamiliar context of facing death, and in order to do this 
there needs to be some balance between despair and hope: life without hope is 
meaningless (Buckley and Herth, 2004). There is an increasing body of 
literature illuminating the importance of helping patients to regain a sense of 
hope even in the most dire circumstances; much recent work relates to people 
suffering from AIDS/HIV (Kylma, 2005). In the accounts of patients with 
mesothelioma many features combined to diminish hope: the prior knowledge of 
mesothelioma as a terrifying fatal disease, sometimes within the patient‟s 
family, the perceived (or actual) communication from doctors that „nothing can 
be done‟, uncontrolled breathlessness and/or pain, the loss of agency and 
control compounded by rapid bodily deterioration, the erratic unpredictable 
disease trajectory, notions of stigma and contagion as well as the unfamiliar and 
worrying involvement in claiming State benefits and litigation. The bereaved 
relatives‟ accounts also reflected hopelessness, often in combination with 
helplessness, leaving them feeling inadequate and impotent. Hopelessness, 
helplessness and despair, have been shown to be inter-related and predictors 
for depression and suicide (Breitbart and Krivo, 1998:542-3).  
 
The meaning of the ‘coping narrative’ 
The patients with mesothelioma experienced rapidly deteriorating health, 
unpredictable emergency admissions due to recurrent effusions, and multiple 
invasive medical interventions that all impacted upon their normal activities. 
McNamara (2001:35-7) explains that patients seek to understand their new 
„illness identity‟ in terms of the effects of the bodily changes and that 
deterioration reinforces their gradual loss of self and awareness of impending 
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death. Similarly, Cassell (2004:33-6) describes how uncertainty around 
unpredictable symptoms and their management leads to loss of control which 
compounds the identity crisis of terminal illness; previously competent mature 
adult patients and their close relatives become disabled by loss of agency. 
Patients approaching death are confronted with multiple losses and fears, often 
the fear relates to the process of dying more than the loss of life. Loss of 
identity, independence, and the expected future life, commonly feature in the 
concerns of patients close to death. Fears tend to focus on separation from 
loved ones and the familiar life, uncontrolled symptoms, being a burden, as well 
as the dying process (Brennan, 2004: 268-270). As Charmaz (1983) points out 
„the language of suffering is a language of loss‟.  In spite of these factors, a 
striking feature of the patients‟ accounts was their determination to assure me 
that they were coping; I have called this „the coping narrative‟ and will now 
elaborate on it.  
 
The patients‟ emphasis on being in control and coping may have been one way 
of maintaining a sense of coherence at a time of turmoil. Terminal illness 
destroys prior notions of identity and purpose; in this chaotic situation it may be 
important to retain some degree of control wherever possible and that may be 
easier to maintain in conversations with a stranger than with family and friends 
Moynihan (in Brennan, 2004:162-4) describes gender differences in coping 
strategies in terminal disease: she describes men with prostate cancer „coping 
with silence‟. This may again relate to characteristics of the men from this 
generation and socio-demographic group in whom displays of emotion are 
regarded as unmanly  
 
In his book, The Wounded Storyteller (1995), Frank categorises three typical 
illness narratives: the restitution narrative that seeks a positive outcome, the 
raw uncontrolled chaos narrative that is disrupted with no hope of an acceptable 
outcome - „sucked into the undertow of illness‟, and the quest narrative in which 
illness is experienced as a journey or transformation.  The „coping narrative‟ 
identified in this study can be interpreted in a variety of ways, illustrating the 
complexities of the lived world experience that are revealed by qualitative 
enquiry (Kvale 1996:5; Kleinman, 1988:49-50). Although it may seem 
tautologous to describe the „coping narrative‟ as a coping strategy, this is 
nonetheless what the study appeared to reveal. 
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It seemed that „coping‟ was a positive choice and was essentially a vital 
component of a restitution narrative that sought to contain the catastrophe of 
terminal illness (Frank, 1995:77-84). Coping is associated with traditional 
masculinity in British culture and is part of the metaphorical „stiff upper lip‟ that 
typifies the male response to crisis as stoical, competent, unemotional, and 
dependable. In contrast, „not coping‟ is seen as a dereliction of masculinity. 
Patients, and their spouses, referred to themselves as „coping‟ even when 
circumstances were obviously difficult. This can be compared to accounts from 
men with advanced prostate cancer who expressed themselves as usually 
being well, in spite of their terminal illness, and revealed that their sense of 
„wellness‟ depended more on not being acutely ill or symptomatic than any 
medical definition of being well in terms of absence of disease (Lindqvist et al, 
2006). The patients with mesothelioma were mostly symptomatic and were 
telling their illness stories, thus they could not represent themselves as being 
„well‟ but perhaps their perception of, or desire to be seen as, „coping‟ was an 
alternative positive stance that had „not coping‟ as its counterpoint. The patients‟ 
concerns that were expressed about „not coping‟ mainly related to uncontrolled 
physical symptoms rather than emotions, although there was a hint of fear of 
losing emotional control in one man who wondered how he would cope when 
things got worse, remembering how his father had suffered when dying from 
mesothelioma. Perhaps related to the coping narrative, two male patients with 
mesothelioma did describe making efforts to attempt to stay „healthy‟, and this 
contradicts the traditional Men‟s Health discourse that presents men as doing 
little or nothing to protect their health (Gough, 2006). These efforts may also 
represent an element of regaining control over a chaotic situation – another 
version of the restitution narrative. 
 
„Coping‟ can be seen as a way of regaining some mastery over the disruption of 
life as it was and as it had been expected to continue, note the gendering of the 
term „mastery‟. Even when a medical or social assessment of coping would 
have concluded that assistance was required, the patients‟ responses reflected 
their (unspoken) need to keep up the „pretence‟ (or performance in Goffman‟s 
(1959:44-59) terms) within the family, or, more particularly, outside the family, 
that they are in control of the situation. This highlights one of the alarms raised 
by Lindqvist et al’s (2006) study which illustrated that, by focussing on the 
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physical problems in advanced disease, healthcare professionals may actually 
interfere with patients‟ strategies to find meaning and hope in their situation and 
to regain some degree of control. There are also problems with medical models 
of coping that categorise the ways in which people cope with, or adjust to, 
terminal illness: applying singular labels to these issues, such as „emotion-
based coping‟ or „fighting spirit‟, diminishes the complexity and individuality of 
each patient‟s own response and does not acknowledge that coping is not a 
fixed entity and varies with time and situation (Brennan, 2004:23) 
 
The perception of coping may be one way of fostering hope when facing death. 
The „resigned acceptance‟ reported in earlier work concerning the psychological 
reactions to mesothelioma could be seen as reflecting hopelessness (Lebovits 
et al, 1983). In attempting to fend off despair, arguably a rational reaction to 
impending death in a secular society, the development of a coping narrative 
engenders hope and restores a sense of self. This may be particularly relevant 
in these patients from traditional families and „old-fashioned‟ industries because 
it supports the traditional masculine hegemony. The interviews also revealed 
that although most patients were presenting themselves in the interviews as 
coping, there were brief acknowledgements that sometimes the „mask slipped‟ 
and emotional distress could not be held back. The exception was the 
„devastated‟ man who was too ill to speak: in his case his physical condition 
was so weakened that with only days to live he had lost all agency; in this 
situation his loss of self was „non-negotiable‟ (Lawton, 2000:117) and, without 
hope, he exhibited complete despair. Whereas the patients‟ accounts to me 
focussed on their ability to cope, the bereaved relatives told a different and 
more intimate story of severe distress, hidden behind closed doors and 
contained within the family, usually between husband and wife. The findings 
mirror many reports of living with terminal illness in which patients oscillate 
between hope and despair, often referred to as the „emotional roller coaster‟ but 
in mesothelioma, survival time is shorter than for many common cancers and 
the adjustment process may be impaired by rapid physical decline, punctuated 
by crises, that has an additional negative impact on hope.  
 
The coping narrative links to two other perspectives on how patients cope with 
terminal illness. Folkman and Lazarus (1988) defined two categories of coping: 
emotion-based and problem-based coping. These categories tended to be 
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gendered, with men more likely to exhibit problem-based coping than women. 
Morse (2001) distinguished between suffering experienced as enduring and 
alternatively as emotional suffering. It would seem that the narrative of coping, 
as expressed by the patients with mesothelioma, has features in common with 
both problem-based coping as opposed to emotion-based coping and enduring 
as opposed to emotional suffering. This should not come as a surprise given the 
personal characteristics of the patients involved in this study and reflecting the 
types of lives they had lived – they approached dying in the way that they had 
lived. However, two patients were exceptional in that they made practical plans 
to assist their spouse in bereavement and these patients were both women. 
This contradicts the Folkman and Lazarus (1988) theories of coping in which 
women tended to exhibit emotion-based coping and men, problem-based 
coping. In this study the women patients were the practical ones when it came 
to planning ahead. Perhaps this can be seen as a demonstration of reciprocal 
caring in which these wives were thinking more about their husbands, and how 
they would cope when alone, than themselves. 
 
Thus coping may be seen as an active and unemotional means of „enduring‟ an 
illness rather than the passive and emotional „suffering from‟ it (Morse, 2001). 
Morse illustrates how enduring focuses attention on the present and this has 
obvious benefit in mesothelioma if it allows patients to „live for the day‟ and 
avoid the future confrontation with impending death and the past issues to do 
with blame and causation. Emotional suffering on the other hand reveals the 
reality of all that is lost when life is ending. It appears to demonstrate 
hopelessness and helplessness, and the visible nature of emotional suffering 
impacts on those close to the patient. Unemotional coping may have been one 
way in which to handle anger and other negative emotions. Previous studies of 
patients with mesothelioma revealed anger as a common reaction and related 
to the culpability of negligent employers who failed to implement asbestos 
safety procedures (Lebovits et al, 1981 and 1983). Frank (1991:112), writing 
about his personal experience of cancer, criticises the notion of the typically 
passive cancer patients and explains that patients with cancer cannot risk being 
angry as it could alienate healthcare staff and thus potentially impact on their 
treatment; he states that patients with cancer tend to express anger when they 
feel they have nothing left to lose. This resonates with the anger in the focus 
groups with bereaved relatives: they certainly felt they had nothing left to lose 
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(Boxes 5.7 and 5.8). As Hill et al (2003) report, patients with lung cancer have 
many concerns about the burden of the illness on their family, this is another 
reason why patients attempt to reduce the manifestation of emotional suffering. 
Many of the bereaved relatives‟ accounts reflected pride in the way that their 
loved ones had borne their illness with great fortitude, reflecting the metaphor of 
the „heroic‟ patient in their battle with terminal disease in which perseverance 
and stoicism, rather than physical superiority, are the elements of mythical 
heroism - another restitution narrative that reflected „rising to the challenge‟.  
(Frank, 1995:117-9). 
 
The coping narrative may have been a useful and effective device to block 
enquiry that might follow an admission of problems in order to prevent 
emotional distress for the patient and/or their spouse. On the other hand, this 
also let me, as the researcher, „off the hook‟ and led me away from enquiring 
into sensitive areas, thus fending off potential distress for me too – this 
(subconscious) apparent collusion was not noticed during the interviews but 
grew from my later considerations and interpretation of the data. Perhaps, if 
serial interviews had been conducted, further delving into „not coping‟ may have 
been possible but it would have been essential to be sensitive to the ethical 
issues inherent in any interaction that could impair patients‟ strategies for 
dealing with their illness.  
 
However, I reach a different conclusion to Frank (1995:94) in consideration of 
the problems he envisages with restitution narratives when the disease is not 
amenable to treatment: Frank states that in such circumstances „other stories 
have to be prepared or the narrative wreckage will be real‟. My interpretation 
from this study is that it is possible to develop restitution narratives in the face of 
terminal illness in which the eventual positive outcome is a good death, or 
perhaps more accurately „good dying‟, rather than recovery from ill-health. This 
is articulated in the „coping narrative‟ as described above, in which the elements 
can be summarised as: coping as a positive choice, coping as mastery, coping 
as fostering hope, coping as enduring, and coping as a blocking tactic. 
 
Finally, it has to be remembered that the patients who were interviewed had 
volunteered for the study. In some cases they revealed an altruistic motive for 
participating in the interviews and this would also support the notion of a 
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restitution narrative, perhaps in terms of a „manifesto‟ (Frank, 1995:120-1). 
However, given the multiple concerns that patients with mesothelioma are faced 
with and the link between severe psychological distress, symptom burden and 
lung cancer (Zabora et al, 2001), as well as the severe emotional distress 
exhibited in the focus groups with bereaved relatives, it must be considered that 
patients with mesothelioma inevitably face a severe psychosocial burden. 
Although it is beyond the scope of this study, it must be considered whether 
another category described by Frank (1995:97-114), that of the „chaos or 
unspeakable narrative‟, might apply to some of the non-participants and that the 
„coping narrative‟ may be the most acceptable alternative for some patients in 
contrast to revealing the actual horror of the situation.  
 
7.4 The disease burden, trajectory and service usage 
 
Disease burden is a term used in epidemiology to describe the loss of expected 
years of life due to a particular disease and relates to the impact on productivity 
and economic contribution that individuals make to society (WHO, 2007). In this 
chapter I will use the term in a less technical sense: disease burden in this 
context relates to symptom burden; the impact of medical investigations and 
interventions; the psychological and social toll of the disease; the progression of 
the disease, as well as the untimely, potentially preventable, and unanticipated 
death. In view of their interconnectedness, this subchapter considers disease 
burden, trajectory and service usage together. This study did not aim to conduct 
statistical or economic analysis of healthcare services utilised by patients with 
mesothelioma but, as shown in Chapter 3, was able to determine the figures for 
hospital admissions, GP consultations and outpatient attendances in the last 
year of life from the medical records sample.  
 
The severity of the symptoms and the disease impact, discussed earlier are in 
line with Nowak et al’s (2004) study: patients with mesothelioma completing the 
EORTC QLQ-C30 quality of life questionnaire revealed higher scores in the 
areas of pain, social role and functioning, and equal scores for breathlessness, 
when compared with patients who had lung cancer.  
 
All the data sources demonstrate that patients had a considerable number of 
encounters with healthcare staff due to the specific symptom burden, the 
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difficulty in achieving a diagnosis and the particular problems around 
management of recurrent pleural effusions as well as for terminal care in most 
cases. Presumably the fact that „best practice‟ has not been determined for 
mesothelioma accounts to some extent for the variation in management, both 
between individual patients, and across the three study sites. However, even 
when guidelines are available, such as the BTS (Antunes et al, 2003) guidance 
on the management of pleural effusions, (Box 1.2) and also the BTS (2001) 
statement on mesothelioma that suggests early referral to palliative care, they 
do not appear to be implemented – a situation by no means unique to 
mesothelioma. A Mesothelioma Framework (Department of Health, 2007) has 
just been launched by the Lung Cancer and Mesothelioma Advisory Group of 
the Department of Health – this provides guidance to Trusts, Cancer Networks 
and purchasers on „the optimum organisation of services for patients‟ but is not 
an evidence-based clinical guideline (Peake, 2007). The BTS Statement on 
Mesothelioma (2001) is also currently being updated. However, given the 
dearth of new research in mesothelioma, and the historical privileging of 
oncological and technical approaches above palliative care, it is to be hoped 
that these opportunities to promote the pivotal role of palliative care will not be 
missed. 
 
Presentation and referral 
The most likely reason for the relatively early presentation of patients with 
mesothelioma to their GP is the highly-symptomatic onset due to pleural 
effusion and/or pain in most cases, although it is not possible to ascertain from 
this study to what extent insidious symptoms may have been present prior to 
the acute presentation and for how long. The medical records survey revealed 
that the median time from recorded symptom onset to presentation to GP was 
17 days, (mean 43 days, range: same day -212 days). Studies in lung cancer 
tend to show longer intervals: for example, mean 138 days for non-specific 
symptoms and 72 and 79 days for dyspnoea and cough respectively 
(Thompson and Hetzel, 1997) and between 21 and 93 days in „almost two thirds 
of patients who attended their GP because of chest symptoms‟ (Kirshnasamy 
and Wilkie, 1999: 52). The longest delays to presentation in this study were 
attributable to patients having complicating co-morbidities that obscured the 
significance of new symptoms. Contrastingly, Hawley‟ et al’s (2004) interview 
study with 9 patients with mesothelioma in Australia found „considerable‟ (but 
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un-quantified) delays between symptom onset and presentation to hospital 
similar to lung cancer but these different patterns may reflect different funding of 
healthcare and different access to services, for example due to rurality. 
 
From the medical records survey, and confirmed by the interviews with patients, 
GPs tended to act quickly when a patient with breathlessness and/or chest pain 
presented to them, with the result that most patients were seen in hospital 
within a month of onset of symptoms. However the median interval between 
symptom onset and presentation at hospital varied from 30 days in Barrow and 
Leeds, to 80 days in Doncaster, giving an overall median interval of 36 days; 
this difference across the sites is unexplained. Examination of the notes of 
patients with the longest intervals revealed that they tended to have 
complicating co-morbidities to which new or deteriorating symptoms were 
attributed initially, but this was not more common in the medical records from 
Doncaster patients. This situation of relatively rapid access to hospital services 
reflects the situation in three areas where mesothelioma is relatively common 
and therefore doctors might be expected to have a high index of suspicion for 
the diagnosis when presented with typical symptoms. However, it is more likely 
that the dramatic presentations of rapidly developing breathlessness and/or 
pain prompt the early referral to hospital. In lung cancer it appears that patients‟ 
decisions to see their GPs relate to the number of new symptoms rather than 
severity of symptoms (Krishnasamy and Wilkie, 1999: 52). In this mesothelioma 
study and the lung cancer study, (Krishnasamy and Wilkie, 1999:55) similar 
percentages (15% and 16% respectively) of patients accessed hospital services 
without GP referral. 
 
Confirming the diagnosis 
Delay in reaching diagnosis is common in mesothelioma (BTS 2001) and in this 
study confirming the diagnosis took over three times as long as in lung cancer. 
In lung cancer, 43% of patients received the diagnosis within 2 weeks of having 
a chest x-ray in line with national guidance (Krishnasamy and Wilkie, 1999:55; 
BTS, 1996). In the same study, the longest delay from hospital presentation to 
diagnosis was 8 months and related to one of the 8 patients with mesothelioma 
(n=208). The authors comment that delays in diagnosis in lung cancer usually 
relate to lack of a co-ordinated approach to investigation, usually when patients 
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have not been referred to a consultant in respiratory medicine initially. This may 
be relevant to delayed diagnosis in mesothelioma but there are additional 
technical problems related to obtaining and analysing histological specimens. 
The medical records‟ review revealed lack of histological confirmation of 
mesothelioma in 22% of patients before death (page 108). The challenges of 
diagnosis reflect the acknowledged problems in histological analysis and 
differing levels of access to thoracoscopy that affects the yield of biopsies; 
consequently there are calls for greater access to the relatively new technique 
of medical thoracoscopy and for a national reference laboratory for 
mesothelioma (Munaavar, 2006; Haselton, 2001). The median interval of 79 
days between hospital presentation and diagnosis represents a long time in 
limbo for patients and their relatives, and the interviews revealed that this 
caused great distress for patients and relatives and reduced their confidence in 
doctors. 
 
Disease trajectory 
The course of the disease was one of several emergency presentations due to 
effusions and brief deteriorations followed by partial improvement after invasive 
procedures such as thoracoscopy or pleurodesis, usually superimposed on 
relentless decline. Illustrative representations of the disease trajectory have 
been produced for cancer, chronic organ failure, and frail elderly or dementia, 
and they have been useful in drawing attention to the differing ways in which 
these different diseases tend to progress (Lunney et al, 2003). More recently 
these typical trajectories have been promoted as a useful tool in palliative care, 
extending beyond cancer diagnoses (Murray et al, 2005a and 2005b; Dy and 
Lynn, 2007). These illustrations, although criticised for being „unscientific‟, (if 
there is no standard measurable variable on the vertical axis), are nevertheless 
helpful in focussing the attention, in a conceptual sense, of healthcare 
professionals on proactive care. Trajectories have also challenged researchers 
to determine how the terminal phase can be identified with the intention of 
thereby improving patient care, particularly in respect of diseases other than 
cancer, by „countering the technological imperative‟ and signalling the time for 
referral to palliative care (Murray et al, 2005a). However, with the median 
prognosis in mesothelioma of less than 10 months in this study, the latter 
consideration should be irrelevant and all patients should be referred at 
diagnosis (BTS, 2001).  
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It is possible to use an illustrative representation of the disease trajectory in 
mesothelioma to show just how different it is compared with most cancers, 
Figure 7.1. The dip at the start of the graph represents the initial presentation 
with severe shortness of breath due to a large pleural effusion, with or without 
pain. After pleural aspiration, symptoms improve for a short time then recur 
when the effusion recurs. Further deteriorations in symptoms occur with 
recurring effusions and with pleurodesis or thoracoscopy but the disease 
usually progresses rapidly and leads to death within the year in 63% of cases, 
with a median survival of 294 days. There are specific challenges concerning 
the mesothelioma trajectory: delay in diagnosis shifts the start of the graph; 
there may be different trajectories relating to differing histological types that are 
known to impact on prognosis; and there may be subsets reflecting recurrent 
pleural effusions requiring more interventions or pain at presentation, which is 
an indicator of worse prognosis. 
Function*
Time Median survival = 294 days
*
 
           Figure 7.1 Disease trajectory in mesothelioma (*„Function‟ represents 
estimated performance status) 
 
In Figure 7.1 above, „function‟ on the vertical axis is derived from all four data 
sources whereas in more scientific representations it represents measurements 
of ability to perform activities of daily living (ADL). A more accurate picture 
would require a prospective study of serial measurements of function relating to 
ADL in a statistically valid number of patients with mesothelioma. The ethical 
and practical challenges of this type of enquiry involving people close to death 
have resulted in relatives being used as proxies, although concerns around 
reliability have been described earlier (p71). Nevertheless, further investigation 
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of the disease trajectory in mesothelioma would appear to be worthwhile and 
may inform decisions concerning treatment options. 
 
Hospital care 
The medical records survey revealed a considerable burden of medical 
interventions for patients with mesothelioma in the last year of life: median 
figures demonstrated attendance at 5 outpatient clinics, two or three admissions 
to hospital, one attendance at a Day Unit and 10 consultations with the GP, 6 of 
these as home visits. This is in comparison with perhaps one admission of 3 or 
4 days for patients with lung cancer (Krishnasamy and Wilkie, 1999:100).  In 
addition, a third of patients with mesothelioma may access hospice facilities, a 
few see benefits advisors, and the majority also receive care from community 
nursing teams, lung cancer clinical nurse specialists and Macmillan nurses.  
 
Deficiencies in the organisation of the care of patients with cancer have been 
highlighted in the Cancer Plan (DH, 2000b) and recent guidance on supportive 
and palliative care (NICE, 2004) particularly regarding inter-professional 
communication and coordination of services. The Cancer Plan promoted the 
development of multi-disciplinary teams that have been shown to improve the 
co-ordination of care of cancer patients and reduce clinical variation. It has also 
been demonstrated that for specific cancers, excluding mesothelioma, delays in 
diagnosis and treatment have been much improved by Cancer Plan 
performance targets (National Audit Office, 2005). However, this system 
appears to disadvantage patients with relatively rare cancers such as 
mesothelioma. Mesothelioma is included in lung cancer MDTs regardless of 
how much experience the MDT members have concerning this disease. Given 
the many differences between lung cancer and mesothelioma, such as 
causation; incidence and distribution; symptoms; difficulty in diagnosis; 
trajectory; lack of effective treatments and problems with palliation, lung cancer 
MDTs are not necessarily the ideal place to situate mesothelioma – but in the 
absence of any better arrangement it is the best compromise. Similarly the 
patients are usually referred to a Macmillan nurse on a geographical rather than 
diagnostic basis and again experience of mesothelioma is not taken into 
account93. 
 
                                                 
93
 The new Mesothelioma Framework (2007) is designed to address these service provision issues  
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Ethical dilemmas surround the issue of offering experimental chemotherapy of 
minimal potential benefit to patients with terminal illness; issues such as the 
definition of medical futility (Brody, 1997); allocative justice; patient autonomy; 
paternalism and medical nihilism to name a few. However, Slevin et al (1990), 
caution that healthcare professionals and patients have differing perceptions of 
risk and acceptability regarding chemotherapy: patients with cancer find „low 
benefit‟ chemotherapy more acceptable than the professionals. This raises 
questions about the accuracy of patients‟ understanding of issues such as 
statistical risk information; opportunity costs; the need to believe that something 
can be done; and the quality of any information of the benefits of palliative care. 
O‟Neill (2003) describes the ethics of patients‟ decision-making as having three 
components: competence, access to adequate information and voluntarism. 
The importance of the manner in which information is provided and the quantity 
given is key: O‟Neill (2003) stresses the value of allowing the patient to select 
when and how much information is given, that it may be extended „in layers‟, 
and that patients are assured that they can rescind decisions without penalty. A 
further complication is the dependent relationship between patient, particularly 
with life-threatening illness, and doctor, as described by Frank (1991:112); this 
may lead to the patient attempting to „best guess‟ the decision that would meet 
with their doctor‟s approval (Harris, 2003). 
 
 
Palliative care 
It is both disappointing and surprising that less than half the patients (49%) 
were referred to palliative care in the survey of medical records, given the high 
symptom burden, terminal nature of the disease, and the short median survival. 
This finding mirrors results from Hawley et al’s (2004) study of mesothelioma in 
Australia: they found that delay in referral to palliative care was related to the 
working definition of palliative care used by the referring doctor: those who 
believed that palliative care equated to terminal care referred late and, 
interestingly, this belief appeared to be shared by patients and their relatives. 
Similarly, Jarrett et al (1999) suggested that patients and relatives who hold 
restricted views of the role of specialist palliative care teams may be 
disadvantaged by not revealing aspects of need that do not fit with this view and 
also demonstrated that satisfaction with services is directly related to patients‟ 
and relatives‟ expectations of those services. Late referral was found to limit the 
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value of the palliative care involvement; early referral allowed trusting 
patient/nurse relationships to develop; fostered communication around hopes 
and fears; enabled access to 24 hour support and advice services; improved 
co-ordination of care, and increased the likelihood of patients dying in the place 
of choice. Barriers to accessing palliative care included poor co-ordination of 
services and lack of knowledge of mesothelioma and the Dust Diseases 
Board94 (Hawley et al, 2004).  
 
UK studies have also demonstrated benefits for patients when they are referred 
to specialist palliative care services but that there is inequity of access (Hearn 
and Higginson, 1998; Clark et al, 2005:Ch.8). Factors likely to affect access in 
mesothelioma are the delay in diagnosis; lack of awareness of the steep and 
erratic trajectory; the „therapeutic imperative‟ that privileges active treatments 
and interventions over the palliative care approach; lack of understanding of the 
benefits of palliative care, and medical attitudes, including nihilism. In addition, 
there are resource issues with almost 100 vacant consultant posts in palliative 
medicine in the UK (Association for Palliative Medicine, 2005), variable 
provision of palliative care teams across the UK and uneven distribution of 
hospices and associated services such as Hospice at Home (Wood et al, 2004). 
Nevertheless, the severe symptom burden and specific needs would suggest 
that input from specialist palliative medicine may be needed as much, if not 
more, in mesothelioma than in other cancers, as suggested by the BTS (2001) 
 
Community care  
 
Most of the final year of life of patients with cancer is spent at home and GPs 
and community nurses provide the majority of the healthcare during that time 
(Thomas et al, 2001). This study found similar results: 90% of the time from 
presentation to death was spent at home but the incidence of mesothelioma is 
such that even GPs in the highest incidence areas see at most two cases per 
year and most GPs do not see even one case per year95. In contrast, GPs see 
up to 10 new cases of lung cancer each year, usually between one and five 
                                                 
94
 The Dust Diseases Board refers to The Workers’ Compensation Dust Diseases Board (DDB) of New 
South Wales: this is a statutory body that provides state financial benefits to people who have developed 
mesothelioma as a result of occupational exposure to asbestos. 
95
 In 25 years as a GP practising 10 miles from Barrow-in-Furness I cared for 4 patients with 
mesothelioma but the first 2  were so memorable, and their management so challenging, that they 
prompted this study. 
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(Krishnasamy and Wilkie, 1999:94). The medical records data showed 
considerable involvement of most GPs in supporting their patients with 
mesothelioma in the community, in line with studies confirming that care of 
patients with terminal illness, although sometimes demanding, is regarded as 
an important and satisfying GP role (Field, 1998; Borgsteede et al, 2006). The 
focus group reports confirmed the central role of the District Nurse in 
maintaining patients in their own homes and supporting the carers (King et al, 
2006). The role of the Macmillan nurses was less related to direct hands-on 
care but was related to giving information about the illness, benefits and 
services. This echoes work by Skilbeck and Payne (2005) that revealed that 
GPs preferred to work alongside District Nurses than Macmillan nurses with 
terminally ill patients. Although the paper questioned this preference, it is 
understandable for two reasons: the GP and District Nurse frequently work 
closely together in the care of many shared patients and meet regularly, thus 
developing a strong working relationship over time and the patient and District 
Nurse may also have a long-established relationship; the GP may only have a 
few terminally ill patients each year of who approximately a quarter will have 
cancer and therefore the contact with the Macmillan nurse will be less frequent. 
The changing role of the Macmillan nurse, moving away from hands-on-care to 
a more advisory and educational role, has been criticised by Skilbeck and 
Payne (2005) and this was echoed by one bereaved relative whose 
expectations of the service had not been met (Box 5.7).   
 
The NHS is currently developing an extensive programme to address the care 
of patients at end-of-life and this includes three initiatives designed to improve 
end-of-life care: firstly the Gold Standards Framework (Thomas, 2003; Thomas 
and DH, 2005) which is a tool that assists GPs in identifying patients in the 
palliative stage, keeping a register of all palliative patients and adopting a 
systematic approach to their care; secondly, the Liverpool Integrated Care 
Pathway (LICP)  is a tool that ensures a systematic approach to the care of 
people with cancer in the last few days of life, and thirdly, the Preferred Place of 
Care is a document that enables patients to make decisions about where they 
would like to receive care at the end-of-life (Department of Health, 2004; NHS 
End of Life Care Programme, 2007; Storey et al, 2003).  
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The Gold Standards Framework, (GSF), is linked to the Quality and Outcomes 
Framework that attracts GP remuneration. Alongside a useful website, 
(www.goldstandardsframework.org.uk), that details prognostic indicators which 
help to identify the palliative stage in cancers and chronic illnesses, GPs are 
advised to use the „surprise question‟ – ‘Would I be surprised if my patient were 
to die in the next 12 months?’ – in order to identify patients who should receive 
active palliative and supportive care (Murray et al, 2005). Using this criterion, all 
patients with mesothelioma should be included in GPs‟ palliative registers at 
diagnosis and thus access palliative care routinely. A small evaluative study of 
the GSF suggests that it improves practice in primary care (Thomas and Noble, 
2007) and GPs value its introduction (King et al, 2005). 
 
The Preferred Place of Care document requires training of community nursing 
teams in advanced communications skills and palliative care before it is 
implemented and this has delayed its general implementation (Storey et al, 
2003). Alongside these developments, charitable funding has provided for 
Macmillan GP Facilitator posts to improve knowledge of palliative care in rural 
Primary Health Care Teams (Noble et al, 2001). However only 14% of patients 
with mesothelioma died at home in contrast to the national average, around 
26%, and against the 50-70% of cancer patients who wish to die at home (Table 
3.28; Higginson et al, 1998; Gomes and Higginson, 2006); this supports the 
proposition of mesothelioma as a particularly burdensome disease. 
 
Although the aim of improving end-of-life care by these three initiatives is 
laudable, they have attracted some criticisms. Finlay (2006) comments that „the 
End-of-Life Care initiatives may help but cannot substitute for personal care‟. 
The routinisation of care conflicts with the principle of individualised care 
espoused by hospice and palliative care and it has been suggested that these 
systematic approaches represent a further example of the medicalisation of a 
natural phase of life (Clark et al, 2002).  
 
Hospice and voluntary sector care 
Patients with mesothelioma were found to access hospice services in over a 
third of cases, with one third of deaths occurring in hospices; in other cancers 
18% die in hospices (Eve and Higginson, 2000). This is likely to be related to 
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two factors associated with hospice admission: precipitous functional decline 
and severe symptom burden (Teno et al, 2001; Clark et al, 2005).  
 
The role of the voluntary sector in providing palliative care has now been 
acknowledged in the Cancer Plan (DH, 2000) to ensure „realistic‟ funding for 
„core services‟. Macmillan Cancer Support is the only UK cancer charity that 
funds posts specifically related to mesothelioma: these include a combined lung 
cancer and mesothelioma clinical nurse specialist post, a part-time nurse 
consultant and an administrator running the charity, Mesothelioma UK, that 
provides information and advice to patients, relatives and healthcare 
professionals via a telephone helpline and the website: 
www.mesothelioma.uk.org and also runs educational events. The need for this 
service is evident from approximately 600 telephone calls per annum and over 
20,000 hits on the website in 18 months (Mesothelioma UK, 2006). 
 
7.5 Caring within the family 
 
The very term „carer‟ causes problems for lay people: in Smith‟s study of 16 
family caregivers less than half „readily identified themselves as a carer to their 
loved one‟ and participants also described considerable confusion around the 
definition and role (Smith, 2001). Nevertheless, in this study the term is used to 
denote untrained lay informal family members who provided the majority of the 
care for people suffering from mesothelioma, the majority were wives of 
patients. Although acknowledging concerns around bereaved relatives‟ proxy 
accounts of patients‟ suffering (Addington-Hall and McPherson, 2001), these 
issues were only part of the experience of caring; this study was investigating 
the experience of mesothelioma and the bereaved relatives were primarily 
reporting their recollections of their individual experiences as carers.  
 
 
The carer’s role and responsibilities 
The roles and responsibilities of family members who take on a major caring 
role in the home have been well described (Brennan, 2004:134-9; Rose, 2001; 
Soothill et al, 2001). The extensive and often unfamiliar tasks of family caring at 
the end of life can be summarised as: personal care; emotional care; domestic 
care; management of finances and ongoing care of other dependents such as 
 289 
elderly parents or children. Alongside the distress of trying to cope with the 
impending death of a lifetime spouse or partner and sharing the experience of 
their suffering, these carers‟ tasks are acknowledged to be exhausting, 
physically and emotionally, to the extent that, in cancer, carers‟ needs may 
exceed those of the patients (Harding and Higginson, 2003).  
 
Family care giving is culturally situated: societal norms colour attitudes and 
expectations around caring at the end-of-life (Oliviere and Monroe, 2004:31). 
Rose (2001) postulates that, if caring is seen as a normal activity based on 
reciprocity and altruism, this might explain why caregivers expect little other 
than information from healthcare staff. Conversely, this could explain why the 
healthcare system does not have a systematic approach to supporting carers 
(Harris, 1998). In this study the bereaved relatives did not question the value or 
appropriateness of fulfilling the carer‟s role, thus supporting (traditional) 
society‟s expectation that wives in particular would provide care and comfort to 
ill spouses. Between 58 and 75% of carers are women (Lee, 2001b; Office of 
Population Consensus and Surveys, 1990) and Lee (2001b) revealed that 
although many women, particularly if older, internalised the „natural‟ ethic of 
care; others felt that caring was a social imposition based on sexist 
assumptions. There is less written concerning the husband‟s role as carer but 
the two husbands of patients who were interviewed exhibited similar 
commitment to the caring responsibilities as the care-giving wives.  
 
The study findings supported earlier work showing that younger women, in the 
„sandwich generation‟ particularly, suffer from the burden of caring (Payne et al, 
1999).  Younger women were found to be more likely to have other caring 
responsibilities with regard to children and also elderly parents; in addition, 
being younger, the death of their husbands tended to be particularly untimely.  
Multiple caring roles were immensely demanding: for example, the mother of 
young children found that supporting their regular activities as well as their 
emotional needs as their father was dying put her under almost intolerable 
strain. Similarly, the daughter who was trying to cope with her dying father at 
the same time as work full-time and keep an eye on her elderly mother with 
memory impairment found the demands almost unmanageable. Rose (2001) 
describes the „immense impact‟ of caring on „normal‟ life for these women. 
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Nolan (2001a) identified two principles around carer support: firstly, family 
members should be enabled to make a fully informed choice as to whether or 
not they took on the carer role and secondly, they should be fully prepared for 
the role and given continuing support throughout the episode of care. However, 
although the bereaved relatives seemed glad in hindsight that they had been 
the main carers, spouses, usually wives, recalled that they had been 
precipitated into the situation of full-time caring without being given any option 
or consideration, as shown in previous studies (Rose, 2001; Nolan, 2001a). 
Family carers‟ expressions of pride that they had been able to care for their 
loved one and memories of appreciation of their efforts by the patients echoed 
previous reports: Rose (2001) describes the „bittersweet‟ experience of caring in 
terminal illness in which the sadness of facing the death of a spouse is 
balanced to some extent by finding or making positive aspects of the situation 
and Nolan (2001b) describes the positive aspects of caring in terms of 
reciprocal care. Nevertheless, as illustrated in the focus groups, many relatives 
exhibited continuing distress and ongoing exhaustion, months or years into 
bereavement, related to their experiences as the main family carers. 
 
From the focus groups with bereaved relatives it appeared that the patients‟ 
perspective of coping was not always shared by the carer due to the severe 
burden that caring imposed upon them: in most cases patients were determined 
to cope within the family setting and resisted outside assistance, as articulated 
in the coping narrative (p274-8).  Carers who tended to follow the patients‟ 
wishes in choosing to manage without help until a crisis intervened or carer 
breakdown was imminent, evidently had many unmet needs and yet, 
paradoxically, were difficult to help. This has implications for the increasing 
tendency towards community-based care and challenges for supportive 
services. A common finding was that the care responsibilities usually fell to a 
single family member, often irrespective of their other responsibilities, and this 
sometimes led to resentment within the family. Randall and Downie (2006:75-
84, 90-2) voice ethical concerns regarding policy initiatives that promote 
increased care of people with terminal illness at home in that these privilege the 
autonomy of the patients above the wishes of the family carer and ignore the 
potential impact on the carer. They also state that it is unethical to offer services 
that disproportionately disadvantage other patients or which cannot be 
adequately delivered, (Randall and Downie, 2006:183-9) for example, care in 
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the home usually needs support from community nursing teams but access may 
be difficult out-of-hours (Finlay, 2006). 
 
In spite of the statutory entitlement of carers to an assessment of their own 
needs this did not appear to have been conducted formally in any of the families 
involved in the study (Carers‟ (Recognition and Services) Act, 1995). The 
practical difficulties of the home environment added to the strain for some 
carers. For example, one wife carried oxygen cylinders up and down stairs 
repeatedly – it would appear that she did not ask for assistance such as asking 
for them to be delivered to her husband‟s bedside (Box 5.12). Lee (2001b) 
reports that caregivers assumed that their health would suffer as a result of 
being a carer; as in the example above, this may thus become a self-fulfilling 
prophesy linked to carers prioritising the patients‟ needs above their own. Smith 
(2001), in her longitudinal study of family carers, demonstrates how carers‟ 
needs tend to be difficult to elicit given the privileging of (terminally-ill) patients‟ 
needs and the interconnections between the patients‟ and the carers‟ stories of 
the illness experience. Similarly, I found that in the interviews with patients, both 
patients and wives often spoke of „we‟ with regard to the experience of the 
illness, as reported in the section „In it together‟ (p184). 
 
Social exclusion of patients with terminal illness also affects the family carers. 
Firstly the demands of caring may leave no time for outside activities and 
secondly, as demonstrated in the interviews with patients and in the focus 
groups, the patients often come to depend almost totally on their spouse. 
Whereas this may be the preferred situation for many patients, it causes 
additional stress for the carers who need to achieve some balance and have 
some time to themselves in order to mentally process the situation and adjust to 
it. Alongside bodily and mental changes affecting the patient, the physical 
withdrawal from society may amount to the „social death‟ of the patient before 
their physical death; this invariably impacts on the carer too (Lawton, 2000:38). 
The importance of these issues affecting family carers with respect to 
healthcare service planning is included in Chapter 8.  
 
In many cases, as shown by the interviews with patients and the focus groups, 
the reassignment of traditionally gendered roles, unavoidable in bereavement, 
had already began during the illness; typically, wives, or sometimes adult 
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children, had no option other than to take on roles previously held by the 
husbands. However in some cases the illness had progressed so rapidly that 
there was no time to do anything than cope with the day-to-day demands. Living 
longer than predicted also caused difficulties: these included the carers‟ inability 
to plan ahead; problems for carers who needed to pace themselves in order to 
keep going for long enough until the death; practical problems relating to time 
off work; and not knowing when it (the demands of caring) would end, leading in 
one case to financial strains caused by numerous „last‟ holidays. 
 
An unexpected finding was that two bereaved wives disclosed that they had 
been asked by their husbands, both near death, to help them commit suicide. In 
both cases the wives understood these requests as reflecting unbearable 
suffering.  In this small sample it is impossible to assess how common this is in 
mesothelioma but it does indicate, at very least, despair in these two patients, 
and distressing memories for their wives; it also raises questions concerning the 
support for these patients and their families. 
 
Carers’  needs 
The findings highlight the unmet needs of care-giving relatives in terms of 
information about mesothelioma and support, in common with studies in lung 
cancer (Krishnasamy and Wilkie, 1999:90). Relatives lived with constant anxiety 
as they tried to calculate the significance of symptoms, the stage of the illness 
and what time was left (Payne and Ellis-Hill, 2001:9; Rose, 2001:92); direct 
requests for prognosis appear to have been unsuccessful or in some cases 
overoptimistic, as reported in previous studies (Christakis and Lamont, 2000). 
The relatives, in both patients‟ interviews and focus groups, also revealed a 
sense of helplessness with regard to management of symptoms. Although it 
was clear that they felt personally responsible within the family for monitoring 
symptoms and often advising on and administering medication, none of them 
felt adequately informed about managing worrying symptoms and, in particular, 
when to call for help. Rose (2001) illuminates the emotional component from 
carers involved in giving pain-relieving medication when pain may be 
interpreted as evidence of impending death; additional factors may operate 
when the medication is morphine, given its association with death and 
addiction. 
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Relatives had wanted more information than the patients in order to predict 
developments and make plans accordingly, but in most cases they felt the 
information they received was inadequate. The Mesothelioma Information 
Service helpline (Box 6.6) appeared to be a useful national resource for people 
that accessed it and the charismatic, nationally known nurse running the 
helpline reported that she was contacted from far and wide. However, although 
most patients and relatives in this study had been given the information leaflet, 
none appeared to have contacted the helpline. These issues raise the question 
of how to provide information „in the right amount, at the right time and in the 
right format‟ as recommended in the NICE guidance (2004). The challenge is to 
ensure that an individualised approach is adopted and that opportunities for 
provision of information are readily available for relatives (and patients) if and 
when they require them. However, as evidenced in the interviews with 
healthcare professionals, the clinical nurse specialists tend to be the ones 
whom patients and relatives approach for information, but some of these nurses 
were concerned that they do not have sufficient knowledge to answer all the 
questions concerning the relatively rare mesothelioma. This is not surprising 
given that the queries include medico-legal and State benefits issues, both 
complex and often changing, and theoretically outside the nurses‟ role. 
Recognition of carers‟ needs for better access to information has led to the 
development of information services funded by both the NHS and charities 
(Macmillan Cancer Support, 2006) although these are not yet widely available. 
 
The burden of State benefits, civil compensation claims and the 
Coroner’s investigation 
 
It is ironic and sad that, according to findings from patients, bereaved relatives 
and some specialist nurses, procedures for State benefits and, more 
particularly, civil compensation, cause additional suffering for many. Patients 
frequently appeared reluctant to claim State benefits, possibly a feature of the 
independence of this socio-demographic group. With regard to State benefits it 
is clear that without the assistance of specialist nurses or, occasionally, a 
benefits advisor, most patients would not have been able to navigate the 
complexities of the benefits system. A recent report has shown that less than 
50% of cancer patients fail to obtain the benefits that they are entitled to 
(Macmillan Cancer Relief, 2004). In mesothelioma, the situation is even more 
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complex due to the specific criteria for Industrial Injury Disablement Benefit and 
the need for medical confirmation of the diagnosis; for some claimants, 
particularly those who are failing rapidly or very elderly, the system is 
unmanageable without skilled help. Specialist nurses were aware that this was 
not part of their official role but they felt obliged to take it on in the absence of 
anyone else.  
 
In mesothelioma, apart from the above exhausting and demanding tasks for 
carers, there is usually significant work required to process claims for civil 
compensation. The patients felt under pressure to settle the claim before they 
died in order to be certain that their family would have financial security. This 
required frequent meetings with solicitors and sometimes appearances in court, 
an unfamiliar situation and worrying for anyone and particularly burdensome for 
ill people. This additional advocacy role was a major burden, particularly as 
future family financial security could depend upon successful claims. Patients 
often needed to trace former workmates to provide evidence in support of the 
claim; this was time-consuming and embarrassing. Some couples dealt with 
these together but usually the family carer, normally the wife, absorbed the 
extra workload. The civil compensation claims serve to remind the family of the 
occupational origin of mesothelioma and also emphasise the terminal nature of 
the disease: there is no escape from other reminders in the form of rapidly 
deteriorating health in most instances and specific State benefits such as 
Industrial Injuries Disablement Benefit. However there was also a sense that 
obtaining some form of financial compensation satisfied a need for retribution; 
although many patients and relatives discounted the monetary value of the 
award, they appeared to feel that it was evidence of a formal acknowledgement 
of culpability. In some way this was helpful and reflects the feelings of relatives 
bereaved by disasters, as described earlier (Riches and Dawson, 1998; Biddle, 
2003). 
 
The Coroner‟s investigation was mentioned by just two of the patients, 
fleetingly, at interview but was recalled as a major issue for the bereaved 
relatives. Two important points can be drawn from the findings: firstly the 
importance of ensuring that relatives are made aware of the statutory legal 
procedures, including post mortem examination and subsequent inquest, before 
the patient dies; and secondly, that the current system causes considerable 
 295 
additional distress to bereaved relatives. This is explored more in the next 
section. Further, it was apparent that not all healthcare staff understood the 
status of mesothelioma as a prescribed disease and the medico-legal 
implications, and this led to serious distress and inconvenience for some 
relatives. Similarly, not all police officers working in these three high-incidence 
areas evidently understood mesothelioma, perhaps not surprisingly because 
junior officers may attend the death and the current legal procedures do not 
differ from those investigating a sudden and unexpected death that may be a 
criminal matter. Supportive and sympathetic Coroners (or their staff) were seen 
to make a considerable positive impact on the relatives‟ perception of the 
medico-legal process. 
 
7.6 Bereavement after mesothelioma 
 
Experiencing bereavement 
There are no previous reports of bereavement following mesothelioma and in 
this section I will try to illuminate the experience of the bereaved relatives. The 
focus groups with bereaved relatives provided the data for this section but the 
findings must be seen in context: the focus group participants were self-
selected volunteers and as such are likely to be a special group, that is, those 
relatives who probably had strong feelings about their experience of caring for 
someone with mesothelioma and who were able to attend and participate in a 
group. The groups were likely to have excluded people who were emotionally 
upset, or too unwell, or had other commitments or those who simply felt that 
they had nothing to contribute or who felt that the group may cause distress. 
Relatives who felt they had „moved on‟ might also have been reluctant to 
participate. 
 
There is a considerable body of literature on bereavement due to cancer and 
established models of bereavement relate mainly to bereaved married women 
from traditionally configured families (Valentine, 2006). The families affected by 
mesothelioma in this study tended to be similar and the widowed wives had 
mainly depended upon their husband‟s income, managed the home and family, 
and generally led conventional lives typical of their generation and socio-
demographic group. The exceptions applied to the younger bereaved spouses: 
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they were more likely to be in double income families and in one case, the 
family included young children.  
 
Since work by Freud in the early 20th century, many models of bereavement 
have been produced, notably the stages model of Kubler-Ross (1970), then the 
attachment theory of Bowlby (1980), later developed by Murray Parkes (1972) 
who illuminated the dynamic process of grieving. Recent theories stress the 
individual response to bereavement as depending upon personal resources and 
social contexts; in addition the contemporary notion of continuing bonds 
between the bereaved person and the deceased contrasts with earlier models 
that aimed at eventual separation from the dead person (Valentine, 2006). 
 
The death of a spouse is acknowledged to be one of the most significant events 
in the life of an adult and has major psychological, social and physical impact 
(Thompson et al, 1991). Just as terminal illness disrupts and destabilises 
patients‟ and carers‟ biographies, bereavement has a similar impact on family 
carers. The crisis of bereavement can exceed a person‟s normal coping 
mechanisms. It requires an exceptional response and often new coping 
strategies. A new identity and „mental map‟ is required (Attig, 1996:116-7) but 
finding the space and time required is particularly difficult in mesothelioma.  
Following mesothelioma, the newly bereaved person is often exhausted from 
the demands of caring, and usually involved in a worrying Coroner‟s 
investigation and possibly also facing further court appearances concerning civil 
compensation.  
 
 Anticipatory grieving, in which the loss of the dying person is thought about in 
advance of death and attempts are made to begin the adjustment process 
before the death, is considered to be helpful and to reduce the impact of the 
death (Costello,1999; Sweeting and Gilhooley, 1990). This has been described 
as part of the „dual process model‟ of looking forward and looking back, or „loss 
orientation‟ and „restoration orientation‟ (Stroebe, 1999). It might be thought that 
in mesothelioma the unavoidable reality of the impending death, reinforced by 
the lack of effective treatments, might promote anticipatory grieving, but the 
focus group findings did not suggest that this was usually the case. Most of the 
bereaved relatives described themselves as totally immersed in caring 
responsibilities: the demands of the physical and emotional care needs took up 
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all their time and energy and, due to the rapid progression of the disease and 
the severe symptoms, the majority did not have any time in which to think 
ahead and plan for a life without their partner. One wife, who had tried to think 
ahead whilst her husband was ill, had found it overwhelmingly distressing to 
imagine life without him (Box 5.14). Whilst trying to protect herself from this 
distress that interfered with her caring responsibilities, she described oscillating 
back and forth between the present and the future, between hope and despair, 
and trying to minimise thoughts of life alone in order to concentrate on the 
present, although painful thoughts still intruded – an example of the dual 
process of adjustment to forthcoming loss.  
 
The carers‟ burden that involved social isolation, exhaustion, and change in role 
and identity during the illness (Lawton, 2000:105-8) was exacerbated by 
bereavement because now further major adjustments had to be made alongside 
the loss of their long-term partner. For almost all of the bereaved relatives in the 
focus group, at least three months into bereavement, the adjustment process 
was still active and emotions were still raw and uncontrolled. The one exception 
was the woman whose elderly mother had died peacefully at home: as 
described earlier this had been an example of a „good death‟ in that it was 
timely, in the right place, peaceful and she had been ready to die. These factors 
obviously made her bereavement easier to adjust to and left positive memories 
concerning her mother‟s last few days (p191).  
 
This „good death‟ contrasted with the experiences of other focus group 
participants. Many gave accounts of extremely distressing deaths: uncontrolled 
symptoms; distressed patients; poor communication; lack of support; lack of 
preparation; and inability to keep the patient at home, all of which were all 
factors that contributed to difficulties in adjusting to the death. In many of these 
cases the mode of dying was recalled as being more distressing than the actual 
death, many relatives had felt unsupported during the terminal phase and 
exhibited distress around feeling that they had failed to achieve the best care for 
their loved ones. These feelings of dissatisfaction around the quality of end-of-
life care were continued into bereavement and impacted on adaptation to 
bereavement as described by Rogers et al (2000).  
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Social isolation in bereavement after mesothelioma may be particularly severe 
because these relatives appear to become a marginalised group during the 
patients‟ illness. For some, relative poverty may have been another factor 
related to social exclusion as a result of low-paid employment throughout their 
adult life (Johnston and McIvor, 2000b). The lack of public knowledge of 
mesothelioma; the stigma associated with contamination and also with lung 
cancer; the involvement in litigation and, particularly relevant to Barrow, 
continuing to live in a town where the industry responsible for the mesothelioma 
is still the major employer; all contributed to a sense of alienation. Public 
sympathy for loss due to cancer is compromised by these factors, alongside the 
difficulty for bereaved relatives in relating the dire circumstances of the illness 
and the shattering experience of the caring. Society likes happy or at least 
acceptable endings; this is not usually possible with respect to mesothelioma in 
which the bereavement process is impaired by ongoing medico-legal 
processes. In these circumstances the retrospective „heroic narratives‟ become 
particularly important.  
 
Mesothelioma as ‘disaster’     
The focus group findings suggest that bereavement following mesothelioma 
echoes reports of bereavement after disaster (Riches and Dawson, 1998; 
Mead, 1996). The common feeling in the bereaved  relatives that deaths due to 
mesothelioma should be regarded as „mass murder‟ takes it into the wider 
political arena of culpability, corporate manslaughter and the need for society to 
acknowledge and recompense the injured parties. There are significant 
differences however between deaths due to mesothelioma and the public 
perspectives of deaths due to disaster. Most disasters involve multiple deaths 
all occurring at the same time and usually in the same place; neither is true for 
mesothelioma deaths. The usual disaster response is extensive media 
coverage that frequently results in public sympathy, extending to practical 
support in terms of financial aid and also imparts knowledge to the public. This 
does not occur in relation to mesothelioma. Bereavement by disaster intensifies 
grief and, typically, those bereaved by disaster exhibit anger and resentment 
and expect retribution and reparation from the perpetrators (Lee, 1994; Riches 
and Dawson, 1998; Mead, 1996).  
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In mesothelioma the employers in the industries where asbestos exposure had 
occurred provided an obvious focus for the anger of the bereaved relatives.  
Other factors that may increase the outraged reaction of relatives may be the 
lack of public awareness of deaths in spite of the „mesothelioma epidemic‟ (Peto 
et al, 1999) and the lack of the usual social response, although the medico-legal 
processes are identical in typical disasters and mesothelioma. Other social 
factors may prevent publicity around mesothelioma and these mirror the 
elements of disadvantage experienced by the patients and their relatives: the 
age of the patients; the cancer diagnosis; the interval between cause and effect; 
the lack of effective treatments, and the small numbers in most localities. 
 
In their heated discussions and emotional outpourings it was clear that the 
bereaved relatives in this study felt that neither the societal nor the medical 
response to mesothelioma came up to their expectations. Following the 
traumatic experience of the patients‟ illness, through the off-putting complexities 
of the State benefits system, the worry and threat involved in litigation for civil 
compensation, from the indignities and offence they experienced due to the 
post mortem and inquest, these bereaved relatives felt as if they were engaged 
in one struggle after another and that there was no prospect of closure even 
after the death. Lack of medical knowledge about mesothelioma; lack of 
attention to symptom control, and lack of appreciation of the role and needs of 
family carers were seen as major failings of the healthcare system. Perhaps 
linked to their social isolation, they also felt as if nobody really knew or cared 
about their plight. Experience from disasters such as the Hillsborough Stadium 
disaster96 and the sinking of the Herald of Free Enterprise97 suggests that 
compensation claims for psychological impact, particularly for post-traumatic 
stress disorder (PTSD), may represent a symbolic recognition of loss that is not 
fulfilled by the usual legal process. Some of the relatives‟ accounts revealed 
features of PTSD, such as flashbacks and intrusive thoughts, confirming the 
horror of the experience (Mead, 1996). 
 
These features, alongside the stigma associated with mesothelioma, all 
contributed to „spoiled memories‟ of the dead person (Riches and Dawson, 
                                                 
96
 The Hillsborough Stadium disaster occurred at a football ground in Sheffield, Yorkshire in 1989. 
Restraining barriers gave way and 96 people died in the crush. 
97
 The Herald of Free Enterprise was a North Sea ferry that sank off Zeebruge in 1987 because routine 
checks to ensure vital doors were shut had not been conducted causing 197 deaths. 
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1998). Deaths due to mesothelioma can be considered to be „meaningless‟ 
deaths and have features in common with other unexpected, avoidable, sudden 
or untimely deaths such as the murder of a child or deaths due to disasters as 
mentioned above. The difficulty in finding meaning in death due to 
mesothelioma interferes with the construction of a helpful or restitution narrative 
around the experience and further hinders adaptation to the loss (Riches and 
Dawson, 1998). Social isolation adds to this by reducing opportunities to tell and 
retell the story, as confirmed by the cathartic value of the focus groups for some 
participants. Spoiled memories also impair the „continuing bonds‟ that current 
bereavement theory proposes are helpful in grieving (Klass et al, 1996). Attig 
(1996), mentioned above, describes bereavement as a process of „relearning 
the world‟ but the medico-legal processes that are designed to establish the 
official cause of death both disrupt and delay the normal adjustment and „hold 
people in the past‟ by concentrating on negative issues such as blame, 
accountability and the burden of the disease. In these circumstances it is not 
surprising that, as in this study, bereaved relatives develop narratives of dying 
that emphasise the ‟victorious‟ or „heroic‟ death: these narratives assist in 
forming a coherent meaning around the experience that assuages emotional 
distress, counters the negativity and restores the moral reputation of the 
traumatised carer, another example of a restitution narrative (p274). 
 
However not all the consequences of bereavement were negative and in some 
cases the experience of caring had created significant personal development in 
terms of self confidence and pride in having coped well with a devastating 
situation. Valentine (2006), in her review of bereavement studies, points to the 
development of self-help organisations by stigmatised and marginalised groups 
of bereaved people, illustrating both the lack of statutory services and a growth 
of individual action. Two of the bereaved relatives belonged to „asbestos victim 
support groups‟98. This could also be regarded as a positive bereavement 
outcome in which emotional energies were redirected to a constructive activity 
that also rebuilt self esteem and identity, fulfilled the need for action, was 
socially acceptable, and satisfied altruism; it may also have been a way of 
continuing a connection with the dead relative in a way that contained emotional 
distress. 
 
                                                 
98
 At least 2 more bereaved relatives joined support groups following the focus groups. 
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The severity and complex nature of the bereavement after mesothelioma has 
not been described previously and the issues that have been raised by this 
study merit acknowledgement of the devastating experience, both during and 
after the episode of illness, for family care-givers and special attention from 
supportive services. The role of some support groups in welcoming bereaved 
relatives is to be applauded but this is not appropriate for all and, given the 
social isolation and reluctance to seek help for themselves exhibited by many 
carers, perhaps a proactive approach to supporting this group of people is 
needed? 
 
7.7 Users‟ views of services 
 
 
Small and Rhodes (2000:56-85) examined the difficulties in accessing the views 
of patients who may be literally „too ill to talk‟ and highlighted the complex 
issues surrounding user involvement, particularly in terminal illness. In addition, 
patients facing death are unlikely to criticise their healthcare services when 
needing to rely on them in a „life or death struggle‟ (Frank, 1991:112). Another 
factor is the tendency for women to be more critical of healthcare services than 
men; thus terminally ill men with mesothelioma are very unlikely to voice 
complaints (Anderson et al, 2001). The bereaved relatives‟ dissatisfaction 
concerned the following areas: communication and information, inefficiencies 
and poor practice. This is important because dissatisfaction with healthcare is 
related to poor bereavement outcomes (Coyle, 1999; Rogers et al, 2000). It 
must not be forgotten that the patients and the bereaved relatives were very 
different samples and, in particular, the relatives were looking „through the lens 
of loss‟ and, as mentioned earlier, were particularly likely to have a story to tell. 
 
Communication and information 
In contrast to the patients, bereaved relatives voiced many criticisms of the care 
received and three were wondering if they should make an official complaint, 
sometimes many months into bereavement. Some of the issues have been 
raised above but there were serious issues around poor or inadequate 
communication, particularly at the time of disclosure of diagnosis. The breaking 
of bad news is now specifically taught in medical undergraduate and 
postgraduate education and NICE guidance (2004) stipulates that doctors who 
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are in a position to be dealing with bad news consultations should receive 
appropriate communication skills training. Perhaps mesothelioma is a 
particularly difficult diagnosis to disclose given the lack of effective treatments, 
the poor prognosis, the relative rarity of the condition and the attribution to 
asbestos many years earlier. Some relatives clearly perceived „medical nihilism‟ 
as described in the BTS (2001) statement on mesothelioma.  
 
As noted earlier, relatives‟ information needs differed from, and were often 
greater, than those of the patients. The status of relatives with respect to the 
patients in the healthcare system was unclear, both to the relatives and 
apparently to some healthcare professionals: in some cases they felt excluded 
by incorrect interpretations around confidentiality but this contrasted with the 
occasions on which spouses were told the diagnosis before the patients. 
Relatives may be regarded as „secondary patients‟ but this creates tension with 
the traditional doctor-patient relationship (Randall and Downie, 2006:75-7). In 
mesothelioma, where time is short and the disease so devastating, and where 
the burden of most of the care usually falls on the nearest relative, there needs 
to be clarity around the position of relatives for individual patients, including how 
much information the patient wishes them to receive. 
 
Problems around information with regard to complex treatment decisions 
caused some distress but this is not straightforward (Box 5.5). In serious illness 
many patients, particularly if elderly, would rather follow advice from senior 
doctors that they trust than be given complicated choices that they may not fully 
understand (Small and Rhodes, 2001:73). In mesothelioma, where there is no 
standard management plan, and where relatives may obtain confusing and 
conflicting information from different sources including websites, it is clear that, 
as in many terminal illnesses, a trusting relationship with a doctor who 
communicates well is greatly supportive to patients and their families. However 
it appears that patients and families with mesothelioma are in a situation that 
appears to give mixed messages: they were told that there were no active 
curative treatments but then experienced repeated emergency admissions for 
life-saving treatment of pleural effusions. These episodes created severe 
anxiety because, on every occasion, both patients and relatives feared that 
death was imminent (and in some cases this was true). This leads to the 
reflection that patients and their relatives did not appear to understand the likely 
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course of the disease and to question whether having more information, for 
example, about the likelihood of recurrent pleural effusions and how to 
recognise early signs, might reduce the number of crisis admissions. This is 
compounded by lack of up-to-date management of pleural effusions, particularly 
since the introduction of the indwelling pleural catheter99. 
 
With regard to chemotherapy it was evident that opinions were divided: hospital 
doctors tended to see the utility of recruiting patients to trials in the hope that 
eventually effective treatments would result, whereas community doctors and 
nurses, who may have had closer relationships with patients and their families, 
tended to see the matter in terms of the impact and opportunity costs for the 
individual patient and their family. This has to be seen against the lack of any 
effective chemotherapy to date and the delicate balance between the ethics of 
patient autonomy when patients are willing to try anything that may help (Slevin 
et al, 1990), resource implications, distributive justice, and beneficence. 
Interestingly, a recent audit of treatment received by patients with mesothelioma 
in Leeds revealed that of the 36% considered fit for chemotherapy, just over half 
refused the option, thus 17% proceeded with treatment (Chapman et al, 2006). 
 
Frank (1991:56) describes the sensitivity that patients with cancer exhibit with 
regard to communication with doctors and this is dependent on the individuality 
of both participants (Freeling and Gask, 1998). The doctor‟s comment that 
caused great offence to one wife when she expressed concern about her 
husband‟s poor appetite - „feeding the tumour‟ (p182) - was meant to be 
reassuring but had the opposite effect. Interactions that were perceived as 
unfeeling, dismissive or demeaning, caused great distress and destroyed 
relationships between patients or their families and healthcare professionals. 
 
Inefficiencies 
Access to treatments was affected by distance, the 70 miles from Barrow to 
radiotherapy and the 80 miles to the nearest thoracic surgery centre 
discouraged some patients and may have impacted on referrals from doctors, 
although that is not proven in this study. Similarly the distance to centres where 
radical surgery was performed also appeared to discourage referrals from 
Barrow but other factors were not examined, the situation was easier for all 
                                                 
99
 Described on page 26 
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referrals in the other 2 sites. This concurs with Cosford et al’s study (1997) that 
found that travel times of more than an hour reduced uptake of radiotherapy. 
Counter-intuitively, a literature review examining the impact of travel times on 
cancer patients described the evidence for a negative effect of long travel times 
on psychological distress, compliance, and uptake of services, as inconclusive. 
However the study concluded that travelling far can be inconvenient, a practical 
hardship and „may be perceived or experienced as a barrier to treatment by 
patients‟ (Payne et al, 2000; Jarrett et al, 2000) 
 
A low referral rate (49%) to palliative care was evident from the medical records 
survey, although this reflected practice a few years earlier than that received by 
the patients interviewed and referred to in the bereaved relatives‟ focus groups; 
indeed, most of the bereaved relatives reported accessing hospice services. All 
three study sites had hospices in their localities and all these hospices worked 
closely with NHS palliative care services. Increasing awareness of palliative 
care services and mesothelioma may have contributed to this difference. 
However it is not surprising that hospice care featured in a third of the 80 
medical records cases given the high symptom burden and demands on carers. 
Carer exhaustion is a common reason for hospice admission at end-of-life 
(Hinton, 1994) and was reported by most of the bereaved relatives. 
 
Many problems related to inefficient follow up arrangements including obtaining 
results of investigations and resourceful relatives had attempted to „beat the 
system‟.  Out-of-hours GP services also caused problems, in particular, 
concerning access to opioid medications when duty doctors were unfamiliar 
with the patients (Worth et al, 2006; Small Practices Association, 2006). This 
lack of efficiency added to the distress of patients and relatives. 
 
In addition to relatives‟ perceptions that doctors, particularly junior doctors, often 
did not know much about mesothelioma, relatives also reported apparently 
unsupervised and inexperienced junior doctors performing invasive procedures 
in three cases. This clearly disturbed the relatives but also demonstrates the 
power imbalance between patient/relative and doctors as no complaints were 
made at the time of any of the three incidents. 
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7.8 Reflections on the research process and methods 
 
 
Looking back I feel that the study answered the research questions reasonably 
well, given the constraints and limitations described in the methods chapter 
(pages 89-100). However, some improvements or amendments need to be 
considered. In the original proposal I had planned to conduct more than one 
interview with each patient; in the event, practical considerations resulted in 
single interviews in every case. This is regrettable because there was little 
opportunity for the patients to develop a trusting relationship with me (only one 
patient knew me before the study). If a longitudinal study had been conducted 
data concerning spiritual matters or psychosocial distress may have been more 
evident. These data were noticeably lacking from most of the interviews and yet 
previous work around psychosocial distress in relation to cancer site and 
severity of physical symptoms (Zaborra et al, 2001) would suggest that, in 
mesothelioma, these would be likely to be major issues. Given that a „coping 
narrative‟ helps patients to reduce emotional distress in mesothelioma it is 
unlikely that patients would disclose potentially upsetting issues unless they felt 
secure and trusted the researcher. However, as an experienced GP and 
hospice doctor, I am practised in establishing professional relationships in a 
short time. Patients may have chosen to concentrate on physical issues due to 
their own preconceived ideas about what would be most relevant to disclose to 
a researcher who was a doctor. It would be interesting to examine any 
difference in issues raised if, in future studies, the researcher was non-medical, 
for example, a psychologist or social worker. A longitudinal series of interviews 
would also have explored the changing experience of mesothelioma for 
individual patients and their families over time. 
 
A noticeable feature of the interviews with patients was that all but one of the 
patients‟ spouses were present although this was not specified on the invitation; 
this linked to the theme of „in it together‟ (pages 153-5). The interviews were not 
intended to be with couples but it may have been helpful to conduct some joint 
interviews with patient/family-caregiver dyads: this may have more accurately 
reflected the lived experience of mesothelioma, given the evidently close 
relationships in these couples and the apparently jointly agreed coping 
strategies revealed in some of the interviews.  
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A longitudinal study incorporating serial interviews with patient/family-caregiver 
dyads during the illness and subsequent interviews with the spouse in 
bereavement would have additional value. Ethical issues would need careful 
consideration, in particular the need to ensure that consent was reconfirmed at 
all stages and that support for grieving relatives was available. 
 
Similarly, serial interviews with healthcare professionals may also have 
provided richer data than single interviews. It is possible that some of the 
participants may have been reluctant to appear critical of their local services, 
particularly to an unknown researcher who was also not local. Similarly, 
participants may have been reluctant to speak freely about their own or the 
profession‟s knowledge gaps to a stranger. 
 
A deficiency in the design of the study was the lack of involvement of 
community (district) nurses who provide the majority of „hands on‟ care for 
terminally ill people in their own homes. This reflected a practical problem: 
District nurses work in teams and, in a small study, it may have been difficult to 
easily identify nurses who had significant experience of nursing patients with 
mesothelioma at home. Adding another data source would also have made the 
study unmanageable for me as a single researcher but should be considered for 
a future study. Similarly, given the findings that revealed the severity of the 
bereavement reaction following mesothelioma, investigation of the experience 
from the perspective of people providing bereavement support services would 
complete the picture and is again a topic for future study. 
 
However, all the above suggestions would have greatly increased the workload 
and could not have been incorporated by me as a single researcher without 
reducing other parts, and this may have impacted on the findings. Conducting 
this multi-method study as a single researcher gave me a unique perspective on 
the weight of the various findings and enabled me to draw them together to 
produce a comprehensive integrated account. 
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In summary 
In this chapter I have discussed the main findings from the study. In the final 
chapter I will restate what I set out to do and evaluate the study against these 
original intentions. I will outline the findings and, in particular, new findings, with 
regard to the implications for service provision and further research. I will also 
review the study in terms of the palliative care perspective and the tradition of 
social medicine. 
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Chapter 8: Conclusions 
The intention of this study was to produce a comprehensive account of the 
experience of pleural mesothelioma in Northern England from the perspective of 
palliative medicine and in the tradition of social medicine. The study was 
designed to answer the following research questions:  
 What is the experience of pleural mesothelioma for patients and their 
families? 
 What is the experience of pleural mesothelioma for healthcare 
professionals and service providers. 
 
In this final chapter I review the extent to which each of the research questions 
has been answered, draw out the main messages from the study, and indicate 
how the study contributes to existing knowledge. This is followed by my 
reflections on the study following the tradition of social medicine and from the 
perspective of palliative care. I conclude with consideration of some of the 
implications of the study for service provision and research in palliative and 
supportive care relating to mesothelioma. 
 
What is the experience of pleural mesothelioma for patients and their families? 
This study expands upon the few previous sociological and medical accounts of 
patients‟ experiences of mesothelioma, confirming that these patients face a 
particularly difficult set of circumstances. The major features of experiencing 
mesothelioma as a patient are as follows: the disease usually presents acutely 
with frightening symptoms of breathlessness and/or pain; the diagnosis is often 
delayed; multiple invasive interventions are required for diagnostic and 
therapeutic purposes; the illness is hard to bear with a severe symptom burden 
and rapid physical decline; multiple hospital admissions, often as emergencies 
and involving several hospitals, are required in the last year of life due to 
recurrent pleural effusions or medical interventions; a small number receive 
chemotherapy and few patients are deemed suitable for surgery and virtually all 
patients are made aware that these treatments are not curative. Due to the 
distressing nature of the symptoms and erratic trajectory, relatively few patients 
die at home and „bad deaths‟ are not uncommon. Moreover, although some 
patients may be aware that they are at risk of mesothelioma, the disease is not 
widely-known by the public, and medical knowledge may also be inadequate. In 
 309 
spite of the severe symptom burden, the study revealed that less than half the 
patients were referred to palliative care and in many cases this was at a very 
late stage.  
 
The study provides the first detailed account of the experience of mesothelioma 
from bereaved relatives who had been the main informal carers. Although the 
bereaved relatives‟ focus groups inevitably provided retrospective accounts 
through the lens of loss, and were more emotional than accounts from patients‟ 
interviews, they largely agreed with the patients in emphasising the delays in 
diagnosis, severe symptoms, unpredictability of the illness, rapid deterioration in 
health, and the anxiety of not knowing what to expect or what to do to help. The 
role of main family carer was illuminated as requiring a considerable 
commitment, not only with regard to the well-documented physical and 
emotional labour tasks, but the family carers of patients with mesothelioma 
frequently took on the main responsibility for dealing with medico-legal matters, 
as in the following section. This was endorsed by the data from healthcare 
professionals, particularly those working in community settings.  
 
What are the psycho-social aspects of the experience of mesothelioma for 
patients and their families? 
The psycho-social issues around facing death due to terminal illness have been 
well described but this study demonstrated that mesothelioma differs in several 
areas that affect both patients and their families: causation due to occupational 
exposure to asbestos brings a number of issues concerning attribution and 
blame, specific State benefits, and civil compensation; patients are made aware 
that there is no cure:  for many patients this is interpreted as „there‟s nothing 
they can do‟; the disease is unevenly distributed, relatively rare, and public 
knowledge is poor, therefore public support for patients and their families is less 
assured; and, in addition, patients and their families may have background 
awareness of asbestos-related disease that give rise to anticipatory anxiety. In 
mesothelioma, anticipatory anxiety concerns not only the worries around the 
possibility of developing the disease but, following diagnosis, focuses on feared 
symptoms such as severe pain or breathing difficulties and a „bad death‟ based 
on knowledge of other sufferers. The study also revealed that, once the 
diagnosis had been confirmed, many patients and their relatives felt that they 
were „in limbo‟ without any plan of treatment and this created a sense of 
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abandonment and neglect, in contrast to their hopes and expectations. 
Confusion and disappointment regarding oncological treatments and radical 
surgery added to the sense of disadvantage. This mirrored the frustrations 
expressed by healthcare professionals at the lack of standardised management 
of mesothelioma and their distress at the lack of effective treatments. As in 
previous accounts of cancer patients‟ views on the services they received, 
trusting relationships with key healthcare professionals were essential in 
supporting patients and their families. 
 
The „narrative of coping‟ adopted by patients in order to manage the emotional 
distress and devastation of mesothelioma has not been described before. 
Exploration of this concept illuminated various reasons why this narrative may 
be utilised by patients to help them deal with their illness but, paradoxically, that 
it hinders access to palliative and supportive services. 
 
The case study method, incorporating mixed methods and multiple data 
sources, revealed some differing perspectives and this was particularly 
noticeable with respect to the emotional tone of the patients who were 
interviewed compared with the bereaved relatives‟ accounts. Stoicism and 
controlled emotions on the part of the patients contrasted with the highly 
emotional and often angry accounts from bereaved relatives in the focus 
groups. These varying accounts reveal the multi-layered nature of human 
experience and, although not intended to compare „like with like‟, nevertheless 
illuminate some of the complexities in mesothelioma that are faced by patients 
and relatives. 
 
The study illuminates the ways in which the situation may often be exacerbated 
by the very systems that are designed to provide financial assistance, namely 
the complex and burdensome State benefits and civil compensation 
procedures. The apparently common practice of combining disclosure of the 
diagnosis with advice on claiming State benefits and seeking civil compensation 
was distressing to some patients and, to a greater extent, to relatives. Failure to 
pre-warn relatives about the necessity for a post mortem examination and 
inquest created additional distress. Reactions to the Coroner‟s investigation 
were mixed, and insensitive handling caused further trauma to newly-bereaved 
relatives.  
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The study provides the first account of the experience of mesothelioma for 
family carers. Although many unmet needs were identified by bereaved 
relatives, this was complicated by the tendency for families of patients with 
mesothelioma to be caught up in the „narrative of coping‟ which inhibited them, 
as well as the patients, from accessing supportive services. As in other studies 
in cancer, relatives felt under-rated by healthcare professionals, particularly in 
secondary care, and dissatisfied with the style and content of information 
provided. This was frequently exacerbated by the burden of State benefit claims 
and civil compensation procedures, and then, after death, by the Coroner‟s 
investigation. 
 
Particular issues concerning bereavement after mesothelioma have not been 
reported before. The study suggests that the severity of bereavement following 
mesothelioma appears to relate to the avoidable causation of the disease, the 
lack of effective treatments; the distressing symptom burden; the unpredictable 
disease trajectory and rapid decline; and, often, a bad death. In many cases 
relatives had not been prepared in advance for the post mortem and inquest 
and this study supports a previous small audit which advised that relatives 
should be informed about the Coroner‟s investigation before the patient dies. 
The study highlighted an almost complete lack of support for bereaved family 
carers in mesothelioma. The relatives‟ description of deaths due to 
mesothelioma as „mass murder‟ goes some way to explain the similarities with 
reactions following death due to disasters and features of „tragic grief‟.  
 
What is the disease trajectory, disease burden, and service usage in 
mesothelioma? 
Although descriptions of the course of mesothelioma have been written 
previously, this study provides the first graphical representation of the disease 
trajectory, based upon quantitative and qualitative data. This image 
demonstrates that mesothelioma differs from the „cancer trajectory‟ typified by a 
slow deterioration over years followed by a more rapid decline in the final few 
months. The depiction of the mesothelioma trajectory reinforces the particularly 
disruptive nature of the disease due to its erratic course and suggests that a 
more proactive approach is required in order to minimise the impact of the 
disease. 
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This study supports previous work suggesting that the disease burden in 
mesothelioma is particularly high in both physical and psychological terms. This 
has implications for service provision – although not wishing to endorse a 
„league table‟ of suffering in cancer, and accepting that all terminal illness is 
devastating, nevertheless, the particular set of unique circumstances faced by 
patients with mesothelioma and their relatives as demonstrated by this study, 
would appear to demand that they should be receiving better services than they 
currently access. 
 
The study demonstrates that from healthcare professionals‟ perspectives, 
mesothelioma is associated with many challenges. The difficulty in achieving 
diagnosis not only worried patients and relatives but was also distressing for the 
professionals, and was common, even in the three high-incidence areas 
involved in this study. Lack of a standard approach to management also caused 
particular difficulties although a contrasting view emphasised the need for 
individualised care and would mirror the emphasis on holistic person-centred 
approach of palliative care. The acknowledged problems in achieving symptom 
control also distressed professionals although the findings may suggest that, 
with modern palliative medicine, the numbers of patients with truly refractory 
pain may be smaller than previous accounts indicate. This links to the 
discussion (page ref) regarding interventional analgesia, particularly cordotomy, 
and raises questions around the need for invasive procedures in all but a tiny 
minority if all patients accessed specialist palliative medicine. 
 
Service usage was demonstrated by the medical records survey and showed 
that patients with mesothelioma spend the time from diagnosis to death   
encountering a variety of health services in multiple venues. Although the 
majority of the last year of life is spent at home, the burden of repeated 
emergency admissions could be minimised by more effective management of 
pleural effusions, and an open access arrangement to respiratory wards and/or 
patient-held records that included diagnosis and management guidance. The 
tensions around the centralising of specialist services against the wishes of the 
patients and relatives to have local services were evident in the study.   
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From the palliative care perspective the study suggests that the usual medical 
approach to the management of pleural mesothelioma tends to be structured in 
a way that reflects better outcomes in other cancers rather than reflecting the 
fatal reality of mesothelioma. The study highlighted the fact that, in common 
with other cancers, patients with mesothelioma, who virtually all need palliative 
care expertise, are not accessing it either early enough or at all, in spite of this 
being recommended practice. The management of mesothelioma in the 
community was shown to rely heavily on primary care teams and these 
occasional patients could entail a considerable workload, particularly for GPs, 
District nurses and Macmillan nurses. Lack of resources and inadequate 
knowledge plus lack of access to expert advice on State benefits were seen to 
disadvantage patients with mesothelioma. Ensuring that all patients with 
mesothelioma are entered onto primary care palliative care registers should link 
patients to end-of-life care initiatives including the Preferred Place of Care 
Document and increase the likelihood of patients and their families being helped 
with advanced care planning. 
 
Dealing with patients with a rapidly fatal disease, distressing symptoms, and, 
sometimes, angry relatives, has a significant emotional impact on healthcare 
professionals and this does not appear to have been previously acknowledged 
with respect to mesothelioma. Whereas the nursing profession does put support 
in place in terms of clinical supervision, albeit not necessarily adequately, 
medicine has no system for this and traditionally ignores the emotional issues 
for doctors in caring in distressing situations. 
 
Thus from a palliative care perspective, mesothelioma would seem to be a 
striking example of the „inverse care law‟ in that this group of severely 
symptomatic and psychologically distressed patients fail to be referred early, if 
at all, to specialist palliative care. This needs to be addressed in a systematic 
way and not left to patients to request assistance; as shown by the discussion 
of the „narrative of coping‟, patients with mesothelioma, and their relatives, are 
unlikely to ask for assistance, even when it is clearly required, until a crisis 
occurs. 
 
Viewed from the tradition of social medicine, mesothelioma, as it affected the 
patients and families in this study, reflects the social context of the post-war 
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years and the risk-taking macho culture of that era. Sadly it also reflects major 
neglect of asbestos hazards in the workplace in spite of increasing regulation 
from 1931, and more recently, 1969. Mesothelioma should be a public health 
priority as UK deaths now exceed those from cervical and other well-known 
cancers.  As the most common fatal industrial malignancy, and one in which 
25% of deaths are now occurring in the building trades, the changing 
epidemiology demands a robust approach to asbestos hazards advice, in 
particular concerning asbestos in domestic and commercial buildings. The 
changing distribution, away from centres of traditional heavy industry, to a more 
generalised distribution, also poses a challenge to public health in terms of risk 
education and service provision. The social medicine perspective also 
illuminates the interaction of industrial, social and medico-legal issues that 
exacerbate the situation of people affected by mesothelioma and explains some 
of the anger due to a sense of betrayal by government agencies, employers and 
the insurance industry, alongside distress around the severe physical impact of 
the disease and lack of effective treatments (LaMontagne and Walker, 2005). 
 
Implications for service provision and research 
The challenges to healthcare service providers are clear: there is a need to 
develop appropriate and acceptable palliative and supportive care services that 
patients with mesothelioma access as a matter of routine practice early in their 
illness. Similarly, supportive services for relatives caring for someone with 
mesothelioma need to be an integrated part of routine care, and, importantly, 
must include bereavement care. I suggest that this could be operationalised by 
appointing a Lead Palliative Physician for mesothelioma alongside the 
Mesothelioma Lead Physician and Lead Nurse in each Cancer Network. The 
intention would be to provide „palliative care in parallel’ with oncological 
treatments or to support primary health care and palliative care teams in 
patients with advanced disease. The Lead Palliative Physician could also 
deliver an educational programme about mesothelioma in collaboration with the 
Network Lead Physican and Nurse and also collaborate in research. These 
Network Leads could link to specialist centres for mesothelioma, ensuring that 
appropriate patients were able to access surgery or newer interventions but, 
hopefully preventing inappropriate referrals. 
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These issues set the agenda for future research and, as the European 
mesothelioma epidemic nears its peak, there should be no delay. The 
Australian and U.S. governments have provided state funding for research in 
mesothelioma and, with an incidence only second to Australia, state funding for 
mesothelioma research is long overdue in the UK. The situation is dire in the 
resource poor countries where unregulated active asbestos industries continue 
and sadly ensures a continuing legacy in terms of future patients with 
mesothelioma; in their circumstances palliative care is likely to be the only 
economically viable approach.  
 
The implications for research posed by this study focus on the following 
questions: 
 
1. How can we ensure that patients with mesothelioma receive the palliative 
and supportive care services that they need and when they need them?   
One suggestion would be to incorporate routine referral to palliative care at 
point of diagnosis into the Mesothelioma Framework. This could be supported 
by the routine use of an assessment tool such as SPARC100 on diagnosis of 
mesothelioma. This intervention would need to be evaluated, possibly by means 
of a study in high incidence areas, before wider dissemination. 
 
2. What are effective interventions in the management of pain and 
breathlessness in mesothelioma?  
This could be addressed by prospective investigation of standard specialist 
palliative interventions in mesothelioma including non-pharmacological 
interventions shown to be effective in other conditions. This could possibly lead 
towards the development of an evidence-based guidance or care pathway that 
would marry oncological interventions and best practice  management of pleural 
effusions with palliative interventions, the concept of ‘palliative care in parallel’. 
 
3. What are effective interventions in the psychosocial areas in mesothelioma 
for patients and their family carers? 
                                                 
100
 SPARC is the Sheffield Profile for Assessment and Referral to Care, a questionnaire that asks about 
physical and psychological symptoms, social concerns and information needs with respect to the 
preceding month. It can be completed by the patient, a relative or administered by a healthcare 
professional.  
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The study reveals deficiencies with respect to information, communication and 
emotional and practical support, mirroring work in cancer in general. 
Fragmentation of care between multiple professionals and patchy professional 
knowledge of mesothelioma exacerbate these problems and leads to the 
suggestion that perhaps patients with mesothelioma would benefit from access 
to a key worker, for example, a clinical nurse specialist with accredited training 
in mesothelioma. A key worker could also facilitate communication between 
primary and secondary care professionals and ensure that patients were 
included in the end-of-life care programme. This type of service would need to 
be set up as a research project and evaluated. 
 
4. How can services be organised most effectively for patients with 
mesothelioma? 
This is the remit of the newly-released Mesothelioma Framework which 
suggests consideration of mesothelioma MDTs, specifically lung cancer MDTs 
that deal with a minimum number of cases of mesothelioma, in order to improve 
the quality and consistency of care.  This study would support this concept and 
would also suggest the inclusion of a palliative physician in each mesothelioma 
MDT meeting.  
 
5. How can relatives of patients with mesothelioma be supported during the 
illness and in bereavement?  
The explanation of the „coping narrative‟ indicates that supportive services need 
to be proactive in order to overcome the reluctance of relatives, as well as 
patients, to ask for assistance. Specific carer assessment tools, for example the 
Carer Strain Index, (Robinson, 1983) could be evaluated in mesothelioma with 
the intention of pre-empting crises and reducing carer strain. 
 
A problem with the current model of support from clinical nurse specialists is 
that they do not provide ongoing support for relatives into bereavement. 
Bereavement research would suggest that ongoing support from a professional 
who knew the family during the illness and continued during bereavement might 
produce better outcomes; again, this would need to be set up as a project and 
evaluated. 
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In conclusion, the lack of effective care of patients with mesothelioma and their 
families is a sad reflection on multiple disadvantage as this dreadful disease 
mainly affects older men from the „traditional working class‟. Indeed, the whole 
story of the experience of mesothelioma can be summed up as one of 
disadvantage, devastation and difficult dying. Cassell (2004: v) states that ‘the 
test of a system of medicine should be its adequacy in the face of suffering’. 
This study reveals many inadequacies in the care of patients with mesothelioma 
who are experiencing severe suffering, and also in the support of their family 
carers. I hope that this study will go some way to informing the development of 
services and research in palliative and supportive care in order to improve the 
care provided to patients with mesothelioma and support for the family 
members who care for them. 
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APPENDICES 1-13 
 
Appendix 1: INFORMATION LEAFLET for BARROW PATIENTS 
 
 Research title: 
 Palliative Care in Mesothelioma: What are the needs of patients and their 
families? 
 
Aims 
To understand the meaning and experience of Mesothelioma from the 
perspective of patients and their families, to understand more about the disease 
and its impact on patients and their families and to use this information to 
develop recommendations for service developments and further research into 
Mesothelioma. 
 
Background 
Barrow in Furness has a high incidence of Mesothelioma due to asbestos 
usage in the shipyard many years ago although not all cases are related to 
shipyard work. The published literature on Mesothelioma mainly relates to 
research into possible treatments for this condition, very little is written from the 
patients‟ point of view. It is now national policy to incorporate the views of 
patients into the planning of health service developments and the first step is to 
understand how patients experience the illness and its management. 
 
Method 
7 patients with Mesothelioma from the Barrow area will be recruited to take part 
in the interview part of this study. They will all be given this leaflet and can ask 
their Macmillan nurse or the Lung Specialist nurse for further information if 
necessary. Patients who are willing to volunteer to be interviewed will be asked 
to sign a consent form which will be explained to them and countersigned by the 
Macmillan or Lung Specialist nurse. The rest of the study includes a review of 
hospital and GP records of patients with Mesothelioma and interviews with 
doctors and nurses working in this field and groups of relatives. In order to 
obtain a view of the situation for Mesothelioma patients in different areas and 
circumstances the study will be carried out in Leeds and Doncaster as well as in 
Barrow. 
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Researcher 
Dr Helen Clayson has been a GP in Kirkby-in-Furness since 1980 and is also 
Medical Director of St Mary‟s Hospice, Ulverston. At present she is on 12 
months study leave from the practice to do this research and is registered as an 
MD student at Sheffield University.Her particular interest in Mesothelioma arose 
from looking after people with this condition and realising how little was written 
about the patients‟ experience of this disease. 
 
Interviews 
Dr Clayson will visit people in their homes to conduct the interviews. She will 
wish to talk to you about the following areas: Family background and 
occupational history, the onset of the disease and medical interventions, the 
impact of the disease on you and your family and coping with the illness. The 
interview should take around 1 hour. You can refuse to answer any of the 
questions and will have the opportunity to raise any other important issues if 
you wish. 
 
Data handling 
The interviews will be recorded onto mini-disk and then this data will be 
transferred onto a word processor for analysis by Dr Clayson.The disks, tapes 
and any written data will be kept securely locked when not in use by Dr 
Clayson. All information from the interviews will be covered by the Data 
Protection Act. The tape recordings will be destroyed at the end of the study by 
the researcher. 
 
Results 
The results of the interviews will be written up and submitted as part of the MD 
thesis and may be also submitted for publication as whole or part of articles in 
peer-reviewed professional journals. No details of individual patients such as 
name, address, date of birth or other identifying features will be included in the 
reports; patients will be identified by allocated numbers. In the event of the 
researcher wanting to publish any potentially identifiable information, e.g. a 
direct quotation from an interview, specific consent would be sought from the 
patient concerned and the information not published unless consent had been 
 356 
given. At the conclusion of the study a summary of the research findings will be 
available for patients and families who have taken part if they wish to see it. 
 
Invitation to participate 
If you wish to take part in this study your Macmillan nurse will ask you to sign a 
consent form. You are fully entitled to withdraw from the study at any time 
without any need to give a reason and without incurring any displeasure or 
disadvantage. 
 
Further information: Dr Helen Clayson can be contacted on 01229 
889836(answer-phone) or at St Mary‟s Hospice, Ford Park, Ulverston, Tel 
01229 580305, 
Alternatively please feel able to discuss this with your Macmillan or Lung 
Specialist nurse who will be fully informed about this study 
 
 
Thank you for your consideration of this research project 
 
 
 
Dr Helen Clayson 
 
  
.   
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Appendix 2: CONSENT FORM (Interviewee‟s copy) 
 
Dr. Helen Clayson 
 
MB.BS., F.R.C.G.P., F.R.C.P., D.R.C.O.G. 
 
 
 
 
 
                                            CONSENT FORM (Interviewee‟s copy) 
 
 
Study title:  Palliative care in mesothelioma: What are the needs of 
patients and their families? 
 Name:                                                                                        d.o.b. 
 
Address: 
 
I confirm that I have read and understood the information leaflet regarding 
this study and I am willing to be interviewed at home by Dr Helen Clayson.  
I understand that I can withdraw from the study at any time and that 
participation or non-participation will not have any effect on my treatment 
or management. 
 
Signature of interviewee:  
 
Date: 
 
Countersignature( Macmillan nurse or researcher): 
 
Date: 
The Surgery 
Askew Gate 
Kirkby-in-Furness 
Cumbria LA17 7TE 
Tel: (01229) 889247 
Fax: (01229) 889097 
             e-mail: 
drclayson@aol.com 
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Appendix 3: GP letter re patient recruitment 
 
Dr. Helen Clayson 
 
MB.BS, F.R.C.G.P., F.R.C.P., D.R.C.O.G. 
 
 
 
 
Dear Doctor, 
 
 
 
Re: 
 
I am just writing to inform you that your patient has agreed to be interviewed by 
me as part of a research project entitled „Palliative care in mesothelioma: 
What are the needs of patients and their families?‟ 
 
The aim of the study is to explore the meaning and experience of mesothelioma 
to patients and their families and to then use this data to develop 
recommendations regarding the provision of services in Primary Care and 
Community settings. 
 
The interview will be at the patient‟s home and should take about an hour on 
…….. 
 
A full research protocol is available if you would like to see it. 
 If you wish any further information please contact me or Joanne Brodie, 
Research Secretary, at the Trent Palliative Care Centre on 0114 262 0174. 
 
Yours sincerely, 
 
 
Helen Clayson 
Honorary research Fellow, University of Sheffield 
The Surgery 
Askew Gate 
Kirkby-in-Furness 
Cumbria LA17 7TE 
Tel: (01229) 889247 
Fax: (01229) 889097 
             e-mail: 
drclayson@aol.com 
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Appendix 4: PALLIATIVE CARE IN MESOTHELIOMA: PATIENT 
INTERVIEW SCHEDULE 
 
1. Personal history 
 
Eg : can you tell me about your family background and then your work history? 
 
2. The disease 
 
      Eg: Can you tell me about the start of this illness? 
 
Eg: How was the diagnosis made? 
 
Eg: What symptoms are you experiencing? 
 
3. Asbestos exposure 
 
Eg: What do you believe about the cause of this illness? 
 
Eg: Were you aware of the risks of asbestos at any time? 
 
Eg: How did you learn about asbestos risks? 
 
4. Impact of the disease and coping strategies 
 
Eg: Can you describe how you learnt of the diagnosis? 
 
Eg: Can you describe your reaction? 
 
Eg: How have you dealt with those feelings? 
 
Eg: Who or what has been helpful? 
 
Eg: What effects has this had on your family? 
 
5.  Are there any other matters that you would like to raise? 
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Appendix 5: Advertisement published in local newspapers in 
Barrow, Leeds and Doncaster to recruit bereaved relatives. 
 
 
 
 
MESOTHELIOMA RESEARCH PROJECT 
 
 
Dr Helen Clayson, Research Fellow, University of Sheffield, is currently 
studying the impact of mesothelioma, the asbestos-related cancer, on patients‟ 
families. In order to understand the effects on families she is arranging a series 
of small local discussion groups of close relatives of people who have died with 
mesothelioma in the Leeds and Doncaster areas between 1st January 2000 and 
1st January 2003. If you are a bereaved relative or partner and feel that you 
might be able to contribute to this study please request an information leaflet, all 
enquiries and any participation in a group will be completely confidential. 
 
Please contact Joanne Brodie at the Trent Palliative Care Centre : 0114 262 
0174 ext 25. 
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Appendix 6: Recruitment letter : Bereaved relatives, 
Leeds 
 
Printed on headed notepaper from Trent Palliative Care Centre, University of 
Sheffield. 
 
May 2003 
 
Dear 
 
Re: Discussion groups for bereaved relatives of mesothelioma patients. 
 
I am pleased to enclose an information leaflet about my research project 
entitled „Palliative Care in Mesothelioma what are the needs of patients and 
their families‟? 
 
Once you have read it, if you are willing to take part in a discussion group, 
please sign the consent form and return it to me in the FREEPOST envelope. 
 
If you need any further information please contact Joanne Brodie, research 
secretary: tel 0114 2620174 extension 25 
 
Thank you for your interest and help 
 
Yours sincerely 
 
 
 
Helen Clayson 
Honorary Research Fellow, 
University of Sheffield. 
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Appendix 7: INFORMATION LEAFLET FOR BEREAVED RELATIVES / 
MAIN CARERS  (LEEDS) 
 
You are being invited to take part in a RESEARCH study. Before you decide 
it is important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully and 
discuss it with friends, relatives and your GP if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
 
Research title:  Palliative care in mesothelioma: what are the needs of 
patients and their families? 
 
What is the purpose of this study? 
This study is exploring the impact of mesothelioma on patients and their 
families. We know that understanding a disease from the patients‟ perspective 
can lead to significant improvements in the way in which health services are 
provided and hope that this study will help mesothelioma patients and their 
families in future. This part of the study will take 12 months. 
 
The researcher 
The study is being carried out by Dr Helen Clayson who is a GP and Palliative 
Care doctor currently working with the Trent Palliative Care Centre, University 
of Sheffield.  Her particular interest in mesothelioma developed after being 
involved in the care of patients with this disease from the shipyard town of 
Barrow-in-Furness.  The research done to date mainly concentrates on trying to 
find an effective treatment for the disease, there is very little written from the 
perspective of the patient and his/her family. 
 
 
 
Why have I been chosen? 
This part of the study is designed to examine the impact of caring for someone 
who has had mesothelioma.  You are invited to take part in a small discussion 
group of bereaved relatives or main carers of mesothelioma patients that will be 
led by Dr Clayson. Each group will consist of 5 or 6 bereaved relatives of 
mesothelioma patients who died between 1.1.2001 and 1.1.2003 in the Leeds 
area, the researcher, Dr Clayson who will lead the group, and a research 
assistant. 
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Do I have to take part?   
It is up to you to decide whether or not to take part. If you do decide to take 
part, you will be given this information sheet to keep and be asked to sign a 
consent form (enclosed). If you decide to take part, you are still free to withdraw 
at any time and without giving a reason. This will not incur any displeasure or 
disadvantage 
 
What will it involve? 
You are invited to contribute to a discussion meeting with 5 or 6 other bereaved 
relatives from the Leeds area. Dr Clayson will lead the discussion which will cover the 
following areas: the time before the diagnosis, the impact of the diagnosis, coping with 
the illness, the effect on the family and your experience of the services provided to your 
relative and to you. You will also be given the opportunity to raise any other issues that 
you feel are important. A research assistant will also be present to help with note-taking 
and the discussion will be recorded.    
 
When and where ? 
The groups will be held in a convenient central location in Leeds, light refreshments will 
be provided and transport will be provided or, alternatively, a token payment of £5 
towards expenses will be offered to anyone providing their own transport. 
NB In order to cover a fairly recent experience the group members need to be relatives 
or main carers of people who have died from mesothelioma between 1st January 2001 
and 1st January 2003. 
 
 
Are there any risks ? 
Some people may find that talking about the final illness of a loved one may be 
distressing, others may find it helpful. The researcher, as a GP, has a lot of experience 
of people who are grieving and the research assistant will also have experience in this 
area and be available for help if necessary. A leaflet giving details of helpful agencies 
and organisations for bereaved people will be available at the discussion meeting. 
      
Are there any benefits of taking part? 
There is no direct benefit to you if you do decide to take part in a discussion group but 
it is hoped that this research will lead to improvements in our understanding of the 
impact of the disease and also to improvements in the ways in which services are 
provided to patients with mesothelioma and their families. The discussion will also 
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provide you with the opportunity to raise any important issues that you have as a result 
of your experience caring for a close relative with mesothelioma. 
 
Will it be confidential? 
All information provided by you or about you will be kept strictly confidential. The 
researcher will comply with all the requirements of the Data Protection Act. Your name, 
address or any other details by which you could be identified will not be disclosed to 
any other party by the researcher.  The researcher will destroy all tape-recordings at 
the end of the study.   
 
What will happen to the results of this study? 
The results of the study will be written up as a postgraduate degree and will also be 
published in professional journals. The researcher will ask each group at the end of the 
discussion if there are any parts of the discussion that they would not wish to be 
published, participants names will not be used in any articles. Publication of articles 
relating to the study is likely to start in 2003. 
 
Funding  
 The study is being funded by a grant from the Scientific Foundation Board of the Royal 
College of General Practitioners.  
 
 If you would like to take part in a discussion group you will need to sign the consent 
form which is attached and return it in the FREEPOST envelope. A copy of the consent 
form will be given to you for you to keep.  
 
If you would like more information regarding the study please ring the Research 
Secretary, Joanne Brodie at the Trent Palliative Care Centre on 0114 262 0174, 
extension 25 and she will make arrangements for the researcher to contact you. 
 
Thank you for your interest and for taking time to read this information sheet and also 
thank you if you do decide to take part in the discussion group.   
  
 
Dr Helen Clayson 
Honorary Research Fellow 
University of Sheffield. 
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Appendix 8: Leeds focus group consent form 
 
Centre Number: Leeds 
Study Number: 
Patient identification number for this study: 
 
                        CONSENT FORM FOR RESEARCH STUDY 
 
Title of Project: Palliative Care in Mesothelioma    -    Focus groups, Leeds 
 
Name of researcher: Dr Helen Clayson 
 
Please tick to confirm 
 
 I have read the information sheet for the above study 
 
 I have had the opportunity to ask questions about the study, and to discuss            
it with family and friends 
 
 I understand the purpose of the study and how I will be involved 
 
 I understand and accept that if I take part in this study I will not 
      gain any direct personal benefit from it 
 
 I understand that all information collected in the study will be held in confidence 
and that if it is presented or published all my 
 personal details will be removed. 
 
           I confirm that I will be taking part in this study of my own free 
     will, and I understand that I may withdraw from it at any time 
     and for any reason without my medical care or my legal rights 
     being affected. 
 
I agree to take part in the above study.     
                                       Signature:                                                           Date: 
 
                                      Countersigned:                                                    Date: 
 (person taking consent) 
         
          Researcher if different from above:                                                Date: 
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     APPENDIX 9: FOCUS GROUP SCHEDULE 
 
 
1. The time before the diagnosis 
  
Eg: Was this a worrying time for you?                                                    
Expand/clarify       
 
Eg: Were you aware of there being a high risk of mesothelioma?                     “ 
 
Eg: How informed were you about the situation?                                              “ 
 
 
2. The diagnosis 
  
Eg:  How were you informed of the diagnosis? 
 
Eg:  Could this have been handled better?                                                         “ 
 
Eg:  How much did you understand at that time? 
 
Eg:   Can you describe your feelings at that time?                                             “ 
 
Eg:  How did this affect your relative? 
 
Eg:  Who informed other family members? 
 
Eg: What was the impact on the family?                                                            “ 
 
 
3. Coping 
 
Eg:  Who or what helped you to cope?                                                               “ 
 
Eg:  Did anything or anyone hinder your efforts? 
 
Eg:  Was coping difficult?                                                                                   “ 
 
Eg:  What might have improved things for you? 
 
Eg:  How did the illness affect your social/family/marital life? 
 
4. The final stage 
 
Eg:  Were you prepared?  Expand/clarify 
 
Eg:  Could anything have improved the situation for you at that time?               “ 
 
Eg:  Were you aware of the procedures after the death? 
 
Eg:  If not, how and by whom should this information be given? 
 
Eg:  Was your relative aware of the procedures that would be necessary after 
his/her death? 
 
Eg:  What are your feelings about this?                                                                “ 
 
5.   Do you have any other important matters to raise that would improve the care of 
mesothelioma patients and their families? 
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Appendix 10: Invitation to healthcare professionals 
 
Header: my surgery or TPCC, University of Sheffield 
 
Dear Colleague, 
 
Re research project:  Palliative care in Mesothelioma – What are the needs of patients   and 
their families? 
 
 
I am writing to request your assistance with my study. In order to answer the research question I 
am using both quantitative and qualitative methods including interviews with Mesothelioma 
patients, focus groups of bereaved relatives of Mesothelioma patients, interviews with 
„stakeholders‟ ie professionals involved in the care of Mesothelioma patients and also reviewing 
the hospital and GP case notes of patients who died with Mesothelioma in the Furness area 
between 1997 and 2001. 
 
I would very much appreciate being able to interview you in view of your experience with these 
patients. The interview would take approximately 30 minutes and would be arranged at your 
convenience. For the purpose of the study the interview would be recorded onto mini-disc then 
transcribed by me .I understand that  health care professionals may have particular concerns 
regarding confidentiality and I can assure you that the study complies with the Data Protection 
Act. 
 
A full research proposal can readily be forwarded to you if you wish. 
I enclose a reply slip and sae and I do hope that you will be willing to contribute to this study. 
 
 
Yours sincerely 
 
 
Dr Helen Clayson 
---------------------------------------------------------------------------------------------------------- 
 
I do/do not agree to being interviewed by Dr Helen Clayson [delete as necessary] 
 
The most convenient time/s would be: 
 
Signed:                                                Please print name clearly: 
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Appendix 11: INTERVIEW SCHEDULE – STAKEHOLDERS 
 
1) CONTACT WITH PATIENTS 
Can you describe your contact with mesothelioma patients? 
What do you see as the main issues in caring for this group of people? 
Do you feel that this group of patients has any particular features compared 
with lung cancer patients? 
 
2) CONTACT WITH BEREAVED RELATIVES 
Do you have any contact with bereaved relatives of mesothelioma patients? 
If yes, has this influenced your practice in any way? 
If yes ,do you have a policy or routine for dealing with the bereaved 
relatives? 
Do you have any suggestions about the care of bereaved relatives? 
 
3) BEST PRACTICE 
How would you describe „best practice‟ in the care of mesothelioma 
patients? 
Are there any developments that you would like to see in this area? 
Do you perceive any difficulties in achieving „best practice‟ 
If yes, are there any factors which could be overcome to achieve the desired 
changes? 
Can you identify any other people or agencies that you feel should have 
more involvement in the care of mesothelioma patients or their families? 
 
4) CLINICAL TRIALS  
How do you feel about clinical trials in mesothelioma? 
Does this affect your practice with regard to recruitment to trials? 
Does the issue of trials pose any ethical dilemma for you? 
 
 
5)  AOB 
Are there any other issues re the care of mesothelioma patients or their 
families that you would like to raise? 
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Appendix 12: DATA ENTRY PROFORMA: MESOTHELIOMA 
NOTES SURVEY  
 
 
A :  Demography 
 
Unique identifier   
DOB d  m  y  
Gender M/F 
Marital status M/S/W/D/Cohabiting 
Post Code   
Occupation … 
GP Code  
Asbestos exposure  
Dates of exposure m  y ,    m  y  
 m  y ,    m  y  
 m  y ,    m  y  
 
Occupation/s when exposed … 
 
Smoking status Never/Ever smoked 
Number currently smoked/day  
Date smoking ceased d  m  y  
 
 
B  Disease presentation 
Onset of symptoms d  m  y  
Date of presentation d  m  y  
       to secondary care  
Mode of presentation … 
 
C  Investigations (enter no of times for each category and dates) 
CXR     Dates: 
Pleural aspiration     Dates: 
Biopsy: Needle    Dates:  
Open    Dates:             VATS  Dates: 
Biopsy site: Pleural  Lung  Peritoneal  
Metastasis   
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  Other  
CT scan  Dates:  
MRI scan    Dates:  
22(a) Other  
 
D  Confirmation of diagnosis 
Histology:  Epith     Sarc     Mixed     Other … 
Histology obtained by: Pleural fluid     Biopsy     PM     Other 
…  
Date of diagnosis d  m  y   
Date patient informed d  m  y  
Patient informed by … 
 
 
E  Recorded symptoms 
Pain   
Dyspnoea   
Weight loss  
Depression  
Anxiety  
Emotional distress   
Psychological  
Social problems   
Other major symptoms … 
 
F  Therapeutic interventions (enter no of times for each category nos 37 – 40)  
Pleural aspiration  Dates:… 
Pleurodesis  Dates:… 
Debulking  Dates:… 
Paracentesis  Dates:… 
 
Pain relief techniques: 
Tens  Dates:…       Intercostal  Dates:…      Paravertebral  Dates:.. 
Interpleural  Dates:…  Epidural  Dates:…     Intrathecal  Dates:… 
PCC  Dates:…     Other … 
 
Palliative chemo  Dates:… 
Chemo trial  Dates:…   
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DXT  Dates:… 
Curative surgery  Dates:… 
Palliative surgery  Dates:… 
Immunological Rx  Dates:…  
 
Palliative drug therapy: 
 
(a) Opiates  
            Types of medication: 
Date of 1st … : 
Max daily dose:  
               
              (b) Adjuvant analgesics  
 
             Types of medication: 
        Date of 1st … : 
              Max daily dose: 
 
              (c) Anti emetics  
              Types of medication: 
              Date of 1st …: 
              Max daily dose: 
 
              (d) Anxiolytics  
              Types of medication: 
              Date of 1st …: 
              Max daily dose: 
 
              (e) Anti depressants  
              Types of medication: 
              Date of 1st …: 
              Max daily dose: 
 
              (f) Other  
              Types of medication: 
              Date of 1st …: 
              Max daily dose: 
        
G.  Primary care episodes (12 months prior to death)  
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Consultations: 
Date Health Professional    
Consulted                         
Reason Action 
    
 
                                       
H.  Secondary care episodes 
 
     50:  OPD attendances 
Date Hospital Department Reason                                                  
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Admissions to hospital  
 
 
 
 
 
 
Admissions to Hospice 
Date Reason 
  
 
 
 
 
 
Day Care Yes/No/Not recorded 
 
Date    Reason Hospital    Dept                                                       
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I.  Referrals 
Respiratory Physician       
Oncologist        
Palliative Care Physician    
Radiotherapist      
Thoracic Surgeon 
58(a) Pain consultant      
Lung Cancer Nurse      
Macmillan Nurse      
Psychiatrist      
Psychologist      
Social Worker      
Support organisation       
  65  Other/s … 
 
J.  Co-morbidity 
 
 66 Other significant diagnoses 
 
Date diagnosed           Condition 
 
K.  Details of death 
 
67 Date d  m  y  
68 Place Home     Hospital     Hospice     Other 
… 
69 Referred to Coroner  
70 Date of PM d  m  y  
71 Date of Inquest d  m  y  
72 Outcome of Inquest … 
73 Details on death certificate: 
1(a):                             1(b):                    11: 
74   Mode of death: 
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Appendix 13: Oral presentations and publications 
related to the study 
 
Presentations 
 
7.3.2007 
Palliative aspects of mesothelioma care. Improving outcomes in Mesothelioma: 
The National Mesothelioma Framework. Leeds. 
 
3.3.2007 
Active symptom control and psychological aspects. European School of 
Oncology, Mesothelioma Conference. Brussels. 
 
20.10.2006 
Patients‟ and carers‟ experience of mesothelioma. Supportive care satellite 
symposium, 8th International Meeting of the International Mesothelioma Interest 
Group. Chicago. 
 
25.5.2006 
Experiencing mesothelioma: Palliative care needs of patients and their families. 
European Association of Palliative Care Research Forum, Venice. 
 
11.5.2006 
Mesothelioma from the patient‟s perspective. Clydeside Action on Asbestos 
Mesothelioma conference. London School of Hygiene and Tropical Medicine. 
 
8.5.2006 
Palliative care in mesothelioma. Lancashire and S Cumbria Cancer Services 
Network Mesothelioma Study Day. Preston. 
 
5.4.2006 
Palliative care service issues in mesothelioma. Palliative Care Congress. 
Sheffield. 
 
 
10.6.2005 
Mesothelioma and palliative care. Cancer Research Away Day. Sheffield. 
 
18.5.2005 
End-of-life care in mesothelioma. Mesothelioma: the silent epidemic. British 
Museum, London. 
 
9.3.2005 
End-of-life care. Mesothelioma Summit. BMA House, London. 
 
25.6.2004 
Mesothelioma from the patient‟s perspective. 7th International Conference of the 
International Mesothleioma Interest Group. Brescia, Italy. 
 
23.3.2004 
Palliative care research in mesothelioma: The experience of patients and their 
families. Mesothelioma: The silent epidemic. Newcastle. 
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31.10.2003 
Palliative care in mesothelioma: What are the needs of patients and their 
families. National Lung Cancer Forum for Nurses Conference. Edinburgh. 
 
 
16.1 2003 
Mesothelioma: The search for effective treatments. 
And 
Palliative care in mesothelioma: What are the needs of patients and their 
families? 
Mesothelioma Network Nurses Study Day. Sheffield 
 
22.3.2002 
Palliative care in mesothelioma: What are the issues? Mesothelioma: the silent 
epidemic. Lakeside, Cumbria. 
 
11.7.2002 
Palliative care in mesothelioma. Sheffield Palliative Care Studies Group 
Research meeting. Sheffield. 
 
22.11.2001 
Palliative care in mesothelioma: What are the issues? Lung Cancer Research 
Group, Leeds General Infirmary. Leeds. 
 
 
Publications 
 
Ahmedzai S A, Clayson H (2006) Palliative Care in Mesothelioma.  In: O‟Byrne K 
and Rusch V (eds) Malignant Pleural Mesothelioma.  Oxford: Oxford University Press, 
402-433 
 
Clayson H, Seymour J, Noble B (2005) Mesothelioma from the patient‟s 
perspective. Hematol Oncol Clin N Am 19:1175–1190 
 
Clayson H, Seymour J, Noble B, Bath P. (2003) Magic mineral to public health 
disaster. Eur J Pall Care, 10, 5. 
 
Suffering in mesothelioma: Concepts and constructs. (2003) Progress in 
Palliative Care, 11,(5):251-255 
 
 
 
 
 
 
 
